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ABSTRACT 
 
Alane Elizabeth Murdock: Breastfeeding and Contraceptive Use: Analysis of a Statewide 
Survey 
(Under the direction of Miriam Labbok) 
 
Combined estrogen/progestin contraceptive methods have a negative effect on 
breastfeeding duration when compared to progestin-only methods, non-hormonal 
methods or using no method.  These results suggest that combined hormonal methods 
should not be recommended to breastfeeding women.  This is consistent with current 
CDC recommendations and strengthens the evidence on which they’re founded because 
this study is recent, US-based, examined current contraceptive options, and controlled for 
confounding using up-to-date statistical approaches.  No effect of progestin-only 
contraceptive use on breastfeeding duration was found when compared to either non-
hormonal methods of birth control or using no method. These results are limited by the 
lack of information on the timing of initiation of use; in particular, we were not able to 
distinguish early use, i.e., immediate postpartum, from later use. Consequently, these 
results should not be interpreted to mean that progestin-only methods are compatible with 
breastfeeding, but rather that good information about the timing of use will be necessary 
to clarify the relationship between progestin-only contraceptive use and breastfeeding 
outcomes.  
Postpartum contraceptive use by women who initiated breastfeeding was found to 
be associated with maternal age, maternal educational attainment, race/ethnicity, first 
birth, infant NICU stay, and the number of breastfeeding-related hospital practices 
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experienced by the mother.  Differences in contraception use correspond to breastfeeding 
rates, suggesting that the issues may be related either with common etiology or by direct 
effects between them.  Pregnancy prevention may outweigh breastfeeding protection in a 
mother’s use of contraception after birth.  If so, accurate and available information about 
the impact of hormonal contraception on breastfeeding is need by these women, as well 
as having access to reliable and attractive contraceptive methods which are compatible 
with breastfeeding.      
Overall, these results highlight the importance of labor and delivery practices that 
allow and enable immediate breastfeeding initiation for long-term breastfeeding success.  
These results support the importance of the Ten Steps to Successful Breastfeeding for 
breastfeeding duration, and suggest that greater adoption of and adherence to this 
standard could improve breastfeeding outcomes.  
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SPECIFIC AIMS 
Breastfeeding and Contraceptive Use: Analysis of a Statewide Survey 
Breastfeeding and contraception are both important public health policy issues 
with personal and societal implications.  Breastfeeding is known to be associated with 
better short and long-term health outcomes for both mother and baby.  As such, 
improving breastfeeding initiation, exclusivity, and duration have been key goals of the 
Healthy People 2010 and 2020 initiatives in the United States (US). Fertility control also 
has important health implications, particularly in the postpartum timeframe when longer 
birth intervals reduce maternal mortality and morbidity and improve infant health. 
Furthermore, the 1994 International Conference on Population and Development in Cairo 
broke new ground by declaring access to voluntary family planning to be a human right, 
and critical for both individual and national development while noting the importance of 
breastfeeding for health.   
   The issue of hormonal contraception in the postpartum period, however, is 
controversial.  While there are frequently reported clinical observations of reduced milk 
supply when hormonal methods are introduced, this is not confirmed in research on 
progestin-only methods.  It is biologically plausible that synthetic hormones would 
interact with the physiological systems that support breastfeeding since progesterone and 
estrogen are involved in the development of the mammary gland, and its functions, 
including the onset of lactation.  Further, the US and International sources give 
conflicting advice based on the same exact research literature.  This project aims to 
 2 	  
contribute to this conversation by exploring the causal relationship between contraceptive 
use and breastfeeding duration in a US population.   
 
Specific Aims 
Aim #1: To evaluate the association between demographic, social, and healthcare 
factors and the likelihood of weaning.  
Hypothesis: Demographics, social factors, and healthcare practices experienced during 
labor and immediately postpartum are associated with the duration of breastfeeding.  
 
Aim #2: To assess whether there is an association between demographic, social, and 
healthcare factors and contraceptive use in the postpartum time frame.  
Hypothesis: There are associations between demographic and healthcare factors such as 
race/ethnicity, pregnancy wantedness, income, maternal age, education, and hospital 
practices, and the use of contraceptives, including the specific type of contraceptive used, 
in the postpartum time-period. 
 
Aim#3: To assess the impact of the postpartum use of progestin-only contraceptive 
methods on duration of any breastfeeding. 
Hypothesis: Women who use progestin-only contraception postnatally are more likely to 
cease breastfeeding than women who do not use contraception and women who use non-
hormonal methods of contraception. 
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Aim #4: To assess the impact of the use of combined progestin/estrogen 
contraceptive methods in the postpartum period on breastfeeding success, measured 
as the hazard of breastfeeding cessation. 
Hypothesis: Women who use combined progestin/estrogen contraception in the 
postpartum period are less likely to be breastfeeding at each time-point than women who 
do not use contraception, women who use non-hormonal methods, and women who use 
progestin-only contraception. 
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CHAPTER I: BACKGROUND AND SIGNIFICANCE 
 
Breastfeeding in the United States 
Breastfeeding is the optimum form of infant feeding according to the World 
Health Organization (WHO) and the American Academy of Pediatrics (AAP). (1,2) 
Research has revealed many short and long term health benefits for the baby and mother 
substantiated in the research literature. (3) Exclusive breastfeeding is recommended for 
the first six months of life with continued breastfeeding afterwards by the AAP and 
WHO. The Healthy People 2010 initiative of the US Department of Health and Human 
Services set a goal for the country of at least 75% breastfeeding initiation and at least 
50% breastfeeding continuation at 6 months. (4) By 2010, 76.9% of infants had ever been 
breastfed and 47.2% were nursing at six months, nearly meeting the Healthy People 2010 
target. (5) However, only 16.3% were breastfeeding exclusively at six months, the 
recommendation from the WHO and AAP. Healthy People 2020 set new goals for 
breastfeeding over the current decade including an 81.9% initiation rate, 60.6% 
continuation at six months, and 25.5% exclusive breastfeeding at six months. (6) To meet 
these ambitious targets new programs and policies will be needed. This project aims to 
inform that process by providing up-to-date information about breastfeeding and 
contraceptive use in the United States.  
Breastfeeding has been shown to have a profound effect on short and long-term 
health for mother and infant.  Breastfed infants have lower rates of a wide range of 
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illnesses including ear infections, bacterial meningitis, urinary tract infections, intestinal 
infections, diarrhea, and childhood cancers. (7-15) Lower rates of sudden infant death 
syndrome, asthma, obesity, and diabetes are also seen in children who are breastfed. (16-
24)  Childhood cognitive development may also be enhanced by breastfeeding. (25-27)    
Mothers also experience better immediate and long-term health outcomes from 
breastfeeding.  Women who breastfeed experience less postpartum bleeding and are less 
likely to have delayed uterine involution. (28) They also have lower rates of breast and 
ovarian cancer and fewer hip fractures and osteoporosis later in life. (29-33)  Therefore, 
the impact of low rates of breastfeeding on long-term health for individuals and on 
healthcare costs as a nation is large. (34) Infant morbidity and mortality related to the low 
prevalence of meeting the 6-month exclusive breastfeeding recommendations of the 
American Academy of Pediatrics, alone, is estimated to cost the United States $13 billion 
annually. (35) It is well substantiated that breastfeeding has far-ranging effects on the 
immediate and long-term health of women and children, and a large impact on our 
healthcare system and economy.   
However, research on breastfeeding has suffered from issues of data quality and 
selection bias.  Study questions related to breastfeeding are often over-simplified, missing 
variability in behavior such as exclusivity and intensity.  The ability to breastfeed could 
be a proxy for better health, economic, or social factors.  Distinguishing the direct effect 
of breastfeeding from the effect of being the type of parent or family that can breastfeed 
has also made it difficult to isolate the impact of breastfeeding itself from the context of 
successful breastfeeding. Ethical and human subjects issues make many study designs 
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meant to address this problem, such as performing a randomized controlled trial (RCT), 
inappropriate and impractical.    
Family Planning 
At the International Conference on Population and Development (ICPD) in Cairo, 
the world community set a goal of “universal access to reproductive health” including 
family planning.  They identified voluntary family planning as a central component of 
human rights and of national development, and highlighted the fact that family planning 
is one of the most cost effective ways to combat poverty.  Still, studies funded by the Bill 
and Melinda Gates Foundation estimated that, as of 2009, more than 200 million women 
around the world lacked access to modern methods of contraception, and predicted that 
by 2050 this would increase by 40%. (36,37)  
Family planning has been in the forefront of public health in the US for a century.  
In its list of “10 great public health achievements of the 20th century,“ the CDC cited 
family planning as one of the top accomplishments. They say, “…smaller families and 
longer birth intervals have contributed to the better health of infants, children, and 
women, and have improved the social and economic role of women.” (38)  
Still, the rate and number of unintended pregnancies in the US are high and there 
is wide variation in prevalence by demographic factors such as race and education.  
Analysis by Finer and Henshaw showed that between 1994 and 2001, the rate of 
unintended pregnancy among white women was 35 per 1,000 births, while among black 
women it was 98 per 1,000 and among Hispanic women, 78 per 1,000. (39)  Education 
also strongly predicted unintentional pregnancy, with a rate of 26 per 1,000 for women 
with college degrees, and 76 per 1,000 for women without a high school degree. 
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Contraceptive use follows similar racial and education patterns and is thought to be a 
response to and a cause of these differences. (40) Thus, there is an unmet need for 
contraception in the US that varies by race and education, but is present to some degree 
for women of all demographic backgrounds. Trussell et al. estimate that the annual cost 
of unintended pregnancy in the US is $4.5 billion. (41) 
Postpartum contraceptive use has a significant contribution to this issue. (42)  
Truitt et al. note, “Each year over 100 million women make decisions about beginning or 
resuming contraception after childbirth.” A woman’s decision-making concerning 
contraception may shift at this time as her priorities adjust with the birth of a child. New 
considerations and goals may cause her to reevaluate her previous choices.  Further, her 
access to medical care might change, making contraception more or less available than 
before. Thus, accurate information, specific to the health and social issues at this stage is 
needed by women in the postpartum.  
The public health implications of postpartum family planning are also important 
since the length of the inter-birth interval has serious implications for both maternal and 
infant health.  Women with short birth intervals, less than six months, were found to have 
higher risk of maternal mortality (odds ratio (OR) 2.54; 95% confidence interval (CI) 
1.22-5.38), third-trimester bleeding (OR:1.73, CI: 142-2.24), premature rupture of 
membranes (OR: 1.72,  CI: 1.53-1.93), puerperal endometritis (OR:1.33, CI:1.22-1.45), 
and anemia (OR:1.30, CI: 1.18-1.43). (43)  Among women with previous Cesarean 
deliveries, birth intervals of less than 18 months were associated with a higher risk of 
uterine rupture, 2.25% vs. 1.05% for intervals of 19 months or longer. (44)  
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While there are contraceptive methods compatible with lactation, such as barrier 
methods or the Lactational Amenorrhea Method (LAM), many women require or prefer 
to use other forms of contraception including hormonal contraception in the early 
postpartum time frame. (45-47) Thus, accurate information about the compatibility of 
specific contraceptive methods and breastfeeding is needed for these women to make 
informed choices about both.  
 
Maternal Anatomy and Physiology of Breastfeeding 
The breast contains the mammary gland and associated structures including 
muscle, nerves, blood supply and connective tissue.  Milk is produced in the alveoli, 
structures lined with columnar epithelial cells producing the milk. Each alveola is a sac 
for collection of the milk and is connected to a ductule. The ductules connect to a larger 
duct known as the lactiferous sinus, or milk duct, which aggregates milk from many of 
these ductile tributaries until they reach the nipple where about seven to twenty milk 
ducts provide milk to the infant during suckling. (48,49) 
Hormones play an important role in breast development and lactation, including 
mammogenesis, lactogenesis, galactopoiesis, and involution.  As an organ, the mammary 
tissue of the breast is unusual in that it remains only partially developed into adulthood. 
(50) In response to the hormones of pregnancy, the mammary gland completes its 
development in preparation for lactation. (51) Estrogen and progesterone, two of the 
central mediators of the menstrual cycle, are key hormones during pregnancy; the 
elevated serum levels of these two hormones are necessary to maintain the pregnancy, 
changing over the course of pregnancy. (49) In the mammary gland, estrogen causes the 
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milk ducts to proliferate and differentiate while progesterone increases the number of 
alveoli, which are foci of milk production. (52) This proliferation of the mammary gland 
cells also works in concert with adrenocorticotropic hormone (ACTH), growth hormone 
and prolactin to increase breast size during pregnancy. (51,53) Placental lactogen 
influences growth of the areola, the darker skin around the nipple, and prolactin affects 
nipple growth. (53) Thus normal breast development during pregnancy relies on a variety 
of hormone signaling pathways and interactions. 
Prolactin plays a central role in the mammary gland transition from pre-lactation 
to the onset of lactation known as lactogenesis. During pregnancy, prolactin levels rise 
from a pre-pregnancy level of about 10-20 ng/ml to about 200-400 ng/ml at the end of 
pregnancy. (54) Angiotensin II, gonadotropin-releasing hormone (GnRH) and 
vasopressin stimulate the anterior pituitary to release prolactin.  Another hormone, 
prolactin, which is associated with milk production, is present throughout pregnancy. 
However, prolactin’s effect on milk production is inhibited in three ways during 
pregnancy, delaying copious milk production until after birth.  
First, high serum progesterone levels during pregnancy act on the alveolar cell 
receptors and selectively inhibit prolactin’s action at this site. (55-57) The inhibitory 
effect is so strong that the presence of retained placental fragments after birth is enough 
to delay or inhibit lactation. (58) Hartmann showed that Lactogenesis II could be blocked 
in sheep by artificially keeping progesterone levels high after birth, suggesting that 
exogenous progesterones might be capable of inhibiting lactation in humans as well. (55) 
Progesterone is also implicated in closure of the tight junctions in the alveolar cells.  The 
removal of progesterone after birth, coupled with the presence of glucocorticoids, closes 
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the tight junctions between the lactocytes and allows the milk products to be retained in 
the alveoli for release during suckling.    
Second, high estrogen and progesterone levels act on the anterior pituitary to 
suppress prolactin secretion. And third, human placental lactogen (HPL), released by the 
placenta, competes for prolactin receptors in the alveolar cells, the milk production cells, 
preventing prolactin from binding to its signaling pathway. (59) This is why steroid 
hormones were given to women in the past, before the side effects were fully understood, 
as an effective means to prevent their milk from coming-in and reduce the associated 
engorgement of not breastfeeding. (42) 
After birth, delivery of the placenta in the final stage of labor leads to a rapid 
decline of progesterone levels, a ten-fold decrease in the first four days postpartum. This, 
in turn, removes the inhibition of the alveolar cell receptors, allowing prolactin to signal 
milk production in these cells. It follows that the second stage of lactation, lactogenesis 
II, the onset of copious milk production that is colloquially known as the mother’s milk 
‘coming-in,’ occurs during this time frame, between 36 and 96 hours postpartum. (60,61) 
Likewise, the drop in progesterone after birth (Figure 1, as illustrated in a rat model) 
releases the anterior pituitary from its inhibiting effect, allowing the baseline prolactin 
secretion to be superimposed by a distinctive, pulsatile prolactin release which occurs 7 
to 20 times a day primarily in response to feeding, with higher levels released during 
sleep. (62) Moreover, the drop in human placental lactogen (HPL) after delivery of the 
placenta releases prolactin receptors in the breast from competition by HPL, allowing 
prolactin to act freely on its signaling pathway.  
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Lactogenesis II is a function of endocrine influence, i.e., it relies on hormones 
released at one site acting on another site in the body through bloodstream transport. Put 
another way, breastfeeding establishment is hormonally driven. (64,65) It follows that 
milk ‘coming in’ is primarily a response to hormonal changes and not a response to 
suckling. (64,65) However, without frequent early breastfeeding and related breast 
stimulation, lactogenesis II is delayed. (64)  Later in lactation, after four to six weeks, 
signaling shifts to an autocrine system, i.e., signaling by a cell that acts on the same cell. 
At this stage, milk production is driven by milk removal and sensory stimulation. (49,66) 
Thus, many women experience a change between the initiation phase of nursing and 
onset of galactopoiesis, the maintenance stage, by about 6 weeks, with the early weeks 
marked by a sense of heightened responsiveness and perhaps fragility that gives way to a 
more stable and resilient system somewhere between 6 and 8 weeks postpartum. This 
shift follows the transition from endocrine signaling to apocrine signaling.  
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Figure 1: 
(63) 
 
During lactation maintenance, galactopoiesis, prolactin secretion depends on 
suckling stimulus and regular emptying on the breast. (51) Prolactin release from the 
anterior pituitary is controlled by inhibition from the hypothalamus, i.e., when this 
inhibition is released, the anterior pituitary releases prolactin. Nipple stimulation and 
removal of milk from the breast inhibits the hypothalamus from releasing dopamine, a 
prolactin inhibitory agent. (67) The drop in dopamine allows the release of prolactin, 
which then leads to milk production. In the normal breastfeeding process, prolactin levels 
in the blood rise and fall in relation to the frequency, duration, and intensity of nipple 
stimulation, peaking about 45 minutes after nursing. (68) It has been shown that the 
neurological input that results from nipple and areolar stimulation, prolactin levels do not 
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rise. (69) Even midway through the first year of life, prolactin levels have been shown to 
increase two-fold after nursing. (70) 
Many factors have been shown to be associated with prolactin levels in nursing 
mothers. Prolactin increases with the number and intensity of feedings, and the surges are 
higher when more than one child is being nursed. (54,71,72) Prolactin follows a circadian 
rhythm with the highest response levels seen at night. (49) Prolactin levels are higher in 
amenorrheic women and lower in depressed women. (70,73) Prolactin is also negatively 
affected by smoking. (74) Average levels decline over the duration of breastfeeding, but 
remains elevated as long as the mother breastfeeds. (70,71,75) The prolactin levels at 10 
days postpartum average about 90 ng/ml and at 180 days are 44.3 ng/ml. (70)  
  Effective prolactin signaling is essential for initial milk production; without it, 
breastmilk production is not stimulated. (76) Therefore, it is theoretically feasible that 
introduction of synthetic hormones, such as those used for hormonal contraception, could 
interfere with the hormonal drop-off necessary for milk production, undermining 
breastfeeding. Since prolactin regulation is hormonally driven during breastfeeding 
establishment, there is heightened concern over the use of hormonal contraception in the 
early postpartum when endocrine pathways predominate for breastfeeding signaling. 
Concerns remain, however, even during galactopoiesis since inhibition of prolactin by 
estrogen and progesterone is still possible.    
Another potential point of interaction between exogenous hormones and the 
breastfeeding mechanism is the prolactin receptor (PrlR) on the cell surface of lactocytes. 
Binding of prolactin to the PrlR receptor starts a signaling cascade, which leads to 
expression of genes that promote milk protein synthesis. PrlR is up-regulated in 
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lactocytes at birth and with lactogenesis II, increasing the number of receptors available 
for prolactin binding.  Zuppa et al. showed that multiparous women had lower serum 
prolactin levels than primiparous women in the first 4 days after birth, but the infants of 
multiparous women received more milk. (77) They concluded that the multiparous 
women must have higher numbers of PrlR receptors, enabling stronger cell signaling with 
less prolactin.  The implication is that the number of PrlR receptors not the serum 
prolactin level determines the milk output. This is consistent with the decrease in 
prolactin over time and with the finding that prolactin levels are not linked to milk yield. 
(70,71,78,79) If the increase in the number of prolactin receptors that occurs in the 
immediate postpartum is important to milk supply throughout breastfeeding, then 
disruption of this up-regulation, to the extent that it is unique to this time-frame, could 
cause lasting damage to the milk production signaling pathway. High progesterone levels 
during pregnancy suppress the up-regulation of prolactin receptors in lactocytes. (80) 
Therefore, the effect of high postnatal progesterone levels due to early use of hormonal 
contraception should be examined as a potential inhibitor of prolactin receptor 
proliferation during lactogenesis II.  
Glucocorticoids also play an important role in lactogenesis II and galactopoiesis, 
and may interact with synthetic hormones from contraceptives. The primary 
glucocorticoid in humans is cortisol, which increases five-fold during pregnancy. 
(51,66,81) However, it is bound by corticosteroid binding globulin (CBG), which keeps 
the levels of bio-available cortisol low. (51,81) CBG decreases around birth, allowing an 
increase in serum cortisol levels at this transition point. Glucocorticoids regulate the 
permeability of tight junctions between lactocytes; closure of these junctions is a critical 
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step in lactogenesis II. (82) They also prevent involution and apoptosis, the processes of 
dismantling the breast tissue that occurs as a result of weaning, during on-going lactation. 
(83,84) Glucocorticoids also work synergistically with prolactin to enable synthesis of 
milk proteins by turning on transcription of milk protein genes in the lactocyte nucleus. 
(85-87) 
Progesterone binds the glucocorticoid receptor, although with lower affinity than 
cortisol itself.  This competitive inhibition may be the mechanism by which progesterone 
inhibits milk production during pregnancy. (88-90) High levels of progesterone during 
pregnancy out-compete cortisol for the receptor site because serum cortisol levels are 
held in check by CBG, thus inhibiting cortisol’s milk production effects. Around birth, 
CBG levels fall, releasing cortisol and making higher concentrations available in the 
blood.  With the dramatic decline of serum progesterone after birth, the balance of 
competition for the glucocorticoid receptor site shifts in favor of cortisol, and milk 
production is released. Exogenous progesterone, as from contraception, could compete 
with cortisol for these receptor sites at any time during lactogenesis II or galactopoiesis, 
inhibiting milk production.  
Estrogen, too, has been shown to impact lactation; in humans it is considered a 
potent inhibitor of milk production based on clinical reports. (91-95) In some animal 
models, estradiol increases milk production by reducing inhibition of prolactin 
production in the anterior pituitary.  In rats, this is accomplished by reducing the number 
of prolactin receptors on the lactotroph.  With fewer prolactin receptors, the lactotroph’s 
response to circulating prolactin is muted allowing it to continue producing prolactin in 
spite of circulating prolactin levels. (96) It is not known whether this is also true at the 
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level of the anterior pituitary in humans.  However, the literature suggests that in at least 
some women estrogen can suppress milk production.  Moreover, in the first days after 
birth, the blood brain barrier in infants is partially open, theoretically allowing synthetic 
hormones that pass through the mother’s milk to expose the infant brain with exogenous 
hormones to unknown effect. (97) 
Based on the clinical observations and the biological plausibility of the underlying 
biological processes, it is reasonable to question what effect hormonal contraception 
might have on breastfeeding. In The Textbook of Human Lactation, Hale and Hartman 
say, “In all species…progesterone withdrawal is essential for initiation of lactation.” (p. 
99) (48) What then happens if synthetic progesterone in the form of hormonal 
contraceptives is given to breastfeeding women, and is there a critical window during 
which these exogenous agents alter the course of breastfeeding, and another window in 
which there is no impact? Likewise, how do exogenous estrogens affect lactation success, 
and do all forms of contraception that include estrogen have the same effect on 
breastfeeding? 
 
WHO AND CDC GUIDELINES FOR CONTRACEPTIVE USE 
The WHO addressed the question of contraceptive use during lactation when it 
produced the first Medical Eligibility Criteria (MEC) for Contraceptive Use in 1996. (98) 
The latest WHO MEC, the fourth edition, was released in 2009 and includes more than 
1800 specific recommendations for 18 contraceptive methods and more than 160 medical 
conditions. (99,100) From the start, the WHO partnered with the Division of 
Reproductive Health of the US Centers for Disease Control and Prevention (CDC) to 
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identify and evaluate the available literature and synthesize the data to be used as the 
foundation of the guidelines. An on-going system to identify new, relevant research 
called Continuous Identification of Research Evidence (CIRE) was developed by the 
WHO, CDC and Johns Hopkins University in 2002, and allows the guidelines to be 
updated as new information becomes available.  Until 2010, the US never formally 
adapted the WHO MEC for use in the United States, rather leaving it to training 
programs, courses, and organizations to establish their own standards based on the 
international consensus.  
In the CDC’s adaptation of the 2009 WHO MEC, the same 1-4 safety rating given 
in the WHO guidelines are used, adjusting only a small number of recommendations in 
light of US-specific conditions or new evidence that had become available after the WHO 
developed its guidelines. In June of 2008, the CDC convened a panel of 8 family 
planning experts to select areas of the WHO MEC for adaptation to the US, preserving 
the WHO guidance, “…except when a compelling reason existed for adaptation…” (99) 
In addition to removing sections for practices and drugs not used in the US, six topics 
were chosen for consideration for adaptation to the US setting, including contraception 
during lactation. Of the approximately 23 adaptations made to the WHO MEC, eight 
were for contraceptive use during lactation.  The WHO and CDC guidelines were based 
on the same scientific literature, but came to different conclusions, with the CDC 
consistently down-grading the safety guidelines for hormonal contraceptive use by 
lactating women (Appendix C). Notably, seven of the eight changes shifted the guidelines 
from category 3 to category 2, i.e., from, “3= A condition for which the theoretical or 
proven risks usually outweigh the advantages of using the method,” to, “2=A condition 
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for which the advantages of using the method generally outweigh the theoretical or 
proven risks.”  (99,100) 
Soon after release of the CDC MEC, the WHO released revised recommendations 
based on a literature review that revealed an increased risk of venous thromboembolism 
in women who used combined hormonal contraception in the first 42 days postpartum. 
The WHO’s update applied to non-breastfeeding women only since the recommendations 
for breastfeeding women already advised against use of these methods in this time period. 
This update from the WHO led the CDC to update the US MEC, matching the WHO 
guidance on combined hormonal contraception in the early postpartum for all women. 
(101)  Then in June 2013, the CDC released an updated MEC clarifying that use of 
Progestin-only contraception in the immediate postpartum period is acceptable for 
breastfeeding women. (102) 
 Observation from clinical practice, however, suggests that use of contraceptives in 
accordance with these guidelines will interfere with lactation.  Dr. Ruth Lawrence, author 
of the seminal textbook on lactation, sums up this perspective in a recent editorial, “The 
breastfeeding community has struggled with the question of early use of 
medroxyprogesterone (Depo-Provera, Pfizer, New York, NY) and the suppression of 
lactation. Simple principles of lactation would suggest the use of medroxyprogesterone is 
detrimental when it is the physiologic decrease in progesterone with the passage of the 
placenta that initiates lactation…The question remains to be solved in the clinical 
laboratory and the peer-reviewed literature.”  (p 1)(103) However, these clinical 
observations have not been validated in the scientific literature, nor could they be, since 
studies have not been carried out in a US context to address this controversy. Thus, the 
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issue of whether and when hormonal contraceptives are compatible with lactation has still 
not reached a consensus between the breastfeeding and family planning communities. 
 This project hopes to further that conversation by providing additional evidence on 
the associations between postpartum contraceptive use and breastfeeding duration and 
analysis of a causal link between progestin-only methods or combined estrogen/progestin 
methods and breastfeeding duration.     
 
Summary of the Current Literature on Hormonal Contraceptive Use and Lactation 
 
To establish the current state of knowledge on hormonal contraception and 
breastfeeding, relevant articles from several sources were gathered. First, since this 
project is largely a response to the current WHO and US guidelines for contraceptive use 
during lactation, any study in humans that was used as a basis for the WHO MEC and US 
MEC was included. (98,99) In additional, papers reviewed in each of three current review 
articles were included. (104-107) Lastly, to ensure that this document is up to date, 
specific recent papers not mentioned elsewhere were included. The results are 
summarized by type of hormonal contraceptive in Appendices 1 and 2. Single studies 
often evaluated more than one type of hormonal contraception, and therefore, are 
represented in every section for which they are relevant, creating some redundancy 
between sections. A summary and evaluation of the findings follow. 
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Combined Hormonal Contraception (CHC) 
The CDC identified 10 relevant papers addressing combined hormonal 
contraception and breastfeeding in its review of literature for the WHO MEC.  However, 
in the documentation in the MEC they write: 
 
“Evidence: Clinical studies demonstrate conflicting results regarding 
effects on milk volume in women exposed to COCs during lactation; 
however, no consistent effects on infant weight have been reported.(133-
142) Adverse health outcomes or manifestations of exogenous estrogen in 
infants exposed to combined contraceptives through breast milk have not 
been demonstrated; however, studies have been inadequately designed to 
determine whether a risk of either serious or subtle long-term effects 
exists.” (98) 
 
 
In spite of the potential negative effects on breastfeeding, a report from 1994 showed that 
many breastfeeding mothers in that era strongly preferred to use combined hormonal 
contraceptives. (108) It is not known whether today’s mothers have the same preference, 
and given the greater public awareness of the benefits of breastfeeding for both mother 
and baby, extrapolation from 1994 is limited. However, many of the reasons cited by 
mothers in 1994 are still relevant today: familiarity with the method, beneficial effects for 
menstrual cycling, and control of bleeding. CHCs, then, remain an important part of the 
contraceptive options still considered by breastfeeding mothers. In their review of the 10 
articles used for the WHO and CDC MECs, Kapp and Curtis say, “the body of evidence 
pertaining to the use of combined contraception during lactation is limited and largely of 
poor methodological quality and includes only oral formulations.” (p 12) (104)  
The WHO identified four studies that used full or partial randomization.  
According to Kapp and Curtis, two of these were of poor quality and the other two, which 
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were only fair quality, had conflicting results. The RCTs done by Kaern and by Miller 
and Hughes were both deemed to be poor quality because they failed to show how they 
randomized their treatment. Miller and Hughes saw marked differences in breastfeeding 
duration between COC users and non-users, as well as, lower infant weight gain and a 
need for supplemental calories around four to five weeks in this group.  However, the 
paper did not specify important information needed to evaluate the findings such as how 
the subjects were randomized, what statistical tests and values were used, and blinding 
and allocation techniques which together make their results unreliable.  Kaern also found 
a statistically significant difference in supplementation among women who received 
COCs from one to eight days postpartum, but contrary to their findings, concluded that 
lactation was not inhibited. They followed their subjects only until discharge at eight days 
postpartum, however, and provided very limited study details and statistics, again making 
it difficult to draw reliable conclusions from their work. 
The results of the study by Guiloff et al. are questionable because they used the 
woman’s previous breastfeeding duration, recalled at the time of the referent 
breastfeeding experience and contraceptive intervention, as the control for her current 
duration.  Work by Zuppa et al. on prolactin levels provides one possible explanation as 
to why this is a poor control (77); multiparous women were found to have lower prolactin 
levels in the first days postpartum, but to have more milk than primiparous women.  
Another major problem is recall bias in women’s report of past breastfeeding duration.  
Other studies have found longer breastfeeding durations with subsequent children; this 
means that the Guiloff study found similar breastfeeding durations between groups for 
which different durations were expected. 
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Two studies from the same research group in Chile were found to be of fair 
quality by Kapp and Curtis. (109,110) Croxatto and Diaz used a partially randomized 
study design to examine COC use beginning at 30 days postpartum.  In both cases, they 
found that the COC group had significantly higher rates of breastfeeding cessation and 
lower infant weight than the non-hormonal control group.  However, the women in their 
studies were allowed to choose whether to receive treatment, that is, the control group 
was selected from only those women who were willing to use lactation for pregnancy 
prevention, but the treatment group included women who were not willing to rely on 
lactation for contraception.  Since the study subjects were not truly randomized, the 
treatment and control groups could have been different on relevant covariates, but no 
adjustment was made for confounding. 
An RCT carried out by the WHO in Hungary and Thailand had a strong multi-
center design, but failed to address confounding. (111) They found differences in milk 
volume and mineral and fat content for COC users, but no difference in infant weight, 
length, rate of growth or illness.  They also saw no effect on breastfeeding cessation.  
However, they did not address supplementation, and in settings where breastfeeding is 
normative, supplementation may be the more logical relevant place to observe impacts on 
breastfeeding.  Since this study, with a strong RCT design, found differences in the 
quantity and quality of the milk, it substantiates that COC use can affect breastmilk. The 
lack of effect on infant growth may be more context specific, and it may not be the best 
measure of breastfeeding success since infants supplemented with formula may not grow 
differently.  Without information on supplementation, it is impossible to know whether 
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the intensity of breastfeeding is affected or whether supplementation is normative in these 
settings.    
A study carried out at a US Military hospital in Germany is perhaps most 
interesting not for its results, but for the commentary by the author. (92) He says, “There 
were some apparently well-motivated patients, who seemed to have lactation suppression 
from the pills and were unable to breast feed more than from 1 to 5 weeks.” (p 102) 
Among breastfeeding women, 54% of the COC group was still nursing at 6 weeks, 
compared to 59% of the control group.  Likewise, 25% of COC users cited decreased 
milk supply as their reason for stopping compared to 13% of the control group. In spite of 
this, the author concludes that there was no suppression of lactation from COCs.  
Similarly, a retrospective cohort study from Sweden reported no detrimental effects of 
COC use while breastfeeding because they found no differences in number of serious 
illnesses or in school performance up to age 8 between COC users and non-hormonal 
controls. (112) However they did find that the mean duration of breastfeeding was shorter 
in the COC group than controls, 3.7 vs. 4.6 months. Lastly, another study based in Chile 
found lower rates of exclusive breastfeeding with COC use, and lower infant weight gain 
at 4 months, a time when many dyads experience a need for increased milk supply. (113) 
However, like the other studies discussed here, no adjustment was made for confounding, 
making the results difficult to interpret. 
Taken together, the work to date on COCs and breastfeeding suggests a negative 
effect on milk supply, but the literature is impaired by study design and lack of 
adjustment for confounding.  All of the non-RCT studies failed to address confounding in 
any way. Since the RCTs rely on robust randomization to address this issue, the lack of 
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clarity about methods and success in the randomization process calls into question 
whether confounding can be ruled out in these studies. Indeed, in several cases, subjects 
were allowed to de facto pick their treatment by choosing their mode of hormone 
delivery.  To the extent that differences between women correlate with their choice of 
mode of contraceptive delivery, the RCTs would be compromised. All in all, there is still 
a need for well-designed research on the topic.  
 
Progestin-only Contraception (POC) 
 There are considerably more studies available on the effects of progestin-only 
contraception (POC) on breastfeeding, perhaps reflecting the belief that POCs are the 
preferred type of contraception to use while breastfeeding and the fact that a variety of 
methods of POC are available, utilizing different active ingredients and delivery systems.  
The WHO MEC is based on 36 studies in humans; the review by Kapp, Curtis, and 
Nanda includes an additional 5 human studies included in this summary of the literature, 
and several additional papers specifically suggested for inclusion have been incorporated 
as well.  
 
Progestin Vaginal Ring (PVR): Five articles that explored the impact of using a 
progestin releasing vaginal ring while breastfeeding were identified and reviewed. (114-
118) All of the studies involved initiation of use between four and nine weeks 
postpartum.  All five of the studies found use of the PVR to be compatible with 
breastfeeding. (118)  Two found that PVR users had better breastfeeding outcomes than 
users of non-hormonal IUDs.  However, issues common to the topic area were also a 
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problem in this part of the literature, namely, inadequate handling of confounding and a 
failure to standardize treatment.  The work by Diaz et al. used a historical control in 
which a women’s report of previous breastfeeding outcomes were used as the control 
group for her outcome in the study.  This is problematic due to recall bias in reporting of 
earlier breastfeeding experiences, and because key breastfeeding outcomes generally 
improve with parity.  (114) The multi-center work by Sivin et al. showed marked 
differences between centers at baseline, but did not address this potential confounding in 
their analysis. (118)  Shaaban et al. did not report their baseline characteristics, and also 
did not attempt to control for confounding in their analysis. (117)  The two papers by 
Massai et al. had limitations in their design.  The 1999 study had a very large window 
postpartum for initiation of use, five to nine weeks, and also might have included repeat 
reporting. (115) The 2005 study compared different regimens of treatment, but lacked a 
non-hormonal control. (116) Taken as a group, the findings of these five papers show a 
consistent trend towards compatibility of use for initiation during breastfeeding in the 
second and third months postpartum.  However, there are significant concerns about the 
reliability of the findings. 
    
Progestin-releasing IUD: The recommendations given in the WHO MEC for postpartum 
use of intrauterine devices (IUD) for contraception for both breastfeeding and non-
breastfeeding women are based on 25 papers on IUD use in the postpartum window. 
(98,101,119) None of these papers focus on breastfeeding as an outcome, rather they are 
primarily concerned with the safest time for insertion to avoid expulsion, infection, and 
uterine perforation.  While these issues are important for the mother’s health and for her 
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contraceptive efficacy, they do not inform a conversation about the effect of exogenous 
hormones on lactation initiation and success. Indeed, while the WHO does not 
recommend insertion of a progesterone releasing IUD until at least 4 weeks postpartum, 
they do not cite any papers to substantiate this decision. In their adaptation of the WHO 
guidelines, the CDC classifies insertion of the levonorgestrel-releasing IUD, known by 
the brand name Mirena, immediately after delivery of the placenta as being acceptable 
(level 2) for breastfeeding women. They too cite no papers on which they based this 
recommendation. In addition to concerns about the unknown effect of exogenous 
hormones in the immediate postpartum time period, are concerns about whether the 
stronger uterine contractions experienced by breastfeeding women could cause expulsion 
of the device.  
A search on PubMed using similar search words as employed by the WHO in 
their review of the relevant literature on combined hormonal contraception and progestin-
only contraception identified three papers with primary research on hormone containing 
IUDs and breastfeeding. Shaamash et al. executed a randomized controlled trial (RCT) 
comparing the Mirena IUD and Copper T (Cu T380A) IUDs and found no difference 
between the two groups in their exclusivity or continuation rates, nor the number of feeds 
per day. (120) However, a review of their results across four time-points in the first year 
shows that, in every instance, the Mirena IUD had worse breastfeeding results than the 
Copper T, a picture that would be consistent with a reduced milk supply.  For example, 
the Mirena group had more episodes of breastfeeding at each time point, and higher rates 
of partial breastfeeding at three and six months, a time frame when exclusive nursing is 
recommended.  The Mirena group had higher weaning rates and lower cumulative 
 	   27 
continuation rates throughout the year. What makes these trends worrying in spite of their 
lack of statistical significance is that the breastfeeding rate in this population far exceeds 
the US breastfeeding rate and population health is dependent on breastfeeding for both 
infant and maternal health.  Sixty percent to 80% of women in this part of Egypt are 
nursing at 1-year, compared to just 25.5% in the US. (5,121) Indication of challenges in a 
population where breastfeeding is normative, even weak indications, might be a sign of 
issues that would have a far greater impact on breastfeeding outcomes and the related 
ramifications for population health in the US setting.  For example, if Mirena put 
downward pressure on the milk production pathways, the result of this challenge would 
be slight in a population with frequent nursing, little mother-baby separation, and strong 
social support for breastfeeding continuation.  Whereas the same downward pressure 
could have a large impact in a setting where increasing the frequency of feeding is neither 
practical nor socially supported.  Thus, the population differences between nursing 
behavior in Egypt and the US make generalizing the results of the Shaamash et al. RCT 
to the US setting difficult.  
The study by Chen et al. in Pittsburgh is more readily generalizable to the US 
setting.  In their RCT of Mirena insertion timing, they compared postplacental insertion, 
i.e., within 10 minutes of delivery of the placenta, to delayed insertion, i.e., six to eight 
weeks postpartum. They showed effective randomization with the two groups having 
similar social and demographic characteristics, and slightly higher breastfeeding initiation 
rates among the postplacental group, 64.0% vs. 58.7%. The median duration of 
breastfeeding however, was significantly different, 5 weeks for the postplacental group 
(range 0.5-27 weeks) and 8.5 weeks for the delayed insertion group (range 0.1-43 weeks). 
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More women in the delayed group continued to breastfeed at 6-8 weeks, three months, 
and six months postpartum, and these differences were statistically significant at 6 
months (p=0.02).  These trends held when only those who initiated breastfeeding were 
analyzed and when only primiparous women were included. These results suggest that 
hormonal exposure in the immediate postpartum has negative effects of breastfeeding 
when compared to later exposure. Their study was not designed to reveal whether 
hormonal exposure in general is deleterious to breastfeeding, though comparison between 
the groups gives some indication of the hormonal /non-hormonal effects in this time-
frame. Overall the findings are consistent with the understanding that progesterone 
signaling in the immediate postpartum can be disrupted by exogenous synthetic hormone 
exposure, negatively impacting breastfeeding.    
Heikkilä and Luukainen looked at hormonal vs. non-hormonal IUD use with 
consistent insertion times. (122) They found that in the immediate months after insertion, 
IUDs with 30 µg /day of levonorgesterel negatively impacted breastfeeding relative to 
use of a non-hormonal IUD. Those in the hormonal group discontinued breastfeeding at 
significantly higher rates, 44% vs. 21% at 75 days post-insertion, and also introduced 
substitute foods sooner, 3.4 months vs. 3.9. Their work is consistent with concerns about 
the effect of synthetic progesterone exposure, but cannot be directly generalized to the 
current US method, Mirena, which has 20 µg /day of levonorgesterel.  As with the 
Egyptian study, the location and date of the work also make direct comparisons difficult. 
Taken together, however, these studies suggest that exogenous progestins can 
impact breastfeeding, especially at the margins, i.e., when breastfeeding cessation is 
already likely. Not only is more work needed on this topic, but these studies also suggest 
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that properly controlling for factors which challenge breastfeeding continuation will be 
important.        
 
Progestin-releasing Implants: Twenty articles were identified that discussed the use of 
a subdermal progestin releasing implant, but only one of these studies was conducted in 
the US. Two were randomized controlled trials and the rest were all cohort studies. 
(114,117,123-140) Among studies with insertion times around one month postpartum or 
later, most studies found no differences in breastfeeding or infant growth outcomes.  Two 
articles noted a statistically significant difference in infant weight at 3 or 4 months that 
disappeared at later time-points. (130,135)  This time period is often marked by an 
increased demand for milk, and these findings might suggest that the response in milk 
production to higher infant demand is sluggish in women using progestin-releasing 
implants. Schiappacasse et al. found higher rates of respiratory infections, skin 
conditions, and eye infections among infants of Norplant users compared to non-
hormonal IUD users, but Kapp et al. suggest in their review that the high urban pollution 
at the study site in Chile may limit the relevance of this finding for US settings. (105,134)  
Most studies evaluated later insertion, i.e., around or after the first month 
postpartum.  However, three articles specifically looked at timing of insertion. (123-125) 
Brito et al. saw no effect of early insertion, but in their DMPA control group, use was 
initiated at six weeks, introducing an additional dimension that makes their findings 
difficult to interpret. (124) The other two papers both compared early and later insertion 
of the same implant, with an additional non-hormonal control group in one of these 
papers; their results conflicted, however.  Seth et al. found statistically significant 
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differences in supplementation rates at three months relative to a non-hormonal control 
group, but their sample was small and they did not attempt to control for differences in 
group characteristics. (123) Gurtcheff, found no difference in onset of lactogenesis II 
between early and later insertion, and also found similar breastfeeding failure rates in 
both arms of the study. (125) Thus, additional work is still needed to clarify the impact of 
early insertion relative to later insertion or use of non-hormonal methods. 
These twenty studies shared a number of problems in their methodology that add 
difficulty to the interpretation of their results.  Many did not attempt to adjust for 
confounding in any way.  This is particularly problematic since only two studies were 
randomized and the rest had some degree of self-selection of treatment by study subjects. 
Several studies reported very high loss to follow-up or discontinuation rates. Lastly, the 
Copper IUD was used as a control for most studies.  Some findings suggest that outcomes 
for Copper IUD users may differ from those who use barrier or surgical methods or no 
method of contraception. If this is so, these studies might have used an inappropriate 
control group that masked the real impact of progestin releasing implants. Still, the 
consistency of the results across the later insertion date studies gives weight to the finding 
that use of progesterone releasing implants inserted in the later postpartum are compatible 
with successful breastfeeding. 
Finally, only one study was conducted in the US, the others were undertaken 
primarily in Chile, Egypt, Thailand and India. Differences in breastfeeding norms among 
these countries and the US highlight a need for US-based research. For instance, if the 
lower infant weight gain seen around 3 and 4 months in several studies indicates that use 
of an implant results in a diminished response to infant demand, then in settings where 
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pressure on the supply and demand feedback system is high, there would be more 
vulnerability to breastfeeding problems. For instance, in the US where there is large 
social pressure to nurse less frequently, and where separation of mother and baby is the 
norm, a diminished response to infant demand could have a much larger impact on 
breastfeeding exclusivity and duration than in settings where frequent nursing is 
common.  
 
Injectables, DMPA and NET-EN: Fourteen articles on injectable forms of progestin-
only contraception were identified, covering a wide array of locations including two in 
the US.  Ten studies were designed to elucidate differences between types of 
contraceptives, one study looked specifically at timing, two looked at both timing and 
type, and one was purely observational. Of the ‘type’ studies, three compared 
administration of an injectable at or before hospital discharge to a placebo or use of a 
non-hormonal method. The results of these studies were mixed; one found a trend 
towards longer breastfeeding duration with DMPA use compared to use of a non-
hormonal method (10.14 vs. 6.57 weeks, p=0.19), but was not sufficiently powered to 
distinguish a difference between the two groups. (141) Another reported statistically 
significant differences in breastfeeding cessation at four weeks, but no difference at two 
or six weeks. (142) The third found continuation rates at 12 weeks postpartum of 68% 
and 74% for NET-EN and placebo, respectively, but said that the results were not 
significant at either six or twelve weeks. (143) The first and third both suffered from 
samples sizes too small to power their studies, and the first two failed to address 
confounding in any way.  
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Three studies looked specifically at timing of use, comparing early application to 
later. (124,144,145) Unfortunately two of these were designed such that their results are 
highly questionable.  Guiloff et al. used historical controls, comparing the current 
breastfeeding outcomes to recalled outcomes from a previous infant. Not only is recall 
bias a major challenge to their results, but prior breastfeeding experience is also known to 
be associated with current breastfeeding success, which means that historical controls 
may introduce bias. Brito et al. compared insertion of an etonogestrel implant in the first 
two days postpartum with DMPA administration at 6 weeks. Though they report no 
difference in exclusive breastfeeding rates at 12 weeks, there is no way to distinguish the 
timing effect from the method effect, which could spuriously make both appear 
acceptable even if both negatively impact breastfeeding. (124) In the final study, Karim 
et al. primarily evaluated milk composition and infant growth outcomes between several 
methods used early and late. However, breastfeeding outcomes, specifically duration, 
were only assessed anecdotally, making the study nearly worthless for evaluating impacts 
on lactation, per se, since infant growth outcomes can be influenced by supplementation. 
(145)  
Finally, seven studies explored the effect of late initiation of injectable 
progesterone-only contraception. The timing of onset of use varied from five to seven 
weeks in the earliest study to two to four months in the latest. These studies found either 
no difference in breastfeeding outcomes or a positive impact.  A study in Chile found that 
DMPA users were the most likely to nurse past 20 months, and another in Chile found 
that DMPA users breastfed on average for 21 months compared to 13 for non-hormonal 
controls. (146,147) However, both of these projects as well as two others made no effort 
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to adjust for confounding. (93,111,146,147) Of the other three, one simply failed to report 
baseline characteristics and methods and another grouped DMPA and POP use together. 
(117,148) The final project, a WHO multi-center cohort study, found no differences in 
breastfeeding outcomes across the study sites, but identified large differences in 
breastfeeding outcomes at individual sites. (137,138) 
Overall, the literature on use of injectable progestin-only contraception during 
breastfeeding is disappointing.  While a relatively large number of studies have been 
done, issues with study design and methodology call the results of every one into 
question. New studies are needed which utilize more robust techniques to address 
confounding.  Furthermore, thoughtful measures and comparisons need to be made in 
order to distinguish the effects of timing from the impact of type of contraception.     
 
Progestin-only Pill (POP), aka Mini-pill: Fifteen articles on use of Progestin-only pills 
(POP) were included in this summary.  Five studies examined initiation of use within a 
week of delivery, and eight looked at late onset of use, ranging from one to four months 
postpartum. No studies compared timing of initiation. Two additional studies looked at 
Chlormadinone derivatives. However, both addressed breastfeeding in ways that make 
them not informative for this topic. (149,150)  
Among early onset use, two studies reported a positive effect of POP use, two 
reported no effect, and one reported a negative effect. Kamal et al. administered POP 
contraception at 2 days postpartum and followed-up for 14 days. (151)  They noted that 
the POP group initiated breastfeeding at three days versus five days for controls.  
However, given the unclear terminology, it is unclear whether this truly reflects a 
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difference in lactation or whether it is indicative of a behavioral difference. This study 
was also very small and subjects self-selected their treatment category. McCann reported 
that POP users began supplementation later than non-hormonal controls, 5.4 vs. 4.6 
months, respectively, but the study had a very high rate of loss to follow-up (i.e., 55% at 
nine months) making their finding questionable. (152) Giner et al. saw no effect on 
breastfeeding initiation, milk volume, or infant growth, but also had a small sample, 
twenty women, and did not describe their methods clearly. (153) A Scottish cohort found 
no significant differences in breastfeeding rates at three and six months, but allowed the 
subjects to self-select their treatment and did not control for confounding. (154) A 
prospective cohort study done in Los Angeles, California reported that 76.7 % of POP 
users were still breastfeeding at four weeks compared to 83.1% of users of non-hormonal 
methods (p=0.022). (142) However, they observed no difference at two and six weeks.  
Moreover, they grouped DMPA, POP and implant users together in this analysis, and 
additionally made no attempt to adjust for confounding although the treatment groups 
differed significantly on mother’s age, mode of delivery, and prior breastfeeding 
experience.  
Among the late-onset studies, four identified no differences between POP and 
control groups, one had mixed results, two found positive effects.  An additional project 
from India looked primarily at infant hormone exposure, and is therefore not directly 
related to the impact on breastfeeding per se. (136) Among the four articles that identified 
no effects on breastfeeding outcomes with POP use, all began use at six weeks or later. 
They also all had methodological shortcomings around failing to address confounding.  
One study whose results were reported in two different papers, made no attempt to 
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address confounding, although loss to follow up was high in some groups. (93,111) 
Another used historical controls, which, as discussed above, are not appropriate for 
breastfeeding outcomes. (114) The other article, a WHO multi-center cohort study, found 
that the breastfeeding outcomes varied greatly by site, although the overall results 
showed no effect of POPs. (137,138) Work by Guiloff et al, which showed no effect of 
one synthetic progesterone on median duration of breastfeeding and a sizable impact 
from a different synthetic progesterone, was also undermined by the use of historic 
controls. (144)  
Finally, two studies of late onset POP (28-56 days use showed positive effects.  In 
an Icelandic cohort, 78% of POP users were breastfeeding seven months after initiating 
use between days 28 and 56 postpartum compared with just 59% of IUD users. (155)  
This group had a relatively long follow-up, two and a half years, but small sample size, 
42 and 41 in the treatment groups, respectively. In Chile, Zacharias et al. found that the 
median duration of breastfeeding for IUD, DMPA and POP users, who began use 
between three and six weeks postpartum, was 19 months, versus 17 months for those 
using no method of contraception, but breastfeeding exclusively.  However, it is difficult 
to draw conclusions since three methods were grouped together. Moreover, they too did 
not adjust for confounding. (147) 
Across the literature examining POP, then, the results are mixed. Interpretation is 
difficult due to small sample sizes, poor study design, and failure to address confounding. 
In spite of the body of literature already available on this topic, then, new work is needed 
to elucidate the impact of POP use on breastfeeding outcomes and, if appropriate, the 
optimal timing of initiation. 
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Factors Associated with Breastfeeding Outcomes 
 
Breastfeeding is a biological, behavioral, and social process and as a consequence 
a large number of factors are associated with breastfeeding outcomes. A literature search 
was conducted using PubMed with the search terms breastfeeding, breastfeed, predictor, 
and determinant..  Further searches for breastfeeding and postpartum depression, race, 
obesity, nativity, income, SES, parity, WIC, and pregnancy intention were also 
conducted.  
 
Demographic Factors: A variety of demographic factors have consistently been reported 
to be associated with breastfeeding outcomes. Many studies report that older mothers 
breastfeed longer than younger mothers including large cross-sectional studies, such as 
the work of McDonald, et al. that included over 90,000 infants. (156,157)Increasing 
parity has also been found to be associated with breastfeeding success, with primiparous 
women demonstrating less breastfeeding success. (158,159)  The mother’s educational 
attainment is also widely reported to be associated with breastfeeding rates. (160-162) 
For example, a medical records review carried out in San Francisco, California, found 
statistically significant differences in breastfeeding initiation and continuation at 1 month 
postpartum by educational level. (156)  A large prospective cohort study associated with 
an RCT of home visits found that women with college degrees are more likely to initiate 
and continue breastfeeding than those with 12 or fewer years of education. (163) In 
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summary, the literature is consistent in reporting that maternal age, parity, and education 
are associated with breastfeeding outcomes. 
Association of breastfeeding initiation and rates of continuation with 
race/ethnicity have also been widely reported and consistently show higher initiation 
among Whites and Hispanics, with lower initiation and continuation among Blacks.  
Large cross-sectional surveys, such as the Pregnancy Risk Assessment Monitoring 
System (PRAMS) and the National Survey of Children’s Health, which included over 
33,000 children, report that Black women have the lowest breastfeeding rates of any 
racial/ethnic group. (160,164,165) Singh et al. found that differences in breastfeeding by 
race/ethnicity were greater for duration than for initiation. (160) Gill’s systematic review 
of the literature for the years 1998-2008 found that Hispanic mothers generally have the 
highest initiation and early breastfeeding rates, but often do not breastfeed exclusively. 
(166) Fewer studies report on breastfeeding rates for Asian Americans, however Soni et 
al. carried a review of electronic medical records and found that Asians had the highest 
rates of exclusive breastfeeding. (167)This study only had 100 subjects, but Taveras et al. 
found similar results in a sample of 1,163 mothers. (163) The CDC analysis of the 
breastfeeding data found in the National Immunization Survey, confirms these 
associations over several years. The ongoing gap between racial groups is of great 
concern as the Black population is lagging behind in the overall increasing rates of 
initiation, exclusivity and duration.  
Associations between breastfeeding outcomes and marital or partnership status 
have been found as well.  Geraghty et al. carried out a study in partnership with the 
Cincinnati Children's Research Human Milk Bank in which they found that marital status 
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was associated with breastfeeding duration.(158) However, the association may be more 
nuanced than that. Singh et al. found that children in 2-parent step-families were less 
likely to be breastfed, while Pippins et al. found that both married women and those 
living with her partner were more likely to breastfeed. (156,160) Overall, partnership 
status is commonly found to be a significant factor in breastfeeding outcomes. 
Parental immigrant status, or nativity, has also been found to be associated with 
breastfeeding duration and may modify the relationship between SES and breastfeeding 
outcomes.  In a large national sample, Singh et al. found that children born to immigrants 
were the most likely to be breastfed until 6- and 12-months. (160) The association was 
more significant among lower SES households than higher SES households. While 
nativity is not a commonly used demographic variable in the breastfeeding literature, 
these findings suggest that it could be an important issue, especially because the 
breastfeeding-supportive association found at lower levels of SES runs counter to other 
breastfeeding trends such as maternal education and family income.  
Regional differences in breastfeeding rates across the US have also been reported 
by the CDC and other national databases. (5,161,168)  In these large national surveys, 
Western states breastfeed at the highest rates, followed by the Northeast, Midwest, and 
finally the South.   Interestingly, Belanoff et al. found that breastfeeding duration varied 
more between states for Blacks and Hispanics than for Whites. (164) Their work, using 
data from the 2007 National Survey of Children’s Health, suggests that region may be a 
more important factor in breastfeeding outcomes for racial and ethnic minorities than for 
whites.   Living in rural areas has also been associated with lower initiation and shorter 
duration of breastfeeding. (160,161)  In a mixed methods study of breastfeeding in rural 
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communities, Flower et al. reported much lower rates of breastfeeding initiation and 
continuation at 6 months for rural communities in Pennsylvania and North Carolina than 
the national average.  In their ethnographic study of North Carolina families, they found 
that many women in these areas never even consider breastfeeding.  Thus, on a national 
scale and a state scale, region has been shown to be associated with breastfeeding 
outcomes.   
 
Economic Factors: A number of large, national studies including those by Singh et al. 
and McDonald et al.  (157,160) have found that higher-income women are more likely to 
breastfeed than their lower income counterparts. However, in a study of medical records 
Pippins et al. found that, among the very poor, not having enough money for food was 
associated with breastfeeding. (156) This subtlety may be lost in studies that ask fewer 
specific questions about economic status.  Those that group these factors into socio-
economic status (SES) consistently report an association between lower SES and worse 
breastfeeding outcomes. (160)  
Even when controlling for SES and/or household income, maternal employment 
is consistently found to be associated with shorter breastfeeding durations.  Maternal 
employment at 2-months and full-time employment were associated with breastfeeding 
discontinuation by 6-months in studies by Flower et al. and Chapman et al.  (161,169)  
This effect may vary by workplace; in their prospective cohort study of 1,163 mothers, 
Taveras et al. found lower rates of breastfeeding continuation at 12-weeks for those who 
returned to work, with lower rates for those who reported having problems with 
breastfeeding at work or school. (163)  In a Canadian population, Kehler and Tough 
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found that not only was working full-time was associated with a higher risk for 
breastfeeding discontinuation, but intending to return to work within the first year after 
birth was as well. (162)  
 
Health Factors: The mother’s history of health and health behavior may be predictive of 
breastfeeding success. Mothers who smoke have consistently been shown to be less likely 
to breastfeed and to do so exclusively. (156,157,160)  Many studies also find a negative 
association between maternal obesity and breastfeeding. (162,170-173) Li et al. also 
found that women who were obese before pregnancy breastfed two week less on average 
than mothers who were not obese before pregnancy. (173)  However, differences in this 
association by race have been reported; Kugyelka et al. found that while obese Hispanic 
mothers breastfed at lower rates than non-obese Hispanic mothers, there was no 
association between obesity and breastfeeding continuation for black mothers, a result 
consistent with several other studies(165,169,174)  While obesity has been suggested as 
affecting breastfeeding through health-related mechanisms, the racial differences in this 
association suggest that social or cultural influences may also be involved.  
Gestational weight gain has also been found to be negatively associated with 
breastfeeding duration.  Li et al. analyzed outcomes for over 124,000 mother-baby pairs 
from the Pediatric Nutrition Surveillance System (PedNSS) and the Pregnancy 
Nutrition Surveillance System (PNSS) and found that both pre-pregnant body mass index 
(BMI) and gestational weight gain were associated with shorter breastfeeding duration. 
(173) They found that women who gained either more or less than the recommended 
amount of weight during pregnancy had 1-week shorter breastfeeding durations than 
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those who gained the recommended amount.  In contrast, Hilson et al. found that the 
association held only for women who were overweight or obese before pregnancy. (175)  
Obesity, pre-pregnancy BMI, and gestational weight gain are all active areas of research 
with interesting, but as yet, unresolved findings. 
 
Reproductive Health: A women’s reproductive health has also been found to be 
associated with breastfeeding success. Looking at all hospital births in a year in Ontario, 
Canada, McDonald et al. found that women with no pregnancy complications and who 
did not use reproductive assistance have higher rates of exclusively breastfeeding at 
hospital discharge. (157) Their work used a very large database, over 92,000 infants, but 
generalizing to the US setting is limited by differences in access to healthcare, standard 
of care, and maternity leave policies to name just a few factors. This same study showed 
that mothers with twins were less likely to breastfeed than women with singleton births, a 
finding consistently reported in the literature. Flower et al. reported that older gestational 
age is associated with better breastfeeding outcomes. (161) Their work focused primarily 
on rural settings, and may not be generalizable to other areas.  However, the work of 
McDonald et al. supports their finding; they report that increasing gestational age has a 
dose response on breastfeeding rates.  For each additional week of gestation from 37 to 
39 weeks, infants have better breastfeeding outcomes. (157)  
 
Psychosocial Factors: Entwistle et al. found that breastfeeding outcomes were 
associated with the mother’s self-confidence, and were influenced by the social context 
around breastfeeding in her home-life, as well as her knowledge about breastfeeding. 
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(176) While less readily generalizable, this qualitative analysis of in-depth interviews 
may have allowed the interaction between these psychosocial factors to become apparent 
to the researchers.  These findings are in alignment with those from large national cohorts 
like that used by Singh et al. who found that breastfeeding duration increased with greater 
familial support. (160)  Similarly, Kehler et al. used a longitudinal study design and 
found that women who were anxious during pregnancy were at higher risk for 
breastfeeding discontinuation. (162) Thus, several types of studies support an association 
between a mother’s psychosocial context and her breastfeeding outcomes. 
Feelings directly about breastfeeding have also been found to be associated with 
breastfeeding outcomes.  A lack of confidence by the mother in her ability to breastfeed 
at 1- or 2-days postpartum was shown by Taveras et al. to be associated with 
breastfeeding discontinuation by 2-weeks in a prospective cohort study. (163) Work by 
Dunn et al. in Canada analyzed a telephone survey carried out at 6-weeks postpartum, 
and found that maternal confidence was associated with breastfeeding. (177)  They found 
a stronger relationship for older mothers than for young, suggesting that age might 
moderate this association.  A study of obesity and breastfeeding by Hilson et al. found 
that indifference toward breastfeeding was associated with shorter duration. (171)   The 
same study identified an association between a mother’s self-image and breastfeeding 
outcomes; the mother’s dissatisfaction with her appearance was associated with shorter 
duration of breastfeeding. Similarly, ethnographic data suggest many women never 
consider breastfeeding or discontinue because of discomfort, embarrassment or lack of 
assistance. (161) Partner support has been reported to be important for breastfeeding 
outcomes as well. A randomized controlled trial (RCT) of a breastfeeding class for 
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fathers found a slight difference in breastfeeding rates at one month, 38% versus 35%, 
and a large difference at three months, 35% versus 19%. (178) Their study was small, but 
the study design adds credence to their finding. 
Pregnancy wantedness is a factor discussed in the family planning literature, but 
which has not been explored in the breastfeeding literature for over 20 years. The 
wantedness of the pregnancy has been shown to be associated with other child outcomes 
such as antenatal care, stunting and later mental health for the child, signs that care giving 
may be different for infants born of unwanted or mistimed pregnancies. (179-181) Taylor 
et al. found that unintended pregnancies were negatively associated with breastfeeding 
initiation and duration for white mothers in a US-based study from 1995. (182)  While 
pregnancy wantedness is a different construct from pregnancy intention, these results 
suggest that pregnancy wantedness may be a worthwhile and overlooked factor to 
consider for breastfeeding outcomes. 
 
Program Participation: WIC participation has widely been reported to be negatively 
associated with breastfeeding outcomes.  For example, Flower et al. found that receipt of 
WIC is associated with breastfeeding discontinuation by 6-months. (161) In fact, they 
reported that participation in WIC, independent of household income, is associated with 
worse breastfeeding outcomes suggesting that WIC participation is not simply a proxy for 
economic standing.  However, this finding does not rule out the possibility that WIC 
participation is a proxy for SES, which has also been reported to be negatively associated 
with breastfeeding. (160)  It is also possible that the association is directly related to the 
WIC program itself.   
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While the impact of groups like La Leche League have long been shown to be 
associated with breastfeeding outcomes, other peer counseling programs have gotten 
mixed reviews. (183-189) Pippins et al. found that receiving instruction about 
breastfeeding was positively associated with breastfeeding outcomes. (156) In contrast, 
Anderson et al. found no difference in breastfeeding continuation between treatment and 
controls in an RCT of breastfeeding education versus education plus peer counseling. 
(190) Another RCT of prenatal and postpartum breastfeeding support found that 
significant differences in breastfeeding rates persisted until 20 weeks. (191,192)  One 
reason for the varying results may be that the effect of program participation must always 
be evaluated in the context of a particular program.  The fact that a variety of studies 
report a beneficial association for breastfeeding programs suggests that designing such a 
program is possible.  
 
Maternal Depression: Some studies have found no association between maternal 
depression and breastfeeding outcomes and others have found a connection. 
(156,159,177,193-196) A study by Dennis et al. found no association between depressive 
symptoms at one week postpartum and breastfeeding at the same time point, but did find 
an association with 4- and 8-week discontinuation of breastfeeding. (197) Bogen et al. 
did not find a direct association between maternal depression and breastfeeding outcomes 
but did none-the-less find an association with use of selective serotonin reuptake 
inhibitors (SSRI). Among those with lower depression scores (HDRS<9), SSRI use at 2-
weeks was associated with not breastfeeding at 12-weeks. However, SSRI use by those 
with higher depression scores (HDRS >=9) was associated with continuation of 
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breastfeeding at 12-weeks. (159) So, this is an area of research that is still very active and 
not fully resolved.  
 
Maternity Services and the Ten Steps to Successful Breastfeeding: In 1989, the 
UNICEF and the World Health Organization put forward the Ten Steps to Successful 
Breastfeeding, a set of recommendations designed to guide clinical care towards practices 
that would preserve and support a woman’s ability to breastfeed. (198) The PROBIT 
study, conducted in 1996 to 1997 in Belarus, took advantage of the Belarusian healthcare 
system that allowed systematic assignment to intervention and control to show that the 
Ten Steps could have a substantial impact on breastfeeding outcomes. (199) The very 
strong design of this study has stood as a model for breastfeeding research.  A very 
different type of study, one using in-depth interviews of a small group of women in the 
United Kingdom (UK) also found that maternity services affected breastfeeding 
outcomes. (176) Work by Declercq et al. and DiGirolamo showed that implementing 
even some of the steps results in improved breastfeeding outcomes. (200,201)  More 
recent work, conducted in North Carolina, has shown that these practices have a 
significant effect on breastfeeding outcomes including initiation, continuation, and 
exclusivity. (202) Together these studies, using a variety of methods and settings, 
substantiate an association between the WHO Ten Steps and breastfeeding outcomes.    
Other healthcare related factors are also associated with breastfeeding outcomes. 
According to McDonald et al. working in Canada, women who have undergone fertility 
treatments are less likely to breastfeed exclusively, as are those who do not attend 
prenatal care classes. (157) In the UK, where midwifery care is common, women who are 
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attended at birth by a midwife or family practice doctor are more likely to breastfeed 
exclusively than those attended by an obstetrician. (157) Late preterm birth, 37 to 39 
weeks gestation, was found to have a dose response association with breastfeeding rates, 
with each week being better for breastfeeding. (157) Finally, Cesarean birth, whether 
planned or unplanned, was a risk factor for not breastfeeding compared to spontaneous 
vaginal birth. (157)  The importance of the relationship with one’s pediatrician has also 
been examined. In a prospective cohort study of psychosocial risk factors, Taveras et al. 
found that receiving encouragement to breastfeed from the woman’s clinician was 
associated with breastfeeding continuation at 12-weeks. (163) Together these results from 
two large population-based samples suggest that healthcare-related factors may be 
associated with breastfeeding outcomes.  
 
Breastfeeding Factors: A mother’s plans about breastfeeding have widely been reported 
to be associated with breastfeeding outcomes.  For example, in a prospective study 
following mothers from pregnancy through 12-weeks postpartum, Bogen et al. found that 
a mother’s intention to breastfeed is associated with breastfeeding rates at two-weeks 
postpartum, and furthermore, intending to exclusively breastfeed is associated with 
‘primarily breastfeeding’ as opposed to ‘not breastfeeding’ or ‘partially 
breastfeeding.’(159) Likewise, using a PRAMS sample of over 16,000 mothers Colaizy 
et al. found that women with a “definite intention to breast-feed” were more likely to 
breastfeed for 4 weeks or more compared to those with “tentative intention.”(203) 
Similar results come for the study of obesity and breastfeeding where a shorter intended 
duration of breastfeeding by obese mothers mediated some of the negative association 
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found between the breastfeeding and obesity. (171)  Breastfeeding intensity and 
exclusivity has also been shown to be associated with later breastfeeding outcomes. For 
instance, exclusive breastfeeding at 2-weeks was found to be associated with continuing 
to breastfeed at 12 weeks. (159)  Bogen et al. also found that prior breastfeeding 
experience was associated with breastfeeding outcomes. (159) Work by Taylor et al. 
explains this association further using a national probability sample of 2,115 women; 
they found that in families with more than one child, over 70% of women made the same 
feeding choice with each of their children. (204)  Early breastfeeding experience may 
also be associated with later outcomes. Taveras et al. found that early breastfeeding 
problems were associated with breastfeeding discontinuation by 2-weeks. (163) 
Furthermore, Chapman et al. found that low breast-feeding frequency on day 1 
postpartum was found to be negatively associated with breastfeeding duration. (169)  
The strongest evidence of an association with breastfeeding outcomes exists for  
maternal age, parity, education, maternal employment, smoking, multiple gestation, and 
the mother’s pre-birth intention to breastfeed.  Racial differences have also been 
consistently reported, however, this is an area where improvements and change have also 
been seen.  Factors with good evidence, but where some variation in the particulars for 
the association have been reported include income, SES, region, urbanicity, social 
support, partner support, participation in a peer support group, cesarean birth, and receipt 
of hospital practices included in the Ten Steps to Successful Breastfeeding.  Evidence of 
an association with nativity, gestational age, mental health, attitude towards 
breastfeeding, depression, maternal confidence, fertility treatments, early BF experience, 
marital status, partnership status, obesity, pre-pregnant BMI, gestational weight gain, 
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pregnancy complications, pregnancy wantedness, instruction about breastfeeding have all 
been reported as well and are active areas of research and discussion in the field. 
 
Behavioral Theory 
 
The Theory of Planned Behavior, which is based on the Theory of Reasoned 
Action, posits that the most important determinate of behavior is behavioral intention. 
(205) Three factors predict an individual’s behavioral intention: one’s attitude toward the 
behavior, one’s subjective norm, and one’s perceived behavioral control. Each of these 
three factors, in turn, is determined by a weighted composite of many factors.  That is, the 
influence of these underlying factors on behavioral intention is mediated by the attitude, 
subjective norm, and perceived control.   
For breastfeeding, the Theory of Planned Behavior would suggest that the 
mother’s intention to breastfeed would be the major determinant of whether or not she 
begins breastfeeding after birth. The mother’s intention to breastfeed is one of the 
variables in this project, which will allow us to examine this hypothesis in two ways. 
First, bivariate analysis of breastfeeding intention and breastfeeding initiation will be 
used to examine the correlation between the intention and initiating the behavior as 
described in the Theory. Second, multivariate analysis will be used to assess whether 
there is an association between intention to breastfeed and breastfeeding duration, that is, 
continuing the behavior.   
Some factors that could influence a woman’s breastfeeding intention can also be 
assessed in this project. A series of questions on the maternity care related practices that a 
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woman experiences would contribute to both her perception of the subjective norm 
around breastfeeding, at least within the hospital environment, and could also affect her 
perceived behavioral control.  For example, the question about whether the mother felt 
supported by all facility staff in her infant feeding choice is, in essence, about her 
perception of the subjective norm among the facility staff. So to, whether she is given a 
formula sample bag at discharge could affect her sense of whether formula feeding or 
breastfeeding is the normative behavior in her community.  Her perceived behavioral 
control could be influenced by several of the other hospital practices that were part of the 
questionnaire. Being given immediate skin-to-skin contact with her infant after birth 
gives the mother the ability to breastfeed if she wishes. Likewise, rooming in, i.e., having 
her baby with her at least 22 out of 24 hours, gives her access to her child for feedings. 
Finally, being visited by a lactation consultant (LC) and having a feeding observed by an 
LC could improve her sense of behavioral control by getting help and/or reassurance, and 
also through feeling that there are resources available to assist her should she need them. 
By exploring these factors in both the analysis of breastfeeding initiation and 
breastfeeding duration, these parts of the Theory of Planned Behavior can be tested in 
this project.    
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Conceptual Model 
Figure 2: Conceptual Model 
 
 
 
 
 
The aim of this project is to explore the possible causal pathway from 
contraceptive use to lactation duration diagramed in the conceptual model above. As the 
model shows, a variety of factors likely influence contraceptive use and breastfeeding 
duration.  Not only will those factors need to be addressed in the statistical analyses to 
control for their potential confounding effects, but they also represent potential 
intervention points and constraints when discussing the practical implications of this 
project’s results. 
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The factors that influence contraceptive use and/or lactation duration are broken 
down into four main types: demographic, social, health, and maternity-related. 
Demographic factors include traits of the woman or her household which are either not 
changeable, or would not generally be changed in response to breastfeeding and family 
planning. This includes the mother’s race and ethnicity, her age, her socio-economic 
status, her level of education, the region in which she lives, her enrollment in the Special 
Supplemental Nutrition Program for Women, Infants and Children (WIC), and her 
marital status.    
Social factors are associated with the mother’s plans and ideas that influence her 
approach to contraception and lactation. Importantly, these factors have the potential to 
be changed, though it may be difficult or unlikely that they will be. Many things may fall 
into this category, and each woman may have unique priorities that she takes into account 
when making choices about contraception and breastfeeding. However, some common 
issues are her pre-birth intention to breastfeed, her plans about working after the birth, the 
perceived support from people whose opinions she values, and her feelings about whether 
she wanted the pregnancy.  
Breastfeeding is, at its core, a biological and behavioral process. (48-50) As such, 
health factors for both mother and baby could affect this process. The main factor 
available in the dataset is whether the infant spent time in the Neonatal Intensive Care 
Unit (NICU). NICU policies and practices may directly influence a dyad’s ability to 
initiate and continue breastfeeding. It is also a proxy for infant health status, particularly 
prematurity, which is known to be related to developmental challenges to breastfeeding 
like lack of coordination of the suck-breathe-swallow rhythm necessary for successful 
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nursing. Therefore, NICU stay is an important measure that covers many of the health-
related issues that impact breastfeeding from the infant’s side of the equation. Knowledge 
about the interaction of health-related issues and breastfeeding outcomes could inform 
the implementation and targeting of programs, and could lend further importance to 
prevention efforts for the health issues themselves.  
 Finally, factors related to the healthcare system are known to play an important 
part in successful breastfeeding initiation and establishment, and offer one of the most 
fruitful intervention points in improving breastfeeding outcomes. The Ten Steps to 
Successful Breastfeeding developed by the WHO gives a framework for best practices 
related to maternity care and breastfeeding.  They delineate concrete actions the facility 
and staff should take to ensure that every mother has the opportunity, access, information, 
and support to breastfeed if she chooses.   
 
APPROACH 
 
Study Overview 
This document and the articles prepared for publication will explore the 
relationship between predisposing factors and breastfeeding outcomes, and then will 
utilize these relationships in the study of the impact of contraception on breastfeeding 
duration. An aim of this work is to inform clinical practice from labor through the early 
months postpartum, as well as give useful information for programs that support and 
increase breastfeeding in the United States. The primary focus of this project is 
elucidating the impact of hormonal contraceptive use while breastfeeding on the duration 
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of breastfeeding. To fully understand these relationships, the associations with socio-
demographic and health variables will also be explored, as well as the relationship, if any, 
between these factors, hospital practices and postpartum contraceptive use. 
 
Study Sample 
This project utilizes secondary data from a data set that had, as its primary 
purpose, assessing the impact of The Period of Purple Crying education campaign in 
North Carolina. This CDC-funded study included an intervention phase with education 
for parents about normal crying behavior of infants as a means of reducing child 
maltreatment, in particular, shaken baby syndrome, and a follow-up survey to which a 
small set of additional questions was added. The additional questions related to 
breastfeeding, other infant feeding practices, and healthcare practices during delivery and 
immediately postpartum, and contraceptive use. These variables were added with the aim 
of identifying modifiable practices, barriers, and influences that impact breastfeeding 
success in order to inform interventions to improve breastfeeding outcomes in North 
Carolina and nationally. Factors associated with disparities in breastfeeding initiation 
and/or continuation were of particular interest since these not only offer a high-impact 
opportunity to improve community breastfeeding rates, but also an important touch-point 
to improve health disparities for target populations with disproportionately poor 
breastfeeding, mortality and morbidity rates. 
The survey was conducted in 2010-11 by telephone interview of new mothers 
drawn from birth certificate records in North Carolina. About 2000 women were selected 
from the approximately 130,000 annual live births in the state. Mothers of two- to three-
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month-old infants were targeted, though the actual sample included mothers with both 
older and younger infants (range 0 to 36 months). The birth certificates were selected 
with over-sampling for Hispanic maternal ethnicity (some Hispanic origin, no Hispanic 
origin), baby’s birth date (<2 months, 2-3 months), hospital size (small, medium, large 
based on live births per hospital), and location (urban/rural based on the NC Rural Profile 
2004). A random sample was taken from the birth certificate data using a sampling rate of 
2 for Hispanic origin and 1.5 for baby’s birth date <2 months. Proportionate sampling 
rates for urban/rural location and hospital size were used. Once selected, the mothers’ 
telephone number was back-matched from name and address information on the birth 
records, and only those for whom a telephone number could be matched and which 
reached a household in North Carolina were considered eligible. The interview was 
conducted in English or Spanish only, all other languages were ineligible. If more than 
one child met the criteria, the one referenced on the birth certificate was the referent for 
the survey. The female parent or female legal guardian was interviewed.  
Data collection was carried out by the Carolina Survey Research Laboratory at the 
University of North Carolina at Chapel Hill. The survey was conducted in a single 
interview, and therefore, the data are cross-sectional in nature. The survey was conducted 
from April 21, 2010 to March 17, 2011. A Spanish language version of the questionnaire 
was translated from the English and verified by DTS Language Services, Inc. of Raleigh, 
North Carolina. At least 12 call attempts were made including at least one weekend, one 
evening and one daytime call before a potential participant was dropped.  
Among the eligible participants chosen at random from North Carolina birth 
certificate records, there were 1,644 (98.5%) complete interviews and 25 partial 
 	   55 
interviews. The partial interviews were included in the data set, but had a high percentage 
of missing values. An additional 642 women were eligible to participate in the survey, 
but chose not to, and the eligibility of another 1896 women could not be determined due 
to a failure to successfully make contact with these households.  Thus, the survey 
response rate was estimated to be between 52% and 72% depending on what proportion 
of the group with unknown eligibility status one assumes would have been eligible.   
This dataset is particularly useful in addressing the question of postpartum 
contraceptive use and breastfeeding because of the level of detail in the questions added 
on these two topics. It is relatively rare for a survey to ask about postpartum 
contraceptive use and breastfeeding and to do so with well-designed questions for both 
topics.  
These data are particularly valuable for the health-system related measures, 
capturing many of the modifiable factors in delivery and breastfeeding support. How 
these factors relate, if at all, to contraceptive use is one of the novel dimensions of this 
work. While some aspects such as mode of delivery are not available, other factors like 
the timing of the first feeding, which is often not queried, are available. Moreover, a 
series of questions relating to the Ten Steps to breastfeeding success, a WHO program to 
encourage good hospital practice in support of breastfeeding, enables a rich exploration 
of this initiative, improving the ability to both control for confounding and draw 
inferences for policies and programs. Lastly, this data set is unusual in that it includes 
questions about pregnancy wantedness, something few surveys consider.  Therefore these 
data provide an important opportunity to further the knowledge available on the 
relationship among these variables. 
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Analytic Sample 
 This dataset included 1,669 women of whom 1,443 intended to breastfeed (86%), 
206 did not intend to breastfeed, and 20 did not respond about their breastfeeding 
intentions. Birth control use was reported for 1,655 women, of whom 1,321 reported 
using some form of birth control since delivery (79%), while 334 had not used birth 
control since giving birth, and 14 did not respond.  Hormonal contraception was used by 
47.5% of women, or 792 respondents. (Table 1)  
The entire sample was used for this project.  Since the sample was drawn from 
state birth certificate data, it represents a random cross-section of live births in North 
Carolina during this recruitment time-period. No further restrictions were applied, 
notably no restriction on health status of either the mother or baby.  Such challenges, in 
and of themselves, could have limited a mother-baby dyad’s ability to breastfeed. No 
sample weights were used to adjust the data to be specifically representative of either the 
North Carolina or US population or any other demographically specific group. In this 
way, the sample is reflective of the general NC population who have telephones and are 
reachable by phone, and inference to programs and practices aimed at the entire 
population of newborns and their mothers must be carried out with caution. 
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Table 1: Description of the Sample (N=1,669) from a survey evaluating the Period of Purple 
Crying Intervention Program, 2010-11. 
 n %   n % 
Maternal Age    Income   
  <20 104 6.2%    <20K 283 17.0% 
  20-24 217 13.0%    20 to <40K 300 18.0% 
  25-29 375 22.5%    40 to <60K 182 10.9% 
  30-34 541 32.4%    60 to <80K 220 13.2% 
  35-39 314 18.8%    80 to <100K 181 10.8% 
  >=40 92 5.5%    >=100K 325 19.5% 
  Missing 26 1.6%    Missing 178 10.7% 
Race/Ethnicity    NICU Stay   
  Non-Hispanic White 1,069 64.1%    No 1,442 86.4% 
  Hispanic 316 18.9%    Yes 198 11.9% 
  Non-Hispanic Black 207 12.4%    missing 29 1.7% 
  Asian 33 2.0%     
  Native American, Alaskan 
Native 11 0.7% 
 
Older Sibling   
  Native Hawaiian, Pacific 
Islander 3 0.2% 
 
  Yes 1,059 35.1% 
  Missing 30 1.8%    No 586 63.5% 
      Missing 24 1.4% 
Maternal Education       
  < High school 207 12.4% 
 Intended to 
Breastfeed   
  High school/GED 486 29.1%    No 206 12.3% 
  College/Graduate 649 38.9%    Yes 1,443 86.5% 
  Graduate Degree 300 18.0%    Missing 20 1.2% 
  Missing 27 1.6%     
    Ever Breastfed   
Pregnancy Intention      No 250 15.0% 
  Wanted 975 58.4%    Yes 1,398 83.8% 
  Wanted, not at this time 413 24.7%    Missing 21 1.3% 
  All pregnancies are wanted  228 13.7%     
  Not Wanted 21 1.3% 
 Time of Breastfeeding 
Initiation (N=1398)   
  Missing 32 1.9%    Never 250 15.0% 
      <1 hour 607 36.4% 
Contraceptive Use      1-2 hours 279 16.7% 
  None 294 17.6%    2-6 hours 256 15.3% 
  Non-hormonal 356 21.3%    6-24 hours 92 5.5% 
  Progesterone-only 383 22.9%    >24 hours 144 8.6% 
  Combined estrogen/prog. 166 9.9%    missing 41 2.5% 
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MEASURES 
 
Key Variables 
Breastfeeding Duration: The primary outcome variable of interest is breastfeeding 
duration, which was calculated based on the mother’s response to several questions. Near 
the beginning of the survey, women were asked how old their baby was in months. The 
baby’s age in weeks was then calculated by multiplying this response by 4.  Later in the 
survey, women were asked, “Are you still breastfeeding?” Those who answered “no,” 
“refused,” or “don’t know” were then asked, “How long did you breastfeed?” Their 
answer was recorded in weeks and used as their final breastfeeding duration. This 
response was also checked against the baby’s age calculated from the mother’s earlier 
response, and any responses that exceeded the baby’s age by more than three weeks were 
dropped from the analysis as being implausible; no subjects were dropped due to 
implausible values for infant age.    
 For those who responded “yes” to the question “are you still breastfeeding?,” 
breastfeeding duration was calculated based on the baby’s age reported in months at the 
beginning of the survey. To convert it to weeks, their response to this question was 
multiplied by 4. On average, women would have nursed for the number of months they 
reported, plus about half of the following month. Therefore, an additional two weeks was 
added to the month–to-weeks conversion calculated above to account for the average 
number of weeks represented by whole months, which was the way this question was 
asked. Since the ultimate breastfeeding duration is unknown for these respondents, their 
data are right censored. 
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Contraceptive Use: Contraceptive use was examined as both an outcome and an 
exposure in this project using the respondent’s answer to the question, “Which of the 
following birth control method or methods have you used since [BABY NAME] was 
born?” 
 Respondents were allowed to identify up to eight different methods used, but no 
one reported more than three. They were also able to specify “other” and if so were asked 
to describe the method they used.  From these responses, additional categories were 
coded by hand: Tubal Ligation/Hysterectomy/Surgery, Vasectomy, Nuva Ring, 
Spermicide, Pill-Unknown type, Implanon, Patch. All verbal responses were readily 
identifiable as falling into one of the resulting 15 categories. Where more than one 
contraceptive type was reported, the woman’s contraceptive use was classified by a 
single type in the following order: combined estrogen/progestin, progestin-only, non-
hormonal methods, no contraceptive used. 
 Where more than one method was used, the order and trimming of their use is 
unknown, and for all women information on the dose of hormonal contraceptive was not 
available.  Information on the timing of contraceptive use was not obtained in the survey, 
and therefore the timing of use relative to breastfeeding cessation cannot be determined.  
This leaves open the possibility that breastfeeding cessation preceded the contraceptive 
use in which case any association found would run in the opposite direction to the study 
question, i.e. breastfeeding cessation leading to contraceptive use.  The age of the infants 
in this population and the fact that a large number of the participants were still nursing at 
the time of the study mitigate, but do not eliminate this possibility.   
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Independent Variables 
Maternal Age: Maternal Age was determined from the respondent’s answer to question 
F01, “How old are you?”  Ages in the sample were measured in years and ranged from 14 
to 46.  All responses were considered plausible and therefore none were eliminated for 
being out of range. The modeling of maternal age was explored both as a continuous 
variable and as a categorical variable to determine which better captured the relationship 
between maternal age and the outcomes of interest, breastfeeding duration and 
contraceptive use. 
 
Maternal Race/Ethnicity: Infant race/ethnicity was used to capture the effects of race 
and ethnicity on the outcomes of interest. For breastfeeding, race/ethnicity is likely to 
represent social and cultural mechanisms of influence and not likely to represent 
biological differences in a woman’s ability to breastfeed.    
The mother’s race/ethnicity was determined from a combination of the question 
”Are you Hispanic or Latino?,” and the question “Which one or more of the following 
would you say is your race?” Based on these two questions, categories for Non-Hispanic 
White, Non-Hispanic Black, Hispanic, and Other were constructed.  The category “other” 
included those who identified themselves as Asian, Native American/Alaskan Native, 
Native Hawaiian/Pacific Islander, and other.  
Given that respondents could identify themselves as multi-racial, a rubric for how 
to assign a single race/ethnicity to each participant was necessary, and is presented in 
Figure 3. Women who identified themselves as Hispanic were considered Hispanic 
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regardless of their race.  Of those remaining, women who identified themselves in a 
single racial category were classified as that race.  Women who identified more than one 
race were asked whether they considered themselves White or non-white. Those who 
responded “white” were coded as white. Among those who responded “non-white” a 
hierarchy was used with the overall goal of being as conservative as possible based on 
knowledge of US breastfeeding rates for minority populations, tending to bias the results 
towards the null (no difference in breastfeeding pattern by race) rather than away from it.  
 
Figure 3: Decision Making Rubric for Maternal Race/Ethnicity 
 
 
 
Maternal Educational Attainment: Maternal education was modeled as a categorical 
variable drawn from the single question about education level asked on the survey, which 
was “What is the highest level of school you’ve completed so far?” The available options 
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were “below high school,” “high school graduate or GED,” “College degree (associates 
or bachelors),” and “graduate degree.”  
 
Household Income: Household income was based on a series of questions that together 
identified the respondent’s income level within a $20,000 range. The initial question was 
“Is your total family income, before taxes, under or over $40,000?” Respondents could 
select “under $40,000,” “over $40,000,” “exactly $40,000,” “refused,” or “don’t know.”  
Follow-on questions sequentially narrowed the response to finer and finer ranges. For 
example, those who identified their family income as over $40,000 were then asked “Is 
your total family income over $60,000?,”  and could respond “no,” “yes,” “refused, “or 
don’t know.” 
   
Parity Proxy: First Live Birth: Respondents were asked whether they had any older 
biological children. While this does not directly ask about parity, a factor associated with 
breastfeeding duration, it is a reasonable proxy since infant and child mortality in the US 
is low. More detailed information about prior breastfeeding experience, the number of 
older children, and non-living biological children is not available. While these are likely 
also associated with maternal choices, a variable like this one that essentially captures 
whether the child in the survey is the oldest living child is a reasonable approximation of 
the influence of these factors. A dichotomous (yes/no) variable was based on the 
participant’s response to the question, “Do you have any biological children older than 
[BABY NAME].” Answers of, “refused,” and, “don’t know,” were coded as missing.  
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NICU Stay: Admittance to a Neonatal Intensive Care Unit (NICU) has been shown to be 
associated with breastfeeding initiation and duration, although evidence about direction is 
mixed.  A dichotomous variable (yes/no) for NICU stay was coded based on the 
participant’s response to the question, “Did [BABY NAME] spend any time in the 
neonatal intensive care unit or “NICU” before being discharged from the hospital?”  
Responses of “refused” or “don’t know” were coded as missing. 
 
Breastfeeding Intention: The mother’s intention to breastfeed prior to giving birth was 
queried with the question, “Before [BABY NAME] was born, did you intend to 
breastfeed?” A dichotomous variable (yes/no) was coded from the responses with, 
“refused,” and “don’t know,” coded as missing. 
 
Length intended to breastfeed: Women who identified themselves as having intended 
to breastfeed before birth were then asked how long they intended to breastfeed, and their 
answer was recorded in weeks. If they answered in months, the survey administrator was 
instructed to multiply their response by 4 and to record this. 
  
Ever Breastfed: Women were asked, “Did you ever breastfeed [BABY NAME]?” Their 
response was recoded as a dichotomous variable (yes/no) with “refused” and “don’t 
know” coded as missing. 
 
Pregnancy Wantedness: The degree to which the pregnancy was desired was queried 
using a scale for pregnancy ‘wantedness’ put forth by the WHO. Mothers were asked, 
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“Would you say your pregnancy with [BABY NAME]…,” and then given the following 
4 options: “…was wanted and occurred at about the time you planned,” …was wanted, 
but not at this time, “…was wanted because all pregnancies are wanted, or, “ “…was not 
wanted.” Respondents could also answer “refused” or “don’t know” both of which were 
coded as missing values.  Only 8 respondents identified their pregnancy as not wanted, 
therefore this category was grouped with the mistimed pregnancies.  To evaluate the best 
coding to captured the relationship between pregnancy wantedness and the outcome of 
interest, either contraceptive use or breastfeeding duration, coding pregnancy wantedness 
as either a categorical variable (one to three) or as dummy variables for each category 
was explored.  Dummy variables were used for all analyses.   
  
Hospital Practices: Women were asked questions related to the Ten Steps to Successful 
Breastfeeding identified by the WHO as important healthcare related practices to ensure 
that breastfeeding is supported by the healthcare system. Women’s responses to each 
item were captured as a dichotomous variable (yes/no). All women named at least one 
practice, therefore, if a respondent did not identify a practice it was recorded as a “no” for 
that practice. The following practices were evaluated: immediate skin-to-skin contact 
between mother and baby, visit by a lactation consultant or breastfeeding specialist, 
breastfeeding observed by a lactation consultant or breastfeeding specialist, mother felt 
supported by all hospital staff in decision regarding breastfeeding, baby was with the 
mother at least 22 out of every 24 hours, mother received a formula sample bag. These 
practices were examined both individually and as a composite, ordinal variable for the 
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number of practices experienced by the mother, to see which method was best in the 
model.  
The timing of breastfeeding initiation has important biological implications and is 
often a function of hospital practices. Among respondents who said that they had ever 
breastfed, women were asked how many hours it was until the first breastfeeding. Their 
responses were captured in four time bins, which were coded as a categorical variable: 
less than 1 hour, one to two hours, two to 24 hours, and over 24 hours. 
 
Missing Data  
 A complete case analysis was done, excluding respondents with missing values 
for any variables used in that specific analysis. With the exception of the variables for 
household income (10.7% missing) and intended duration of breastfeeding (17.8% 
missing), the level of missing data in this sample was very low, between 1% and 3% for 
all variables.  Two analyses, a likelihood ratio test and forest plots of the parameter 
estimates for the covariates, were used to determine that income could be excluded from 
the analysis without significantly affecting the models.  The high degree of missing data 
for intended breastfeeding duration was thought to be non-random, potentially 
representing differences in confidence, determination, and/or education about 
breastfeeding, which could be reflected by having an intended duration or not having a 
clearly defined plan for this. Therefore, both income and intended breastfeeding duration 
were excluded from the model. 
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HYPOTHESES 
 
Aim 1: To evaluate the association, if any, between demographic, social, and healthcare 
factors and the likelihood of weaning.  
Hypothesis: Demographics, social factors, and healthcare practices experienced during 
labor and immediately postpartum are associated with the duration of breastfeeding. 
 
Aim 2: To assess whether there is an association between demographic, social, and 
maternity-related healthcare factors and contraceptive use in the postpartum time frame.  
Hypothesis: There are associations between demographic and healthcare factors such as 
race/ethnicity, pregnancy wantedness, income, maternal age, education, and hospital 
practices, and the use of contraceptives, including the specific type of contraceptive used, 
in the postpartum time-period. 
 
Aim 3: To assess the impact of the postpartum use of progestin-only contraceptive 
methods on duration of any breastfeeding.  
Hypothesis: Women who use progestin-only contraception postnatally are more likely to 
cease breastfeeding than women who do not use contraception and women who use non-
hormonal methods of contraception. 
 
Aim 4: To assess the impact of the use of combined progestin/estrogen contraceptive 
methods in the postpartum period on breastfeeding success, measured as the hazard of 
breastfeeding cessation.  
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Hypothesis: Women who use combined progestin/estrogen contraception in the 
postpartum period are less likely to be breastfeeding at each time-point than women who 
do not use contraception, women who use non-hormonal methods, and women who use 
progestin-only contraception. 
 
STATISTICAL ANALYSIS 
Analytic Sample 
For analysis of breastfeeding duration in the entire population, the sample size 
was 1,573, 94.2% of the original sample.  For analysis of breastfeeding duration limited 
to those who initiated breastfeeding, the sample size was 1,333 of the 1,429 eligible 
women (93.3%). For the analysis that included contraceptive information and was limited 
to women who initiated breastfeeding, the sample size was 1,319 of the 1,429 eligible 
study participants (92.3%).   
 
Descriptive Statistics 
 Descriptive statistics for all variables are presented for the sample as a whole and 
for strata based on the type of birth control used after birth and by breastfeeding 
initiation. This informed a discussion of demographic variation in these factors. Counts 
and percentages of the population/strata are presented for dichotomous and categorical.  
Mean, standard deviation, minima, and maxima are shown for continuous variables 
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Analyses for Aim 1 
 A Cox proportional hazards model as described by Allison was used to perform a 
survival analysis of breastfeeding duration. (206) The analysis was carried out in two 
ways: among the entire study sample and among only those who initiated breastfeeding. 
These analyses provided a meaningful measure of the hazard of breastfeeding cessation 
from which survival curves stratified by study covariates were drawn. Time to 
breastfeeding cessation was the dependent variable and maternal, infant, and healthcare 
factors were the independent variables. Because some study participants are still nursing 
at the time of their interview, some of the data are right censored. The censoring should 
be random due to the random sampling study design.  Moreover, censoring should be less 
of an issue at earlier time points where the sample includes many participants that have 
breastfed beyond this time point.  The discrete method was used to account for the fact 
that there was a high degree of tied data that likely reflects that events actually occur at 
the same time-point for the women who did not initiate breastfeeding. 
To select appropriate control variables, an initial set of variables was identified 
based on the theoretical relationships between factors described in the literature.  An 
initial analysis was run using all variables identified and available in the dataset. Those 
with a p-value less than 0.05 were considered significant and were retained in the model.  
Additionally, variables that were expected to be significantly related to the outcome, but 
were not significantly associated with the outcome in the original model were explored 
using Likelihood ratio tests, Bayesian Information Criterion (BIC), Akaike Information 
Criterion (AIC) tests to assess model fit with and without these variables.  Variables for 
region and income were dropped from the model because they were neither significant, 
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nor improved the model fit.  The BIC and AIC were also used to determine the best 
modeling for maternal age. Variables for intention to breastfeed and intended duration of 
breastfeeding were co-linear.  Intention to breastfeed was retained in the model and 
intended duration was dropped because the high degree of missing data (17.8%) for 
intended duration was believed to be non-random (discussed elsewhere). Other variables 
were not co-linear, although in an analysis of the ability to impute the missing values for 
income, intention to breastfeed was strongly predictive of income.  Income was also 
dropped from the analysis as described above.   
 
Analyses for Aim 2 
A log binomial regression was performed with type of contraceptive used as the 
dependent variable and demographic, social, and healthcare factors as the independent 
variables according to the following model: 
 
Logt P(Y=1) = β0 + β1X1 + β2X2 + β3X3 + β4X4 + β5X5 + β6X6 + β7X7 + β8X8 + β9X9 + 
β10X10 + β11X11 + β12X12 + β13X13 + β14X14 + β15X15 + β16X16 + β17X17 + ε   
 
Y: Whether a particular type of contraceptive is used 
X1: Breastfeeding intention (yes/no) 
X2: Breastfed ever (yes/no) 
X3: Intended duration of breastfeeding 
X4: Maternal age 
X5: Maternal race/ethnicity  
X6: Maternal educational attainment (yes/no) 
X7: Pregnancy wantedness 
X8: 1st live birth (yes/no) 
X9: NICU stay (yes/no) 
X10: Baby’s sex 
X11: Timing of first breastfeed 
X12: Immediate skin-to-skin contact between mother and baby 
X13: Visit by a lactation consultant or breastfeeding specialist (yes/no) 
X14:  Breastfeeding observed by a lactation consultant or breastfeeding specialist (yes/no) 
X15:  Mother felt supported by all hospital staff in her breastfeeding decision (yes/no) 
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X16:  Baby was with the mother at least 22 out of every 24 hours (yes/no) 
X17:  Mother received a formula sample bag (yes/no) 
 
The analysis was limited to those who initiated breastfeeding.  Results of the log 
binomial regression are informative for discussion of associations between the 
independent variables in the final model and the dependent variable, type of 
contraceptive used. The independent variables provide a list of considerations that can 
inform policies and programs for intervention.  A causal relationship is not assessed by 
this analysis however.   
 
 Analyses for Aims 3 and 4: Propensity Score and Inverse Probability Weight  
A Kaplan-Meier survival analysis was performed with breastfeeding duration as 
the dependent variable and type of contraceptive used as the primary independent 
variable. Kaplan-Meier curves are appropriate for this analysis because they allow the 
relationship between the dependent and independent variable to take any form, i.e., the 
model is non-parametric. Since clinical observation suggests that the resilience of the 
biological systems underlying breastfeeding might be more fragile in the early 
postpartum than later on, it is valuable to choose a statistical model like this one, which 
does not make assumptions about the nature of the relationship, and furthermore, allows 
the mathematical relationship to be different at different time-points in the breastfeeding 
life-cycle.  
The independent variable of interest, type of contraceptive used, was not 
randomly assigned in this study. Cole and Hernán suggest that in studies without random 
assignment of the ‘treatment’, unadjusted Kaplan-Meier curves can lead to issues with 
confounding due to group-level differences between the treatment and control 
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populations. (207) They suggest using inverse probability weights based on propensity 
scores to address this issue, allowing the propensity score to represent the likelihood of 
being in the treatment or control based on the covariates that underlie the propensity 
score calculation. The goal is to balance differences that exist in the distribution of other 
variables between the treatment and control groups that make them imperfect 
counterfactuals, that is, to find a mathematical way of accounting for the systematic 
differences between the groups.  In this case, adjustment for the factors found in Aim 2 to 
be significantly associated with type of contraceptive used is important to control for 
confounding by these factors as described by Robins et al.  (208) The assumption of 
propensity scores is that there are no unmeasured confounders, if this assumption is met, 
then the difference between the outcomes of the treatment and control groups can be 
considered the average treatment effect. (209) 
Thus, a propensity score was estimated for each study participant using the 
variables identified in Aims 1 and 2. This score was then used as the basis of an inverse 
probability weight (IPW) used in the analysis of Aims 3 and 4. The IPW captures the 
marginal probability of a study subject receiving the treatment that they actually received 
given the exposures, or covariates, observed for that individual. In other words, how 
much does that individual look like the rest of the group in which they are a member, 
either treatment or control. Because it is an inverse, group members who look like the 
opposite group are weighted more strongly than members who look like their own group, 
and this is done in proportion to their similarity to the other group.   
 
Inverse Probability Weight: 
 
 Wi = 1 / f(x) 
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Where: 
Wi  = the inverse probability weight for individual i 
       = the inverse probability of individual i receiving the treatment they received (X) 
given, or conditional, on the observed covariate vector Z 
f(x)=stabilized weights which are a function of (X|Z) where 
X = the independent variable or treatment 
Z = covariates or confounders 
 
An advantage of using propensity scores is that they allow you to estimate what 
the population effect would be if everyone received treatment.  However, this 
interpretation relies on the assumption of no unmeasured confounders. That is, that all 
confounders have been measured and included in the creation of the propensity score.   
 
Analyses for Aim 3 
To explore a relationship between use of progestin-only contraceptive methods 
and duration of breastfeeding, a Kaplan–Meier survival analysis was performed using 
inverse probability weights as described above. The analysis compared the use of any 
progestin-only contraception method with use of a non-hormonal method and with no use 
of contraception.  The composition of each group was as follows: 
 
Progestin-only: 
Mini-Pill 
IUD with Hormone, aka Mirena 
Contraceptive shot, aka Depo-Provera 
Implanon 
 
Non-hormonal:   
IUD with Copper 
Condom 
Spermicide 
Vasectomy 
Tubal Ligation/Hysterectomy/Surgery 
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No Contraception: 
No contraception used 
 
Biologically, non-hormonal methods and no contraceptive use should not interact 
with the mechanism of breastfeeding, and therefore might reasonably be analyzed 
together.  Socially, however, these groups might be quite different in ways that would 
confound the breastfeeding data. For example, people who do not use contraception after 
birth could differ from those who use contraception in terms of their plans to breastfeed 
since some women perceive familiar forms of contraception as being contra-indicated for 
breastfeeding. Moreover, the Lactational Amenorrhea Method (LAM), which was not 
explicitly mentioned on the survey, is an effective form of birth control for those who 
breastfeed according to its guidelines for the first six months. Taking this rationale into 
account, non-hormonal methods were analyzed separately from no contraception. 
 
Analysis of Aim 3: 
All Progestin-only methods vs. Barrier methods 
All Progestin-only methods vs. No contraception 
 
Analyses for Aim 4 
A relationship between the use of combined estrogen/progestin methods of 
contraception and breastfeeding duration were examined using the Kaplan-Meier survival 
analysis described above utilizing propensity score based inverse probability weights to 
control for social, demographic, health, and healthcare factors. As with Aim 3, an 
analysis of all forms of combined hormonal contraception was done with comparison 
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groups of progestin-only methods, non-hormonal methods, and no contraception.  The 
categories were defined as in Aim 3 with the addition of the following grouping: 
 
Combined estrogen/progestin methods 
Combined pill 
Nuva ring 
Contraceptive patch 
 
The following comparisons will be made: 
Analysis 1: 
Combined estrogen/progestin vs. Progestin-only 
Combined estrogen/progestin vs. non-hormonal methods 
Combined estrogen/progestin vs. no contraception 
 
 
LIMITATIONS 
 
Although the project improves on the designs of previous investigations, there are 
several limitations to the data and analysis.   
 
Competing Reasons for Breastfeeding Cessation: In the United States, there is a large 
drop-off in breastfeeding rates during the first year, which could affect the ability of my 
analyses to detect any associations between all the factors considered. Unmeasured 
factors that contribute to breastfeeding cessation could be wrongly attributed in this study 
as an effect of contraceptive use. The use of propensity scores is intended to address the 
multi-faceted nature of this topic area and, therefore, address this concern.  If factors such 
as social, demographic, and healthcare are more important to breastfeeding cessation than 
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biological factors, it may be difficult to detect the biological impact of contraceptive use 
if there is residual confounding.  
 
Sample Population: The sample population was selected from North Carolina Birth 
Certificates and contacted by telephone. To the extent that differences exist between 
those who are available by landline telephone and those who cannot be reached by this 
means, including those who do not have a landline telephone, my sample may be biased.  
For instance, people who use cell phones exclusively would not be available by landline 
telephone, and this could disproportionately include younger, poorer, and more transient 
mothers.  Moreover, if willingness to participate were not randomly distributed, my 
sample would be biased. These concerns are addressed in two ways. First, the initial 
selection process from birth certificate records, which was random, provides the best 
possible foundation for sample selection. In addition to this, many measures were 
undertaken to contact potential subjects including attempting to make contact at different 
times of the day and week, multiple attempts to contact women, and contact attempts 
over several months. Furthermore, if the potential participant declined, efforts were made 
by specially trained personnel to convince the potential study subjects to participate. In 
sum, these efforts should minimize the potential issues. 
 
Questionnaire: The study design relied on maternal self-report and is therefore subject to 
bias, in particular, recall bias and bias in reporting perceived positive behavior. Survey 
respondents reported their answers to a survey administrator, potentially introducing a 
bias in avoiding stigma.  However, to mitigate these issues, specific efforts were made to 
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the wording of the questionnaire and survey administrator’s demeanor and tone such that 
the questions would be perceived as neutral.    
A small number of study participants (25, 1.5%) stopped responding mid-way 
through the questionnaire, leading to a large amount of missing data for these 
participants. This could introduce bias since those who complete the survey may differ in 
some way from those who are unable or unwilling to do so.  To obtain a complete 
questionnaire response from each respondent, efforts were made by the data collection 
company to re-contact these participants if at all possible.  Still, about 1% of participants 
were unable or unwilling to complete the questionnaire. These analyses will use a 
complete case analysis design, such that participants with missing values will be 
excluded in the analytic sample. 
   The breastfeeding and contraception portion of the survey were imbedded in a 
larger survey on infant crying behavior and parenting. Adjustments to the skip pattern on 
the breastfeeding questions makes analysis of exclusive breastfeeding possible only for 
those who are still nursing, and therefore analysis of this outcome is not proposed as part 
of this project. This is unfortunate, since exclusivity is a relevant outcome of interest in 
relation to milk supply, a potential point of impact for exogenous hormones like those in 
hormonal contraception. The cross-sectional study design led to a high degree of 
censored breastfeeding data.  A longitudinal study design could have captured the timing 
of breastfeeding cessation and contraceptive use more thoroughly.  In spite of this, the 
other benefits of this data set make it a valuable and appropriate choice for this project. 
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INNOVATION 
 
This project is innovative in three ways.  First, the data were collected from a US 
cohort, which addresses a gap in the literature regarding the specific interaction of US 
breastfeeding patterns and norms with the biological pressure, if any, of hormonal 
contraception.  Because breastfeeding is a multi-faceted biological process with many 
opportunities to be affected by the mother’s behavior, practices of the healthcare system, 
social and psychological context, and social norms including laws and regulation, this 
topic is, by necessity, culturally specific.  Examining this topic in a contemporary US 
setting, then, is important for informing policy and interventions that are appropriate for 
our cultural context and current contraceptive formulations and products.  
Second, this project improves significantly on the methodology used in much of 
the literature. The use of both survival analysis and propensity scores is a significant 
improvement on the techniques used in nearly all of the previous studies. Indeed, only 
one of the articles reviewed used survival analysis, and use of this technique was 
specifically identified by Kapp et al. as being superior for this topic area. (105) The vast 
majority of the background literature was impacted by an inability to adequately address 
confounding. Yet, for both breastfeeding and contraceptive use, a wide variety of factors 
are known to be associated with outcomes. Thus making it especially critical to isolate 
the biological interaction of interest from all the other influences. Propensity scores offer 
a methodological and theoretical advantage over other techniques used to control for 
confounding, provided they include the relevant factors.  Furthermore, they may allow 
examination of causality whereas other methods enable discussion only of association. To 
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the best of my knowledge, propensity scores have never been used to examine 
breastfeeding and contraception. Therefore, this project innovates by introducing a new 
statistical method, propensity scores, to the field and by using survival analysis on this 
topic for only the second time. 
Third, this project furthers our knowledge by combining well-designed measures 
of breastfeeding with robust measures of contraceptive use. In the public health literature, 
few data sets capture both breastfeeding and contraceptive use and even fewer do it with 
measures that are well designed to address these research questions. The Purple Crying 
data set is unusual in both ways, and therefore offers a special opportunity to explore the 
biological interaction between the two. 
Finally, this project is innovative in its exploration of social, demographic and 
healthcare factors and their relationship to the interaction between breastfeeding and 
contraceptive use. A thorough understanding of the interplay of these issues is important 
for understanding how to improve outcomes, diminish health disparities, and enable 
women to make informed choices about their lives. This project seeks to elucidate the 
highest impact opportunities, as well as the places where further study is needed. In 
summary, this project innovates by examining the topic in a culturally relevant setting, 
applying novel methods, combining robust measures, and exploring the associated 
factors.
 79 	  
CHAPTER II: FACTORS ASSOCIATED WITH BREASTFEEDING DURATION 
IN A NORTH CAROLINA POPULATION 
 
INTRODUCTION 
 
Breastfeeding is the optimal form of infant feeding according to both the World 
Health Organization (WHO) and the American Academy of Pediatrics (AAP). (1,2) The 
health benefits of breastfeeding are well established with short and long term advantages 
for the baby and mother substantiated in the research literature. (3) Breastfed infants have 
lower rates of a wide range of illnesses including ear infections, bacterial meningitis, 
urinary tract infections, intestinal infections, diarrhea, and childhood cancers. (7-15) 
Lower rates of sudden infant death syndrome, asthma, obesity, and diabetes are seen in 
children who are breastfed. (16-24)  Childhood cognitive development may also be 
enhanced by breastfeeding. (25-27)    
Mothers experience better immediate and long-term health outcomes with 
breastfeeding.  Women who breastfeed have less postpartum blood loss and are more 
likely to experience rapid uterine involution. (28) They also have lower rates of breast 
and ovarian cancer and fewer hip fractures and osteoporosis later in life. (29-33)  The 
impact on long-term health for individuals and on healthcare costs as a nation is, 
therefore, large. (34) Infant morbidity and mortality related to the low prevalence of 
meeting the 6 month exclusive breastfeeding recommendations of the American 
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Academy of Pediatrics alone is estimated to cost the United States (US) $13 billion 
annually. (35) 
The AAP and WHO recommend exclusive breastfeeding for the first six months 
of life with continued breastfeeding afterwards. The Healthy People 2010 initiative of the 
US Department of Health and Human Services set a goal for the country of at least 75% 
breastfeeding initiation and at least 50% breastfeeding continuation at 6 months. (4) By 
2010, 76.9% of infants had ever been breastfed and 47.2% were nursing at six months, 
nearly meeting the Healthy People 2010 target. (5) However, only 16.3% were 
breastfeeding exclusively at six months, the recommendation from both the WHO and 
AAP. Healthy People 2020 set new goals for breastfeeding over the current decade 
including an 81.9% initiation rate, 60.6% continuation at six months, and 25.5% 
exclusive breastfeeding at six months. (6) To meet these ambitious targets new programs 
and policies will be needed.  
This project aims to inform that process by providing up-to-date information 
about breastfeeding in a US population. North Carolina offers an ideal setting for this 
work because it falls in the middle of the spectrum of US states in terms of breastfeeding 
outcomes, has a diversity of urban and rural areas, and has significant immigration from 
other parts of the country, mixing social norms from other regions. Geophysically, socio-
culturally and economically, there is a diversity of settings within the state that 
encompass a wide spectrum of the American social context. Politically, the electorate 
splits closely between major parties.  There is a sizable minority of African Americans 
and Hispanics.  Together, this makes North Carolina an informative setting to explore the 
current state of breastfeeding in the US, and well suited to addresses this question.  
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MATERIALS AND METHODS 
 
Subjects 
North Carolina birth certificate records were used to identify English- and 
Spanish-speaking new mothers for a one-time telephone survey. Women were selected 
from the approximately 130,000 live births annually in the state. Potential study subjects 
were selected in four rounds with over-sampling for Hispanic maternal ethnicity, baby’s 
age (<2 months, 2-3 months), size of the hospital where the mother gave birth, and 
urban/rural location. Once selected, the mother’s telephone number was back-matched 
from name and address information on the birth records, and only those records for which 
a telephone number could be matched and for whom a household in North Carolina could 
be reached were considered eligible for study participation by the study sponsors. Unless 
there was more than one eligible child in the household, no effort was made to verify that 
the study participant matched the infant referenced on the birth certificate. The female 
parent or legal guardian was interviewed one time, and interviews were conducted 
between April 2010 and March 2011.  The complete sample included 1,669 women, 
while the study sample was restricted to participants with complete information on all 
study variables included in the analysis, leaving 1,573 respondents or 94.2% of the 
original sample.   
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STATISTICAL ANALYSES 
 
 Chi square and Wilcoxon rank sum tests were performed to assess differences 
between those who initiated breastfeeding and those who did not. Cox proportional 
hazards models using the discrete method were used to examine the association between 
the independent variables and breastfeeding duration, with time measured in weeks. Two 
analyses were performed. The first analysis included the entire study population, 
regardless of whether they initiated breastfeeding.  This enabled us to examine the 
associations for the general population of women giving birth in this setting. The second 
analysis was among only those women who initiated breastfeeding, allowing us to 
explore the associations of timing of initiation, as well as, other independent variables 
with breastfeeding duration among initiators. Women who were still breastfeeding at the 
time of the interview were right censored in our analysis, whereas those who had ceased 
to breastfeed prior to the interview had a known, final breastfeeding duration. The final 
model was developed beginning from a full model that included all possible covariates 
known from the literature to be associated with breastfeeding outcomes and which were 
available in the sample.  To assess the best way to code variables where more than one 
logical option existed, nested models were compared using likelihood ratio tests with a 
cut-off of p<0.05. Non-nested models were compared using Akaike Information Criterion 
(AIC) and Bayesian Information Criterion (BIC), and covariates that were neither 
statistically significant at the p<0.05 level nor crucial factors from the literature were 
removed from the model.  A final, reduced model is presented here. All analyses were 
performed using SAS software version 9.2.   
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MEASURES 
 
Demographic characteristics. Maternal age, infant race/ethnicity, region of birth, 
maternal educational attainment, and the baby’s gender were assessed via the survey 
questionnaire. The BIC was used to determine that maternal age could be sufficiently 
modeled as a continuous variable as opposed to an ordinal variable with 5-year bins or 
with a quadratic term. Maternal age was mean-centered for ease of interpretation.  
Race/ethnicity of the infant was determined based on the mother’s response to separate 
questions about race and Hispanic ethnicity. Participants could choose as many categories 
of race as they wished. A single category of race/ethnicity was used for the analyses and 
was coded to be the most conservative estimate of breastfeeding impact based on 
breastfeeding rates in the general population.  If Hispanic ethnicity was indicated, it was 
chosen over other racial and ethnic categories.  Infants with only one race reported on the 
survey were identified as that race.  Among the remaining study subjects who were 
reported to be mixed-race, any infant identified as being “white” in a separate question 
about whether the parent considered the child white, was identified as “non-Hispanic 
white.”  Next, those who were reported to be mixed-race with one race being black were 
identified as “non-Hispanic black.” All remaining study subjects were classified as, 
“other,” which included Asian, Pacific Islander, Hawaiian, Alaskan native, and Native 
American, as well as, anyone who identified their child as “other”. 
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Health factors. Particular health factors related to breastfeeding initiation and duration 
were assessed by specific questions in the interview. Nulliparous or multiparous status 
was determined based on the mother’s response to whether there was an older biological 
sibling. Neonatal intensive care unit (NICU) stay for the infant was also directly queried 
in the interview. 
 
Psychosocial factors. An aim of this study was to assess whether pregnancy wantedness 
is associated with breastfeeding outcomes. The wantedness of the pregnancy has been 
shown to affect other outcomes such as antenatal care, stunting and later mental health 
for the child, signs that care giving may be different for infants born of unwanted or 
mistimed pregnancies. (179-181)Moreover, pregnancy intention was shown to be 
associated with breastfeeding initiation and duration for white mothers in a US-based 
study from 1995. (182) Pregnancy intention was assessed using the World Health 
Organization’s four part scale: wanted at this time, wanted not at this time, not wanted, 
and all pregnancies are wanted. The impact of a mother’s intention to breastfeed was also 
explored via a direct question about her pre-birth intention to breastfeed.    
  
Hospital practices. The Ten Steps to Successful Breastfeeding have been shown to 
impact both initiation and duration of breastfeeding in other populations (Table 2). (199) 
Mothers in this sample were asked about the seven practices that derive from the Ten 
Steps and that apply to the immediate postpartum time frame. A likelihood ratio test was 
used to inform the modeling of timing of initiation. Time points that would be 
informative to current recommendations and practices were also considered in developing 
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four categories of timing of breastfeeding initiation for our model. Provision of a hospital 
sample bag was modeled as a dichotomous variable (yes/no) that was considered 
independently from the other practices because many hospitals in this region implement 
this practice secondary to a statewide campaign. (210)  The other 5 hospital practices 
were explored individually and as a proxy variable, scored zero to five, of how many of 
the practices were experienced by the mother. The practices were not specific to the Ten 
Steps, but are aspects of specific steps.  These practices are immediate skin-to-skin 
contact between mother and infant after birth (Step 4), rooming-in at least 22 of every 24 
hours (Step 7), visit by a Lactation Consultant (LC) or breastfeeding support person 
(proxy for Step 5), observation of a feeding by an LC or breastfeeding support person 
(also Step 5), and all facility staff supporting the mother’s decision on infant feeding 
(also Step 5).   
 
Breastfeeding. The outcome of interest, breastfeeding duration, was determined based on 
three questions from the interview. At the beginning of the interview, mothers were asked 
the birth date of their infant, and the infants age at the time of the survey was calculated 
from the difference between the interview date and the infant’s birth date. Later, 
respondents were asked whether they were still breastfeeding their infant, and if not, a 
follow-up question was asked about the age at which they ceased breastfeeding their 
infant. About 70% of the respondents were still breastfeeding at the time of the survey, 
and their breastfeeding duration was right censored in the analysis. Among those who 
reported having stopped breastfeeding, their breastfeeding duration was calculated based 
on the mother’s report of the infant’s age at cessation. This was compared to the actual 
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infant’s age at the time of the survey, and implausible values due to impossible 
relationships between the times reported were discarded as unreliable; however, no 
subjects were dropped due to implausible values for infant age.    
 
Interaction Terms. An exploratory analysis of interactions between the factors in the 
model was performed by modeling interaction terms between the variables for hospital 
practices and maternal age, timing of breastfeeding initiation, NICU stay, infant gender, 
intention to breastfeed.  In addition, interaction terms for first born status and NICU stay 
and for the wantedness dummy variables were explored, as well as breastfeeding 
intention and infant gender since breastfeeding duration has been shown in some studies 
to be associated with infant gender.  A statistically significant interaction between NICU 
stay and parity was found for one of our analyses. In the other analysis, its significance 
diminished beyond the p< 0.05 level when other factors were included in the model. An 
interaction between maternal age and the hospital practices proxy variable was also 
found, and it was significant in some analyses at the p<0.05 level.  A likelihood ratio test 
and the BIC were used to inform the final selection of the ordinal hospital practices 
variable for the model. 
 
Missing Data. With the exception of the variables for household income (10.7% missing) 
and intended duration of breastfeeding (17.8% missing), the level of missing data in this 
sample was very low, between 1% and 3% for all variables.  A likelihood ratio test was 
carried out for the model with and without household income, and it was determined that 
household income was not critical for the model. Forest plots were used to assess whether 
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estimates of the other variables were affected by including or excluding income, and in 
no case did the change in parameter estimate exceed the confidence interval for that 
variable. Likewise, the high degree of missing data for intended breastfeeding duration 
was thought to be non-random, potentially representing differences in confidence, 
determination, and/or education about breastfeeding that could be reflected by having an 
intended duration or not having a clearly defined plan for this. Therefore, both income 
and intended breastfeeding duration were excluded from the model.  A complete case 
analysis was performed, excluding respondents with missing values for any variables, 
which led to a final study sample of 1,573 (94.2% of the original 1,669 respondents).    
 
IRB.  This study received IRB approval from the University of North Carolina, Chapel 
Hill. 
 
RESULTS 
 
Description of the population by Univariate and Bivariate Analyses 
The sample included 1,573 women for whom there was complete information on 
all variables in the analysis (Table 3).  Most of these women initiated breastfeeding 
(1,333), with only 15.3% not initiating after birth (Tables 5a and 5b).  The mean maternal 
age in the population was 30.2 years old, with a minimum of 14 and a maximum of 46 
(Table 5a).  The sample was 65.9% non-Hispanic white, 12.5% non-Hispanic black, 
18.7% Hispanic, and 2.9% other. There were slightly more female infants (51.9%), and 
11.6% of infants spent time in the NICU in comparison to about 6.7% nationally. (211)  
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First time mothers made up 64.5% of the population and 12.3% of women had less than a 
high school degree, 29.1% had a high school education, 40.0% had a college degree, and 
18.6% had a graduate degree.  The mean infant age at the time of the interview was 3.52 
months (Table 5a), and across the range of infant ages there was variation in whether or 
not the mother-baby dyad was still breastfeeding (Table 4). 
  Significant differences on most variables existed between women who initiated 
breastfeeding and those who did not (Tables 5a and 5b). While the minimum and 
maximum ages of these groups were nearly identical, minimum of 14 for both, and 
maximum of 46 and 45 respectively, the median age of those who ever breastfed was 31, 
whereas those who never breastfed had a median age of 29.  Race/ethnicity was also 
significantly different between the groups who did and did not breastfeed.  Blacks were 
much less likely to breastfeed than other groups, with 67.5% breastfeeding.  Hispanics 
were much more likely to breastfeed; fully 92.9% initiated breastfeeding.  Whites and 
those classified as other had nearly equal breastfeeding initiation rates, 85.6% and 86.7% 
respectively.  Mothers with more education were more likely to initiate breastfeeding, 
with the least likely being those with only a high school degree (75.5%), followed by 
mothers with less than a high school education (81.4%), and mothers with a college 
degree (87.0%).  Nearly all women with a graduate degree initiated breastfeeding 
(96.6%).  Timely, wanted pregnancies were more likely to be followed by breastfeeding 
initiation (88.0%), than mistimed and unwanted pregnancies (79.6%) or for women for 
whom ‘all pregnancies would be wanted’ (80.7%). 
Intention to breastfeed was strongly associated with breastfeeding initiation, but 
doesn’t appear to be absolutely necessary for initiation or to guarantee initiation. A 
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notable group of women who had not intended to breastfeed did initiate (15.9%), and a 
smaller group who had planned to breastfeed never initiated (5.5%).  
Women’s experience with breastfeeding-related maternity care practices is also 
significantly different between those who initiate and those who do not. Formula sample 
bag were received at hospital discharge by 87.9% of women who did not breastfeed, 
whereas 76.4% of women who initiated breastfeeding received one.  Among women who 
initiated breastfeeding, 44.4% started within the first hour after giving birth, 20.1% 
started between one and two hours, 25.4% started between 2 and 24 hours, and 10.1% 
started after the first day (Table 6).  Five other maternity care practices were combined 
into a proxy variable for the number of breastfeeding-supportive hospital practices 
experienced by women in our study, and the association with breastfeeding initiation was 
significant for this composite measure. While the minimum and maximum were the 
same, zero and five respectively, the median number of practices experienced by those 
who did not initiate was two, compared to four practices for those who did breastfeed.  
All five of the individual practices that comprised this proxy variable were also 
significantly different between those who ever breastfed and those who did not.   
The infant’s gender, whether he or she was the first-born, and whether he or she 
had been admitted to the NICU were not significantly different between those who 
initiated breastfeeding and those who did not, though the trends on each of these 
characteristics are in keeping with results from other studies showing lower breastfeeding 
rates for boys, infants in the NICU, and first babies. 
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Multivariate Analysis of Factors Associated with Breastfeeding Duration for All 
Mothers 
In a Cox proportional hazards model of time to breastfeeding cessation including 
all mothers in our sample, breastfeeding duration was significantly associated with 
race/ethnicity, maternal education, firstborn status, mother’s intention to breastfeed, 
receipt of a formula sample bag, and an interaction between maternal age and hospital 
practices (Table 7). Maternal age, pregnancy wantedness, the baby’s gender, the number 
of hospital practices experienced, and an interaction between NICU stay and first-born 
status did not predict breastfeeding duration in this model. 
Blacks had the highest odds of breastfeeding cessation (OR 1.35, 95% CI 1.05 – 
1.07), while Hispanics had the lowest (OR 0.55, 95% CI 0.42 – 0.72).  Maternal 
education was associated with breastfeeding duration in a dose response manner. 
Compared to mothers with a high school education, the odds of breastfeeding cessation 
among college-educated women were 45% lower (OR 0.55, 95% CI 0.39 – 0.77), and 
among women with a graduate degree were 67% lower (OR 0.33, 95% CI 0.22 – 0.50).  
First-born infants had higher odds of breastfeeding cessation than infants with 
multiparous mothers (OR 1.46, 95% CI 1.19 – 1.79).  That is, mothers who had older 
children were less likely to stop breastfeeding than first time mothers. Intention to 
breastfeed was highly associated with breastfeeding continuation (OR 0.08, 95% CI 0.06 
– 0.10).  Hospital policies were also significantly associated with breastfeeding outcomes. 
Receiving a formula sample bag at hospital discharge was associated with an increased in 
the odds of cessation (OR 1.80, 95% CI 2.44 – 2.26).  Hospital practices were not 
significantly associated with breastfeeding duration, but an interaction term for hospital 
practices and maternal age was significantly associated (OR 0.99, 95% CI 0.98 – 1.00).  
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That is, for each 1-year increase in maternal age and one practice increase in the number 
of hospital practices received, there was a 1.3% decrease in the odds of breastfeeding 
cessation  
Survival curves of breastfeeding duration (figure 4) were drawn showing the 
variation of a single variable. All other covariates held constant at their mean value from 
the regression model: Firstborn (0.35), NICU (0.12), interaction term for NICU and 
firstborn (0.05), black race/ethnicity (0.13), Hispanic race/ethnicity (0.19), other 
race/ethnicity (0.03), unwanted or mistimed pregnancy (0.26), all pregnancies wanted 
(0.14), maternal age (7.4 x1015 ), high school education (0.29), college education (0.40), 
graduate school education (0.19), intention to breastfeed (0.88), infant gender (0.52), 
receipt of a formula sample bag (0.78), hospital practices (3.67), interaction term for 
hospital practices and maternal age (110.41).    
 
Multivariate Analysis of Factors Associated with Breastfeeding Duration Among 
Those Who Initiate Breastfeeding 
Among women who initiated breastfeeding, the predictors of breastfeeding 
duration in a multivariate analysis using a Cox proportional hazards model were 
race/ethnicity, education, pregnancy wantedness, first-born status, an interaction between 
NICU stay and first-born status, intention to breastfeed, receipt of a formula sample bag, 
and timing of initiation (Table 8).  All statistically significant associations were smaller 
when the analysis sample was limited to those who initiated, with the exception of those 
women who had a graduate school education, which was larger here (OR 0.49, 95% CI 
0.31-0.76).  In addition, the interaction term for maternal age and hospital practices is not 
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statistically significant in this sub-population, although it was marginally significant for 
all mothers.   
Two factors were significant here but not in the large sample, pregnancy 
wantedness and an interaction between NICU stay and first-born status.  Women with 
mistimed or unwanted pregnancies had higher odds of breastfeeding cessation than 
women with timely, wanted pregnancies  (OR 1.32, 95% CI 1.06-1.65). An interaction 
between NICU stay and first-born status is associated with longer breastfeeding duration 
among infants with older siblings who spent time in the NICU relative to first-born 
infants who had NICU stays (OR 0.56, 95% CI 0.32 – 0.97).  In this sub-population of 
only those who initiate breastfeeding after birth, the significance of differences in 
breastfeeding outcomes for blacks relative to white (OR1.11, 95% CI 0.85-1.47) and for 
college-educated relative to less educated women (OR 0.74, 95% CI 0.51-1.07), which 
was observed in the analysis of all mothers, disappeared.   
Timing of initiation is also associated with breastfeeding duration; initiation 
within the first hour is associated with longer durations. Compared to those who initiate 
within the first hour, those who initiate between the first and second hour have a 43% 
higher odds of cessation (OR 1.43, 95% CI 1.10 – 1.85), and those who initiation later in 
the first day have a 80% higher odds of cessation (OR 1.80, 95% CI 1.42 – 2.29).  Those 
who initiate after the first day have 62% higher odds of cessation compared to those 
within the first hour (OR 1.62, 95% CI 1.13 – 2.32). 
Survival curves of breastfeeding duration for women who initiate breastfeeding 
(figure 5) were drawn showing the variation of a single variable.  All other covariates 
held constant at their mean value from the regression model: First-born (0.36), NICU 
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(0.11), interaction term for NICU and firstborn (0.05) Black race/ethnicity (0.10), 
Hispanic race/ethnicity (0.21), other race/ethnicity (0.03), mistimed/unwanted pregnancy 
(0.25), all pregnancies wanted (0.13), maternal age (4.9 x 1015), high school education 
(0.26), college education (0.41), graduate school education (0.21), intention to breastfeed 
(0.98), baby’s gender (0.52), breastfeeding initiation between 1 and 2 hours (0.20), 
breastfeeding initiation between 2 and 24 hours (0.25), breastfeeding initiation after 24 
hours (0.10), receipt of a formula sample bag (0.76), hospital practices (3.88), interaction 
term for hospital practices and maternal age (117.28). 
 
DISCUSSION 
 
A Cox proportional hazards model of time to cessation of breastfeeding for all 
mothers in the sample found race/ethnicity, maternal educational attainment, having 
one’s first biological child, intention to breastfeed and an interaction term for maternal 
age and the number of hospital practices experienced by the mother to be significantly 
associated with breastfeeding duration.   
Racial and ethnic differences in breastfeeding outcomes found in this study are 
consistent with national trends.  Hispanics have the highest initiation and continuation 
rates, followed by whites and then blacks whose initiation rate lags whites by nearly 
twenty percentage points.  This striking racial health-behavior disparity may be a 
foundation for other health disparities since breastfeeding is associated with a reduction 
in many infectious and chronic diseases.  In terms of breastfeeding, race may serve in 
part as a proxy for a variety of socioeconomic and cultural factors that define distinct 
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contexts for breastfeeding.  In order to improve breastfeeding outcomes for black 
mothers, identifying and addressing their specific barriers to breastfeeding will be 
important.  In this study, breastfeeding durations for the sub-population of women who 
successfully initiate breastfeeding did not differ for black and white mothers.  This 
suggests that achieving breastfeeding initiation is critical in addressing the lower 
breastfeeding rates among blacks, and that once over this hurdle, breastfeeding outcomes 
are similar to those of whites. In light of this, efforts to reduce health inequity based on 
lower breastfeeding rates for blacks should be targeted at increasing breastfeeding 
initiation in this group. 
Breastfeeding duration was nearly identical for mothers with high school degrees 
and those who had not completed high school, but there seemed to be a dose-response 
effect for higher levels of education.  Similar to the results for race, the difference in 
breastfeeding duration between college educated mothers and those with less education 
disappeared in the analysis that included only those who had initiated breastfeeding, 
implying that the positive association with being college educated primarily affects 
breastfeeding initiation. Women with a graduate degree, however, continued to have a 
significantly lower risk of breastfeeding cessation even after accounting for differences in 
initiation.  Maternal educational is often considered a proxy for socioeconomic status; 
however, in this instance it may be capturing additional dimensions relevant for 
breastfeeding outcomes, such as increased knowledge of breastfeeding, maternal self-
efficacy, ability to seek and obtain support, differences in partnership dynamics, 
economic power within the family, and differences in decision-making responsibility, 
among many other possible explanations.  Further, highly educated women may be more 
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likely to have work environments that are conducive for breastfeeding, have access to 
maternity leave, or be able to choose not to work.  Identifying the factors that contribute 
to the better outcomes among these mothers could inform policies and programs to help 
meet the national breastfeeding continuation goals. 
Mothers with timely, wanted pregnancies were most likely to begin breastfeeding, 
while all others initiated at similar, lower rates.  Pregnancy wantedness was significantly 
associated with duration among those who initiated breastfeeding.  This factor – 
wantedness of the pregnancy - is not generally included in the US-based studies however 
in this study there is a suggestion that those who successfully control fertility may also 
have increased success in the health and parenting choices made after birth. This further 
highlights the importance of a woman’s ability to access effective and attractive 
contraception not only for the mother’s health outcomes, but also for those of her child. 
Conversely, a possible confounder could be that access to both fertility control and 
breastfeeding are the result of access to adequate health care.  Since birth spacing 
contributes to both maternal and child health, and since there is an association in this 
study between fertility control and breastfeeding success, further study of this issue in the 
US context is warranted.  
First time mothers were found to breastfeed for shorter durations, on average, 
compared to mothers with older biological children. While this is a not uncommon 
finding in the literature, in this study there is an interaction between infant NICU stay and 
first-born status, showing a lower risk of breastfeeding cessation among first time 
mothers whose baby spends time in the NICU.  This is somewhat counter-intuitive, 
because the infants in these mother-baby dyads are less healthy than their peers.  Since 
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the improved breastfeeding outcomes are unlikely to be attributable to infant factors, this 
suggests that, for first-time mothers, interaction with the NICU is beneficial for 
breastfeeding. At least one older study based on national datasets found that prolonged 
infant stay in the hospital was associated with increased breastfeeding duration. (212)  
Future studies could explore this situation to see if there are factors that might modeled as 
healthcare practices to promote breastfeeding for all first-time mothers.  
Intention to breastfeed was strongly associated with breastfeeding duration.  The 
magnitude of this association suggests that program or clinical activity designed to 
influence women’s breastfeeding intention may be a high-yield opportunity for 
improving breastfeeding outcomes.  Hence, there may be a need for health education 
campaigns aimed at women and their families before conception or early in prenatal care, 
instead of at the end of their pregnancies.  In bivariate analyses, intention to breastfeed 
was highly associated with initiation, but not completely predictive. About 5.5% of 
women who intended to breastfeed did not initiate; this may have been due to adverse 
experiences during or immediately following labor and delivery, such as maternal or 
infant illness, hospital practices or other events that interfered with initiation.  On the 
other hand, 15.9% of women who had not planned to breastfeed nonetheless initiated 
breastfeeding. From a breastfeeding advocacy standpoint, these changes from original 
intention suggest that experiences around the time of birth can affect breastfeeding 
outcomes.  Such impact of the hospital experience on breastfeeding outcomes is 
illustrated in the extensive literature on hospital practices that serve as barriers to 
breastfeeding. (213)  A higher percentage of women were converted from non-intention 
to breastfeeding than the other direction, and this may indicate that activities ongoing in 
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NC hospital settings are reflected in breastfeeding support. This hypothesis is supported 
by the fact that those who initiated breastfeeding reported more of the Ten Step hospital 
practices that are known to be associated with breastfeeding initiation in other settings. 
(199) 
The Ten Steps to Successful Breastfeeding guidelines were developed by 
UNICEF and WHO to provide guidance for clinicians providing obstetric and maternity 
care regarding practices that support a mothers’ ability to succeed in breastfeeding 
initiation and achieve longer durations of breastfeeding.  Seven of these steps related to 
maternity care practices around birth and the immediate postpartum time frame. Women 
who received a formula sample bag, part of Step 6, were less likely to initiate 
breastfeeding than those who did not receive a sample bag.  Because initiation comes 
before the sample bag would be offered, this could reflect a lack of system-wide support 
for breastfeeding.  This study confirmed that receipt of formula sample bags is associated 
with shorter breastfeeding duration.  Having formula on-hand may provide an easy 
“solution” during breastfeeding challenges, and creates a path to feeding supplements, 
which can disrupt the physiology of milk supply and lead to weaning.  Another 
explanation for this association may be that formula sample bags could be a proxy for a 
number of other, unmeasured practices and interactions that either discourage 
breastfeeding or pre-dispose it to be of shorter duration, as suggested by the association 
with breastfeeding initiation. In North Carolina, the setting for this study, efforts by the 
North Carolina Breastfeeding Coalition (NCBC) to encourage hospitals not to provide 
these bags in North Carolina have resulted in hospitals eliminating formula sample bags 
as a first step, and this may or may not be the only, clearly defined change to 
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breastfeeding-related maternity practices. (210)  Thus, stopping provision of formula 
sample bags may be an early marker that a hospital is moving towards more 
breastfeeding friendly policies. 
Initiation of breastfeeding within the first hour after birth, as per Step 4 of the Ten 
Steps, is significantly associated with breastfeeding duration.  Relative to early initiation, 
all later time points, including initiation between the first and second hours, were 
associated with significantly shorter duration of breastfeeding, and none of these later 
times of initiation were significantly different from each other.  This supports the concept 
that there may be a critical window for breastfeeding initiation and further supports the 
contention that hospital policies for delivery practices may have a long-term impact on 
breastfeeding.   
The five other hospital practices evaluated in this study were immediate skin-to-
skin contact after birth, infant rooming-in, visit by a lactation consultant or other 
breastfeeding support person, observation of a feeding by a lactation consultant or other 
breastfeeding support person, and whether the mother felt supported in her feeding choice 
by all facility staff.  The mean number of practices reported by women who initiated 
breastfeeding was 3.9, in contrast to only 2.5 for women who did not begin nursing.  
Individually, all five practices were also significantly associated with breastfeeding 
initiation, confirming that the maternity care practices endorsed in the Ten Steps are 
positively associated with this measure of breastfeeding success.  While there was a trend 
towards positive associations with breastfeeding duration, this association was not 
statistically significant.  This could indicate that other factors have a bigger impact on 
longer-term breastfeeding outcomes.  Recall bias or confusion with the survey questions 
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could also be an issue.  Nonetheless, all seven of the Ten Step hospital practices 
evaluated in this study were found to have a significant association with breastfeeding 
outcomes, adding evidence that these measures are relevant and worthwhile for 
breastfeeding promotion in the current US maternity care setting.  This has important 
implications for public health policy and for best practices for clinical care.  This work 
further substantiates that implementation of the Ten Step guidelines could improve 
breastfeeding outcomes in the US and should be strongly considered by policy-makers.  
Finally, an interaction term between maternal age and the number of hospital 
practices reported by the mother shows a protective effect that increases with both 
maternal age and the number of breastfeeding supportive hospital practices a woman 
receives.  This result should be interpreted with caution since it is only marginally 
significant at the p<0.05 level and since neither factor on which it is based is, by itself, 
significantly associated with breastfeeding duration in the multivariate analysis. On the 
other hand, both maternal age and hospital practices have been associated with increased 
duration of breastfeeding in other studies, so it is plausible that these factors could play a 
role in breastfeeding success. While the odds ratio appears to be small, just 1.3% lower 
odds per maternal year and hospital practice, the impact can quickly add up when one 
considers maternal ages of 20, 30 or 40 years, and multiple hospital practices. The 
implication of this term, if valid, is that hospital practices affect older mothers differently 
than younger ones. Further research is needed to clarify whether this effect is spurious, 
but to the extent that it reflects real differences among mothers, it has important 
implications for the implementation of breastfeeding-related hospital practices and for 
improving health disparities between mothers of different ages.     
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LIMITATIONS 
 
The high amount of censored data in this sample (69.0%) may limit the power to 
detect differences in breastfeeding duration.  While their ultimate duration of 
breastfeeding is unavailable for these women, it is informative that they were able to 
breastfeed as long as they reported.  Censoring would likely be a less significant issue at 
earlier time-points, which is the time frame of most interest since women may be a more 
vulnerable to breastfeeding cessation as the biology and behavior of breastfeeding are 
being established.  Censoring could bias the sample if it were associated with 
breastfeeding.  This sample was selected at random from birth certificate data, limiting 
this possibility; however, if availability by landline telephone or willingness to participate 
in a telephone survey was correlated with breastfeeding outcomes or contraceptive use 
this could introduce bias.         
Intensity or exclusivity of breastfeeding could not be evaluated in this sample, and 
therefore could not assess these more nuanced breastfeeding outcomes. This is 
unfortunate, since exclusivity is a relevant outcome of interest for behavioral, health, and 
policy reasons. In the United States, there is a large drop-off in breastfeeding rates during 
the first year, which could affect the ability of this study to detect associations between 
specific factors and breastfeeding outcomes.  If unmeasured or poorly measured factors 
are more important to breastfeeding cessation than the factors examined here, it may be 
difficult to detect their impact on breastfeeding due to residual confounding.    
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Confounding is a particular problem in this area of work as seen by the significant 
demographic differences between those who did and did not initiate breastfeeding and by 
breastfeeding duration.  Breastfeeding outcomes have been associated with many factors 
including demographic, social, psychological, health, and healthcare.  This dataset is 
unusual for the number and quality of breastfeeding-related questions available.  
However, information on partnership status, social support for breastfeeding, maternal 
depression, urbanicity, maternal obesity, employment and others were not available in 
this dataset.  To the extent that the factors available are more proximal to the outcome, 
they may serve as adequate proxies for these and other unmeasured factors and mitigate 
the vulnerability of this analysis to issues of confounding. 
The sample population was selected from North Carolina Birth Certificates and 
contacted by telephone. Differences in the covariates and in breastfeeding outcomes may 
exist between those available by landline telephone and those who cannot be reached by 
this means including those who do not have a landline telephone.  For instance, people 
who use cell phones exclusively would not be contacted in this study, and this could 
disproportionately exclude younger, poorer, and more transient mothers leading to 
sample bias.  If willingness to participate in a telephone survey is not randomly 
distributed, the sample would also be biased. These concerns are addressed in two ways. 
First, the random selection process using birth certificate records provides an unbiased 
foundation for sample selection.  In addition, many measures were undertaken to contact 
potential subjects including multiple contact attempts, contact at different times of the 
day and week, and contact attempts over several months. Furthermore, if the potential 
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participant declined, efforts were made by specially trained personnel to convince the 
potential study subjects to participate.  
The retrospective study design relied on maternal self-report and is vulnerable to 
recall bias which would be more likely to affect transient factors and factors with 
perceived positive or negative connotation.  For example, unwanted and mistimed 
pregnancies are reported less often in this sample than has been found in national data.  
Mothers may be reluctant to tell the interviewer that their pregnancy was unwanted or 
mistimed, and she might also unconsciously re-evaluate the wantedness of her pregnancy 
as she begins to bond with her baby.  Similarly, a mother’s recall of her intention to 
breastfeed may change in light of her actual experience of breastfeeding.  Reporting of 
hospital practices may be also be bias by events that happen later, and mothers could 
simply not remember what occurred during that time.  Some may not even know whether 
and when events happened, which could be correlated with maternal or infant health.  
Non-random missing data could also lead to sample bias, however the amount of missing 
data for the variables used in the model was 1%-3%, which is very low.  This sample is 
likely comparable in these regards to other studies on breastfeeding since the results on 
covariates commonly reported in the literature are consistent with other breastfeeding 
studies.  
 
CONCLUSION 
 
Overall, these results highlight the importance of labor and delivery practices that 
allow and enable immediate breastfeeding initiation for long-term breastfeeding success.  
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These results support the importance of the Ten Steps to Successful Breastfeeding for 
breastfeeding duration, and suggest that greater adoption of and adherence to this 
standard could improve breastfeeding outcomes.   
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Table 2. The Ten Steps to Successful Breastfeeding, WHO/UNICEF 
1. Have a written breastfeeding policy that is routinely 
communicated to all healthcare staff 
2. Train all healthcare staff in skills necessary to implement this policy 
3. Inform all pregnant women about the benefits and management of breastfeeding 
4. Help mothers initiate breastfeeding within a half-hour of birth 
5. Show mothers how to breastfeed, and how to maintain lactation even if they should be 
separated from their infants 
6. Give newborn infants no food or drink other than breast milk, unless medically 
indicated 
7. Practice rooming-in—allow mothers and infants to remain together—24 h a day 
8. Encourage breastfeeding on demand 
9. Give no artificial teats or pacifiers to breastfeeding infants 
10. Foster the establishment of breastfeeding support groups and refer mothers to them on 
discharge from the hospital 
 
Table 3: Characteristics of the sample (N=1,573) from a Survey Evaluating the 
Period of Purple Crying Intervention Program, 2010-11. 
 Total Percent of Total 
 N=1573 100% 
Race/Ethnicity   
Non-Hispanic White 1,037 65.9% 
Non-Hispanic Black 197 12.5% 
Hispanic 294 18.7% 
Other 45 2.9% 
Maternal Education   
Less than High School 194 12.3% 
High School 457 29.1% 
College 629 40.0% 
Graduate School 293 18.6% 
Pregnancy Wantedness   
Wanted at This Time 940 59.8% 
Not Wanted / Mistimed 420 26.7% 
All Pregnancies Wanted 217 13.8% 
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First Child   
Yes 558 35.5% 
No 1,015 64.5% 
Baby’s Gender   
Female 817 51.9% 
Male 756 48.1% 
NICU Stay   
no 1,390 88.4% 
yes 183 11.6% 
Intended to Breastfeed   
No 195 12.4% 
Yes 1,378 87.6% 
Received Formula Sample Bag   
No 343 21.8% 
Yes 1,230 78.2% 
Immediate Skin-to-Skin   
No 712 45.3% 
Yes 861 54.7% 
Rooming-In   
No 386 24.5% 
Yes 1,187 75.5% 
LC Visit   
No 423 26.9% 
Yes 1,150 73.1% 
LC Observe Breastfeeding   
No 484 30.8% 
Yes 1,089 69.2% 
Staff Supported Mother’s Decision   
No 91 5.8% 
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Yes 1,482 94.2% 
 
 
 
 
 
 
 
 
Table 4: Breastfeeding Status by Month Amongst Those Surveyed at that Time 
Point or Later  (Total N=1,573). Sample Drawn From a Survey Evaluating the Period 
of Purple Crying Intervention Program, 2010-11. 
 Not 
Breastfeeding 
n (%) 
Breastfeeding 
n (%) 
Total 
n 
1 Month 410 (26.1%)  1163 (73.9%) 1,573 
2 Months 557 (35.9%)  993 (64.1%) 1,550 
3 Months 624 (45.8%) 739 (47.0%) 1,363 
4 months 297 (48.8%) 311 (51.8%) 608 
5 Months 42 (58.3%) 30 (41.7%) 72 
> =6 Months 27 (60.0%) 18 (40.0%) 45 
 
 
Table 5a: Characteristics of the Population (continuous variables) by 
Breastfeeding Initiation From a Survey Evaluating the Period of Purple Crying 
Intervention Program, 2010-11. (N=1,573). 
 No 
Breastfeedi
ng 
Initiated 
Breastfeedi
ng 
Total 
 N=240  N=1333 N=1573 
Maternal Age** (years)    
Mean 29.2  30.3 30.2 
Median 29 31 31 
Infant Age at interview (months)    
Mean 3.78 3.47 3.52 
Median 3 3 3 
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Hospital Practices***    
Mean 2.5 3.9 3.7 
Median 2 4 4 
*** p<0.001      **  p<0.01      *    p<0.05      
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Table 5b: Characteristics of the Population by Breastfeeding Initiation From a 
Survey Evaluating the Period of Purple Crying Intervention Program, 2010-11. 
(N=1,573). 
 No 
Breastfeedi
ng 
n (%) 
Initiated 
Breastfeedi
ng 
n (%) 
Total 
n 
 N=240  N=1333 N=1573 
Race/Ethnicity***    
Non-Hispanic White 149 
(14.4%) 
888 
(85.6%) 
1,037 
Non-Hispanic Black 64 (32.5%) 133 
(67.5%) 
197 
Hispanic 21 (7.1%) 273 
(92.9%) 
294 
Other 6 (13.3%) 39 (86.7%) 45 
Maternal Education***    
Less than High School 36 (18.6%) 158 
(81.4%) 
194 
High School 112 
(24.5%) 
345 
(75.5%) 
457 
College 82 (13.0%) 547 
(87.0%) 
629 
Graduate School 10 (3.4%) 283 
(96.6%) 
293 
Pregnancy Wantedness***    
Wanted at This Time 113 
(12.0%) 
827 
(88.0%) 
940 
Not Wanted / Mistimed 85 (20.4%) 331 
(79.6%) 
420 
All Pregnancies Wanted 42 (19.4%) 175 
(80.7%) 
217 
First Child    
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Yes 77 (13.8%) 481 
(86.2%) 
558 
No 163 
(16.1%) 
852 
(83.9%) 
1,015 
Baby’s Gender    
Female 122 
(14.9%) 
695 
(85.1%) 
817 
Male 118 
(15.6%) 
638 
(84.4%) 
756 
NICU Stay    
no 205 
(14.8%) 
1,185 
(85.3%) 
1,390 
yes 35 (19.1%) 148 
(80.9%) 
183 
Intended to Breastfeed***    
No 164 
(84.1%) 
31 (15.9%) 195 
Yes 76 (5.5%) 1,302 
(94.5%) 
1,378 
Received Formula Sample Bag***    
No 29 (8.5%) 314 
(91.6%) 
343 
Yes 211 
(17.2%) 
1,019 
(82.9%) 
1,230 
Immediate Skin-to-Skin*†    
No 124 
(17.4%) 
588 
(82.6%) 
712 
Yes 116 
(13.5%) 
745 
(86.5%) 
861 
Rooming-In**†    
No 79 (20.5%) 307 
(79.5%) 
386 
Yes 161 
(13.6%) 
1,026 
(86.4%) 
1,187 
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LC Visit***†    
No 177 
(41.8%) 
246 
(58.2%) 
423 
Yes 63 (5.5%) 1,087 
(94.5%) 
1,150 
LC Observe Breastfeeding***†    
No 187 
(38.6%) 
297 
(61.4%) 
484 
Yes 53 (4.9%) 1,036 
(95.1%) 
1,089 
Staff Supported Mother’s 
Decision***† 
   
No 32 (35.2%) 59 (64.8%) 91 
Yes 208 
(14.0%) 
1,274 
(86.0%) 
1,482 
*** p<0.001      **  p<0.01      *    p<0.05      
† This variable is included in the ordinal “Hospital Practices” variable and is not 
included as a separate variable in the analyses. 
 
 
Table 6: Timing of Breastfeeding Initiation For Women Who Initiated 
Breastfeeding, From a Survey Evaluating the Period of Purple Crying 
Intervention Program, 2010-11. 
 Percent in the 
entire sample 
(N=1,573) 
Percent among 
those who initiate 
(N=1,333) 
No Breastfeeding 240 (15.3%)  0 (0%) 
< 1 Hour 592 (37.6%) 592 (44.4%) 
1 to 2 Hours 268 (17.0%) 268 (20.1%) 
2 to 24 Hours 339 (21.6%) 339 (25.4%) 
Over 24 hours 134 (8.5%) 134 (10.1%) 
Total 1,573 (100%) 1,333 (100%) 
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Table 7: Parameter Estimates for the Cox Proportional Hazards Model of Time 
to Cessation of Breastfeeding for All Mothers (N=1,573).  Sample Drawn From a 
Survey Evaluating the Period of Purple Crying Intervention Program, 2010-11. 
 Odds 
Ratio 
Lower 95% 
Confidence 
Limit 
Upper 95%  
Confidence 
Limit 
Maternal Age 1.03 0.98 1.07 
Race/Ethnicity***    
White referent   
Black 1.35* 1.05 1.72 
Hispanic 0.55*** 0.42 0.72 
Other 0.86 0.50 1.48 
Maternal Education***    
Less Than High School referent   
High School 0.99 0.74 1.32 
College 0.55** 0.39 0.77 
Graduate School 0.33*** 0.22 0.50 
Pregnancy Wantedness    
Wanted at this Time referent   
Not Wanted / Mistimed 1.19 0.97 1.46 
All Pregnancies Wanted 1.19 0.93 1.52 
First Born 1.46** 1.19 1.79 
NICU Stay 0.99 0.72 1.37 
NICU Stay x First Born 0.65 0.39 1.08 
Baby’s Gender 1.10 0.93 1.30 
Intended to Breastfeed 0.08*** 0.06 0.10 
Received Formula Sample 
Bag 1.80*** 
1.44 2.26 
Hospital Practices 1.19 0.85 1.67 
Hospital Practices X 0.99* 0.98 1.0 
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Maternal Age 
*** p<0.001      **  p<0.01      *    p<0.05     
 
 
 
 
 
Table 8: Parameter Estimates for the Cox Proportional Hazards Model of Time 
to Cessation of Breastfeeding Among Those Who Initiate Breastfeeding 
(N=1,333).  Sample Drawn From a Survey Evaluating the Period of Purple Crying 
Intervention Program, 2010-11. 
 Hazard 
Ratio 
Lower 
95% 
Confidence 
Limit 
Upper 
95%  
Confidence 
Limit 
Maternal Age 1.01 0.95 1.06 
Race/Ethnicity***    
White referent   
Black 1.11 0.85 1.47 
Hispanic 0.58*** 0.43 0.77 
Other 0.81 0.44 1.49 
Maternal Education***    
High School referent   
Less than High School  1.12 0.82 1.54 
College  0.74 0.51 1.07 
Graduate School  0.49** 0.31 0.76 
Pregnancy Wantedness*    
Wanted at this Time referent   
Not Wanted / Mistimed 1.32* 1.06 1.65 
All Pregnancies Wanted 1.15 0.87 1.52 
First Born 1.32* 1.06 1.65 
NICU Stay 1.09 0.75 1.58 
NICU Stay x First Born 0.56* 0.32 0.97 
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Baby’s Gender 1.18 0.98 1.42 
Intended to Breastfeed 0.38*** 0.24 0.60 
Received Formula Sample Bag 1.66*** 1.30 2.12 
Hospital Practices 1.34 0.90 1.99 
Hospital Practices X Maternal Age 0.99 0.98 1.00 
Timing of Initiation*** < 1 Hour referent   
1-2 Hours  1.43** 1.10 1.85 
2-24 Hours  1.80*** 1.42 2.29 
> 24 Hours  1.62** 1.13 2.32 
*** p<0.001      **  p<0.01      *    p<0.05     
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Figure 4: Survival Plots of Time to Cessation of Breastfeeding by Demographic 
Characteristics Among All Study Participants (N=1,573) From a survey evaluating the 
Period of Purple Crying intervention program, 2010-11. Curves show the variation of a 
single variable with all other covariates held constant at their mean value from the 
regression model: Firstborn (0.35), NICU (0.12), interaction term for NICU and firstborn 
(0.05), black race/ethnicity (0.13), Hispanic race/ethnicity (0.19), other race/ethnicity 
(0.03), unwanted or mistimed pregnancy (0.26), all pregnancies wanted (0.14), maternal 
age(7.4 x1015 ), high school education (0.29), college education (0.40), graduate school 
education (0.19), intention to breastfeed (0.88), infant gender (0.52), receipt of a formula 
sample bag (0.78), hospital practices (3.67), interaction term for hospital practices and 
maternal age (110.41).    
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Figure 5: Survival Plots of Time to Cessation of Breastfeeding by Demographic 
Characteristics among Women Who Initiated Breastfeeding (N=1,333) From a 
survey evaluating the Period of Purple Crying intervention program, 2010-11. Curves 
show the variation of a single variable with all other covariates held constant at their 
mean value from the regression model: First-born (0.36), NICU (0.11), interaction term 
for NICU and firstborn (0.05) Black race/ethnicity (0.10), Hispanic race/ethnicity (0.21), 
other race/ethnicity (0.03), mistimed/unwanted pregnancy (0.25), all pregnancies wanted 
(0.13), maternal age (4.9 x 1015), high school education (0.26), college education (0.41), 
graduate school education (0.21), intention to breastfeed (0.98), baby’s gender (0.52), 
breastfeeding initiation between 1 and 2 hours (0.20), breastfeeding initiation between 2 
and 24 hours (0.25), breastfeeding initiation after 24 hours (0.10), receipt of a formula 
sample bag (0.76), hospital practices (3.88), interaction term for hospital practices and 
maternal age (117.28). 
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CHAPTER III: FACTORS ASSOCIATED WITH POSTPARTUM 
CONTRACEPTIVE USE AMONG BREASTFEEDING WOMEN 
 
 
INTRODUCTION 
 
Family planning has a major impact on the health of individuals and society. The 
International Conference on Population and Development (ICPD) in Cairo identified 
voluntary family planning as a central component of human rights and national 
development, emphasizing that family planning is one of the most cost effective ways to 
combat poverty. (214) But in spite of great improvements in the efficacy and availability 
of birth control, research funded by the Bill and Melinda Gates Foundation estimated 
that, as of 2009, more than 200 million women around the world lacked access to modern 
methods of contraception, and predicted that by 2050 this would increase by 40%. 
(36,37)  
  Many new methods of birth control have been developed in the US, and yet the 
number of unintended pregnancies remains high. The societal implications are large; 
Trussell et al. estimate that the annual cost of unintended pregnancy in the US is $4.5 
billion. (41) In addition, racial and socioeconomic differences in the rate of unintended 
pregnancies represent a substantial health disparity, one that facilitates transfer of health 
and economic disparities to a new generation. Analysis by Finer and Henshaw showed 
that between 1994 and 2001, the rate of unintended pregnancy among white women was 
35 per 1,000, while among black women it was 98 per 1,000 and for Hispanic women it 
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was 78 per 1,000. (39)  Education is associated with the occurrence of unintentional 
pregnancy, with 26 per 1,000 for women with college degrees, and 76 per 1,000 for 
women without a high school degree. Contraceptive use follows similar racial and 
education patterns and is thought to be both a response to and a cause of these 
differences. (40)  
A significant portion of this issue is postpartum contraception. (42)   About 100 
million women around the world make decisions about postpartum contraception each 
year, yet little attention is paid to understanding the particular priorities and needs of 
women at this unique moment in their reproductive lives. (42) Accurate information, 
specific to the health and social issues at this stage, is needed by women in the 
postpartum as a foundation for informed decision-making.  
Postpartum family planning is also important for public health since the length of 
inter-birth intervals has serious implications for mother and baby.  Women with short 
birth intervals, less than six months, have a higher risk of maternal mortality (OR 2.54; 
95% CI 1.22-5.38), third-trimester bleeding (OR1.73; 95% CI 1.42-2.24), premature 
rupture of membranes (OR 1.72; 95% CI 1.53-1.93), puerperal endometritis (OR 1.33; 
95% CI 1.22-1.45), and anemia (OR 1.30; 95% CI 1.18-1.43). (43)  Among women with 
previous Cesarean deliveries, birth intervals of less than 18 months are associated with a 
higher risk of uterine rupture, 2.25% vs. 1.05% for intervals of 19 months or longer. (44) 
It should be noted that the International Conference on Population and Development 
(ICPD) in Cairo also emphasized the importance of breastfeeding for the health of the 
mother and child. (214) Since the postpartum period is also the time-period when mothers 
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would be breastfeeding, effective pregnancy prevention that is compatible with 
breastfeeding is crucial to meeting both important health goals. 
The Lactational Amenorrhea Method (LAM), a method of family planning based 
on the physiology of lactation, has been shown to be effective for up to the first six 
months for women who are breastfeeding according to the guidelines; however, many 
women  prefer to use other contraception in the early postpartum period or require it 
when LAM no longer applies. (45-47) Accurate information about the compatibility of 
specific contraceptive methods with breastfeeding is needed for women to make 
informed choices about both family planning and breastfeeding.  
The World Health Organization (WHO) and the American Academy of Pediatrics 
(AAP) concur that breastfeeding is the optimal form of infant feeding. (1,2) The health 
benefits of breastfeeding for both mother and baby are well established, with short and 
long term advantages substantiated in the research literature. (3) Breastfed infants have 
lower rates of a wide range of infectious, diseases, and chronic illnesses including ear 
infections, bacterial meningitis, urinary tract infections, intestinal infections, diarrhea, 
and childhood cancers. (7-15) Lower rates of sudden infant death syndrome, asthma, 
obesity, and diabetes are also seen in children who are breastfed. (16-24)  Childhood 
cognitive development may also be enhanced by breastfeeding. (25-27)    
Mothers experience better immediate and long-term health outcomes with 
breastfeeding.  Women who breastfeed experience less postpartum blood loss and more 
rapid postpartum uterine involution. (28) They also have lower rates of breast and ovarian 
cancer and fewer hip fractures and osteoporosis later in life. (29-33)  Therefore, the 
potential impact on long-term health for individuals and on healthcare costs as a nation is 
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large. (34) Infant morbidity and mortality related to the low prevalence of 6 months of 
exclusive breastfeeding is estimated to cost the United States $13 billion annually in 
pediatric costs alone. (35)  
The AAP, WHO, and nearly all health professional organizations recommend 
exclusive breastfeeding for the first six months of life with continued breastfeeding 
thereafter as solids are introduced. (215,216)  The Healthy People 2010 initiative of the 
US Department of Health and Human Services set national goals for breastfeeding 
initiation and continuation, but by 2010 only 16.3% of mother-baby dyads were 
breastfeeding exclusively at six months. (5) National breastfeeding targets were extended 
under Healthy People 2020, with new goals of 81.9% initiation, 60.6% continuation at six 
months, and 25.5% exclusive breastfeeding at six months. (4) To meet these goals, 
significant effort will be needed to further understand and address barriers to 
breastfeeding. 
One area of controversy and confusion for mothers and clinicians is contraceptive 
use while breastfeeding, especially concerning the compatibility of hormonal 
contraceptive methods with breastfeeding. Clinical reports from lactation specialists 
indicate a negative impact of hormonal contraception on breastfeeding success, which 
contrasts with the recommendations in the Medical Eligibility Criteria for Breastfeeding 
(MEC) released by the Centers for Disease Control (CDC) in 2008, and updated in 2009 
and 2013.  These, guidelines maintain that these methods are safe to use during 
breastfeeding. This is in contrast with the most recent edition of the WHO MEC that is 
based on the same body of research evidence. (98-100,102)  
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This study aims to increase understanding of women’s use of contraception in the 
postpartum period to inform the discussion of contraceptive use during breastfeeding in 
the early months postpartum. Much of the research underlying both the WHO and CDC 
recommendations was carried out in countries that have very different breastfeeding 
patterns than the US. Moreover, a substantial portion of this literature is more than 20 
years old, raising the question of whether the contraceptive methods available at that time 
and the social context, for instance women’s roles, attitudes towards breastfeeding, and 
awareness of the health implications of breastfeeding, are generalizable to the US today. 
This study, conducted in 2010-11 in North Carolina, addresses several social context 
issues and includes more current methods of contraception. North Carolina falls in the 
middle of the spectrum of US states in terms of breastfeeding initiation, has a variety of 
urban and rural areas, and has immigration from other parts of the country and beyond, 
mixing social norms from other regions. Geophysically, socio-culturally and 
economically, there is a diversity of settings within the state that encompass a wide 
spectrum of the American social context. Politically, the electorate splits closely between 
major parties.  There is a sizable minority of African Americans and Hispanics.  
Together, this makes North Carolina an informative setting to explore the current state of 
breastfeeding in the US, and well suited to addresses the question of use of contraception 
in the postpartum period. 
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MATERIALS AND METHODS 
 
Subjects 
A survey of new mothers in North Carolina was carried out between April 2010 
and March 2011. State birth certificate records were used to identify approximately 2,000 
mother-baby dyads with infants about two to three months old. The mother’s telephone 
number was then back-matched from name and address information on the birth 
certificate and attempts were made to contact her by landline telephone. Only those who 
had a valid telephone number that reached a residence in North Carolina were considered 
eligible for the study. Once contacted, the female parent or guardian was asked to engage 
in a one-time telephone interview in English or Spanish. Questions were specific to the 
infant in the household, and if more than one child was eligible for the survey, the child 
referenced on the birth certificate was the focus of the study. Otherwise, no additional 
check was made to verify that the interviewee corresponded with the person referenced 
on the birth certificate. Over-sampling was used to identify sufficient number of mothers 
of Hispanic ethnicity, babies of less than two months age and two to three months age, 
and to ensure a distribution of urban/rural participants, as well as, size of hospital at 
which the birth occurred.  The sample included 1,669 study participants, of which 1,644 
had completed interviews.   
To look at the predictors of contraceptive use during breastfeeding in the 
postpartum period, the study population was limited to only those women who initiated 
breastfeeding, excluding 240 who did not (N=1,404).  Finally, only participants with 
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complete information on all study variables were included in the analysis, leaving 1,319 
respondents in the analytic sample or 93.9% of the eligible participants.  
 
STATISTICAL ANALYSES 
  
 Chi square and Kruskal-Wallis tests were performed to assess differences in the 
distributions of covariates among users of each type of contraceptive in the postpartum 
period. Log binomial models were used to assess predictors of contraceptive choice after 
birth among women who breastfeed. To force convergence, a common weakness of the 
log binomial model, modified Poisson estimates were used as described by Spiegelman 
and Hertzmark (217) Women who used progestin-only methods were compared to those 
who used non-hormonal methods, and separately to those who used no method of 
contraception. Women who used combined estrogen/progestin methods were compared 
in separate analyses to those who used progestin-only contraception, non-hormonal 
contraception, and no form of birth control. To more readily interpret the results, the 
same covariates were modeled in each comparison.  
 Women who were breastfeeding at the time of the interview were right censored 
in our analysis, and actual durations were recorded for those who had ceased to 
breastfeed prior to the interview.  The model was developed based on the literature and 
limited by the variables available in the dataset.  To assess the best way to code variables 
where more than one logical option existed, nested models were compared using 
likelihood ratio tests with a cut-off of p<0.05. Non-nested models were compared using 
Akaike Information Criterion (AIC) and Bayesian Information Criterion (BIC), and 
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covariates that were neither statistically significant at the p<0.05 level nor crucial factors 
from the literature were removed from the model.  Covariates that were significantly 
associated in any model were retained. A final, reduced model is presented here. All 
statistical analyses were performed using SAS software version 9.2. 
 
MEASURES 
 
Demographic characteristics. A variety of maternal and infant demographic data were 
obtained including the mother’s age at the time of the survey, the mother’s level of 
education, household income, the infant’s gender and race/ethnicity, and the county in 
which the birth took place.  
Maternal age was reported in years; a quadratic term and an ordinal variable with 
maternal age grouped by 5-year bins were explored, and the Akaike Information 
Criterion (AIC) and Bayesian Information Criterion (BIC) were used to determine 
whether the linear assumption of continuous coding was preferable for modeling the 
association. The mother’s age was then mean-centered to enable more direct 
interpretation of the model. The survey included separate questions for Hispanic ethnicity 
and for race.  Mothers could identify as many racial categories for their infant as they felt 
were applicable, and were asked whether they considered the child to be white. Infants 
identified as Hispanic ethnicity were recorded as Hispanic.  Infants with only one race 
reported on the survey were identified as that race.  Among the remaining study subjects 
who were reported to be mixed-race, any infant identified as being “white” in a separate 
question about whether the parent considered the child white, was identified as “non-
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Hispanic white.”  Next, those who were reported to be mixed-race with one race being 
black were identified as “non-Hispanic black.” All remaining study subjects were 
classified as, “other,” which included Asian, Pacific Islander, Hawaiian, Alaskan native, 
and Native American, as well as, anyone who identified their child as “other”. 
The state of North Carolina has three primary regions, Western/Mountains, 
Piedmont, and Coastal Plain, which are used for programming, funding, and statistical 
tracking. Since there are differences among these regions in breastfeeding-related birth 
practices, as well as rates of initiation and duration of breastfeeding, the data on county in 
which the birth occurred were transformed into a variable for region of birth.  
 
Health factors. Parity has been shown to be related to breastfeeding outcomes. A survey 
question asking whether there were older biological siblings of the child in the home. If 
there was a report of a biological older sibling, the subject child was considered to be 
born to a multiparous mother. Neonatal Intensive Care Unit (NICU) stay for the infant 
was asked on the questionnaire (yes/no).   
 
Psychosocial factors. The mother’s pregnancy and breastfeeding intention were assessed 
in the interview. Women were asked about their pre-birth intention to breastfeed 
(dichotomous yes/no) and intended duration. A high level of missing data for the 
intended duration question and strong co-linearity between these variables led us to 
choose the dichotomous variable for this study. It has been shown that pregnancy 
intention could also impact breastfeeding outcomes. (182)  Outside of the US, pregnancy 
intention is a focus of work by the World Health Organization which classifies the 
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‘wantedness’ of a pregnancy in four categories: wanted at this time, wanted not at this 
time, not wanted, and all pregnancies are wanted. Mothers in this study were asked about 
their pregnancy intention using these same categories. Small cell-size led us to combine 
unwanted and mistimed pregnancies into one category of unwanted and mistimed 
pregnancies for the purposes of this analysis. 
  
Hospital practices. Breastfeeding-related maternity practices were assessed by asking 
the mother to identify all of the breastfeeding-related maternity practices she had 
experienced during and after her birth.  Receipt of a formula sample bag was explored on 
its own because evidence suggests that a substantial number of hospitals in North 
Carolina have stopped this practice without implementing the others. (210)  These 
formula sample bags are thought to undermine breastfeeding success by providing an 
available alternative to breastfeeding.  Recent work suggests that there may be a 
cumulative effect of breastfeeding-friendly hospital practices known as the Ten Steps. 
Therefore, the remaining five practices were explored individually and as a group using a 
proxy score, recorded as an ordinal variable (0-5), reflecting the total number of practices 
experienced by the mother. The practices derived from the Ten Steps, but are not exact 
reflections of any one specific step.  These practices are immediate skin-to-skin contact 
between mother and infant after birth (from Step 4), rooming-in at least 22 of every 24 
hours (from Step 7), visit by a Lactation Consultant (LC) or breastfeeding support person 
(proxy for Step 5), observation of a feeding by an LC or breastfeeding support person 
(also Step 5), and all facility staff supporting the mother’s decision on infant feeding 
(also Step 5).   
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Postpartum contraceptive use. Study participants were asked which type(s) of 
contraceptive they used since the baby was born, and were allowed to identify as many 
types as applied. Contraceptives were then classified into four categories: no method, 
non-hormonal methods, progestin-only methods, and combined estrogen/progestin 
methods. Where multiple methods were reported, the woman’s use was classified in the 
category thought to have the largest impact on breastfeeding, i.e., combined methods 
first, followed by progestin-only, non-hormonal and then no method.   
 
Interaction terms.  An exploratory analysis of interactions between variables was 
carried out in a separate analysis of direct associations between the independent variables 
and breastfeeding duration using a Cox proportional hazards model of breastfeeding 
cessation. Interactions between the variables for hospital practices and maternal age, 
timing of breastfeeding initiation, NICU stay, infant gender, and intention to breastfeed 
were tested.  In addition, interaction terms for first-born status and NICU stay and for the 
wantedness dummy variables were explored, as well as breastfeeding intention and infant 
gender.  An interaction between infant NICU stay and first-born status was found to be 
significant in some analyses, and was, therefore, kept in the model for all regressions. An 
interaction between the mother’s age and a proxy for all hospital practices developed as 
an ordinal variable was significant and remained in the model. Interactions between the 
individual hospital practices and maternal age were also explored, and a likelihood ratio 
test was used to determine that the ordinal variable and ordinal variable-maternal age 
interaction term were the best for the model.  
	  136 	  
 
Missing Data. This data set included only 1%-3% missing data for all variables except 
intended duration of breastfeeding and household income, which were 10.7% and 17.8% 
respectively. A likelihood ratio test was carried out to determine that including household 
income in the model did not have a significant effect on the results. Forest plots were 
used to assess whether estimates of the other variables were affected by including or 
excluding income, and in no case did the change in parameter estimate exceed the 
confidence interval for that variable. Likewise, the high degree of missing data for 
intended breastfeeding duration was thought to be non-random, potentially representing 
differences in three factors: confidence, determination, and education about 
breastfeeding. Therefore, both income and intended breastfeeding duration were excluded 
from the model.  The analysis included only those participants with complete data, i.e., a 
complete case analysis. The final study sample included 1,319 of the 1,404 respondents 
who were eligible for participation because they initiated breastfeeding.   
 
IRB.  This study received IRB approval from the University of North Carolina, Chapel 
Hill. 
 
RESULTS 
 
Description of the population 
The sample included 1,319 women who had initiated breastfeeding and who also 
had complete information on all variables in the analysis (Table 9).  The mean maternal 
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age in the population was 30.3 years old, with a minimum of 14 and a maximum of 46. 
The sample was 66.4% non-Hispanic white, 10.1% non-Hispanic black, 20.7% Hispanic, 
and 2.8% other. There were slightly more female infants (51.9%), and 11.2% of infants 
spent time in the NICU compared to about 6.7% nationally. (211)  First time mothers 
made up 36.0% of the population and 11.9% of women had less than a high school 
degree, 26.2% had a high school education, 40.6% had a college degree, and 21.3% had a 
graduate degree.  The mean infant age at the time of the interview was 3.29 months 
(Table 11a), and across the range of infant ages there was a distribution of breastfeeding 
status (Table 10).  More women in this population used progestin-only methods of 
contraception at some time since birth (32.1%) than any other type of contraception 
(Table 11a). Non-hormonal methods were used by 29.9% of women, while 24.5% used 
no method, and 13.5 % used combined estrogen/progestin-methods of contraception. 
When comparing users of different types of contraceptive methods in the 
postpartum period using bivariate analysis, statistically significant differences were found 
for maternal age, race/ethnicity, maternal education, first-born child, and visit by an LC 
or breastfeeding support person  (Tables 11a and 11b). No statistically significant 
difference in pregnancy wantedness, baby’s gender, infant NICU stay, intention to 
breastfeed, timing of initiation, receipt of a formula sample bag at hospital discharge, or 
the number of breastfeeding-related hospital practices received was found among 
contraceptive use categories.  
Mean maternal age was different across categories of contraceptive use (Table 
11a). The mean age for hormonal methods, either progestin-only (28.9) or combined 
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estrogen/progestin (28.5) was several years younger than for non-hormonal methods 
(31.5) or using no method of contraception (31.8).  
There are statistically significant differences in contraceptive method used by 
race/ethnicity (Table 11b). About 31.1% of Non–Hispanic white women used a 
progestin-only method; they used non-hormonal methods or no contraception less often 
(29.0% and 25.6% respectively). In contrast, a higher percent of non-Hispanic black 
mothers (41.4%) used a progestin-only method. Very few used a non-hormonal method, 
(18.8%) but 27.1% of non-Hispanic black mothers did not use birth control during this 
period of time.  Hispanic mothers were most likely to use non-hormonal methods 
(37.0%), and least likely to go without contraception (19.8%). All race/ethnic groups had 
low rates of usage for combined estrogen/progestin methods.   
Differences were found between women of different educational attainment as 
well (Table 11b). Women with less than a high school education were mostly likely to 
use a non-hormonal method of contraception in the postpartum period (36.9%), women 
with a high school degree were most likely to use a progestin-only method (34.2%),  
while women with college or graduate degrees had similar usage rates for three 
categories: progestin-only, non-hormonal and no method. 
Parity was strongly associated with the type of contraceptive used after birth 
(Table 11b). Nearly equal percentages of women with first-born and subsequent children 
did not to use contraception after birth (25.5% and 22.7% respectively).  However, first 
time mothers were much more likely to use a hormonal method, 36.0% for progestin-only 
and 19.0% for combined estrogen/progestin, over a non-hormonal method (22.3%).  In 
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contrast, 10.4% of multiparous women used a combined estrogen/progestin method, and 
their top choice was non-hormonal contraception (34.2%). 
There was no statistically significant difference in contraceptive use among 
women based on the number of breastfeeding-supportive hospital practices they 
experienced, however, one of the individual practices included in this composite measure 
did show a significant difference; among those visited by an LC or other breastfeeding 
support person, more women chose progestin-only methods (32.3%) than non-hormonal 
(28.4%), no method  (24.8%) or combined estrogen/progestin methods (14.4%) (Table 
12).  In contrast, among those who did not have an LC or other breastfeeding support 
person visit them, the most common form of contraception was a non-hormonal method 
(36.6%).  Analyses of individual hospital practices showed no significant association 
between immediate skin-to-skin contact, rooming-in, observation of a feeding by an LC 
or other breastfeeding support person, or facility staff supporting the mother’s infant 
feeding choice and type of contraceptive used after birth.  
The other factors in the model, pregnancy wantedness, baby’s gender, infant 
NICU stay, intention to breastfeed, timing of breastfeeding initiation, receipt of a formula 
sample bag, and the number of breastfeeding-related hospital practices experienced by 
the mother, were not significantly associated with type of postpartum contraceptive used.  
The variable for region of birth was not significant in any model and a likelihood ratio 
test was used to determine that it should be dropped from the final model.  
Although pregnancy wantedness was not significantly associated with 
contraceptive use, trends in our data suggest that it might be a worthwhile topic for 
further exploration (Table 11b).  Women who reported that their pregnancy was 
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unwanted or mistimed were less likely to not use contraception after birth (19.4%) than 
women with timely/wanted pregnancies (25.7%), while women who viewed all 
pregnancies as wanted were the most likely to use no form of birth control after birth 
(28.3%).  When they did use contraception, these women most often used non-hormonal 
methods (31.8%), and women with wanted, timely pregnancies used non-hormonal and 
progestin-only methods about equally (29.5% and 31.4%).  In contrast, those with 
unwanted or mistimed pregnancies used  progestin-only contraception more often than 
any other type (36.7%). 
 
Multivariate Analysis of the Predictors of Postpartum Contraceptive Use 
Using log binomial regression models of pairs of contraceptive methods, maternal 
age (p<0.0001), breastfeeding duration (p<0.0001), race/ethnicity (p<0.01), maternal 
educational attainment (p<0.05), having a first-born child (p<0.0001), and visit by a 
lactation consultant or other breastfeeding support person (p<0.05) were associated with 
type of contraceptive used in the postpartum time period in at least one of the pair-wise 
comparisons (Table 13). The wantedness of the pregnancy, the baby’s gender, infant 
NICU stay, an interaction between infant NICU stay and infant first-born status, 
breastfeeding intention, timing of breastfeeding initiation, receipt of a formula sample 
bag, and an interaction between maternal age and the number of hospital practices 
experienced by the mother were not associated with the type of contraception used after 
birth.  
In the comparison of those who used progestin-only methods versus no form of 
contraception, only maternal age was significantly associated with postpartum 
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contraceptive use (RR 0.95, 95% CI 0.98-0.99) (Table 13). Each year of maternal age 
was associated with a 5% increased risk of using progestin-only method in the 
postpartum time-frame compared to using no method of contraception (p<0.05). 
Similarly, in the comparison of those who used progestin-only methods versus non-
hormonal methods, there was a 6% increased risk per year of maternal age for using 
progestin-only methods compared to use of non-hormonal methods (RR 0.94, 95% CI 
0.90-0.98).   
Other factors significantly associated with contraceptive use in this regression 
model were race/ethnicity, education, NICU stay, and hospital practices (Table 13).  
Blacks were at higher risk of using progestin-only methods compared to non-hormonal 
methods than whites (RR 1.28, 95% CI 1.08-1.51), Hispanics (RR 1.29, 95% CI 1.03-
1.61), and 41% higher risk than those classified as other (RR other vs. black 0.59, 95% 
CI 0.36-0.98).  Compared to women who had less than a high school degree, mothers 
with a college degree had a 42% higher risk of using progestin-only contraception after 
birth (RR 1.42, 95% CI 1.09-1.86), and women with a graduate degree had 47% higher 
risk (RR 1.47, 95% CI 1.08-2.01).  Having an infant admitted to the NICU was associated 
with use of progestin-only contraception (RR 1.40, 95% CI 1.08-1.81), as were 
breastfeeding-related hospital practices (RR 1.08, 95% CI 1.00-1.16).  
None of the factors explored in this analysis was significantly associated with the 
use of combined estrogen/progestin contraceptive methods over either no method or 
progestin-only methods (Table 13). However, in the model comparing use of combined 
estrogen/progestin methods to non-hormonal methods, race/ethnicity and having a first-
born child (RR 1.46, 95% CI 1.09-1.96) was associated with contraceptive use.  
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Compared to Hispanics, non-Hispanic blacks were at 74% higher risk (RR 1.74, 95% CI 
1.04-2.92) and non-Hispanic whites were at 35% higher risk (RR for Hispanic vs. white 
0.65, 95% CI 0.43-1.00) of using a combined method of birth control. 
 
 
 
DISCUSSION 
 
In this analysis, significant predictors of the type of contraceptive used include 
maternal age, maternal educational attainment, race/ethnicity, first birth, infant NICU 
stay, and the number of breastfeeding-related hospital practices experienced by the 
mother. More factors were found to be associated with use of progestin-only methods 
than combined estrogen/progestin methods in this analysis, which may be due in part to 
the lower prevalence of combined hormonal methods in this population (13.5%). This 
lower prevalence is not surprising since their use is generally contra-indicated for 
breastfeeding women according to the CDC.   
The comparison group used in the pair-wise regressions had an impact on the 
results of the log binomial regressions.  Significant results were found for both types of 
hormonal contraception, combined estrogen/progestin and progestin-only, in comparison 
with users of non-hormonal methods.  However, for models of combined 
estrogen/progestin methods, neither of the other comparison groups produced significant 
results.  For progestin-only methods, only maternal age was significant when comparing 
with those who used no form of contraception, and this did not improve on the results 
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using the non-hormonal group for comparison since maternal age was also found to be 
significantly associated in that model.  This suggests that the control group used in 
studies of postpartum contraception may impact the ability of these studies to detect 
differences in patterns of use.  Much of the literature used by the WHO and CDC to 
evaluate postpartum contraception, however, has as a control group those who are not 
using contraception.  Many of these studies report no effect of hormonal methods, 
particularly progestin-only methods, but the results of this study suggest that this could be 
due to use of an ineffective control group.  Women who do not use contraception after 
birth may represent a very different population that those who use contraception in this 
period.  For instance, partnership status could be correlated with contraceptive use since 
women without partners may not be sexually active.  Thus, studies that use those who do 
not use contraception as the comparison group may not be adequately controlling for 
partnership status, which has been shown to be positively associated with breastfeeding 
outcomes. (156,158,160)  
In comparisons between progestin-only use and non-hormonal or no method of 
contraception, maternal age was associated with a 4.7% and 6.2% lower risk, 
respectively, of using a progestin-only method. That is to say that for each year older, 
mothers were about 5%-6% less likely to use a progestin-only method compared to the 
other two categories. Results for combined hormonal methods also showed a protective 
trend of age against use of hormonal contraception, but were not significant. This 
difference across ages may reflect women returning to methods they used before 
pregnancy since younger women tend to use hormonal contraception in higher 
proportions than older women. It could also be related to a decline in sexual activity with 
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age, which may be associated with not using contraception.  Older mothers in our model 
are also more likely to not be using contraception, indicating that pregnancy prevention 
may play a smaller role in their decision making than for younger mothers. Healthcare 
providers may also play a role in this difference, suggesting or encouraging hormonal 
methods more often for younger mothers.  Clinicians may assume or younger mothers 
may indicate that preventing future pregnancies is more important to them than older 
women, leading care providers to suggest different methods in an attempt to give these 
women reliable control over their fertility.   Estrogenic hormonal contraception is contra-
indicated with age, which could mean that older mothers are avoiding hormonal methods 
as the risk of side-effects increases. In addition, younger women were traditionally 
steered away from highly effective non-hormonal methods like copper IUDs for fear of 
complication-induced sterility. Differences in contraceptive use after birth follow similar 
patterns to breastfeeding duration, which is shorter for younger mothers.  This highlights 
a need to understand the association between the type of contraceptive used while 
breastfeeding and breastfeeding outcomes to ensure that contraceptive use is not 
contributing to this health disparity.  
Race/ethnicity and parity were the only two factors that were associated with the 
use of combined estrogen/progestin methods after birth.  Race/ethnicity was also a strong 
predictor of progestin-only use.  Black women had a higher risk of using a progestin-only 
method compared to a non-hormonal method when compared with both white and 
Hispanic mothers, and had a 74% higher risk than Hispanic mothers of using a combined 
estrogen/progestin method over non-hormonal contraception (p<0.05), with a similar 
non-significant trend compared to white mothers.  So, black mothers are using hormonal 
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contraception more than other racial and ethnic groups and they also have the lowest 
breastfeeding rates. (160,164,165)  If clinical reports suggesting that hormonal 
contraception negatively impacts breastfeeding outcomes are true, this suggests that the 
contraceptive use patterns of black mothers may contribute to the health disparity in 
breastfeeding outcomes for black mother-baby dyads.  Contraceptive use patterns of
 Hispanic mothers would be consistent with this possibility.  Hispanic mothers 
have the highest rate of breastfeeding, and although they are the group with the highest 
use of postpartum contraception, with over 80% using birth control, they use non-
hormonal methods (37.0%) much more often than white (29.0%) or black (18.8%) 
mothers. Similarly, women classified as other also had high breastfeeding rates and used 
non-hormonal contraception more often than any other form (40.5%).   
There are clear racial and ethnic differences in contraceptive use.  Black mothers 
use progestin-only methods much more often than whites or Hispanics, and have the 
highest use of hormonal methods of any type.  Hispanic mothers are the most likely to 
use contraception, and tend to favor non-hormonal methods, whereas white women are 
about evenly split between non-hormonal, progestin-only and no use, but are the group 
most likely to use combined hormonal contraception.  While sometimes thought to 
represent differences in health factors, race and ethnicity in this case is most likely a 
proxy for social factors that influence a woman’s healthcare choices, as well as those 
offered to her by her healthcare provider or available to her through her health insurance.  
These factors would likely need to be considered for racial/ethnic patterns of use to be 
changed.  
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Less educated mothers were more likely to use contraception after birth than more 
educated women, suggesting that pregnancy prevention is more important for less 
educated mothers perhaps reflecting differences in socio-economic status and the 
perceived impact of a subsequent pregnancy on their household.  Our findings suggest 
that identifying and promoting effective birth control that is compatible with 
breastfeeding is an important factor in improving the disparity in breastfeeding 
continuation between more and less educated mothers. 
  Women with college and graduate degrees were at higher risk of using a 
progestin-only method over a non-hormonal method when compared to women with less 
than a high school education. This may indicated that more educated mothers are more 
likely to follow the CDC recommendations than less educated mothers. However for 
combined hormonal methods, this trend shifts; mothers with the lowest educational 
attainment, less than high school, and mothers with the highest, graduate degrees, are 
both more likely to avoid combined hormonal methods than women in the middle of the 
educational spectrum, high school and college graduates.  If we assume education is a 
proxy for having more resources, then access to healthcare and the cost of a contraceptive 
method may be a more significant factor in contraceptive choice for less educated 
mothers compared to women in the middle of the educational spectrum.  Additionally, 
higher education may result in the women being more informed about which methods are 
contraindicated during breastfeeding. 
   Pregnancy wantedness was not significantly associated with the type of 
contraceptive used after birth; however, trends in our data suggest that this topic might 
merit future research.  The higher rates of contraceptive use among those who reported 
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this was an unwanted or mistimed pregnancy suggest that wantedness of the pregnancy 
may be a factor in choosing contraception after birth, and that a woman’s attitude about 
her pregnancy may affect her preference for birth control in the postpartum period.  This 
study may underestimate the effect of pregnancy wantedness on contraceptive use after 
birth if the women in this study were more successful in controlling their fertility then the 
general population, or demonstrated bias in their response to the survey question in favor 
of a more positive perspective, especially an issue since the women are asked 
retrospectively after the baby’s birth.  Over 60% of women reported that their pregnancy 
was timely and wanted, and only eight women reported that their pregnancy was 
unwanted. In comparison, national data suggest that about half of all pregnancies in the 
US are unplanned.  Pregnancy intention has been shown to be associated with 
breastfeeding outcomes. (182)  Pregnancy wantedness may follow similar trends, an idea 
supported by the association between pregnancy wantedness and other infant care 
outcomes like antenatal care, stunting and later mental health for the child (179-181).  
  First-time motherhood is the second, and only other, characteristic that predicts 
use of combined estrogen/progestin contraception in this population.  First-time mothers 
were at 46% higher risk of using a combined hormonal method compared to non-
hormonal methods, with similar non-significant trends with the other comparison groups.  
The same issues that applied to the higher use of progestin-only methods by younger 
mothers would be a factor here as well.  However, the impact of combined hormonal 
methods on breastfeeding is thought to be more profound than for progestin-only 
methods and therefore the consequences for breastfeeding of this choice may be more 
pronounced. The higher risk of using combined hormonal methods among first-time 
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mothers suggests that these women need better information about and promotion of types 
of contraception that are compatible with breastfeeding.  Additional time might be 
needed in prenatal and postpartum obstetric appointments where contraception is 
discussed in order to provide more thorough counseling on contraceptive options to 
primiparous mothers. 
  Mothers whose babies have been in the NICU are at significantly higher risk of 
using a progestin-only method over non-hormonal contraception (38.9%, p<0.05). These 
women may perceive a greater need for birth control because of the separation from their 
child or because they are not able to fully breastfeed their baby. Changes in the standard 
of care at many NICUs now often encourage mothers to breastfeed, so these mothers may 
also receive more education about breastfeeding-friendly contraception, and be made 
more aware of the CDC recommendations for contraceptive use while breastfeeding.  
This is supported by the finding that the number of breastfeeding-related maternity 
practices experienced by the mother were also associated with the type of contraceptive 
used, with a 7.6% increased risk of using a progestin-only method compared to non-
hormonal methods with each additional practice reported by the mother.  Likewise, 
examination of the individual practices that comprised the ‘Hospital Practices’ variable, 
revealed a significant association between a visit by an LC or breastfeeding support 
person and the type of contraceptive used (Table 2).  It could be that women experiencing 
breastfeeding difficulties are both more likely to receive a breastfeeding support visit and 
more likely to contracept, but since non-hormonal methods are considered by 
breastfeeding advocates to be the more conservative choice for breastfeeding 
preservation, these results, like the findings for hospital practices in general are 
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surprising.  However, given that the CDC recommendations do not prioritize non-
hormonal methods over progestin-only methods while breastfeeding, these results may 
indicate that women are being effectively educated about the current guidelines before 
initiating contraceptive use and that they are following those guidelines. Many women 
seem to be prioritizing pregnancy prevention over preservation of breastfeeding, either 
via a conscious decision or from lack of awareness about the trade-offs.  This further 
underscores the importance of gathering accurate information about the association 
between exposure to progestins while breastfeeding and the need to translate this work 
into evidence based guidelines for contraceptive use during lactation.  Women who had 
not intended to breastfeed before birth, but did initiate breastfeeding, were the most likely 
sub-population to use combined estrogen/progestin methods (22.6%). However, only 
2.4% of mothers in this sample fell into this category.  The higher use of contraceptive 
methods that are not recommended during breastfeeding could represent a lack of 
commitment to breastfeeding by these women, or it could be explained by ignorance of 
breastfeeding-related issues among women who did not think these topics were relevant 
to them prior to birth. Since these women are a breastfeeding success story, further 
attention should be paid to whether their use of contraceptive methods that are 
contraindicated for breastfeeding represents an intentional choice on their part or 
ignorance of potential contraindications. Policy, therefore, might include targeted 
continued postpartum counseling on both breastfeeding and contraception for this 
population.  
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LIMITATIONS 
 
This sample population, selected from North Carolina Birth Certificates, was 
contacted by landline telephone. Differences in the covariates and in contraceptive use 
may exist between women who could be reached on a landline telephone and those who 
could not.  For instance, people who use cell phones exclusively would not be reached, 
and this could disproportionately exclude younger, poorer, and more transient mothers 
from the sample leading to sample bias.  If willingness to participate in a telephone 
survey were not randomly distributed, the sample would also be biased. These concerns 
are partially addressed in two ways. First, the random selection process using birth 
certificate records provides an unbiased foundation for sample selection.  In addition, 
many measures were undertaken to contact potential subjects including multiple contact 
attempts, contact at different times of the day and week, and contact attempts over several 
months. Furthermore, if the potential participant declined, efforts were made by specially 
trained personnel to convince the potential study subjects to participate.  
The retrospective study design relied on maternal self-report and is vulnerable to 
recall bias which would be more likely to affect transient factors and factors with 
perceived positive or negative connotation.  For example, unwanted and mistimed 
pregnancies are reported less often in this sample than has been found in national data.  
Mothers may be reluctant to tell the interviewer that their pregnancy was unwanted or 
mistimed, and she might also unconsciously re-evaluate the wantedness of her pregnancy 
as she begins to bond with her baby.  Similarly, a mother’s recall of her intention to 
breastfeed may change in light of her actual experience of breastfeeding.  Reporting of 
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hospital practices may be also be bias by events that happen later, and mothers could 
simply not remember what occurred during that time.  Some may not even know whether 
and when events happened, which could be correlated with maternal or infant health.  
Finally, reporting of contraceptive use may be subject to recall bias, especially if more 
than one method has been used since birth.  This sample is likely comparable to other 
studies in the field of breastfeeding research since results from this study are consistent 
with other breastfeeding studies on covariates commonly reported in the literature.  
Non-random missing data could also lead to sample bias, however the amount of 
missing data for the variables used in the model was 1%-3%, which is very low.  There 
may be additional factors associated with contraceptive use not captured in this model. 
For instance, partnership status, whether the mother is sexually active, and whether she 
has achieved her desired family size could all be important factors in using contraception, 
but were not available in the dataset.   
Timing of contraceptive use would also have been useful to provide a more 
complete description of postpartum contraception.  This is particularly true for women 
who reported using more than one method since birth because the timing, order and 
duration of these methods were unknown.  Nonetheless, this sample is unusual in that is 
has information about breastfeeding outcomes as well as information about contraceptive 
use, enabling analysis of contraception use during breastfeeding.  Few analyses of 
postpartum contraceptive use have been carried out in adult populations, as opposed to 
among adolescent mothers.  So this study also contributes to the literature by describing 
factors associated with contraceptive use in this large demographic. 
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CONCLUSION 
 
Postpartum contraceptive use by women who initiated breastfeeding is associated 
with maternal age, maternal educational attainment, race/ethnicity, first birth, infant 
NICU stay, and the number of breastfeeding-related hospital practices experienced by the 
mother.  Differing contraceptive use corresponds with varying breastfeeding rates, 
suggesting that the issues may be related either with common etiology or by direct effects 
between them.  Pregnancy prevention may outweigh breastfeeding protection in a 
clinician’s advice and in maternal choice of contraception after birth.  If so, accurate and 
available information about the impact of hormonal contraception on breastfeeding is 
need by these women, as well as having access to reliable and attractive contraceptive 
methods which are compatible with breastfeeding.           
  
 
Table 9: Characteristics of the Population From a Survey Evaluating the Period of 
Purple Crying Intervention Program, 2010-11. (N=1,319). 
 Total Percentage of 
Total 
 N=1,319 100% 
Maternal Age (years)   
Mean 30.3   
Median 31   
Race/Ethnicity   
Non-Hispanic White  876 66.4% 
Non-Hispanic Black 133 10.1% 
Hispanic 273 20.7% 
Other 37 2.8% 
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Maternal Education   
Less than High School 157  11.9% 
High School 345  26.2% 
College 536  40.6% 
Graduate School 281  21.3% 
Pregnancy Wantedness   
Wanted at This Time 816  61.9% 
Not Wanted / Mistimed 330  25.0% 
All Pregnancies Wanted 173  13.1% 
First Child   
Yes 475  36.0% 
No 844  64.0% 
Baby’s Gender   
Female 684  51.9% 
Male 635  48.1% 
NICU Stay   
no 1,171  88.8% 
yes 148  11.2% 
Intention to Breastfeed   
No 31  2.4% 
Yes 1,288  97.6% 
Timing of Initiation   
< 1 Hour 584  44.3% 
1-2 Hours 265 20.1% 
2-24 Hours 336  25.5% 
> 24 Hours 134  10.1% 
Received Formula Sample Bag   
No 311  23.6% 
Yes 1,008  76.4% 
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Hospital Practices   
Mean 3.9 3.9 
Median 4 4 
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Table 10: Percentage of the Sample at Each Month Who are Still Breastfeeding, 
Among Women Who Initiated Breastfeeding (N=1,319).  Sample Drawn From a 
Survey Evaluating the Period of Purple Crying Intervention Program, 2010-11. 
 Not Breastfeeding 
n (%) 
Breastfeeding 
n (%) 
1 Month 169 (12.8%) 1,150 (87.2%) 
2 Months 336 (25.5%) 983 (74.5%) 
3 Months 589 (44.7%) 730 (55.3%) 
4 months 1,017 (77.1%) 302 (22.9%) 
5 Months 1,298 (98.4%) 21 (1.6%) 
> =6 Months 1,310 (99.3%) 9 (0.7%) 
 
Table 11a: Characteristics of the Population (continuous variables) by Method of 
Postpartum Contraceptive Use (N=1,319).  Sample Drawn From a Survey 
Evaluating the Period of Purple Crying Intervention Program, 2010-11, and Limited to 
Women Who Initiated Breastfeeding. 
 
No 
Method 
n (%) 
Non-
Hormona
l 
n (%) 
Progestin
-Only 
n (%) 
Combine
d 
Estrogen 
/ 
Progestin 
n (%) 
Total 
n (%) 
Total 323 
(24.5%) 
395 
(29.9%) 
423 
(32.1%) 
178 
(13.5%) 
1,319  
(100%) 
Maternal Age*** 
(years) 
     
Mean 31.8 31.5 28.9 28.5 30.3 
Median 32 32 30 29 31 
Infant Age at 
interview 
(months) 
     
Mean 3.28 3.23 3.26 3.49 3.29 
Median 3 3 3 3 3 
Hospital Practices      
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Mean 3.9 3.8 3.9 4.0 3.9 
Median 4 4 4 4 4 
*** p<0.001      ** p<0.01      * p<0.05  
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Table 11b: Characteristics of the Population by Method of Postpartum 
Contraceptive Use (N=1,319).  Sample Drawn From a Survey Evaluating the Period 
of Purple Crying Intervention Program, 2010-11, and Limited to Women Who 
Initiated Breastfeeding. 
 
No 
Method 
n (%) 
Non-
Hormonal 
n (%) 
Progestin-
Only 
n (%) 
Combine
d 
Estrogen / 
Progestin 
n (%) 
Total 
n 
 323 
(24.5%) 
395 
(29.9%) 
423(32.1%
) 
178(13.5%
) 
1,319  
Race/Ethnicity**      
Non-Hispanic 
White 
224 
(25.6%)  
254 
(29.0%) 
272 
(31.1%) 
126 
(14.4%) 
 876 
Non-Hispanic 
Black 
36 
(27.1%) 
25 
(18.8%) 
55 
(41.4%) 
17 
(12.8%) 
133 
Hispanic 54 
(19.8%) 
101 
(37.0%) 
87 
(31.9%) 
31 
(11.4%) 
273 
Other 9 (24.3%) 15 
(40.5%) 
9 (24.3%) 4 (10.8%) 37 
Maternal 
Education* 
     
Less than High 
School 
28 
(17.8%) 
58 
(36.9%) 
52 
(33.1%) 
19 
(12.1%) 
157  
High School 70 
(20.3%) 
101 
(29.3%) 
118 
(34.2%) 
56 
(16.2%) 
345  
College 146 
(27.2%) 
148 
(27.6%) 
167 
(31.2%) 
75 
(14.0%) 
536  
Graduate School 79 
(28.1%) 
88 
(31.3%) 
86 
(30.6%) 
28 
(10.0%) 
281  
Pregnancy 
Wantedness 
     
Wanted at This 
Time 
210 
(25.7%) 
241 
(29.5%) 
256 
(31.4%) 
109 
(13.4%) 
816  
Not Wanted / 
Mistimed 
64 
(19.4%) 
99 
(30.0%) 
121 
(36.7%) 
46 
(13.9%) 
330  
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All Pregnancies 
Wanted 
49 
(28.3%) 
55 
(31.8%) 
46 
(26.6%) 
23 
(13.3%) 
173  
First Child***      
Yes 108 
(22.7%) 
106 
(22.3%) 
171 
(36.0%) 
90 
(19.0%) 
475  
No 215 
(25.5%) 
289 
(34.2%) 
252 
(29.9%) 
88 
(10.4%) 
844  
Baby’s Gender      
Female 171 
(25.0%) 
202 
(29.5%) 
230 
(33.6%) 
81 
(11.8%) 
684  
Male 152 
(23.9%) 
193 
(30.4%) 
193 
(30.4%) 
97 
(15.3%) 
635  
NICU Stay      
no 290 
(24.8%) 
357 
(30.5%) 
367 
(31.3%) 
157 
(13.4%) 
1,171  
yes 33 
(22.3%) 
38 
(25.7%) 
56 
(37.8%) 
21 
(14.2%) 
148  
Intention to 
Breastfeed 
     
No 8 (25.8%) 5 (16.1%) 11 
(35.5%) 
7 (22.6%) 31  
Yes 315 
(24.5%) 
390 
(30.3%) 
412 
(32.0%) 
171 
(13.3%) 
1,288  
Timing of 
Initiation 
     
< 1 Hour 162 (27.7) 172 
(29.5%) 
184 
(31.5%) 
66 
(11.3%) 
584  
1 to <2 Hours 53 
(20.0%) 
84 
(31.7%) 
88 
(33.2%) 
40 
(15.1%) 
265  
2 to 24 Hours 77 
(22.9%) 
94 
(28.0%) 
110 
(32.7%) 
55 
(16.4%) 
336  
> 24 Hours 31 
(23.1%) 
45 
(33.6%) 
41 
(30.6%) 
17 
(12.7%) 
134  
Received Formula 
Sample Bag 
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No 83 
(26.7%) 
87 
(28.0%) 
108 
(34.7%) 
33 
(10.6%) 
311  
Yes 240 
(23.8%) 
308 
(30.6%) 
315 
(31.3%) 
145 
(14.4%) 
1,008  
*** p<0.001      ** p<0.01      * p<0.05  
 
 
 
Table 12: Association of Lactation Support Visit in Hospital with Contraceptive 
Method Use (N=1,319). Sample Drawn From a Survey Evaluating the Period of 
Purple Crying Intervention Program, 2010-11, and Limited to Women Who Initiated 
Breastfeeding. 
 
No 
Method 
n (%) 
Non-
Hormonal 
n (%) 
Progestin-
only 
n (%) 
Combined 
Estrogen / 
Progestin 
n (%) 
Total 
n (%) 
Visit*†      
No 56 (23.1%) 89(36.6%) 75(30.9%) 23(9.5%) 243 
(18.4%) 
Yes 267(24.8%) 306(28.4%) 348(32.3%) 155(14.4%) 1,076 
(81.6%) 
Total 323 395 423 178 1,319 
(100%) 
* p<0.05       
† This variable is included in the ordinal “Hospital Practices” variable and is not 
included as a separate variable in the analyses. 
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Table 13: Risk Ratios From Log Binomial Regressions of Pairs of Contraceptive 
Types Used in the Postpartum Period by Women Who Initiated Breastfeeding 
(N=1,319). Sample Drawn From a Survey Evaluating the Period of Purple Crying 
Intervention Program, 2010-11 
 
Progesti
n-only 
vs. No 
Method 
RR 
(95% 
CI) 
Progesti
n-only 
vs. Non-
Hormon
al 
Methods 
RR 
(95% 
CI) 
Combine
d 
Estrogen 
/ 
Progesti
n 
Methods 
vs. No 
Method 
RR 
(95% 
CI) 
Combine
d 
Estrogen 
/ 
Progesti
n vs. 
Non-
Hormon
al 
Methods 
RR 
(95% 
CI) 
Combine
d 
Estrogen 
/ 
Progesti
n vs. 
Progesti
n-only 
RR 
(95% 
CI) 
Maternal Age 0.95* 
(0.92, 
0.99) 
0.94* 
(0.90, 
0.98) 
0.98 
(0.91, 
1.06) 
1.00 
(0.91, 
1.09) 
1.08 
(0.98, 
1.18) 
Race/Ethnicity      
White Referent     
Black 0.96 
(0.79, 
1.16) 
1.28** 
(1.08, 
1.51) 
0.73 
(0.48, 
1.12) 
1.14 
(0.78, 
1.67) 
0.74 
(0.48, 
1.15) 
Hispanic 1.08 
(0.90, 
1.30) 
0.99 
(0.81, 
1.23) 
0.86 
(0.60, 
1.24) 
0.65* 
(0.43, 
1.00) 
0.83 
(0.56, 
1.22) 
Other 0.90 
(0.58, 
1.39) 
0.76 
(0.47, 
1.24) 
0.87 
(0.41, 
1.83) 
0.67 
(0.31, 
1.45) 
0.91 
(0.39, 
2.17) 
Maternal Education      
Less than High School  Referent     
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High School 1.10 
(0.89, 
1.35) 
1.21 
(0.96, 
1.52) 
1.14 
(0.71, 
1.82) 
1.16 
(0.70, 
1.91) 
1.12 
(0.71, 
1.8) 
College 1.18 
(0.91, 
1.52) 
1.42* 
(1.09, 
1.86) 
1.13 
(0.65, 
1.94) 
1.16 
(0.67, 
2.01) 
1.05 
(0.60, 
1.8) 
Graduate School 1.21 
(0.90, 
1.64) 
1.47* 
(1.08, 
2.01) 
0.98 
(0.52, 
1.86) 
0.938 
(0.49, 
1.81) 
0.76 
(0.39, 
1.5) 
Pregnancy 
Wantedness 
     
Wanted at this Time Referent     
Not Wanted / 
Mistimed 
1.03 
(0.89, 
1.19) 
0.97 
(0.83, 
1.14) 
0.92 
(0.69, 
1.24) 
0.85 
(0.63, 
1.14) 
0.86 
(0.63, 
1.18) 
All Pregnancies 
Wanted 
0.89 
(0.71, 
1.12) 
0.91 
(0.72, 
1.15) 
0.85 
(0.60, 
1.20) 
0.81 
(0.57, 
1.15) 
0.99 
(0.68, 
1.44) 
First Born 0.98 
(0.85, 
1.14) 
1.07 
(0.91, 
1.25) 
1.20 
(0.92, 
1.56) 
1.46* 
(1.09, 
1.96) 
1.32 
(0.98, 
1.78) 
Baby’s Gender 1.03 
(0.91, 
1.17) 
1.07 
(0.94, 
1.22) 
0.89 
(0.71, 
1.13) 
0.87 
(0.68, 
1.10) 
0.80 
(0.63, 
1.03) 
NICU Stay 1.14 
(0.89, 
1.46) 
1.40* 
(1.08, 
1.81) 
0.84 
(0.46, 
1.52) 
1.13 
(0.63, 
2.00) 
0.75 
(0.40, 
1.39) 
NICU Stay x First 
Born 
1.04 
(0.74, 
1.45) 
0.80 
(0.56, 
1.13) 
1.54 
(0.78, 
3.04) 
0.99 
(0.499, 
1.95) 
1.23 
(0.57, 
2.67) 
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Intended to 
Breastfeed 
1.10 
(0.75, 
1.60) 
0.85 
(0.62, 
1.17) 
0.68 
(0.38, 
1.19) 
0.46* 
(0.27, 
0.78) 
0.71 
(0.38, 
1.32) 
Timing of Initiation 
 
     
<1 Hour Referent     
1 to <2 Hours 1.15 
(0.98, 
1.36) 
1.01 
(0.85, 
1.21) 
1.35 
(1.00, 
1.84) 
1.17 
(0.85, 
1.61) 
1.17 
(0.84, 
1.62) 
2 to 24 Hours 1.04 
(0.89, 
1.22) 
1.020 
(0.86, 
1.20) 
1.26 
(0.93, 
1.71) 
1.27 
(0.94, 
1.70) 
1.25 
(0.91, 
1.72) 
> 24 Hours 0.95 
(0.74, 
1.21) 
0.88 
(0.67, 
1.14) 
1.20 
(0.73, 
1.97) 
1.06 
(0.64, 
1.75) 
1.16 
(0.68, 
1.96) 
Received Formula 
Sample Bag 
0.99 
(0.86, 
1.14) 
0.95 
(0.82, 
1.10) 
1.28 
(0.95, 
1.71) 
1.24 
(0.92, 
1.67) 
1.38 
(1.00, 
1.90) 
Hospital Practices 0.99 
(0.93, 
1.06) 
1.08* 
(1.00, 
1.16) 
1.02 
(0.90, 
1.15) 
1.13 
(0.99, 
1.28) 
1.05 
(0.92, 
1.21) 
Hospital Practices X 
Maternal Age 
1.00 
(0.99, 
1.01) 
1.01 
(1.00, 
1.02) 
0.99 
(0.98, 
1.01) 
0.99 
(0.97, 
1.01) 
0.98 
(0.96, 
1.01) 
** p<0.01      * p<0.05       
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CHAPTER IV: EFFECT OF PROGESTIN-ONLY CONTRACEPTIVE USE ON 
BREASTFEEDING DURATION 
 
 
INTRODUCTION 
 
Breastfeeding and family planning are both important public health issues with 
personal and societal implications. In the postpartum period, these issues come together 
in a way that is crucial to understand if lasting headway is to be made on both of these 
public health priorities. 
Breastfeeding is associated with better short and long-term health outcomes for 
both mother and baby. Breastfed infants have lower rates of a wide range of illnesses 
including ear infections, bacterial meningitis, urinary tract infections, intestinal 
infections, diarrhea, and childhood cancers. (7-15) Lower rates of sudden infant death 
syndrome, asthma, obesity, and diabetes are also seen in children who are breastfed. (16-
24)  Cognitive development may also be enhanced by breastfeeding. (25-27)   
Mothers also experience better immediate and long-term health outcomes with 
breastfeeding.  Women who breastfeed experience less postpartum blood loss and more 
rapid uterine involution. (28) In the long-term, women who breastfeed have lower rates 
of breast and ovarian cancer, fewer hip fractures and less osteoporosis later in life. (29-
33) 
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These differences in health outcomes translate into a substantial health and 
financial. (34) The cost of infant morbidity and mortality that could be prevented by 
meeting the AAP guideline of exclusive breastfeeding until 6 months is estimated to cost 
the United States (US) $13 billion each year. (35)  
Improving breastfeeding outcomes has been a key goal in the Healthy People 
initiatives. The 2020 goals call for an 81.9% initiation rate, 60.6% continuation at six 
months, and 25.5% exclusive breastfeeding at six months. (6) However, in assessing the 
success of the Healthy People 2010 initiative, it was found that in 2010 while 76.9% of 
infants had ever been breastfed and 47.2% of women were still nursing at six months, 
only 16.3% were breastfeeding exclusively at six months.  This falls short of universal 
adherence to the current recommendation of 6 months exclusive breastfeeding of the 
World Health Organization (WHO) and of the AAP. (5)  
So, while some success has been achieved in improving breastfeeding initiation 
rates, much work still remains to be done on rates of continuation and exclusivity. 
Understanding the factors that affect breastfeeding continuation, therefore, is important to 
meeting national and international breastfeeding goals, and for improving maternal and 
infant health in the US. 
One key area of controversy is how contraceptive use and breastfeeding might 
interact in the postpartum period. In particular, the compatibility of hormonal 
contraceptive methods with breastfeeding is widely disputed. Clinical reports from 
lactation specialists suggest that these methods reduce milk supply and lead to weaning, 
whereas evaluation of the available literature by the Centers for Disease Control (CDC) 
led to formal recommendations in 2008 and 2009 and updated in 2013 that progestin-only 
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methods of birth control were compatible with breastfeeding, some even in the first hours 
after birth. (99,100,102) Further complicating the issue is the fact that the WHO espouses 
different recommendations based on the same body of scientific literature, warning 
against progestin-only methods in the early weeks of breastfeeding. (98) 
What is not disputed is the importance of family planning for women, their 
children, and society. The world community set as a goal “universal access to 
reproductive health,” including family planning at the International Conference on 
Population and Development (ICPD) in Cairo, citing, in particular, the fact that family 
planning is one of the most cost effective ways to combat poverty. Still, researchers 
supported by the Bill and Melinda Gates Foundation estimated that, as of 2009, more 
than 200 million women around the world lacked access to modern methods of 
contraception, and furthermore they predicted that by 2050 this would increase by 40%. 
(36,37)  
In the US alone, unintended pregnancy is estimated to cost $4.5 billion each year. 
(41) The burden of unplanned pregnancies falls disproportionately on ethnic and racial 
minorities and those with less education, the same groups that tend to have lower 
financial means and access to healthcare. Between 1994 and 2001, the rate of unintended 
pregnancy among white women was estimated to be 35 per 1,000, while black women 
had 98 per 1,000 and Hispanic women had 78 per 1,000. (39) Education is also strongly 
associated with unintentional pregnancy, with 26 per 1,000 for women with college 
degrees, and 76 per 1,000 for women without a high school degree. Contraceptive use 
follows similar racial and education patterns and is thought to be both a response to and a 
cause of these differences. (40)  
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A significant portion of this issue is postpartum contraception. It is estimated that 
100 million women around the world make decisions about contraception after childbirth 
each year. (42) The public health implications of postpartum family planning are 
particularly important since inter-birth interval has serious implications for both maternal 
and infant health. Women with birth intervals of less than six months are at increased risk 
for maternal mortality (OR 2.54; 95% CI 1.22-5.38), third-trimester bleeding (OR1.73; 
95% CI 142-2.24), premature rupture of membranes (OR1.72; 95% CI  1.53-1.93), 
puerperal endometritis (OR1.33; 1.22-1.45), and anemia (OR1.30; 95% CI 1.18-1.43). 
(43) Among women with previous Cesarean deliveries, birth intervals of less than 18 
months were associated with a higher risk of uterine rupture, 2.25% vs. 1.05% for 
intervals of 19 months or longer, doubling the risk of this rare event. (44) Thus, 
pregnancy prevention is an important health issue for postpartum women.  
While the Lactational Amenorrhea Method (LAM) has been shown to be effective 
for women who are breastfeeding, many women may not be meeting the requirements or 
simply prefer to use contraception after birth. (45-47) The biological pathways that 
establish and maintain lactation are responsive to endogenous estrogen and progesterone.  
Moreover, exogenous estrogens are reported to reduce milk supply and progestins are 
suspected to as well.  Accurate information about the compatibility of specific 
contraceptive methods with breastfeeding is needed for these women to make informed 
choices about both. The current debate over the impact of progestin-only methods on 
breastfeeding has far-reaching implications for women and society, and deserves 
attention.  
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This study aims to increase understanding of the association between progestin-
only methods of birth control and breastfeeding outcomes in the early months of life. 
Much of the research on which the WHO and CDC recommendations are based were 
carried out in countries like Egypt and Chile that have very different breastfeeding 
patterns than seen in the US. Moreover, a substantial portion of this literature is over 20 
years old, raising the question of whether the contraceptive methods available at that time 
and the social context, for instance women’s roles, attitudes towards breastfeeding, and 
awareness of the health implications of breastfeeding, are generalizable to the US today. 
The survey used for this analysis, collected in 2010-11 in North Carolina, provides data 
to addresses a number of these issues. North Carolina falls in the middle of the spectrum 
of US states in terms of breastfeeding initiation and continuation, has a variety of urban 
and rural areas, and has immigration from other parts of the country and beyond, mixing 
social norms from other regions. Geophysically, socio-culturally and economically, there 
is a diversity of settings within the state that encompass a wide spectrum of the American 
social context. Politically, the electorate splits closely between major parties.  There is a 
sizable minority of African Americans and Hispanics.  Together, this makes North 
Carolina an informative setting to explore the current state of breastfeeding in the US, 
and well suited to addresses the question of whether progestin-only forms of 
contraception are associated with shorter durations of breastfeeding. 
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MATERIALS AND METHODS 
 
Subjects 
A sample of North Carolina mothers was drawn from birth certificate data from 
April 2010 to March 2011 to assess response to a Purple Crying campaign. Additional 
questions were added for this study. Of the approximately 130,000 births in the state 
annually, about 2,000 mothers with infants targeted to be between the ages of two and 
three months were selected. Address and name information from the birth certificate were 
used to back-match landline telephone numbers for these women, and only those with 
working, in-state telephones were considered eligible for study participation. A one-time 
telephone survey was administered in English or Spanish to the female parent or legal 
guardian. If more than one child in the household met study criterion, the child on the 
birth certificate was referenced for the study. Otherwise, the identity of the parent and 
child were not verified to match the birth certificate data. This resulted in 1,669 
interviews, including 25 partial interviews. There was over-sampling for Hispanic 
maternal ethnicity, urban/rural location, hospital size for delivery, and infant age to 
ensure variation in the data on key characteristics. 
For the purposes of this analysis, looking at the association between postpartum 
contraceptive use and breastfeeding duration, the analytic sample was limited to women 
who initiated breastfeeding (N=1,404) and who were using a progestin-only, non-
hormonal, or no method of contraception (1,141).  
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STATISTICAL ANALYSES 
 
Chi-square and Kruskal Wallis tests were performed to assess differences between 
women who used each type of contraceptive in the postpartum period. Women who were 
still breastfeeding at the time of the interview were right censored in our analysis, 
whereas those who had ceased to breastfeed prior to the interview had actual durations of 
breastfeeding. 
 A Kaplan-Meier survival analysis of breastfeeding duration was performed using 
the method described by Cole and Hernán that utilizes inverse probability weights based 
on propensity scores to adjust for differences between the users of different contraceptive 
types. (207) Propensity scores for type of contraceptive used in the postpartum time-
frame were based on maternal and infant demographic variables (maternal age, maternal 
education, race/ethnicity, baby’s gender), psychosocial factors (pregnancy ‘wantedness,’ 
intention to breastfeed), health factors (infant NICU stay, parity, and an interaction term 
for NICU stay and parity), and breastfeeding-related maternity care practices: timing of 
breastfeeding initiation, receipt of a formula sample bag at hospital discharge, an ordinal 
variable for the number of Hospital practices experienced by the mother, and an 
interaction term for maternal age and hospital practices. In order to more readily evaluate 
the results, the same covariates were used to create the propensity scores for each 
analysis.   
 The model was developed beginning from a full model that included all variables 
found in the literature to be associated with breastfeeding outcomes and which were 
available in the survey.  To assess the best way to code variables where more than one 
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logical option existed, nested models were compared using likelihood ratio tests with a 
cut-off of p<0.05. Non-nested models were compared using Akaike Information Criterion 
(AIC) and Bayesian Information Criterion (BIC), and parameters that were neither 
statistically significant at the p<0.05 level nor crucial factors from the literature were 
removed from the model.  Covariates that were predictive in any model were retained.  
 Comparison of the distribution of propensity scores for the treatment groups was 
used to assess whether this method adequately controlled for differences between the 
groups.  Furthermore, an analysis of the area of common support, that is where there is 
overlap in the distribution of propensity scores between the treatment and control groups, 
was made by trimming the propensity scores for each group at 1% and 99% cut-offs and 
restricting the analysis to innermost points of the two groups. (218,219)   
 Progestin-only method users were compared to those who used either non-
hormonal or no method of contraception. Statistical Analyses were performed using SAS 
software version 9.2. 
 
MEASURES 
 
Demographic characteristics. The survey included demographic data for both the 
mother and infant, including infant race/ethnicity, infant gender, maternal age, maternal 
educational attainment, family household income, and the county of birth. 
Mothers were asked to identify the race of their infant, and allowed to choose as 
many categories as they felt applied. They were asked separately about the infant’s 
Hispanic ethnicity. Any child identified as being Hispanic was classified as Hispanic for 
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the purposes of this study, regardless of any racial identification. Among non-Hispanics, 
infants with only one race reported on the survey were identified as that race.  Among the 
remaining study subjects who were reported to be mixed-race, any infant identified as 
being “white” in a separate question about whether the parent considered the child white, 
was identified as “non-Hispanic white.”  Next, those who were reported to be mixed-race 
with one race being black were identified as “non-Hispanic black.” All remaining study 
subjects were classified as, “other,” which included Asian, Pacific Islander, Hawaiian, 
Alaskan native, and Native American, and anyone who identified her child as “other”. 
Region of birth was categorized using the State of North Carolina’s classification 
of counties into Western/Mountain, Piedmont, and Eastern/Coastal. Classification was 
based on the county of birth reported by the mother. However, in no analysis was region 
of birth significant, and a likelihood ratio test was used to determine that this variable 
should be dropped from the final model.  
The mother’s age was recorded in whole years from responses to a single question 
in the interview. Various methods of modeling were explored including binned and 
continuous coding and addition of a quadratic term. The Akaike Information Criterion 
(AIC) and Bayesian Information Criterion (BIC) were used to determine that maternal 
age could be sufficiently coded using a continuous variable. Furthermore, the quadratic 
term was not significant in the model and was therefore excluded. For ease of 
interpretation, maternal age was mean-centered in the analysis. 
 
Health factors. Information about parity and admission to the neonatal intensive care 
unit (NICU) were gathered through the interview. Mothers were asked whether the infant 
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in the study had any older biological siblings. First-born status was extrapolated from 
this. NICU stay for this infant was asked directly in the survey. 
 
Psychosocial factors. The World Health Organization (WHO) classifies pregnancy 
intention into four categories: wanted at this time, wanted not at this time, not wanted, 
and all pregnancies are wanted. Mothers were asked to identify the ‘wantedness’ of their 
pregnancy using the WHO categories. A single category that included both unwanted and 
mistimed pregnancies was included in this analysis because of small cell-size for 
unwanted pregnancies. 
Mothers were also asked about their pre-birth breastfeeding intention and 
intended duration. Breastfeeding intention was collected as a dichotomous yes/no 
response, and intended duration was recorded in weeks.  
 
Hospital practices. The mother’s maternity experiences were assessed by asking her to 
report which of seven maternity care related practices she had experienced. These 
practices were derived from the WHO/UNICEF Ten Steps to Successful breastfeeding. 
(198)  Many hospitals in North Carolina have restricted the provision of formula sample 
bags, possibly without or prior to implementing the other practices. (210)  Therefore, 
receipt of a formula sample bag was analyzed independently from the other practices. 
Timing of initiation was also analyzed on its own because it can only be discussed for the 
sub-population that initiates breastfeeding.  
The remaining practices were explored both independently and as a group via an 
index variable, coded zero to five, for the number of breastfeeding-friendly hospital 
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practices received. The practices were not specific to the Ten Steps, but are aspects of 
specific steps.  These practices are immediate skin-to-skin contact between mother and 
infant after birth (Step 4), rooming-in at least 22 of every 24 hours (Step 7), visit by a 
Lactation Consultant (LC) or breastfeeding support person (proxy for Step 5), 
observation of a feeding by an LC or breastfeeding support person (also Step 5), and all 
facility staff supporting the mother’s decision on infant feeding (also Step 5).   
 
Postpartum contraceptive use. Postpartum contraceptive use was assessed by asking 
the mother to identify all methods she had used since the baby’s birth. Four categories of 
contraceptive use, differentiated based on their reported impact on breastfeeding, were 
used to categorize the 17 distinct types of contraception reported by women in the study. 
For those reporting more than one method, the method in the category most contra-
indicated for breastfeeding was selected based on the following order: combined 
estrogen/progestin, progestin-only, non-hormonal, and no method of contraception. 
 
Breastfeeding. Duration of breastfeeding was determined based on the baby’s age at the 
time of the survey if the mother reported that she was still breastfeeding, and if not, 
duration was measured based on the reported age of breastfeeding cessation. The baby’s 
age was calculated from the date of the interview and the baby’s birth date reported 
during the interview, and was then converted into weeks by dividing the results by seven 
and rounding to the nearest whole week. Age at cessation was collected in whole weeks. 
About 70% of the respondents were still breastfeeding at the time of the interview, and 
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therefore their breastfeeding duration was right censored in our analysis because a final 
duration was not available. 
 
Interaction terms. An exploratory analysis of interactions between variables was carried 
out in a separate analysis of direct associations between the independent variables and 
breastfeeding duration using a Cox proportional hazards model of breastfeeding 
cessation. Interactions between the variables for hospital practices and maternal age, 
timing of breastfeeding initiation, NICU stay, infant gender, and intention to breastfeed 
were tested.  In addition, interaction terms for first-born status and NICU stay and for the 
wantedness dummy variables were explored, as well as breastfeeding intention and infant 
gender.  An interaction between infant NICU stay and first-born status was found to be 
significant in some analyses, and was, therefore, kept in the model for all regressions. An 
interaction between the mother’s age and a proxy for all hospital practices developed as 
an ordinal variable was significant and remained in the model. Interactions between the 
individual hospital practices and maternal age were also explored, and a likelihood ratio 
test was used to determine that the ordinal variable and ordinal variable-maternal age 
interaction term were the best for the model.  
 
Missing Data. The data set had a very low level of missing data, between one and three 
percent for most variables, with the exception of family household income and intended 
breastfeeding duration. A likelihood ratio test was carried out to determine whether 
including household income in the model did not have a significant effect on the results. 
Forest plots were used to assess whether estimates of the other variables were affected by 
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including or excluding income, and in no case did the change in parameter estimate 
exceed the confidence interval for that variable. Therefore, income was dropped from the 
model 
 The large amount of missing data for intended breastfeeding duration was non-
random and could possibly be correlated with the mother’s knowledge about, interest in, 
and/or commitment to breastfeeding. Therefore, the dichotomous variable for intention to 
breastfeed was chosen for use in our model, and not to use the information on intended 
duration. 
 A complete case analysis, excluding participants with missing data on any 
variable in the model, was performed. 
 
IRB.  This study received IRB approval from the University of North Carolina, Chapel 
Hill. 
 
RESULTS 
 
Descriptive Analysis: Univariate and Bivariate Distribution 
The mean maternal age of the population in this sample was 30.6 years old, with a 
minimum of 14 and a maximum of 46 (Table 14). The sample was 65.7% non-Hispanic 
white, 10.2% non-Hispanic black, 21.2% Hispanic, and 2.9% other. There were slightly 
more female infants than male, 52.8% versus 47.2% respectively, and 11.1% of infants 
spent time in the NICU compared to about 6.7% nationally. (211).  First time mothers 
made up 66.3% of the population and 12.1% of women had less than a high school 
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degree. 25.3% had a high school education, 40.4% had a college degree, and 22.2% had a 
graduate degree.  The mean infant age at the time of the interview was 3.26 months 
(Table 16a), and across the range of infant ages there was a distribution of breastfeeding 
status (Table 15).  In this population, 37.1% of women used a progestin-only form of 
contraception after birth, compared to 34.6% use of a non-hormonal method, and 28.3% 
use of no contraception (Table 16a).  
There were significant differences in contraceptive use by maternal age (p<0.001, 
Table 16a). Women using no method of contraception were slightly older, on average 
(mean age 31.8) than women using a non-hormonal method (mean age 31.5) and both 
groups were significantly older than women who used a progestin-only method (mean 
age 28.9).  Race/ethnicity was also a significant predictor of contraceptive use (p<0.01, 
Table 16b). While non-Hispanic white mothers were about equally represented across the 
three categories of contraception, non-Hispanic blacks were more likely to use no method 
(31.0%) or a progestin-only method (47.4%) than a non-hormonal method (21.6%), while 
Hispanic mothers were more likely to use a non-hormonal method (41.7%) over a 
progestin-only method (36.0%) or no method (22.3%).  Contraceptive type varied 
significantly with maternal educational attainment (p<0.05).  Mothers with less than a 
high school education most often used a non-hormonal method (42.0%), those with a 
high school degree were most likely to use a progestin-only method (40.8%), and 
college-educated and graduate school educated women used the three types in about 
equal proportion.  Mothers with their first biological child   were most likely to choose a 
non-hormonal method (38.2%) in contrast, multiparous women were least likely to 
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choose a non-hormonal method (27.7%) and most likely to choose a progestin-only 
method (44.4%). 
No statistically significant differences were found in the type of contraceptive 
used, in relation to the wantedness of the pregnancy, the baby’s gender, whether the 
infant had been in the NICU, the mother’s intention to breastfeed, the timing of 
breastfeeding initiation, whether the mother received a formula sample bag at hospital 
discharge, or the number of breastfeeding-related maternity practices she had 
experienced.  However, among the hospital practices included in the ordinal variable, 
there was a significant difference in contraceptive type used in association with a visit by 
an LC or other breastfeeding support person (Table 17); women who were visited were 
more likely to choose a progestin-only method (37.8%), and women who did not receive 
a visit were more likely to choose a non-hormonal method (40.5%). 
 
Survival Analysis of Breastfeeding Duration by Postpartum Contraceptive Use 
The use of a Cox proportional hazards model of breastfeeding duration, as a 
function of type of contraception used since the baby’s birth, allowed control for 
differences between the users of different types of contraception through inverse 
probability weights based on propensity scores for type of contraception used.  
The Cox proportional hazards model comparing progestin-only methods to no 
method of contraception included 746 subjects with 70.4% right censored. No significant 
difference was seen in breastfeeding duration between users of progestin-only methods 
and those who used no form of birth control (Table 18). No effect was seen in either the 
crude analysis or the model using propensity score weighted independent variables to 
	  178 	  
control for differences between the groups, although the survival curve was slightly 
different in the adjusted model (Figure 6, Appendix 11). A visual examination of 
histograms of the propensity score weights for each study group showed a high degree of 
over-lap in the scores indicating that the propensity score was able to substantially 
control for differences between the treatment and control group (Appendix 1). Moreover, 
an analysis of the area of common support using a 1% cut-off showed consistent results 
with the main analysis.  
There were 818 women included in the Cox proportional hazards model of 
progestin-only use compared to use of a non-hormonal method of contraception, and 
69.0% of them were right censored (Table 18). No difference in breastfeeding duration 
was found between these groups in either the crude or propensity score weighted 
analyses, however, the adjusted survival curves showed a trend towards differentiated 
effects with use of a progestin-only method being associated with longer duration of 
breastfeeding than use of non-hormonal methods (Figure 6, Appendix 11). Visual 
examination of the propensity score weighting using histograms showed good success in 
matching the treatment and control groups, and an analysis of the area of common 
support using a 1% cut-off gave substantially similar results to the unrestricted analysis 
(Appendix 1).  
 
DISCUSSION 
 
There was no statistically significant difference in breastfeeding duration for 
women who used progestin-only methods of contraception compared to those who used 
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non-hormonal methods or no contraception.  Clinical reports suggest that early 
postpartum use of progestin-only methods may adversely affect breastfeeding, however, 
this was not borne out in this analysis.  In the adjusted model of progestin-only methods 
compared to non-hormonal methods, there was a slight, non-significant trend towards 
progestin-only methods having a positive impact on breastfeeding duration. These results 
are consistent with previous literature on later-onset use of progestin-only contraception, 
after 4-6 weeks postpartum, that show either no effect or better breastfeeding outcomes 
for progestin-only users.  
The physiology of breastfeeding should be equally unaffected by no contraceptive 
use and by using a non-hormonal method.  However the results of this study suggest that 
caution should be used in selecting the best comparison group for future research on 
contraceptive use while breastfeeding because the adjusted survival curves and bivariate 
analyses using these two different comparison groups show different trends. To the extent 
that the use or non-use of contraception defines distinct populations of women, those who 
choose not to use contraception may not be the most appropriate comparison group to 
assess the effects of hormonal contraceptive methods.  Women who do not use 
contraception after birth may represent a very different population than those who use 
contraception in this period, and, therefore, utilizing the first group as the comparison 
group may not fully control for factors that are not otherwise captured in the model but 
are associated with contraceptive use.  For instance, studies that have non-users as the 
control group may not be adequately controlling for partnership status which has been 
shown to be positively associated with breastfeeding outcomes. (156,158,160)  Much of 
the literature on which the WHO and CDC MECs are based, however, make use of those 
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who are not using contraception as their control group.  Many of these studies report no 
effect of hormonal methods, particularly progestin-only methods, but the results of this 
analysis suggest that use of an inadequate control group may be contributing to these 
results.  This may be particularly true if the effect being studied is more subtle or time 
varying, as is hypothesized for progestin-only methods, since even relatively small 
mismatches in populations may obscure more subtle associations.  
In bivariate analyses, significant differences between women who used progestin-
only forms of contraception and those who used non-hormonal methods or no 
contraception were found.  Breastfeeding women using progestin-only methods of 
contraception were significantly younger than those using non-hormonal methods or no 
method of birth control.  Younger women may have a preference for hormonal 
contraception, and one may speculate that this could be due to younger women being 
more familiar with it than other methods or perceive it as being more reliable.  Clinicians 
may assume, or younger mothers may indicate that preventing future pregnancies is more 
important to them than it is to older women, possibly leading care providers to suggest 
different methods in an attempt to give these women reliable control over their fertility.  
Age differences in access to healthcare, may lead to differences in the options available 
to women of different age groups.   
There were also distinct patterns of contraceptive use by race/ethnicity. White 
mothers were about equally represented across these three contraceptive use categories. 
In contrast, nearly half of all black mothers used a progestin-only method, while non-
hormonal methods were the most common among Hispanic mothers.  Black mothers are 
more likely to use hormonal contraception than other racial and ethnic groups and they 
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also have the lowest breastfeeding rates. (160,164,165)  If clinical reports suggesting that 
early use of progestin-only methods of contraception negatively impact breastfeeding 
outcomes are true, the contraceptive use patterns of black mothers may contribute to the 
health disparity in breastfeeding outcomes.  Contraceptive use patterns of Hispanic 
mothers would be consistent with this possibility since as a group they tend to use non-
hormonal methods.   
Interestingly, only 22% of Hispanic women did not use contraception compared 
to nearly a third of black and white mothers.  This suggests that pregnancy prevention 
may be a more important to factor for Hispanic mothers after birth than for white and 
black mothers.  This could be due to a greater desire to prevent pregnancy on the part of 
Hispanic mothers themselves, but it could also reflect racial bias from healthcare 
providers or differences in access to contraception based on cost or type of health 
insurance.    
Trends in postpartum contraceptive use in this study highlight the importance of 
racial and ethnic differences on this topic.  While sometimes thought to represent 
differences in health factors, in this case race and ethnicity are most likely a proxy for 
social factors that influence a woman’s healthcare choices, as well as the options offered 
to her by her healthcare provider or available to her through health insurance.  These 
factors would likely need to be considered for racial/ethnic patterns of contraceptive use 
to be changed.   
More educated mothers were about equally divided between these three 
categories, while mothers with a high school only or with less than a high school 
education were more likely to use contraception after birth. These differences may reflect 
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differences in socio-economic status and the perceived impact of another pregnancy 
either by the mother herself or from those around her including healthcare providers. 
Pregnancy prevention may be more important to less educated mothers, but these trends 
could also reflect differences in access to care, perhaps with greater access for less 
educated women via public health programs.  Bias from healthcare providers could also 
play a role, either consciously or unconsciously assuming that more children would be 
undesirable for less educated women.   
Pregnancy wantedness is not significantly associated with the type of 
contraceptive used among mothers who initiated breastfeeding, however, a suggestive 
trend towards contraceptive use among women whose pregnancies were unwanted or 
mistimed is present; 22.5% of these women chose not to use contraception after birth. In 
contrast, 32.7% of women for whom all pregnancies would be wanted went without 
contraception after birth, and 29.7% of women whose pregnancies were wanted and 
timely did not use contraception.  Reporting of mistimed or unwanted pregnancies was 
much lower in this sample than reported nationally, suggesting that this factor is likely 
underreported in this sample.  The trend towards higher contraceptive use after mistimed 
or unwanted pregnancies suggests that a prior unwanted or mistimed pregnancy may 
influence contraceptive use after that birth, and may be an important factor to consider 
for research and clinical practice.   
Mothers with older children were much more likely to use a progestin-only 
method rather than a non-hormonal method after birth, indicating that family size 
influences contraceptive use in the postpartum period.  Clinicians may assume that 
pregnancy prevention is a priority for mothers with more than one child and therefore 
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steer them towards methods with higher efficacy without fully considering the 
implications for breastfeeding.  Having older children may also be a proxy for the mother 
having achieved her desired family size, a factor that was not available in this dataset.  A 
woman who has achieved her desired family size may be more motivated to prevent 
future pregnancies, shifting her decision making balance towards pregnancy prevention 
and away from breastfeeding protection.  If so, this would indicate a need for better 
information about and promotion of types of contraception that are compatible with 
breastfeeding targeted at women who feel they have completed their child-bearing. 
Breastfeeding-related hospital practices were evaluated to assess whether a 
breastfeeding-friendly hospital setting had an impact on breastfeeding-supportive 
contraceptive choice. Timing of breastfeeding initiation, receipt of a formula sample bag, 
and the number of other breastfeeding-related hospital practices experienced by the 
mother were not associated with type of contraception used. However, mothers who had 
a visit by an LC or other breastfeeding support person were most likely to use a 
progestin-only method (37.8%) while those who did not report being visited by a 
breastfeeding specialist were most likely to use a non-hormonal method (40.5%).  This is 
surprising since, as a group, LCs have been advocating for more caution in using 
progestin-only methods while breastfeeding.  This may simply reflect that women who 
are experiencing breastfeeding difficulties are more likely to receive a breastfeeding 
support visit and more likely to initiate contraceptive use.  It could also reflect higher 
rates of breastfeeding challenges for those who initiate contraceptive use immediately 
after birth, an possibility that cannot be addressed with this sample because no 
information about timing of contraceptive use was collected.  Given that the current CDC 
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medical eligibility criteria for postpartum contraceptive use indicates that progestin-only 
methods are compatible with breastfeeding, these results could also reflect better 
education about the CDC recommendations among women who have received a 
breastfeeding support visit. Moreover, while many LCs in private practice may be 
cautious about recommending progestin-only methods based on their clinical observation, 
this variable included other support staff who may be less knowledgeable about these 
issues.  It is possible that in the hospital setting more staff may be adhering to CDC 
recommendations that suggest that early use of progestin-only methods are compatible 
with breastfeeding. 
Whatever the cause, differences in contraceptive use after birth follow similar 
patterns to breastfeeding outcomes, suggesting that the two issues may be related as 
proposed by clinicians.  There is a need to understand the association between the type of 
contraceptive used while breastfeeding and breastfeeding outcomes to ensure that 
contraceptive use is not contributing to health disparities in breastfeeding and the health 
consequences of breastfeeding.  While the results of the survival analysis did not show an 
effect of progestin-only methods, the effect of early use of progestin-only methods could 
not be differentiated from later use because this dataset did not include information on 
timing of contraceptive use. Consequently, these results should not be interpreted to mean 
that progestin-only methods are compatible with breastfeeding. 
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LIMITATIONS  
 
An important limitation of this study is the lack of information about the timing of 
initial contraceptive use. Biological models suggest that early introduction of 
progestogenic contraception after birth may disrupt breastfeeding establishment, while 
later introduction may have no effect or a supportive effect on breastfeeding outcomes. If 
this is the case, this study would not be able to distinguish these effects since all women 
who used progestin-only methods were grouped together, regardless of early or late onset 
of use. The available data did not allow evaluation of the intensity or exclusivity of 
breastfeeding, and therefore assessment of more nuanced breastfeeding outcomes could 
not be carried out.  Examination of these important indicators of breastfeeding success 
would help to clarify the effects of progestin-only contraception on breastfeeding. 
The high amount of censored data in this sample (69.0%) may limit the power to 
detect differences in breastfeeding duration between contraceptive use groups.  While 
duration of breastfeeding is unavailable for these women, it is informative that they were 
able to breastfeed as long as they reported, and that this occurred in the context of their 
reported contraceptive use.  Moreover, censoring would likely be a less significant issue 
at earlier time-points, which is the time frame of most interest since women may be a 
more vulnerable to breastfeeding cessation as the biology and behavior of breastfeeding 
are being established.  This is also the time frame in which progestin-only methods are 
hypothesized to have the greatest impact.  Censoring could bias the sample if it was 
associated with the outcomes, breastfeeding or contraceptive use.  This sample was 
selected at random from birth certificate data, limiting this possibility; however, if 
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availability by landline telephone or willingness to participate in a telephone survey was 
correlated with breastfeeding outcomes or contraceptive use this could introduce bias.         
This analysis is also vulnerable to the possibility that women began using 
contraception after breastfeeding cessation.  However, most women in this sample were 
still breastfeeding, and their achieved duration was accomplished in the context of their 
contraceptive use or non-use.  Moreover, the infants in this sample were relatively young, 
which further limits this possibility of reverse causation.    
Intensity or exclusivity of breastfeeding could not be evaluated in this sample, and 
therefore could not assess these more nuanced breastfeeding outcomes. This is 
unfortunate, since exclusivity is a relevant outcome of interest in relation to milk supply, 
a potential point of impact for exogenous hormones like those in hormonal contraception.  
In the United States, there is a large drop-off in breastfeeding rates during the first 
year, which could affect the ability of this study to detect associations between 
contraceptive use and breastfeeding outcomes.  If factors such as social, demographic, 
and healthcare are more important to breastfeeding cessation than biological factors, it 
may be difficult to detect the biological impact of contraceptive use if there is residual 
confounding.  Unmeasured factors that contribute to breastfeeding cessation could be 
wrongly attributed in this study as an effect of contraceptive use. The use of propensity 
scores is intended to address the multi-faceted nature of this topic area and, therefore, 
address this concern.   
Confounding is a particular problem in this area of work as seen by the significant 
demographic differences between the users of different types of postpartum 
contraception.  Similarly, there were significant demographic differences between those 
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who did and did not initiate breastfeeding and by duration (reported for this sample in 
chapter 2).  However, propensity score weighting was able to adequately balance the 
demographic characteristics of women in the different contraceptive use categories. This 
suggests that this technique may be useful in controlling for confounding and examining 
causality in future studies on contraceptive use while breastfeeding.  
A limitation of propensity scores is the assumption of no unmeasured 
confounders.  Breastfeeding and contraceptive use both have complex etiologies that 
include social, psychological, biological, and healthcare factors.  This dataset is unusual 
in the breastfeeding literature for the number and quality of breastfeeding and 
contraception related questions it asks.  However, information on timing and sequencing 
of contraceptive use, partnership status, social support for breastfeeding, maternal 
depression, urbanicity, and maternal obesity, and others were not available in this dataset.  
To the extent that the factors available are more proximal to the outcome, they may serve 
as adequate proxies for these and other unmeasured factors and mitigate the vulnerability 
of using this statistical approach.  Furthermore, it should be noted that the assumption of 
no unmeasured confounders is also present for other common statistical approaches, and 
therefore not specific to this analytic design. 
The sample population was selected from North Carolina Birth Certificates and 
contacted by telephone. Differences in the covariates and in contraceptive use may exist 
between those available by landline telephone and those who cannot be reached by this 
means including those who do not have a landline telephone.  For instance, people who 
use cell phones exclusively would not be available by this means, and this could 
disproportionately exclude younger, poorer, and more transient mothers from the sample 
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leading to sample bias.  If willingness to participate in a telephone survey were not 
randomly distributed, the sample would also be biased. These concerns are addressed in 
two ways. First, the random selection process using birth certificate records provides an 
unbiased foundation for sample selection.  In addition, many measures were undertaken 
to contact potential subjects including multiple contact attempts, contact at different times 
of the day and week, and contact attempts over several months. Furthermore, if the 
potential participant declined, efforts were made by specially trained personnel to 
convince the potential study subjects to participate.  
The retrospective study design relied on maternal self-report and is vulnerable to 
recall bias which would be more likely to affect transient factors and factors with 
perceived positive or negative connotation.  For example, unwanted and mistimed 
pregnancies are reported less often in this sample than has been found in national data.  
Mothers may be reluctant to tell the interviewer that their pregnancy was unwanted or 
mistimed, and she might also unconsciously re-evaluate the wantedness of her pregnancy 
as she begins to bond with her baby.  Similarly, a mother’s recall of her intention to 
breastfeed may change in light of her actual experience of breastfeeding.  Reporting of 
hospital practices may be also be bias by events that happen later, and mothers could 
simply not remember what occurred during that time.  Some may not even know whether 
and when events happened, which could be correlated with maternal or infant health.  
Finally, reporting of contraceptive use may be subject to recall bias, especially if more 
than one method has been used since birth.  This sample is likely comparable to other 
studies in the field of breastfeeding research since results from this study are consistent 
with other breastfeeding studies on covariates commonly reported in the literature.  
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Non-random missing data could lead to sample bias, however the amount of 
missing data for the variables used in the model was 1%-3%, which is very low.  Few 
factors in the model were significantly associated with contraceptive use suggesting that 
this model was missing variables that influence the use of contraception after birth. For 
instance, partnership status, whether the mother is sexually active, and whether she has 
achieved her desired family size could all be important factors in using contraception, but 
were not available in the dataset.  Timing of contraceptive use would also have been 
useful to provide a more complete description of postpartum contraception.  This is 
particularly true for women who reported using more than one method since birth 
because the timing, order and duration of these methods were unknown.  However, the 
sample is unusual in that is has information about breastfeeding outcomes alongside 
information about contraceptive use, enabling analysis of contraception use during 
breastfeeding.  Few analyses of postpartum contraceptive use have been carried out in 
adult populations, so this study also contributes to the literature by describing factors 
associated with contraceptive use in this large and meaningful demographic. 
 
CONCLUSION 
 
No effect of progestin-only contraceptive use on breastfeeding duration was found 
when compared to either non-hormonal methods of birth control or using no method. 
These results are limited by the lack of information on the timing of initiation of use. In 
particular, early use, i.e., immediate postpartum, could not be distinguished from later 
use. The use of propensity scores in our survival analysis successfully matched our study 
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groups, and may be a technique useful for future work in the field. This is particularly 
compelling given the strong differences identified between women who use different 
types of contraception after birth. 
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Table 14: Characteristics of the Population of Women Who Initiated 
Breastfeeding From a Survey Evaluating the Period of Purple Crying 
Intervention Program, 2010-11. (N=1,141). Limited to Women Who Reported 
Using Progestin-Only, Non-hormonal, or No Method of Birth Control 
 Total Percentage 
of Total 
 1,141 100% 
Maternal Age (years)   
Mean 30.6   
Median 31   
Race/ Ethnicity   
Non-Hispanic White 750 65.7% 
Non-Hispanic Black 116 10.2% 
Hispanic 242 21.2% 
Other 33 2.9% 
Maternal Education   
Less than High School 138 12.1% 
High School 289 25.3% 
College 461 40.4% 
Graduate School 253 22.2% 
Pregnancy Wantedness   
Wanted at This Time 707  62.0% 
Not Wanted / Mistimed 284  24.9% 
All Pregnancies Wanted 150  13.1% 
First Child   
No 385  33.7% 
Yes 756  66.3% 
Baby’s Gender   
Female 603 52.8% 
Male 538 47.2% 
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NICU Stay   
no 1,014 88.9% 
yes 127  11.1% 
Intention to Breastfeed   
No 24 2.1% 
Yes 1,117  97.9% 
Timing of Initiation   
< 1 Hour 518  45.4% 
1 to <2 Hours 225  19.7% 
2 to 24 Hours 281  24.6% 
> 24 Hours 117  10.3% 
Received Formula Sample Bag   
No 278 24.4% 
Yes 863  75.6% 
 
 
Table 15: Percentage of the Sample at Each Month Who are Still  Breastfeeding, 
Among Women Who Initiated Breastfeeding (N=1,319).  Sample Drawn From a 
Survey Evaluating the Period of Purple Crying Intervention Program, 2010-11 and 
Limited to Women Who Reported Using Progestin-Only, Non-hormonal, or No 
Method of Birth Control. 
 Not Breastfeeding 
n (%) 
Breastfeeding 
n (%) 
1 Month 115 (10.1%) 1,026 (89.9%) 
2 Months 242 (21.2%) 899 (78.8%) 
3 Months 454 (39.8%) 687 (60.2%) 
4 months 862 (75.5%) 279 (24.5%) 
5 Months 1121 (98.2%) 20 (1.8%) 
> =6 Months 1132 (99.2%) 9 (0.8%) 
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Table 16a: Characteristics of the Population (continuous variables) by Method of 
Postpartum Contraceptive Use (N=1,319).  Sample Drawn From a Survey 
Evaluating the Period of Purple Crying Intervention Program, 2010-11 and Limited to 
Women Who  Initiated Breastfeeding, and Who Reported Using Progestin-Only, Non-
hormonal, or No Method of Birth Control. 
 
No 
Method 
n (%) 
Non-
Hormonal 
n (%) 
Progestin-
Only 
n (%) 
Total 
n 
Total 323 
(28.3%) 
395 
(34.6%) 
423 
(37.1%) 
1,141(100
%) 
Maternal Age*** 
(years) 
    
Mean 31.8 31.5 28.9 30.6 
Median 32 32 30 31 
Infant Age at Time of 
Interview 
    
Mean 3.28 3.23 3.27 3.26 
Median 3 3 3 3 
Hospital Practices     
Mean 3.9 3.8 3.9 3.9 
Median 4 4 4 4 
*** p<0.001      ** p<0.01      * p<0.05    
 
Table 16b: Characteristics of the Population by Method of Postpartum 
Contraceptive Use (N=1,141).  Sample Drawn From a Survey Evaluating the Period 
of Purple Crying Intervention Program, 2010-11 and Limited to Women Who  
Initiated Breastfeeding, and Who Reported Using Progestin-Only, Non-hormonal, or 
No Method of Birth Control. 
 
No 
Method 
n (%) 
Non-
Hormonal 
n (%) 
Progestin-
Only 
n (%) 
Total 
n 
Total 323 
(28.3%) 
395 
(34.6%) 
423 
(37.1%) 
1,141(100
%) 
Race/ Ethnicity**     
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Non-Hispanic White 224 
(29.9%) 
254 
(33.9%) 
272 
(36.3%)  
750 
Non-Hispanic Black 36 (31.0%) 25 (21.6%) 55 (47.4%) 116 
Hispanic 54 (22.3%) 101 
(41.7%) 
87 (36.0%) 242 
Other 9 (9.1%) 15 (45.5%) 9 (9.1%) 33 
Maternal Education*     
Less than High School 28 (20.3%) 58 (42.0%) 52 (37.7%) 138 
High School 70 (24.2%) 101 
(34.9%) 
118 
(40.8%) 
289 
College 146 
(31.7%) 
148 
(32.1%) 
167 
(36.2%) 
461 
Graduate School 79 (32.3%) 88 (34.8%) 86 (34.0%) 253 
Pregnancy Wantedness     
Wanted at This Time 210 
(29.7%) 
241 
(34.1%) 
256 
(36.2%) 
707  
Not Wanted / Mistimed 64 (22.5%) 99 (34.9%) 121 
(42.6%) 
284  
All Pregnancies Wanted 49 (32.7%) 55 (36.7%) 46 (30.7%) 150  
First Child***     
No 108 
(28.3%) 
106 
(27.7%) 
171 
(44.4%) 
385  
Yes 215 
(28.4%) 
289 
(38.3%) 
252 
(33.3%) 
756  
Baby’s Gender     
Female 171 
(28.4%) 
202 
(33.5%) 
230 
(38.2%) 
603 
Male 152 
(28.3%) 
193 
(35.9%) 
193 (35.9) 538 
NICU Stay     
no 290 
(28.6%) 
357 
(35.2%) 
367 
(36.2%) 
1,014 
yes 33 (26.0%) 38 (29.9%) 56 (44.1%) 127  
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Intention to Breastfeed     
No 8 (33.3%) 5 (20.8%) 11 (45.8%) 24 
Yes 315 
(28.2%) 
390 
(34.9%) 
412 
(36.9%) 
1,117  
Timing of Initiation     
< 1 Hour 162 
(31.3%) 
172 
(33.2%) 
184 
(35.5%) 
518  
1 to <2 Hours 53 (23.6%) 84 (37.3%) 88 (39.1%) 225  
2 to 24 Hours 77 (27.4%) 94 (33.5%) 110 
(39.1%) 
281  
> 24 Hours 31 (26.5%) 45 (38.5%) 41 (35.0%) 117  
Received Formula Sample 
Bag 
    
No 83 87 108 278  
Yes 240 308 315 863  
*** p<0.001      ** p<0.01      * p<0.05    
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Table 17: Population Characteristics for Statistically Significant Individual 
Hospital Practices that Comprise the Ordinal Variable “Hospital Practices” by 
Method of Postpartum Contraceptive Use  (N=1,141).  Sample Drawn From a 
Survey Evaluating the Period of Purple Crying Intervention Program, 2010-11 and 
Limited to Women Who  Initiated Breastfeeding, and Who Reported Using Progestin-
Only, Non-hormonal, or No Method of Birth Control. 
 
No Method 
n (%) 
Non-
Hormonal 
n (%) 
Progestin-Only 
n (%) 
Total 
n 
LC Visit*†     
No 56 (25.5%) 89 (40.5%) 75 (34.1%) 220 
Yes 267 (29.0%) 306 (33.2%) 348 (37.8%) 921 
* p<0.05       
† This variable is included in the ordinal “Hospital Practices” variable and is not 
included as a separate variable in the analyses. 
 
 
Table 18: Hazard of Breastfeeding Cessation as a Function of Type of 
Contraceptive Used (N=1,141).  Sample Drawn From a Survey Evaluating the Period 
of Purple Crying Intervention Program, 2010-11 and Limited to Women Who 
Reported Using Progestin-Only, Non-hormonal, or No Method of Birth Control. 
 
Hazar
d 
Ratio 
Lowe
r 
95% 
CL 
Upper 
95% 
CL 
Likelihood 
ratio test 
Sampl
e Size 
Percent 
censored 
Progestin-only 
methods 
referen
t 
     
No Method 0.92 0.71 1.19 p>0.542 746 70.4% 
Non-hormonal 
methods 0.85 0.67 1.09 p>0.212 817 69.3% 
*Adjusted for maternal age, race/ethnicity, maternal education, pregnancy wantedness, 
parity, baby’s gender, NICU stay, intention to breastfeed, timing of initiation, receipt 
of a formula sample bag, and hospital practices through the propensity score  
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Figure 6: Survival Plots of Breastfeeding Duration by Type of Contraception Used. 
From a Survey Evaluating the Period of Purple Crying intervention program, 2010-11, 
and limited to women who initiated breastfeeding. Curves are Adjusted for maternal age, 
race/ethnicity, maternal education, pregnancy wantedness, parity, baby’s gender, NICU 
stay, intention to breastfeed, timing of initiation, receipt of a formula sample bag, and 
hospital practices through propensity score weights.  
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CHAPTER V: EFFECT OF COMBINED ESTROGEN/PROGESTIN METHODS 
OF BIRTH CONTROL ON BREASTFEEDING DURATION  
 
 
INTRODUCTION 
 
Breastfeeding is the optimum form of infant feeding according to the World 
Health Organization (WHO) and the American Academy of Pediatrics (AAP). (1,2) 
Breastfeeding carries short and long term advantages for both the baby and mother, and 
exclusive breastfeeding is recommended by both the AAP and WHO for the first six 
months of life with continued breastfeeding afterwards as solids are introduced. (3) The 
Healthy People 2010 initiative of the US Department of Health and Human Services set a 
goal for the country of at least 75% breastfeeding initiation and at least 50% 
breastfeeding continuation at 6 months. (4) By 2010, 76.9% of mother-infant dyads 
initiated breastfeeding and 47.2% were nursing at six months, nearly meeting the Healthy 
People 2010 target. (5) However, only 16.3% were breastfeeding exclusively at six 
months, the recommendation from both the WHO and AAP. Healthy People 2020 set 
breastfeeding goals for the current decade of 81.9% initiation, 60.6% continuation at six 
months, and 25.5% exclusive breastfeeding at six months. (6) It is likely that in order to 
meet these ambitious targets new programs and policies will be needed. This project aims 
to inform that process by providing up to date information about breastfeeding and 
contraceptive use in the United States.  
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The health impact of breastfeeding is extensively reported in the literature. 
Breastfed infants have lower rates of a wide range of illnesses including ear infections, 
bacterial meningitis, urinary tract infections, intestinal infections, diarrhea, and childhood 
cancers. (7-15) Lower rates of sudden infant death syndrome, asthma, obesity, and 
diabetes are also seen in children who are breastfed. (16-24)  Childhood cognitive 
development may also be enhanced by breastfeeding. (25-27)    
Mothers also experience better immediate and long-term health outcomes with 
breastfeeding.  Women who breastfeed have less postpartum blood loss and are more 
likely to experience rapid uterine involution. (28) They also have lower rates of breast 
and ovarian cancer and fewer hip fractures and osteoporosis later in life. (29-33)   
The health implications of postpartum family planning are well documented as 
well, and also have serious implications for both maternal and infant health by affecting 
inter-birth interval. Women with short birth intervals, less than six months, were found to 
have higher risk of maternal mortality (odds ratio 2.54; 95% CI 1.22-5.38), third-
trimester bleeding (1.73; 142-2.24), premature rupture of membranes (1.72; 1.53-1.93), 
puerperal endometritis (1.33; 1.22-1.45), and anemia (1.30; 1.18-1.43). (43)  For those 
with previous Cesarean deliveries, birth intervals of less than 18 months were associated 
with a higher risk of uterine rupture, 2.25% vs. 1.05% for intervals of 19 months or 
longer. (44)  
The impact on long-term health for individuals and on healthcare costs as a nation 
is, therefore, large. (34) Infant morbidity and mortality related to the low prevalence of 
meeting the 6 month exclusive breastfeeding recommendations of the American 
Academy of Pediatrics alone is estimated to cost the United States (US) $13 billion 
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annually. (35) Similarly, Trussell et al. estimate that the annual cost of unintended 
pregnancy in the US is $4.5 billion. (41)  The burden of unplanned pregnancies falls 
disproportionately on ethnic and racial minorities and those with less education, the same 
groups that tend to have lower financial means and access to healthcare. Between 1994 
and 2001, the rate of unintended pregnancy among white women was estimated to be 35 
per 1,000, while black women had 98 per 1,000 and Hispanic women had 78 per 1,000. 
(39) Education is also strongly associated with unintentional pregnancy, with 26 per 
1,000 for women with college degrees, and 76 per 1,000 for women without a high 
school degree. Contraceptive use follows similar racial and education patterns and is 
thought to be both a response to and a cause of these differences. (40)  
The health and economic impact of breastfeeding and family planning highlight 
the importance of access to effective family planning methods that are compatible with 
breastfeeding.  The biological pathways that establish and maintain lactation are 
responsive to endogenous estrogen and progesterone.  Moreover, exogenous estrogens 
are reported to reduce milk supply and progestins are suspected to as well.  The WHO 
and Centers for Disease Control (CDC) have developed Medical Eligibility Criteria 
(MEC) for contraceptive use in the breastfeeding population. Both organizations base 
their recommendations on the same body of scientific literature, however, they come to 
different conclusions about the overall safety and timing of use of hormonal 
contraception. (98,99,102) Much of this literature is more than twenty years old and the 
research was conducted in settings like Egypt and Chile where patterns of breastfeeding 
and infant care are very different than in the US.  Moreover, the statistic methods used 
often did not address issues of confounding and bias.  
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In spite of the potential negative effects on breastfeeding reported by both the 
WHO and CDC, a report from 1994 showed that many mothers in that era strongly 
preferred to use combined hormonal contraceptives. (98,99,108) It is not known whether 
today’s mothers have the same preference, and given the greater public awareness of the 
benefits of breastfeeding for both mother and baby, generalizing from 1994 is limited. 
However, many of the reasons cited by mothers in 1994 are still relevant today, 
familiarity with the method, beneficial effects for menstrual cycling, and control of 
bleeding.  
This study aims to elucidate the impact of combined estrogen/progestin methods 
of birth control on breastfeeding duration in a US context, and to employ statistical 
methods to more fully account for differences between women who use different forms 
of contraception. It addresses several of the fundamental issues with the CDC/WHO 
literature because it is both recent, conducted in 2010-1, and US based, i.e., North 
Carolina. North Carolina falls in the middle of the spectrum of US states in terms of 
breastfeeding initiation and continuation, has a variety of urban and rural areas, and has 
immigration from other parts of the country and beyond, mixing social norms from other 
regions. Geophysically, socio-culturally and economically, there is a diversity of settings 
within the state that encompass a wide spectrum of the American social context. 
Politically, the electorate splits closely between major parties.  There is a sizable minority 
of African Americans and Hispanics.  Together, this makes North Carolina an 
informative setting to explore the current state of breastfeeding in the US, and well suited 
to addresses this question. 
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MATERIALS AND METHODS 
 
Subjects 
A telephone survey of new mothers in North Carolina was carried in from April 
2010 to March 2011 with a main purpose of assessing breastfeeding outcomes. About 
2,000 potential study subjects were drawn from birth certificate data on the 
approximately 130,000 births in the state each year. Landline telephone numbers were 
back-matched from the birth certificates and attempts were made to contact new mothers 
in those households. Only those with working telephones and residing in the state of 
North Carolina were eligible for the survey. 1,669 women agreed to participate in the 
study and all but 25 completed the one-time phone interview, which was carried out in 
either English or Spanish by the female parent or legal guardian. Over-sampling of 
certain sub-populations was carried out to ensure sample size for infants less than two 
months and between two and three months of age, maternal Hispanic ethnicity, 
urban/rural location, and hospital size for the birth. The birth certificate information was 
not retained, and no verification was done to ensure that the respondent was the actual 
mother referenced on the birth certificate, with the exception that if more than one child 
in the household met the study criterion, the child referenced on the birth certificate was 
referenced in the study.       
For this analysis, looking at the effect of postpartum exposure to contraception on 
breastfeeding, the analytic sample was limited to women who initiated breastfeeding 
(1,404), regardless of her breastfeeding duration. Only participants with complete 
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information on all study variables were included in the analysis (N=1,319), 93.9% of the 
eligible participants,  
 
STATISTICAL ANALYSES 
 
 Chi squared and Kruskal Wallis tests were performed to assess differences 
between women who used each type of contraceptive in the postpartum period. Women 
who were still breastfeeding at the time of the interview were right censored in our 
analysis, whereas those who had ceased to breastfeed prior to the interview had actual 
durations of breastfeeding.   
 A Kaplan-Meier survival analysis of breastfeeding duration was performed as 
described by Cole and Hernán using inverse probability weights based on propensity 
scores for postpartum contraceptive use. (207) The propensity scores for type of 
contraceptive used in the postpartum time period were calculated based on maternal and 
infant demographic variables (maternal age, maternal education, race/ethnicity, baby’s 
gender), psychosocial factors (pregnancy wantedness, intention to breastfeed), health 
factors (infant NICU stay, parity, and an interaction term for NICU stay and parity), and 
breastfeeding-related maternity care practices: timing of breastfeeding initiation, receipt 
of a formula sample bag at hospital discharge, an ordinal variable for the number of 
Hospital practices experienced by the mother, and an interaction term for maternal age 
and hospital practices. In order to more readily evaluate the results, the same covariates 
were used to create the propensity scores for each analysis.  
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 The model was developed beginning from a full model that included all variables 
known from the literature to be associated with breastfeeding outcomes and which were 
available in the sample.  To assess the best way to code variables where more than one 
logical option existed, nested models were compared using likelihood ratio tests with a 
cut-off of p<0.05. Non-nested models were compared using Akaike Information Criterion 
(AIC) and Bayesian Information Criterion (BIC), and parameters that were neither 
statistically significant at the p<0.05 level nor crucial factors from the literature were 
removed from the model.  Covariates that were predictive in any model were retained. 
 Comparison of the distribution of propensity scores for the treatment groups was 
used to assess whether this method adequately controlled for differences between the 
groups.  Furthermore, an analysis of the area of common support, that is the portion of 
the sample for which propensity scores exist in both groups, was made by trimming the 
propensity scores for each group at 1% and 99% cut-offs and restricting the analysis to 
innermost points of the two groups. (218,219) A visual assessment of the propensity 
score weighting for the two groups showed some area without overlap between exposed 
and control groups, but an analysis of the area of common support, that is the portion of 
the sample for which propensity scores exist in both groups, (innermost 1% cut-offs) 
gave very similar results. 
 In separate analyses, comparison was made between combined estrogen/progestin 
methods and progestin-only methods, non-hormonal methods, and no method of 
contraception. Statistical Analyses were performed using SAS software version 9.2.  
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MEASURES 
 
Demographic characteristics. Infant and maternal demographic characteristics were 
collected during the interview, and only information obtained in the interview was 
retained in the dataset. Study participants were asked about the infant’s gender and 
race/ethnicity, and their own age, educational level, family household income, and county 
of birth.    
Infant gender, male/female, was asked directly in the interview. The infant’s 
race/ethnicity was classified for the purposes of this study using three questions from the 
interview.  Mothers were asked to identify the race of their infant, and allowed to choose 
as many categories as they felt applied. They were asked separately about the infant’s 
Hispanic ethnicity. Any child identified as being Hispanic was classified as Hispanic for 
the purposes of this study, regardless of any racial identification. Among non-Hispanics, 
infants with only one race reported on the survey were identified as that race.  Among the 
remaining study subjects who were reported to be mixed-race, any infant identified as 
being “white” in a separate question about whether the parent considered the child white, 
was identified as “non-Hispanic white.”  Next, those who were reported to be mixed-race 
with one race being black were identified as “non-Hispanic black.” All remaining study 
subjects were classified as, “other,” which included Asian, Pacific Islander, Hawaiian, 
Alaskan native, and Native American, as well as, anyone who identified their child as 
“other”. 
Maternal age was recorded in whole years, coding it as a continuous or ordinal 
variable with 5-year age-bins was assessed to determine which fit the data best by using 
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Akaike Information Criterion (AIC) and Bayesian Information Criterion (BIC) tests. 
Continuous coding was determined to be most appropriate here and the data were mean-
centered for ease of interpretation of the model. In addition, the assumption of linearity 
was tested by exploring a quadratic term for maternal age, and found to be non-
significant. 
Information about the county of birth was organized by region of the state in 
accordance with the boundaries used for programmatic, funding, and demographic uses 
by the state of North Carolina. Those regions are Western/Mountain, Piedmont, and 
Eastern/Coastal. This variable was not significant in any model and a likelihood ratio test 
was used to determine that it should be dropped from the final model. 
  
Health factors. Neonatal intensive care unit (NICU) stay by the infant was asked directly 
in the interview as a yes/no dichotomous question. Mothers were also asked whether 
there were older biological siblings of the child in the study. First-born status was 
extrapolated from this information.  
 
Psychosocial factors. Mothers were asked about their pregnancy intention using the 
WHO categories for pregnancy wantedness: wanted at this time, wanted not at this time, 
not wanted, and all pregnancies are wanted.  We combined the middle two categories into 
a single mistimed/unwanted category for our analysis in order to account for the small 
cell size of unwanted pregnancies. 
The mother’s pregnancy and breastfeeding intention were assessed in the 
interview.  Women were asked about their pre-birth intention to breastfeed (dichotomous 
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yes/no) and their intended duration. A high level of missing data for the intended duration 
question and strong co-linearity between these variables led us to choose the dichotomous 
variable for this study. 
 
Hospital practices. Mothers were asked about their experience of the seven maternity 
care related practices identified in the WHO Ten Steps to Successful Breastfeeding. 
Anecdotal evidence suggests that many hospitals in North Carolina implement a 
restriction on giving out formula sample bags before they implement the other steps. 
(210)  Therefore, we analyzed this step separately.  Timing of breastfeeding initiation 
was also analyzed independently since this practice was seen to have a significant 
association with breastfeeding duration in a multivariate analysis. The other five practices 
were analyzed both individually and as a group using an ordinal variable for hospital 
practices that was coded zero to five for the number of practices experienced by the 
mother. The practices were not specific to the Ten Steps, but are aspects of specific steps.  
These practices are immediate skin-to-skin contact between mother and infant after birth 
(Step 4), rooming-in at least 22 of every 24 hours (Step 7), visit by a Lactation Consultant 
(LC) or breastfeeding support person (proxy for Step 5), observation of a feeding by an 
LC or breastfeeding support person (also Step 5), and all facility staff supporting the 
mother’s decision on infant feeding (also Step 5).   
 
Postpartum contraceptive used. Mothers were asked about the methods of 
contraception they had used since the baby’s birth, and were allowed to identify as many 
methods as applied. Responses were classified into four categories.  Where more than 
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one method was reported, the woman’s use was classified in the category most contra-
indicated for breastfeeding. That is, in this order: combined estrogen/progestin, progestin-
only, non-hormonal, and no method of contraception.     
 
Breastfeeding. Among those who had stopped breastfeeding, breastfeeding duration was 
calculated based on the mother’s report of the infant’s age at cessation. Among those still 
breastfeeding at the time of the survey, the breastfeeding duration was right censored in 
the analysis, indicating that her duration was not a final duration, but rather, a ‘duration-
to-date.’ For these women, duration was calculated based on the date of the interview and 
the baby’s birth date reported by the mother during the interview. Ages were converted to 
weeks by dividing by 7 and rounding to the nearest whole number.  
 
Interaction terms. An exploratory analysis of interactions between variables was carried 
out in a separate analysis of direct associations between the independent variables and 
breastfeeding duration using a Cox proportional hazards model of breastfeeding 
cessation. Interactions between the variables for hospital practices and maternal age, 
timing of breastfeeding initiation, NICU stay, infant gender, and intention to breastfeed 
were tested.  In addition, interaction terms for first-born status and NICU stay and for the 
wantedness dummy variables were explored, as well as breastfeeding intention and infant 
gender.  An interaction between infant NICU stay and first-born status was found to be 
significant in some analyses, and was, therefore, kept in the model for all regressions. An 
interaction between the mother’s age and a proxy for all hospital practices developed as 
an ordinal variable was significant and remained in the model. Interactions between the 
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individual hospital practices and maternal age were also explored, and a likelihood ratio 
test was used to determine that the ordinal variable and ordinal variable-maternal age 
interaction term were the best for the model.  
 
Missing Data.  All variables in the model had low levels of missing data, between one 
and three percent, except family household income and intended breastfeeding duration.  
 The relatively high levels of missing data for intended breastfeeding duration 
raised concerns that the information may not have been missing at random, but rather, 
could represent differences in maternal knowledge about breastfeeding, or interest in or 
commitment to breastfeeding. Therefore, the mother’s intended duration was not used in 
the model and the dichotomous variable for breastfeeding intention was used in the 
model instead. 
 We performed a likelihood ratio test on the model with and without household 
income and determined that the simplified model was preferable. Moreover, using forest 
plots of the other parameter estimates we determined that none of the other associations 
shifted beyond their confidence intervals when income was included in the model. 
Therefore, income was dropped from the model, and a complete case analysis of only 
those participants with complete data was performed.  
 
IRB.  This study received IRB approval from the University of North Carolina, Chapel 
Hill. 
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RESULTS 
 
Description of the population by Univariate and Bivariate Analyses 
The sample included 1,319 of women who had initiated breastfeeding and also 
had complete information on all covariates in the analysis. The mean age in the 
population was 30.3 years, with a minimum of 14 and a maximum of 46 (Table 19). The 
sample was 66.4% non-Hispanic white, 10.1% non-Hispanic black, 20.7% Hispanic, and 
2.8% other. There were slightly more female infants (51.9%), and 11.2% of infants spent 
time in the NICU compared to about 6.7% nationally. (211).  First time mothers made up 
64.0% of the population.  Mothers with less than a high school degree made up 11.9% of 
the population, 26.2% had a high school education, 40.6% had a college degree, and 
21.3% had a graduate degree.  The mean infant age at the time of the interview was 3.29 
months (Table 21a), and across the range of infant ages there was a distribution of 
breastfeeding status (Table 20).  The most common form of contraception in this 
population were progestin-only methods (32.1%), follow by non-hormonal methods 
(29.9%), no contraceptive use (24.5%), and combined estrogen/progestin methods 
(13.5%) (Table 21a).   
When comparing users of different types of contraceptive methods in the 
postpartum period using bivariate analysis, statistically significant differences were found 
for maternal age, race/ethnicity, maternal education, first-born child, and visit by an LC 
or breastfeeding support person  (Tables 21a and 21b). No statistically significant 
difference in pregnancy wantedness, baby’s gender, infant NICU stay, intention to 
breastfeed, timing of initiation, receipt of a formula sample bag at hospital discharge, or 
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the number of breastfeeding-related hospital practices received was found among 
contraceptive use categories.  
Mean maternal age was different across categories of contraceptive use (Table 
21a). The mean age for hormonal methods, either progestin-only (28.9) or combined 
estrogen/progestin (28.5) was several years younger than for non-hormonal methods 
(31.5) or using no method of contraception (31.8).  There were also statistically 
significant differences in contraceptive method used by race/ethnicity (Table 21b). About 
31.1% of Non–Hispanic white women used a progestin-only method; they used non-
hormonal methods or no contraception less often (29.0% and 25.6% respectively). In 
contrast, a higher percent of non-Hispanic black mothers (41.4%) used a progestin-only 
method. Very few used a non-hormonal method, (18.8%) but 27.1% of non-Hispanic 
black mothers did not use birth control during this period of time.  Hispanic mothers were 
most likely to use non-hormonal methods (37.0%), and least likely to go without 
contraception (19.8%). All race/ethnic groups had low rates of usage for combined 
estrogen/progestin methods.   
Differences were found between women by educational attainment as well (Table 
21b). Women with less than a high school education were mostly likely to use a non-
hormonal method of contraception in the postpartum period (36.9%), women with a high 
school degree were most likely to use a progestin-only method (34.2%),  while women 
with college or graduate degrees had similar usage rates for three categories: progestin-
only, non-hormonal and no method. 
Parity was strongly associated with the type of contraceptive used after birth 
(Table 21b). Nearly equal percentages of women with first-born and subsequent children 
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did not to use contraception after birth (25.5% and 22.7% respectively).  However, first 
time mothers were much more likely to use a hormonal method, 36.0% for progestin-only 
and 19.0% for combined estrogen/progestin, over a non-hormonal method (22.3%).  In 
contrast, 10.4% of multiparous women used a combined estrogen/progestin method, and 
their top choice was non-hormonal contraception (34.2%). 
There was no statistically significant difference in contraceptive use among 
women based on the number of breastfeeding-supportive hospital practices they 
experienced, however, one of the individual practices included in this composite measure 
did show a significant difference; among those visited by an LC or other breastfeeding 
support person, more women chose progestin-only methods (32.3%) than non-hormonal 
(28.4%), no method  (24.8%) or combined estrogen/progestin methods (14.4%) (Table 
22).  In contrast, among those who did not have an LC or other breastfeeding support 
person visit them, the most common form of contraception was a non-hormonal method 
(36.6%).  Analyses of individual hospital practices showed no significant association 
between immediate skin-to-skin contact, rooming-in, observation of a feeding by an LC 
or other breastfeeding support person, or facility staff supporting the mother’s infant 
feeding choice and type of contraceptive used after birth.  
 
Survival Analysis of Breastfeeding Duration by Postpartum Contraceptive Use 
The association between type of contraception used after birth and breastfeeding 
duration was explored using a Cox proportional hazards model with propensity score 
based inverse probability weights used to control for differences between groups of 
contraceptive users.   
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In the comparison between combined estrogen/progestin methods and no method of 
contraception, the breastfeeding of 501 subjects was modeled, of which 55.5% were right 
censored (Table 23). After propensity score adjustment, the hazard of breastfeeding 
cessation for users of combined hormonal contraception was 3.07 (95% CI 2.39, 3.96) 
when compared to non-users, which was a shift from the crude results of 3.20.   
Goodness of fit for the propensity score matching between those who used 
combined estrogen/progestin contraceptive methods and those who did not use 
contraception was assessed using histograms of the distribution of propensity scores 
grouped by contraceptive type.  Visual assessment showed a moderately good fit 
(Appendix 2).  Analysis of the area of common support using 1% cut-offs gave consistent 
results with the un-restricted analysis (Appendix 1). 
The breastfeeding outcomes of 573 subjects were analyzed in a comparison of 
combined estrogen/progestin method users and users of non-hormonal contraceptive 
methods. Right censoring was present for 56.0% of the study subjects. In the crude 
analysis, combined hormonal methods had hazard ratio of 2.05 compared to non-
hormonal methods, whereas, after adjustment their hazard of cessation was 2.76 (95% CI 
2.19, 3.49).   Comparison of the histograms for the inverse probability weights of the two 
study populations showed substantial overlap, and analysis of the area of common 
support using a 1% cut-off gave similar results to the un-restricted model, which suggests 
that the propensity score was able to sufficiently balance differences in the distribution of 
covariates between the treatment and control groups. 
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    Outcomes for combined estrogen/progestin methods were compared with 
progestin-only methods using a sample of 601 women with 55.7% right censoring.  
Combined hormonal users had hazard ratio of 1.79 in the crude analysis.  After 
adjustment with propensity score weighting, the hazard for combined users was 2.90 
(95% CI 2.30, 3.66).   
 
DISCUSSION 
 
Use of combined estrogen/progestin contraception was strongly associated with 
breastfeeding duration in our study. The adjusted hazard ratios for use of a combined 
hormonal method compared to no method, non-hormonal methods, or progestin-only 
methods ranged from 2.76 to 3.07 (Table 23).  These results strongly support earlier 
findings from studies carried out in other countries.  Because of the cultural and social 
influences on breastfeeding, it is important for policy and program implementation to test 
the association in a current US population to ensure that results seen elsewhere and in 
previous eras have the same association given the current context for breastfeeding in the 
US.  This study also addresses contraceptive methods and formulations currently 
available in the US.  Furthermore, this study adds strength to earlier findings by 
controlling for many potential confounders not addressed in much of the earlier literature.    
Bivariate analyses, showed significant differences between women who used 
combined estrogen/progestin forms of contraception and those who used progestin-only, 
non-hormonal methods or no contraception.  Breastfeeding women who used a hormonal 
form of contraception after birth were significantly younger than mothers who used a 
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non-hormonal method or chose not to use contraception, which could reflect maternal 
preference, but could also be the result of age differences in clinician recommendation.
 Highly effective forms of non-hormonal birth control, like the copper IUD, were 
traditionally not recommended for younger women, and older mothers may be advised 
against hormonal methods, which are contraindicated with age.  Age differences in access 
to healthcare, could also lead to differences in the options available to women of different 
age groups.  Alternatively, clinicians may assume that preventing future pregnancies is 
more important to younger mothers and suggest hormonal methods in an attempt to give 
these women reliable control over their fertility. Since younger mothers also have shorter 
duration of breastfeeding than older mothers, use of combined estrogen/progestin 
methods could be contributing to this difference in health outcome.    
Differences in contraceptive use by race/ethnicity were identified in the bivariate 
analysis, but were not pronounced for use of combined estrogen/progestin methods.  
White mothers were the most likely to use this form of contraception (14.4%), followed 
closely by blacks (12.8%) and Hispanics (11.4%).  Therefore, use of combined hormonal 
methods is unlikely to explain the differences in breastfeeding outcomes by race.   
Mothers with a high school or college degree were more likely to use combined 
estrogen/progestin birth control than those with either more or less education.  It is 
somewhat surprisingly that mothers without a high school degree would have a better 
health behavior than their more educated peers.  Education may be a proxy for Socio-
economic status in this sample, in which case, less educated mothers may be more likely 
to be receiving their care from public health programs.  This would suggest that these 
programs are more successfully guiding breastfeeding mothers to breastfeeding 
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compatible contraception or making these options more available or more appealing than 
is being done in other segments of the healthcare system.  If so, these public health 
systems could serve a model for shifting postpartum contraceptive use in other settings.   
Primiparous mothers used combined hormonal methods almost twice as often as 
multiparous mothers.  Given the magnitude of effect shown here, this difference could 
explain an important portion of the effect of parity on breastfeeding outcomes, and has 
implications for clinical care.  Given the high use of combined estrogen/progestin 
contraception in the US, first-time mothers may simply be returning to methods of 
contraception with which they are most familiar.  They may also be less aware than more 
experienced mothers that these methods are not recommended while breastfeeding.  If so, 
these mothers may need more information and counseling on contraception, and standard 
of care should be adjusted to provide extra time during postpartum obstetric appointments 
for first time mothers so that this can take place. 
Another place where trends in breastfeeding outcomes may be at least partially 
explained by the use of combined hormonal contraception is the longer breastfeeding 
durations for female infants observed in some studies.  In this sample, mothers of male 
infants used combined hormonal methods 15.3% of the time but only 11.8% of the time 
for female infants.  It’s unclear why this would be the case or why mothers would nurse 
their female baby’s longer, but the sizes of these effects are similar.     
Women who had not intended to breastfeed before birth, but did initiate 
breastfeeding were the most likely sub-population to use combined estrogen/progestin 
methods (22.6%). However, only 2.4% of mothers in this sample fell into this category.  
The higher use of contraceptive methods that are not recommended during breastfeeding 
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could represent a lack of commitment to breastfeeding by these women, or it could be 
explained by ignorance of breastfeeding-related issues among women who did not think 
these topics were relevant to them prior to birth. Since these women are a breastfeeding 
success story, further attention should be paid to whether their use of contraceptive 
methods that are contraindicated for breastfeeding represents an intentional choice on 
their part or ignorance of potential contraindications. Policy, therefore, might include 
targeted continued postpartum counseling on both breastfeeding and contraception for 
this population.  
Confounding is a particular problem in this area of work since the differences 
exist between the groups of women using each type of contraception.  Women who 
breastfeed are also different on a variety of characteristics from those who do not 
breastfeed.  Ethical and human subjects issues make many study designs meant to address 
this problem, such as performing an RCT, impractical.  Therefore, other approaches are 
needed to address confounding.  Results from this study suggest that propensity score 
weighting may be a useful method in this field.  Propensity score weights were used to 
balance the characteristics of the exposure and control groups as a means of controlling 
for the differences in these populations.  Histograms of the propensity score weights used 
in the survival analysis showed considerable overlap between treatment groups, 
suggesting that the propensity score successfully balanced the distribution of their 
characteristics.  However, there were some areas with representation from only one group 
or the other. An analysis of the area of common support gave consistent results to the 
more general hazard model, suggesting that this technique adequately matched the 
treatment and control groups.  If successfully matched, propensity scores allow one to 
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assess the counterfactual scenario where everyone in the sample received the treatment or 
everyone received the control.  This is useful and appropriate for the topic of postpartum 
contraception since contraceptive use is a changeable factor.  Knowing the population 
effect, therefore, could be informative for policy and program design and have 
implications for clinical practice.  
 
LIMITATIONS 
 
An important limitation of this study is the lack of information about the timing of 
initial contraceptive use. Estrogen, too, has been shown to impact lactation; in humans it 
is considered a potent inhibitor of milk production based on clinical reports. (91-95)  
Biological models suggest that early introduction of progestogenic contraception after 
birth may disrupt breastfeeding establishment, while later introduction may have no 
effect or a supportive effect on breastfeeding outcomes. If this is the case, this study 
would not be able to distinguish these effects since all women who used progestin-
containing methods were grouped together, regardless of early or late onset of use. The 
available data did not allow evaluation of the intensity or exclusivity of breastfeeding, 
and therefore assessment of more nuanced breastfeeding outcomes could not be carried 
out.  Examination of these important indicators of breastfeeding success would help to 
clarify the true effects of contraception on breastfeeding. 
The high amount of censored data in this sample (69.0%) may limit the power to 
detect differences in breastfeeding duration between contraceptive use groups.  While 
their ultimate duration of breastfeeding is unavailable for these women, it is informative 
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that they were able to breastfeed as long as they reported, and that this occurred in the 
context of their reported contraceptive use.  Moreover, this would likely be a less 
significant issue at earlier time-points, which is the time frame of most interest since 
women may be a more vulnerable to breastfeeding cessation as the biology and behavior 
of breastfeeding are being established. Censoring could bias the sample if it was 
associated with the outcomes, breastfeeding or contraceptive use.  This sample was 
selected at random from birth certificate data, limiting this possibility; however, if 
availability by landline telephone or willingness to participate in a telephone survey was 
correlated with breastfeeding outcomes or contraceptive use this could introduce bias. 
This analysis is also vulnerable to the possibility that women began using 
contraception after breastfeeding cessation.  However, most women in this sample were 
still breastfeeding, and their achieved duration was accomplished in the context of their 
contraceptive use or non-use.  Moreover, the infants in this sample were relatively young, 
which further limits this possibility of reverse causation.    
Intensity or exclusivity of breastfeeding could not be evaluated in this sample, and 
therefore could not assess these more nuanced breastfeeding outcomes. This is 
unfortunate, since exclusivity is a relevant outcome of interest in relation to milk supply, 
a potential point of impact for exogenous hormones like those in hormonal contraception.  
In the United States, there is a large drop-off in breastfeeding rates during the first 
year, which could affect the ability of this study to detect associations between 
contraceptive use and breastfeeding outcomes.  If factors such as social, demographic, 
and healthcare are more important to breastfeeding cessation than biological factors, it 
may be difficult to detect the biological impact of contraceptive use if there is residual 
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confounding.  Unmeasured factors that contribute to breastfeeding cessation could be 
wrongly attributed in this study as an effect of contraceptive use. The use of propensity 
scores is intended to address the multi-faceted nature of this topic area and, therefore, 
address this concern.   
Confounding is a particular problem in this area of work as seen by the significant 
demographic differences between the users of different types of postpartum 
contraception.  Similarly, there were significant demographic differences between those 
who did and did not initiate breastfeeding and by duration (reported for this sample in 
chapter 2).  However, propensity score weighting was able to adequately balance the 
demographic characteristics of women in the different contraceptive use categories. This 
suggests that this technique may be useful in controlling for confounding and examining 
causality in future studies on contraceptive use while breastfeeding.  
A limitation of propensity scores is the assumption of no unmeasured 
confounders.  Breastfeeding and contraceptive use both have complex etiologies that 
include social, psychological, biological, and healthcare factors.  This dataset is unusual 
in the breastfeeding literature for the number and quality of breastfeeding and 
contraception related questions it asks.  However, information on timing and sequencing 
of contraceptive use, partnership status, social support for breastfeeding, maternal 
depression, urbanicity, and maternal obesity, and others were not available in this dataset.  
To the extent that the factors available are more proximal to the outcome, they may serve 
as adequate proxies for these and other unmeasured factors and mitigate the vulnerability 
of using this statistical approach.  Furthermore, it should be noted that the assumption of 
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no unmeasured confounders is also present for other common statistical approaches, and 
therefore not specific to this analytic design. 
The sample population was selected from North Carolina Birth Certificates and 
contacted by telephone. Differences in the covariates and in contraceptive use may exist 
between those available by landline telephone and those who cannot be reached by this 
means including those who do not have a landline telephone.  For instance, people who 
use cell phones exclusively would not be available by this means, and this could 
disproportionately exclude younger, poorer, and more transient mothers from the sample 
leading to sample bias.  If willingness to participate in a telephone survey were not 
randomly distributed, the sample would also be biased. These concerns are addressed in 
two ways. First, the random selection process using birth certificate records provides an 
unbiased foundation for sample selection.  In addition, many measures were undertaken 
to contact potential subjects including multiple contact attempts, contact at different times 
of the day and week, and contact attempts over several months. Furthermore, if the 
potential participant declined, efforts were made by specially trained personnel to 
convince the potential study subjects to participate.  
The retrospective study design relied on maternal self-report  and is vulnerable to 
recall bias which would be more likely to affect transient factors and factors with 
perceived positive or negative connotation.  For example, unwanted and mistimed 
pregnancies are reported less often in this sample than has been found in national data.  
Mothers may be reluctant to tell the interviewer that their pregnancy was unwanted or 
mistimed, and she might also unconsciously re-evaluate the wantedness of her pregnancy 
as she begins to bond with her baby.  Similarly, a mother’s recall of her intention to 
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breastfeed may change in light of her actual experience of breastfeeding.  Reporting of 
hospital practices may be also be bias by events that happen later, and mothers could 
simply not remember what occurred during that time.  Some may not even know whether 
and when events happened, which could be correlated with maternal or infant health.  
Finally, reporting of contraceptive use may be subject to recall bias, especially if more 
than one method has been used since birth.  This sample is likely comparable to other 
studies in the field of breastfeeding research since results from this study are consistent 
with other breastfeeding studies on covariates commonly reported in the literature.  
Non-random missing data could lead to sample bias, however the amount of 
missing data for the variables used in the model was 1%-3%, which is very low.  Few 
factors in the model were significantly associated with contraceptive use suggesting that 
this model was missing variables that influence the use of contraception after birth. For 
instance, partnership status, whether the mother is sexually active, and whether she has 
achieved her desired family size could all be important factors in using contraception, but 
were not available in the dataset.  Timing of contraceptive use would also have been 
useful to provide a more complete description of postpartum contraception.  This is 
particularly true for women who reported using more than one method since birth 
because the timing, order and duration of these methods were unknown.  However, the 
sample is unusual in that is has information about breastfeeding outcomes alongside 
information about contraceptive use, enabling analysis of contraception use during 
breastfeeding.  Few analyses of postpartum contraceptive use have been carried out in 
adult populations, so this study also contributes to the literature by describing factors 
associated with contraceptive use in this large and meaningful demographic. 
	  223 	  
 
CONCLUSION 
 
Combined estrogen/progestin contraceptive methods had a large effect on 
breastfeeding duration when compared to progestin-only methods, non-hormonal 
methods or using no method.  These results suggest that combined hormonal methods 
should not be recommended to breastfeeding women.  This is consistent with current 
CDC recommendations and strengthens the evidence on which they’re founded because 
this study was recent and US-based, examined current contraceptive options, and 
controlled for confounding using up-to-date statistical approaches.  The use of propensity 
scores in our survival analysis successfully matched our study groups, and impacted the 
estimation of effect, particularly for comparison with non-hormonal and progestin-only 
methods.  Propensity scores may be a useful technique for future work in the field. This is 
particularly compelling given the differences identified between women who use 
different types of contraception after birth. 
 
Table 19: Characteristics of the Population From a Survey Evaluating the Period 
of Purple Crying Intervention Program, 2010-11 (N=1,319). 
 Total Percentage of 
Total 
 N=1,319 100% 
Maternal Age (years)   
Mean 30.3  
Median 31  
Race/Ethnicity   
Non-Hispanic White  876 66.4% 
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Non-Hispanic Black 133 10.1% 
Hispanic 273 20.7% 
Other 37 2.8% 
Maternal Education   
Less than High School 157  11.9% 
High School 345  26.2% 
College 536  40.6% 
Graduate School 281  21.3% 
Pregnancy Wantedness   
Wanted at This Time 816  61.9% 
Not Wanted / Mistimed 330  25.0% 
All Pregnancies Wanted 173  13.1% 
First Child   
Yes 475  36.0% 
No 844  64.0% 
Baby’s Gender   
Female 684  51.9% 
Male 635  48.1% 
NICU Stay   
no 1,171  88.8% 
yes 148  11.2% 
Intention to Breastfeed   
No 31  2.4% 
Yes 1,288  97.6% 
Timing of Initiation   
< 1 Hour 584  44.3% 
1 to <2 Hours 265 20.1% 
2 to 24 Hours 336  25.5% 
> 24 Hours 134  10.1% 
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Received Formula Sample Bag   
No 311  23.6% 
Yes 1,008  76.4% 
Hospital Practices   
Mean 3.9 3.9 
Median 4 4 
 
 
 
 
 
Table 21a: Characteristics of the Population (continuous variables) by Method of 
Postpartum Contraceptive Use (N=1,319).  Sample Drawn From a Survey 
Evaluating the Period of Purple Crying Intervention Program, 2010-11 and Limited to 
Women Who Initiated Breastfeeding. 
 
No 
Method 
Non-
Hormona
l 
Progestin
-Only 
Combine
d 
Estrogen 
/ 
Progestin Total 
 323 
(24.5%) 
395 
(29.9%) 
423 
(32.1%) 
178 
(13.5%) 
1,319 
(100%) 
Maternal Age*** 
(years)      
Table 20: Breastfeeding Status by Month Among Women Who Initiated 
Breastfeeding From a Survey Evaluating the Period of Purple Crying 
Intervention Program, 2010-11. (N=1,319). 
 Not Breastfeeding 
n (%) 
Breastfeeding 
n (%) 
1 Month 169 (12.8%) 1,150 (87.2%) 
2 Months 336 (25.5%) 983 (74.5%) 
3 Months 589 (44.7%) 730 (55.3%) 
4 months 1,017 (77.1%) 302 (22.9%) 
5 Months 1,298 (98.4%) 21 (1.6%) 
> =6 Months 1,310 (99.3%) 9 (6.8%) 
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Mean 31.8 31.5 28.9 28.5 30.3 
Median 32 32 30 29 31 
Infant Age at 
interview 
(months) 
     
Mean 3.28 3.23 3.26 3.49 3.29 
Median 3 3 3 3 3 
Infant Age       
No 83 
(26.7%) 
87 
(28.0%) 
108 
(34.7%) 
33 
(10.6%) 311 
Yes 240 
(23.8%) 
308 
(30.6%) 
315 
(31.3%) 
145 
(14.4%) 1,008 
Hospital Practices      
Mean 3.9 3.8 3.9 4.0 3.9 
Median 4 4 4 4 4 
*** p<0.001       
 
Table 21b: Characteristics of the Population by Method of Postpartum 
Contraceptive Use (N=1,319).  Sample Drawn From a Survey Evaluating the Period 
of Purple Crying Intervention Program, 2010-11 and Limited to Women Who Initiated 
Breastfeeding. 
 
No 
Method 
n (%) 
Non-
Hormona
l 
n (%) 
Progestin
-Only 
n (%) 
Combine
d 
Estrogen 
/ 
Progestin 
n (%) 
Total 
n (%) 
 323 
(24.5%) 
395 
(29.9%) 
423 
(32.1%) 
178 
(13.5%) 
1,319  
(100%) 
Race/Ethnicity**      
Non-Hispanic 
White 
224 
(25.6%)  
254 
(29.0%) 
272 
(31.1%) 
126 
(14.4%) 
 876 
Non-Hispanic 
Black 
36 
(27.1%) 
25 
(18.8%) 
55 
(41.4%) 
17 
(12.8%) 
133 
Hispanic 54 101 87 31 273 
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(19.8%) (37.0%) (31.9%) (11.4%) 
Other 9 (24.3%) 15 
(40.5%) 
9 (24.3%) 4 (10.8%) 37 
Maternal 
Education* 
     
Less than High 
School 
28 
(17.8%) 
58 
(36.9%) 
52 
(33.1%) 
19 
(12.1%) 
157  
High School 70 
(20.3%) 
101 
(29.3%) 
118 
(34.2%) 
56 
(16.2%) 
345  
College 146 
(27.2%) 
148 
(27.6%) 
167 
(31.2%) 
75 
(14.0%) 
536  
Graduate School 79 
(28.1%) 
88 
(31.3%) 
86 
(30.6%) 
28 
(10.0%) 
281  
Pregnancy 
Wantedness 
     
Wanted at This 
Time 
210 
(25.7%) 
241 
(29.5%) 
256 
(31.4%) 
109 
(13.4%) 
816  
Not Wanted / 
Mistimed 
64 
(19.4%) 
99 
(30.0%) 
121 
(36.7%) 
46 
(13.9%) 
330  
All Pregnancies 
Wanted 
49 
(28.3%) 
55 
(31.8%) 
46 
(26.6%) 
23 
(13.3%) 
173  
First Child***      
Yes 108 
(22.7%) 
106 
(22.3%) 
171 
(36.0%) 
90 
(19.0%) 
475  
No 215 
(25.5%) 
289 
(34.2%) 
252 
(29.9%) 
88 
(10.4%) 
844  
Baby’s Gender      
Female 171 
(25.0%) 
202 
(29.5%) 
230 
(33.6%) 
81 
(11.8%) 
684  
Male 152 
(23.9%) 
193 
(30.4%) 
193 
(30.4%) 
97 
(15.3%) 
635  
NICU Stay      
no 290 
(24.8%) 
357 
(30.5%) 
367 
(31.3%) 
157 
(13.4%) 
1,171  
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yes 33 
(22.3%) 
38 
(25.7%) 
56 
(37.8%) 
21 
(14.2%) 
148  
Intention to 
Breastfeed 
     
No 8 (25.8%) 5 (16.1%) 11 
(35.5%) 
7 (22.6%) 31  
Yes 315 
(24.5%) 
390 
(30.3%) 
412 
(32.0%) 
171 
(13.3%) 
1,288  
Timing of 
Initiation 
     
< 1 Hour 162 
(27.7%) 
172 
(29.5%) 
184 
(31.5%) 
66 
(11.3%) 
584  
1 to <2 Hours 53 
(20.0%) 
84 
(31.7%) 
88 
(33.2%) 
40 
(15.1%) 
265  
2 to 24 Hours 77 
(22.9%) 
94 
(28.0%) 
110 
(32.7%) 
55 
(16.4%) 
336  
> 24 Hours 31 
(23.1%) 
45 
(33.6%) 
41 
(30.6%) 
17 
(12.7%) 
134  
Received Formula 
Sample Bag 
     
No 83 
(26.7%) 
87 
(28.0%) 
108 
(34.7%) 
33 
(10.6%) 
311  
Yes 240 
(23.8%) 
308 
(30.6%) 
315 
(31.3%) 
145 
(14.4%) 
1,008  
*** p<0.001      ** p<0.01      * p<0.05  
 
Table 22: Association of Lactation Support Visit in Hospital with Contraceptive 
Method Use (N=1,319). Sample Drawn From a Survey Evaluating the Period of 
Purple Crying Intervention Program, 2010-11, and Limited to Women Who Initiated  
Breastfeeding. 
 
No 
Method 
n (%) 
Non-
Hormonal 
n (%) 
Progestin-
only 
n (%) 
Combined 
Estrogen / 
Progestin 
n (%) 
Total 
n (%) 
Visit*†      
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No 56 (23.1%) 89(36.6%) 75(30.9%) 23(9.5%) 243 
(18.4%) 
Yes 267(24.8%) 306(28.4%) 348(32.3%) 155(14.4%) 1,076 
(81.6%) 
Total 323 395 423 178 1,319 
(100%) 
* p<0.05       
† This variable is included in the ordinal “Hospital Practices” variable and is not 
included as a separate variable in the analyses. 
 
 
 
Table 23: Hazard of Breastfeeding Cessation as a Function of Type of 
Contraceptive Used (N=1,319).  Sample Drawn From a Survey Evaluating the Period 
of Purple Crying Intervention Program, 2010-11 and Limited to Women Who Initiated 
Breastfeeding. 
 
Hazar
d 
Ratio 
Lowe
r 
95% 
CL 
Upper 
95% 
CL 
Likelihood 
ratio test 
Sampl
e Size 
Percent 
censored 
Combined 
estrogen/progestin 
referen
t 
     
No Method 3.07 2.39 3.96 p<.0001 499 54,6% 
Non-hormonal 
methods 
2.76 2.19 3.49 p<.0001 574 55.6% 
Progestin-only 
methods 
2.90 2.30 3.66 p<.0001 600 55.9% 
*Adjusted for maternal age, race/ethnicity, maternal education, pregnancy wantedness, 
parity, baby’s gender, NICU stay, intention to breastfeed, timing of initiation, receipt 
of a formula sample bag, and hospital practices through the propensity score.  
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Figure 7: Survival Plots of Breastfeeding Duration by Type of Contraception Used. 
From a Survey Evaluating the Period of Purple Crying intervention program, 2010-11, 
and limited to women who initiated breastfeeding. Curves are adjusted for maternal age, 
race/ethnicity, maternal education, pregnancy wantedness, parity, baby’s gender, NICU 
stay, intention to breastfeed, timing of initiation, receipt of a formula sample bag, and 
hospital practices through propensity score weights.  
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CHAPTER VI: CONCLUSION  
 
The purpose of this project was to examine the breastfeeding and contraceptive 
use patterns of a US-based population to inform policy, programs, and clinical care 
around breastfeeding and contraceptive use in the postpartum timeframe. The public 
health importance of both breastfeeding and family planning are widely acknowledged as 
individual issues, but where they come together, there has been controversy.  US and 
international sources give contradictory recommendations, and within the US, care-
providers from different branches of the medical community disagree about what they 
witness in their patient populations.  Much of the scientific literature available to inform 
this conversation has significant limitations in its generalizability to the US today.  Many 
of these studies were carried out over twenty years ago, and as a result, the contraceptive 
methods studied are, in many cases, not available today in the same dose or form. The 
statistical methods used, while standard for their era, are often not up to date with current 
practices and in many instances fail to properly control for issues now known to be 
associated with either breastfeeding or contraceptive use. Perhaps most fundamentally, 
the settings for these studies may not be generalizable to the US in 2013. Many were 
carried out in countries that have a very different cultural norm around breastfeeding, 
sexuality, relationships, and women’s roles in society. This is accentuated by the age of 
the studies and the global changes that have taken place in recent decades including 
introduction of computers, cell phones, and the internet, as well as, economic 
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globalization, all of which have changed the social context for breastfeeding and family 
planning considerably.  The context for breastfeeding in these studies may have been 
more conducive to the biological feedback system that establishes and maintains milk 
supply.  This could have made women in these settings less susceptible to the effects of 
hormonal contraception than women who breastfeed with less biologically conductive 
patterns, such as many women in the US today. This study aimed to contribute to this 
important public health topic by contributing up to date information from a setting within 
the US using statistical methods suited to the complexity of the subject area. 
The study was carried out in 2010 and 2011 across North Carolina, an 
advantageous laboratory for breastfeeding research. North Carolina falls in the middle of 
the US spectrum of states in terms of breastfeeding outcomes. It has a diversity of urban 
and rural areas and significant immigration from other parts of the country, providing a 
mixture of social norms from other regions of the country.  The state has been influenced 
on the local, state, and national level by both political parties, which has implications for 
breastfeeding-related laws and policies as well as the social climate. There is also a 
sizable minority of African Americans and Hispanics, allowing examination of racial and 
ethnic differences and issues of health disparity. Together, this makes North Carolina a 
useful setting to explore the current state of breastfeeding in the US, and well suited to 
addresses public health questions of national interest.  
 
Hormonal Contraceptive Use 
Combined estrogen/progestin contraception was negatively associated with 
breastfeeding duration in this study, and the magnitude of the effect after adjusting for 
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confounding ranged from 2.76 to 3.07 in comparisons with no method, non-hormonal 
methods, or progestin-only methods. These results add up-to-date and culturally specific 
evidence to support the current CDC recommendations against use of combined 
hormonal contraception while breastfeeding.  This study also updates the literature in 
regards to current contraceptive options and through use of more-advanced statistical 
methods to control for confounding.  Use of propensity score weighting enables 
estimation of a population effect, which makes it clear that the impact on breastfeeding 
duration would be large if these methods were more widely used.   
Progestin-only methods of contraception had no statistically significant 
association with breastfeeding duration in this study.  Clinical reports suggest that early 
postpartum use of progestin-only methods may adversely affect breastfeeding outcomes, 
however, the most recent updates to the CDC medical eligibility criteria, which were 
released in June 2013 specifically clarify that progestin-only methods are considered 
compatible with breastfeeding beginning immediately after birth.  Non-significant trends 
in the adjusted model of time to breastfeeding cessation are consistent with previous 
literature on late-onset use of progestin-only contraception that shows either no effect or 
longer breastfeeding duration with use of these methods.  However, this analysis lacked 
sufficient information on the timing of contraceptive use to resolve the controversy since 
early and late use of these methods could not be differentiated.  Consequently, these 
results should not be interpreted to mean that progestin-only methods are compatible with 
breastfeeding, but rather that good information about the timing of use will be necessary 
to clarify the relationship between progestin-only contraceptive use and breastfeeding 
outcomes.  
	  235 	  
Differences in the distribution of demographic, psychosocial, health and 
healthcare characteristics of those who use particular types of contraception after birth 
follow similar patterns to breastfeeding outcomes, suggesting that the two issues may be 
interrelated.  A better understanding of these trends is necessary to inform development 
and implementation of policies and programs to improve health outcomes associated with 
breastfeeding and family planning, and to guide best practices in clinical care.   
 
Maternal age 
Maternal age was found to be significantly associated with initiation of 
breastfeeding, as reported elsewhere.  Older mothers were more likely to begin 
breastfeeding than their younger counterparts.  Similarly, breastfeeding women who used 
a hormonal form of contraception after birth were significantly younger than mothers 
who used a non-hormonal method or chose not to use contraception.  In light of the 
association between use of combined hormonal contraceptive methods and shorter 
breastfeeding duration identified in this study, contraceptive use may be a factor in the 
shorter breastfeeding duration for younger mothers, which is reported elsewhere and 
suggested by non-significant trends in this data.  Differences in contraceptive use by age 
could reflect maternal choice; younger mothers may have a preference for hormonal 
contraception perhaps because they are more familiar with it than other methods. Age 
differences may reflect women returning to methods they used before pregnancy, since 
younger women tend to use hormonal contraception in higher proportions than older 
women.  Estrogenic hormonal contraception is contra-indicated with age, which could 
mean that older mothers are avoiding hormonal methods as the risk of side-effects 
	  236 	  
increases. These trends could also be related to a decline in sexual activity with age or a 
difference in how young and old mothers prioritize pregnancy prevention relative to 
breastfeeding protection.  Older mothers in this study were more likely to not be using 
contraception, indicating that pregnancy prevention may play a smaller role in their 
decision making than for younger mothers.  To the extent that maternal preference drives 
this trend, results of this study suggest that younger mothers in particular may need better 
counseling after birth in order to make decisions about contraception that are compatible 
with their breastfeeding plans.  Education about highly effective non-hormonal 
contraceptive options, such as the copper IUD, may be particularly important for younger 
mothers who may be less likely to know about or have tried these methods previously.  
Differences in clinical care may also be a factor in age-related contraceptive 
trends.  Access to healthcare, could lead to differences in the contraceptive options 
available to women by age.  For instance, the out of pocket cost of contraception may 
affect younger mothers disproportionately if their financial means or health insurance 
coverage is lower.  If so, this adds further justification for healthcare policy to ensure 
realistic access to contraception for all mothers.  On the other hand, clinicians may 
assume that preventing future pregnancies is more important to younger women or they 
may have a personal bias towards pregnancy prevention for younger mothers.  As a 
result, they may suggest hormonal methods in an attempt to give these women reliable 
control over their fertility.  To the extent that age-related patterns are clinician-driven, 
better clinician education is called for so that they have the necessary knowledge and 
motivation to help mothers balance pregnancy prevention and breastfeeding protection.  
All of these explanations highlight a need to fully understand the association between the 
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type of contraceptive used while breastfeeding and breastfeeding outcomes to ensure that 
contraceptive use is not contributing to the age-related disparity in breastfeeding 
outcomes.  
 
Race/Ethnicity 
Racial and ethnic differences in breastfeeding outcomes in this study are 
consistent with national trends.  Hispanics have the highest initiation and continuation 
rates, followed by whites and then blacks, whose initiation rate lags whites by nearly 
twenty percentage points.  This striking racial health behavior difference may be a 
foundation for other health disparities for blacks since breastfeeding is associated with a 
range of better health outcomes.  In terms of breastfeeding, race is likely a proxy for a 
variety of socioeconomic and cultural factors that define distinct contexts for 
breastfeeding for different racial/ethnic groups.  To improve breastfeeding outcomes for 
black mothers, identifying and addressing the barriers to breastfeeding specific to this 
group will be important.  In the analysis of breastfeeding duration for the sub-population 
of women who successfully initiate breastfeeding, no significant difference between 
black and white mothers was identified.  This suggests that breastfeeding initiation is a 
critical moment in which to address the lower breastfeeding rates among blacks, and that 
once over this hurdle, their breastfeeding outcomes are similar to those of whites.  Efforts 
to improve the health disparity in breastfeeding rates for blacks should be targeted at 
breastfeeding initiation.   
Hispanic mothers may be a model for breastfeeding promotion; identifying the 
factors associated with their higher rates of initiation and continuation could provide 
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insight into improving outcomes for white and black mothers.  One factor on which they 
differ is postpartum contraceptive use.  Race/ethnicity was one of only two factors 
associated with the use of combined estrogen/progestin methods after birth.  White 
mothers were the most likely to use this form of contraception, and were much more 
likely to do so than Hispanic mothers.  Given the magnitude of effect identified for use of 
combined hormonal contraception, the difference in use of this method may explain some 
of the racial/ethnic differences in breastfeeding duration.  Thus the cultural and 
behavioral decision could have a biological consequence through breastfeeding.     
Race/ethnicity was also a strong predictor of progestin-only use.  Black women 
had a much higher risk of using a progestin-only method compared to both white and 
Hispanic mothers.  Overall, black mothers had the highest use of hormonal contraceptives 
in this population, with over half of black mothers using one of these methods.  This 
study was not able to rule out the possibility that early use of progestin-only methods is 
negatively associated with breastfeeding outcomes.  If clinical reports suggesting this are 
true, contraceptive use patterns of black mothers may contribute to the health disparity in 
breastfeeding outcomes for black mother-baby dyads.  Contraceptive use patterns of 
Hispanic mothers would be consistent with this possibility.  Hispanic mothers have the 
highest rate of breastfeeding, and although they are the group with the highest use of 
postpartum contraception, with over 80% using birth control, they use non-hormonal 
methods much more often than either white or black mothers.  
The high rate of contraceptive use among Hispanics suggests that pregnancy 
prevention may be a more important to factor for Hispanic mothers after birth than for 
white and black mothers.  This could be due to a greater desire to prevent pregnancy on 
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the part of Hispanic mothers themselves, but it could also reflect racial bias from 
healthcare providers or differences in access to contraception based on cost or type of 
health insurance.  While Hispanic mothers have the best breastfeeding outcomes of the 
racial/ethnic groups evaluated in this study, their continuation rate still lags behind 
national goals.  Over 10% of Hispanic mothers who initiated breastfeeding were none-
the-less using combined hormonal methods of contraception.  Given the tendency to use 
birth control in the postpartum period, extra contraceptive counseling may be needed by 
Hispanic mothers to achieve national targets on breastfeeding duration.  
 
Education 
Breastfeeding duration was nearly identical for mothers with high school degrees 
and those who had not completed high school, but for higher levels of education, there 
seemed to be a dose-response effect on breastfeeding duration.  Similar to the results for 
race, the difference in breastfeeding duration between college educated mothers and those 
with less education disappeared in the analysis that included only those who had initiated 
breastfeeding, implying that the positive association with being college educated 
primarily affects breastfeeding initiation. Women with a graduate degree, however, 
continued to have a significantly lower risk of breastfeeding cessation even after 
accounting for differences in initiation.  Maternal educational is often considered a proxy 
for socioeconomic status; however, in this instance it may be capturing additional 
dimensions relevant for breastfeeding outcomes. Other possible explanations for the 
dose-response could be increased knowledge of breastfeeding, maternal self-efficacy, 
differences in partnership dynamics, economic power within the family, and differences 
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in decision-making responsibility, amongst other possible explanations.  Alternatively, 
highly educated women may be more likely to have work environments that are 
conducive for breastfeeding, have access to maternity leave, or be able to choose not to 
work.  Identifying the factors that contribute to the better outcomes of these mothers 
could inform policies and programs to help meet the national breastfeeding continuation 
goals for women of all educational levels. 
One area in which more educated mothers differ from their less educated peers is 
contraceptive use.  Women with college and graduate degrees were at higher risk of using 
a progestin-only method when compared to women with less than a high school 
education. This may indicate that more educated mothers are more likely to follow the 
CDC recommendations than less educated mothers.  To the extent that women are relying 
on these guidelines to make choices in contraceptive use, these results underscore the 
importance of resolving the controversy around progestin-only methods. 
Mothers with a high school education or less were more likely to use 
contraception after birth than college and graduate school educated mothers. This may 
reflect differences in socio-economic status and the perceived impact of another 
pregnancy. Pregnancy prevention may be more important to less educated mothers, but 
bias from healthcare providers could also play a role, either consciously or unconsciously 
assuming that more children would be undesirable for less educated women.  Our 
findings suggest that identifying and promoting effective birth control that is compatible 
with breastfeeding is an important factor in improving the disparity in breastfeeding 
continuation between more and less educated mothers. 
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Cost and health insurance factors may also play a role in which method a woman 
uses, which could affect less educated mothers disproportionately. Legislation ensuring 
access to affordable health insurance and mandating coverage for birth control may 
improve access to contraception for all mothers, but especially for those who currently 
fall between public and high quality private insurance options.  Evidence that this “donut-
hole” effect may apply to postpartum contraception was found in the patterns of use of 
combined estrogen/progestin methods.  Mothers with the lowest educational attainment, 
less than high school, and mothers with the highest, graduate degrees, were both less 
likely to use combined hormonal methods than women in the middle of the educational 
spectrum, high school and college graduates.  This may reflect different factors.  Highly 
educated mothers may be better informed or more concerned about the negative 
association between use of these methods and breastfeeding outcomes, whereas access to 
care and cost may drive contraceptive use by less educated mothers compared to women 
in the middle of the educational spectrum.  If education is a proxy for SES in this sample, 
less educated mothers may be more likely to receive their care from public health 
programs.  If so, this suggests that these programs are more successfully guiding 
breastfeeding mothers to breastfeeding-compatible contraception or making these options 
more available or more appealing than is being done in other segments of the healthcare 
system.  To the extent that this is true, these public health systems could serve a model 
for shifting postpartum contraceptive use in other settings.   
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Pregnancy Wantedness 
Mothers with timely, wanted pregnancies were more likely to begin breastfeeding 
than those with unwanted/mistimed pregnancies or for whom all pregnancies would be 
wanted.  Amongst women who initiated breastfeeding, pregnancy wantedness was 
significantly associated with duration.  This factor, not generally included in the US-
based studies, suggests that control over her fertility may affect the health and parenting 
choices women make after birth.  Effective and available contraception, then, becomes a 
generational issue, conferring life-long health disparities on the children of women who 
do not have access to or choose not to use it.  Improving breastfeeding outcomes for these 
mother-baby dyads could help break this cycle. These mothers may need additional 
breastfeeding support and clinicians involved in both prenatal and postnatal care should 
be educated about the association between wantedness and breastfeeding outcomes.  
Furthermore, pregnancy wantedness could be used as a marker to identify mothers for 
programs encouraging breastfeeding initiation and continuation.   
In this sample, pregnancy wantedness was not significantly associated with the 
type of contraceptive used after that birth.  However, this study may have underestimated 
the association between pregnancy wantedness and contraceptive use because many 
fewer women in this population reported unwanted or untimely pregnancies compared to 
national statistics.  Trends in the data suggest that this topic might merit future research.  
The higher rate of contraceptive use among those with an unwanted or mistimed 
pregnancy suggests that a woman’s attitude about her pregnancy may affect her 
preference for using birth control in the postpartum period.  Given the association with 
shorter duration of breastfeeding identified in this study, contraceptive use may explain 
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some of the differences in breastfeeding outcomes identified for women with 
unwanted/mistimed pregnancies.  These findings suggest that breastfeeding outcomes can 
be influenced by pre-conception factors, and that the interrelatedness of family planning 
and breastfeeding exists even before a woman has conceived her first child.  The effects 
of family planning, then, extend to breastfeeding outcomes and health consequences, and 
further highlight the importance of universal access to available and effective birth 
control to address disparities and improve public health.   
 
Infant Gender 
Another place where trends in breastfeeding outcomes may be at least partially 
explained by contraceptive use is the somewhat surprising observation reported in some 
studies that female infants are breastfed for longer than male infants.  In this sample, 
mothers of male infants used combined hormonal contraceptive methods 15.3% of the 
time compared with 11.8% for mothers of female infants.  Given the magnitude of effect 
identified for use of these methods, the association with shorter breastfeeding intervals 
could be related to this difference in contraceptive use. Male infants tend to have greater 
health issues than female, and improving breastfeeding outcomes for these babies may 
improve their health since breastfeeding is associated with a variety of better infant health 
outcomes.  More research is needed to understand why differences in maternal 
contraceptive use would be related to infant gender, but decreasing the use of combined 
estrogen/progestin contraception by mothers of boys may be a surprising, but fruitful 
avenue for improving gender-based differences in infant health.  
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Parity 
First-time mothers had higher odds of breastfeeding cessation relative to mothers 
with older biological children.  First-time motherhood was also one of only two 
characteristics significantly associated with use of combined estrogen/progestin 
contraception in this population.  The strong association between use of these methods 
and shorter breastfeeding duration identified in this study may explain some of the 
difference in breastfeeding outcomes between these groups.  Social factors and 
experience are sometimes thought to underlie the disparity between primiparous and 
multiparous mothers.  However, if contraceptive use were contributing to differences in 
their duration of breastfeeding, it would provide a far more tractable opportunity to 
improve breastfeeding outcomes for primiparous mothers.   
Evidence for a social effect is found also in this study.  An interaction term 
showing a composite effect for NICU stay and parity shows a lower risk of breastfeeding 
cessation among first time mothers whose baby spends time in the NICU.  This is 
somewhat counter-intuitive since the infants in these mother-baby dyads are less healthy 
than their peers.  Since the improved breastfeeding outcomes are unlikely to be 
attributable to infant factors, this suggests that, for first-time mothers, interaction with the 
NICU is beneficial for breastfeeding.  Thus, NICUs may be a model for healthcare 
practices that promote breastfeeding for first-time mothers.   
 
NICU 
Mothers whose babies have been in the NICU are at significantly higher risk of 
using a progestin-only method compared to non-hormonal contraception. These women 
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may perceive a greater need for birth control because of the separation from their child or 
because they are not able to fully breastfeed their baby. Changes in the standard of care at 
many NICUs now often encourage mothers to breastfeed, so these mothers may be more 
aware of the CDC recommendations for contraceptive use while breastfeeding.  NICU 
stay was not significantly associated with breastfeeding initiation or duration in this 
study, suggesting that the health and other challenges associated with having a baby in 
the NICU, which have the potential to negatively affect breastfeeding, are being 
successfully managed in this regard.  Information about breastfeeding exclusivity was not 
available in this dataset and it may be that breastfeeding exclusivity is lower for NICU 
mothers than the general population.  Even so, these results suggest that practices carried 
out in the NICU may be a useful model for breastfeeding-supportive care in other parts of 
the healthcare system, with special attention paid to the measures NICU units have taken 
to improve their breastfeeding rates. 
 
Intention to Breastfeed 
Intention to breastfeed was highly associated with both initiation and duration of 
breastfeeding.  The magnitude of this association suggests that influencing women’s 
breastfeeding intention may be a high-yield opportunity for improving breastfeeding 
outcomes.  Some studies note that women make decisions about breastfeeding prior to or 
early in their pregnancies, which would point to a need for health education campaigns 
aimed at women and their families before conception or early in prenatal care, instead of 
towards the end of their pregnancies as is common in many prenatal care settings.   
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About 5.5% of women who intended to breastfeed did not initiate; this may have 
been due to adverse experiences during or immediately following labor and delivery, 
such as maternal or infant illness, hospital practices or other events that interfered with 
initiation.  On the other hand, 15.9% of women who had not planned to breastfeed none-
the-less initiated breastfeeding. From a breastfeeding advocacy standpoint, these women 
represent a possible success for the institutions where this conversion from non-
breastfeeders to breastfeeders occurs since they are likely either permissive or 
encouraging of this shift.  Moreover, these changes from original intention suggest that 
experiences around birth can affect breastfeeding outcomes away from what the mother 
intended.  A higher percentage of women were converted from non-breastfeeders to 
breastfeeders than the other direction, and this may indicate that activities ongoing in NC 
hospital settings may be reflected in breastfeeding support. This hypothesis is supported 
by the fact that those who initiated breastfeeding reported more of the Ten-Step hospital 
practices that are known to be associated with breastfeeding initiation in other settings. 
(199) 
Women who had not intended to breastfeed before birth, but did initiate 
breastfeeding were the most likely sub-population in this study to use combined 
estrogen/progestin methods.  The higher use of contraceptive methods associated with 
shorter breastfeeding duration could represent a lack of commitment to breastfeeding by 
these women, or it could be explained by ignorance of breastfeeding-related issues 
among women who did not think these topics were relevant to them prior to birth. Since 
these women are a breastfeeding success story, further attention should be paid to 
whether their use of methods that are contraindicated for breastfeeding represents an 
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intentional choice on their part or ignorance of potential challenges. Policy, therefore, 
might include targeted continued postpartum counseling on both breastfeeding and 
contraception for this population. 
 
Hospital Practices 
The Ten Steps to Successful Breastfeeding guidelines were developed by 
UNICEF and WHO to provide guidance for clinicians providing obstetric and maternity 
care regarding practices that support a mothers’ ability to succeed in breastfeeding 
initiation and achieve longer durations of breastfeeding.  Seven of these steps related to 
maternity care practices around birth and the immediate postpartum time frame. Women 
who received a formula sample bag, part of Step 6, were less likely to initiate 
breastfeeding than those who did not receive a sample bag.  Because initiation comes 
before the sample bag would be offered, this could reflect a lack of system-wide support 
for breastfeeding.  This study confirmed that receipt of formula sample bags is associated 
with shorter breastfeeding duration.  Having formula on-hand may provide an easy 
“solution” during breastfeeding challenges, and creates a path to feeding supplements, 
which can disrupt the physiology of milk supply and lead to weaning.  Another 
explanation for this association may be that formula sample bags could be a proxy for a 
number of other, unmeasured practices and interactions that either discourage 
breastfeeding or pre-dispose it to be of shorter duration, as suggested by the association 
with breastfeeding initiation. In North Carolina, the setting for this study, efforts by the 
North Carolina Breastfeeding Coalition (NCBC) to encourage hospitals not to provide 
these bags in North Carolina have resulted in hospitals eliminating formula sample bags 
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as a first step, and this may or may not be the only, clearly defined change to 
breastfeeding-related maternity practices. (210)  Thus, stopping provision of formula 
sample bags may be an early marker that a hospital is moving towards more 
breastfeeding friendly policies. 
Initiation of breastfeeding within the first hour after birth, as per Step 4 of the Ten 
Steps, is significantly associated with breastfeeding duration.  Relative to early initiation, 
all later time points, including initiation between the first and second hours, were 
associated with significantly shorter duration of breastfeeding, and none of these later 
times of initiation were significantly different from each other.  This supports the concept 
that there may be a critical window for breastfeeding initiation and further supports the 
contention that hospital policies for delivery practices may have a long-term impact on 
breastfeeding.   
The five other hospital practices evaluated in this study were immediate skin-to-
skin contact after birth, infant rooming-in, visit by a lactation consultant or other 
breastfeeding support person, observation of a feeding by a lactation consultant or other 
breastfeeding support person, and whether the mother felt supported in her feeding choice 
by all facility staff.  The mean number of practices reported by women who initiated 
breastfeeding was 3.9, in contrast to only 2.5 for women who did not begin nursing.  
Individually, all five practices were also significantly associated with breastfeeding 
initiation, confirming that the maternity care practices endorsed in the Ten Steps are 
positively associated with this measure of breastfeeding success.  While there was a trend 
towards positive associations with breastfeeding duration, this association was not 
statistically significant.  This could indicate that other factors have a bigger impact on 
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longer-term breastfeeding outcomes.  Recall bias or confusion with the survey questions 
could also be an issue.  Nonetheless, all seven of the Ten Step hospital practices 
evaluated in this study were found to have a significant association with breastfeeding 
outcomes, adding evidence that these measures are relevant and worthwhile for 
breastfeeding promotion in the current US maternity care setting.  This has important 
implications for public health policy and for best practices for clinical care.  This work 
further substantiates that implementation of the Ten Step guidelines could improve 
breastfeeding outcomes in the US and should be strongly considered by policy-makers.  
The number of breastfeeding-supportive maternity practices experienced by the 
mother was associated with use of a progestin-only method compared to non-hormonal 
methods; however the effect was only marginally significant and should be taken with 
caution.  Women who receive the standard of care for maternity practices, however, may 
also be more likely to receive the standard of care, i.e. follow the CDC guidelines, in 
regards to contraceptive use.  However, this result could also represent confounding by 
other factors that are associated with both contraceptive use and hospital care, such as 
health insurance or size or type of hospital at which the woman gave birth.  Likewise, 
examination of the individual practices that comprised the ordinal ‘Hospital Practices’ 
variable, revealed a significant association between a visit by an LC or breastfeeding 
support person and the type of contraceptive used.  It could be that women experiencing 
breastfeeding difficulties are both more likely to receive an LC visit and more likely to 
contracept, but since non-hormonal methods are considered by breastfeeding advocates to 
be the more conservative choice for breastfeeding preservation, these results, like the 
findings for hospital practices in general are surprising.  Again, given that the CDC 
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recommendations do not prioritize non-hormonal methods over progestin-only methods 
while breastfeeding; these results may indicate that women are being effectively educated 
about the current guidelines before initiating contraceptive use and that they are 
following those guidelines. This further underscores the importance of gathering accurate 
information about the association between exposure to progestins while breastfeeding and 
the need to translate this work into evidence based guidelines for contraceptive use 
during lactation.   
An interaction term between maternal age and the number of hospital practices 
reported by the mother shows a protective effect that increases with both maternal age 
and the number of breastfeeding supportive hospital practices a woman receives.  This 
result should be interpreted with caution since it is only marginally significant at the 
p<0.05 level. On the other hand, both maternal age and hospital practices have been 
associated with increased duration of breastfeeding in other studies, so it is plausible that 
these factors could play a role in breastfeeding success. While the odds ratio appears to 
be small, just 1.3% lower odds per maternal year and hospital practice, the impact can 
quickly add up when one considers maternal ages of 20, 30 or 40 years, and multiple 
hospital practices. The implication of this term, if valid, is that hospital practices affect 
older mothers differently than younger ones. Further research is needed to clarify whether 
this effect is spurious, but to the extent that it reflects real differences among mothers, it 
has important implications for the implementation of breastfeeding-related hospital 
practices and for improving health disparities between mothers of different ages.     
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Statistical Methods 
The physiology of breastfeeding should be equally unaffected by no contraceptive 
use and by using a non-hormonal method.  However the results of this study suggest that 
caution should be used in selecting the best comparison group for future research on 
contraceptive use while breastfeeding because the adjusted survival curves and bivariate 
analyses using different comparison groups show different trends. To the extent that the 
use or non-use of contraception defines distinct populations of women, those who choose 
not to use contraception may not be the most appropriate comparison group for the 
effects of hormonal contraceptive methods.  Women who do not use contraception after 
birth may represent a very different population than those who use contraception in this 
period, and therefore utilizing them as a comparison group may not fully control for 
factors that are not otherwise captured in the model but are associated with contraceptive 
use.  For instance, studies that utilize non-users as the control group may not be 
adequately controlling for partnership status, which has been shown to be positively 
associated with breastfeeding outcomes. (156,158,160)  Much of the literature on which 
the WHO and CDC MECs are based, however, make use of those who are not using 
contraception as their control group.  Many of these studies report no effect of hormonal 
methods, particularly progestin-only methods, but the results of this analysis suggest that 
use of an inadequate control group may be contributing to these results.  This may be 
particularly true if the effect being studied is more subtle or time varying, as is 
hypothesized for progestin-only methods, since even relatively small mismatches in 
populations may obscure more subtle associations.  
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Confounding is a particular problem in this area of work since differences exist 
between the groups of women using each type of contraception.  Women who breastfeed 
also differ from those who do not breastfeed on a variety of characteristics.  Ethical and 
human subjects issues make many study designs meant to address this problem, such as 
performing an RCT, impractical.  Therefore, other approaches are needed to address 
confounding.  Results from this study suggest that propensity score weighting may be a 
useful method in this field.  Propensity score weights were used to balance the 
characteristics of the exposure and control groups as a means of controlling for the 
differences in these populations.  Histograms of the propensity score weights used in the 
survival analysis showed considerable overlap between treatment groups, suggesting that 
the propensity score successfully balanced the distribution of their characteristics.  An 
analysis of the area of common support gave consistent results to the more general hazard 
models, reinforcing that the propensity scores adequately matched the treatment and 
control groups.  If successfully matched, propensity scores allow one to assess the 
counterfactual scenario where everyone in the sample received the treatment or everyone 
received the control.  This is useful and appropriate for the topic of postpartum 
contraception since contraceptive use is a changeable factor.  Knowing the population 
effect, therefore, could be informative for policy and program design and have practical 
implications for clinical practice.  
 
Theory of Planned Behavior 
This project confirmed the predictions of the Theory of Planned Behavior. The 
mother’s intention to breastfeed was strongly associated with breastfeeding duration both 
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including and excluding initiation. Moreover, all seven hospital practices evaluated in 
this study were significantly associated with breastfeeding initiation, bearing out the 
prediction of the theory that underlying factors that affect one’s subjective norm, and 
one’s perceived behavioral control can work through behavioral intention to lead to 
behavior. Specifically, in this study, 15.9% of women who did not intend to breastfeed, in 
fact, did initiate. According to the Theory of planned Behavior, the care they received at 
the hospital could have shifted these women’s subjective norm and perceived behavioral 
control enabling them to deviate from their intention and carry out a behavior they had 
not previously planned to take-up. While many other influences may impact this shift, 
hospital practices offer an opportunity for policy and programmatic intervention that 
directly impacts the time period and setting where the decision to breastfeed is made.  
Future work should continue to be informed by this theory since it has shown good 
relevance and insight for this subject matter. 
 
LIMITATIONS 
 
An important limitation of this study is the lack of information about the timing of 
initial contraceptive use. Estrogen has been shown to impact lactation; in humans it is 
considered a potent inhibitor of milk production based on clinical reports. (91-95)  
Biological models suggest that early introduction of progestogenic contraception after 
birth may disrupt breastfeeding establishment, while later introduction may have no 
effect or a supportive effect on breastfeeding outcomes.  If this is the case, this study 
would not be able to distinguish these effects since all women who used progestin-
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containing methods were grouped together, regardless of early or late onset of use. The 
available data did not allow evaluation of the intensity or exclusivity of breastfeeding, 
and therefore assessment of more nuanced breastfeeding outcomes could not be carried 
out.  Examination of these important indicators of breastfeeding success would help to 
clarify the effects of progestin-only contraception on breastfeeding and the true effects of 
hormonal contraception in general.  
The high amount of censored data in this sample (69.0%) may limit the power to 
detect differences in breastfeeding duration between contraceptive use groups.  While 
their ultimate duration of breastfeeding is unavailable for these women, it is informative 
that they were able to breastfeed as long as they reported, and that this occurred in the 
context of their reported contraceptive use.  Moreover, censoring would likely be a less 
significant issue at earlier time-points, which is the time frame of most interest since 
women may be a more vulnerable to breastfeeding cessation as the biology and behavior 
of breastfeeding are being established.  This is also the time frame in which progestin-
only methods are hypothesized to have the greatest impact.  Censoring could bias the 
sample if it was associated with the outcomes, breastfeeding or contraceptive use.  This 
sample was selected at random from birth certificate data, limiting this possibility; 
however, if availability by landline telephone or willingness to participate in a telephone 
survey was correlated with breastfeeding outcomes or contraceptive use this could 
introduce bias.         
This analysis is also vulnerable to the possibility that women began using 
contraception after breastfeeding cessation.  However, most women in this sample were 
still breastfeeding, and their achieved duration was accomplished in the context of their 
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contraceptive use or non-use.  Moreover, the infants in this sample were relatively young, 
which further limits this possibility of reverse causation.     
Intensity or exclusivity of breastfeeding could not be evaluated in this sample, and 
therefore could not assess these more nuanced breastfeeding outcomes. This is 
unfortunate, since exclusivity is a relevant outcome of interest in relation to milk supply, 
a potential point of impact for exogenous hormones like those in hormonal contraception.  
In the United States, there is a large drop-off in breastfeeding rates during the first 
year, which could affect the ability of this study to detect associations between 
contraceptive use and breastfeeding outcomes.  If factors such as social, demographic, 
and healthcare are more important to breastfeeding cessation than biological factors, it 
may be difficult to detect the biological impact of contraceptive use if there is residual 
confounding.  Unmeasured factors that contribute to breastfeeding cessation could be 
wrongly attributed in this study as an effect of contraceptive use. The use of propensity 
scores is intended to address the multi-faceted nature of this topic area and, therefore, 
address this concern.   
Confounding is a particular problem in this area of work as seen by the significant 
demographic differences between the users of different types of postpartum 
contraception.  Similarly, there were significant demographic differences between those 
who did and did not initiate breastfeeding and by duration (reported for this sample in 
chapter 2).  However, propensity score weighting was able to adequately balance the 
demographic characteristics of women in the different contraceptive use categories. This 
suggests that this technique may be useful in controlling for confounding and examining 
causality in future studies on contraceptive use while breastfeeding.  
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A limitation of propensity scores is the assumption of no unmeasured 
confounders.  Breastfeeding and contraceptive use both have complex etiologies that 
include social, psychological, biological, and healthcare factors.  This dataset is unusual 
in the breastfeeding literature for the number and quality of breastfeeding and 
contraception related questions it asks.  However, information on timing and sequencing 
of contraceptive use, partnership status, social support for breastfeeding, maternal 
depression, urbanicity, and maternal obesity, employment and others were not available 
in this dataset.  To the extent that the factors available are more proximal to the outcome, 
they may serve as adequate proxies for these and other unmeasured factors and mitigate 
the vulnerability of using this statistical approach.  Furthermore, it should be noted that 
the assumption of no unmeasured confounders is also present for other common 
statistical approaches, and therefore not specific to this analytic design. 
The sample population was selected from North Carolina Birth Certificates and 
contacted by telephone. Differences in the covariates and in contraceptive use may exist 
between those available by landline telephone and those who cannot be reached by this 
means including those who do not have a landline telephone.  For instance, people who 
use cell phones exclusively would not be available by this means, and this could 
disproportionately exclude younger, poorer, and more transient mothers from the sample 
leading to sample bias.  If willingness to participate in a telephone survey were not 
randomly distributed, the sample would also be biased. These concerns are addressed in 
two ways. First, the random selection process using birth certificate records provides an 
unbiased foundation for sample selection.  In addition, many measures were undertaken 
to contact potential subjects including multiple contact attempts, contact at different times 
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of the day and week, and contact attempts over several months. Furthermore, if the 
potential participant declined, efforts were made by specially trained personnel to 
convince the potential study subjects to participate.  
The retrospective study design relied on maternal self-report and is vulnerable to 
recall bias which would be more likely to affect transient factors and factors with 
perceived positive or negative connotation.  For example, unwanted and mistimed 
pregnancies are reported less often in this sample than has been found in national data.  
Mothers may be reluctant to tell the interviewer that their pregnancy was unwanted or 
mistimed, and she might also unconsciously re-evaluate the wantedness of her pregnancy 
as she begins to bond with her baby.  Similarly, a mother’s recall of her intention to 
breastfeed may change in light of her actual experience of breastfeeding.  Reporting of 
hospital practices may be also be bias by events that happen later, and mothers could 
simply not remember what occurred during that time.  Some may not even know whether 
and when events happened, which could be correlated with maternal or infant health.  
Finally, reporting of contraceptive use may be subject to recall bias, especially if more 
than one method has been used since birth.  This sample is likely comparable to other 
studies in the field of breastfeeding research since results from this study are consistent 
with other breastfeeding studies on covariates commonly reported in the literature.  
Non-random missing data could lead to sample bias; however the amount of 
missing data for the variables used in the model was 1%-3%, which is very low.  Few 
factors in the model were significantly associated with contraceptive use suggesting that 
this model was missing variables that influence the use of contraception after birth. For 
instance, partnership status, whether the mother is sexually active, and whether she has 
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achieved her desired family size could all be important factors in using contraception, but 
were not available in the dataset.  Timing of contraceptive use would also have been 
useful to provide a more complete description of postpartum contraception.  This is 
particularly true for women who reported using more than one method since birth 
because the timing, order and duration of these methods were unknown.  However, the 
sample is unusual in that is has information about breastfeeding outcomes alongside 
information about contraceptive use, enabling analysis of contraception use during 
breastfeeding.  Few analyses of postpartum contraceptive use have been carried out in 
adult populations, so this study also contributes to the literature by describing factors 
associated with contraceptive use in this large and meaningful demographic. 
 
CONCLUSION 
 
Combined estrogen/progestin contraceptive methods had a large effect on 
breastfeeding duration when compared to progestin-only methods, non-hormonal 
methods or using no method.  These results suggest that combined hormonal methods 
should not be recommended to breastfeeding women.  This is consistent with current 
CDC recommendations and strengthens the evidence on which they’re founded because 
this study is recent, US-based, examined current contraceptive options, and controlled for 
confounding using up-to-date statistical approaches.  No effect of progestin-only 
contraceptive use on breastfeeding duration was found when compared to either non-
hormonal methods of birth control or using no method. These results are limited by the 
lack of information on the timing of initiation of use; in particular, we were not able to 
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distinguish early use, i.e., immediate postpartum, from later use. Consequently, these 
results should not be interpreted to mean that progestin-only methods are compatible with 
breastfeeding, but rather that good information about the timing of use will be necessary 
to clarify the relationship between progestin-only contraceptive use and breastfeeding 
outcomes.  
Postpartum contraceptive use by women who initiated breastfeeding was found to 
be associated with maternal age, maternal educational attainment, race/ethnicity, first 
birth, infant NICU stay, and the number of breastfeeding-related hospital practices 
experienced by the mother.  Differences in contraception use correspond to breastfeeding 
rates, suggesting that the issues may be related either with common etiology or by direct 
effects between them.  Pregnancy prevention may outweigh breastfeeding protection in a 
mother’s use of contraception after birth.  If so, accurate and available information about 
the impact of hormonal contraception on breastfeeding is need by these women, as well 
as having access to reliable and attractive contraceptive methods which are compatible 
with breastfeeding.      
Overall, these results highlight the importance of labor and delivery practices that 
allow and enable immediate breastfeeding initiation for long-term breastfeeding success.  
These results support the importance of the Ten Steps to Successful Breastfeeding for 
breastfeeding duration, and suggest that greater adoption of and adherence to this 
standard could improve breastfeeding outcomes.  
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APPENDIX 1: HISTOGRAMS OF THE PROPENSITY SCORE WEIGHTS FOR 
TREATMENT AND CONTROL GROUPS FOR EACH SURVIVAL ANALYSIS  
 
From a Survey Evaluating the Period of purple crying intervention program, 2010-11, 
and limited to women who initiated breastfeeding. Propensity scores are based on 
maternal age, race/ethnicity, maternal education, pregnancy wantedness, parity, baby’s 
gender, NICU stay, intention to breastfeed, timing of initiation, receipt of a formula 
sample bag, and hospital practices.  
 
 
Progestin-Only vs. No Method 
 
Propensity Score Weights 
0= No method 
1= Progestin-only Methods  
 
 
 
 
 
 
 
Progestin-Only vs. Non-hormonal 
Methods 
 
Propensity Score Weights 
0= Non-hormonal methods 
1= Progestin-only Methods  
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APPENDIX 2: HISTOGRAMS OF THE PROPENSITY SCORE WEIGHTS FOR 
TREATMENT AND CONTROL GROUPS FOR EACH SURVIVAL ANALYSIS 
 
From a Survey Evaluating the Period of Purple Crying intervention program, 2010-11, 
and limited to women who initiated breastfeeding. Propensity scores are based on 
maternal age, race/ethnicity, maternal education, pregnancy wantedness, parity, baby’s 
gender, NICU stay, intention to breastfeed, timing of initiation, receipt of a formula 
sample bag, and hospital practices.  
 
Combined Hormonal vs. No Method 
 
Propensity Score Weights 
0= no method 
1= combined hormonal  
 
 
 
 
 
 
Combined Hormonal vs. Non-
hormonal Methods 
 
Propensity Score Weights 
0= non-hormonal methods 
1= combined hormonal 
 
 
 
 
 
 
Combined Hormonal vs. Progestin-
Only Methods 
 
Propensity Score Weights 
0= progestin-only 
1= combined hormonal 
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LNG 0.15 mg; 
N=109 
received 
injectable 
placebo at 30 
days;  N=79 
used oral 
placebo 
N=291 
healthy 
women, 
exclusively 
breastfeedin
g at day 30-
35 
postpartum. 
At 3 months, COC users 
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Croxatto 
et al 
1983 
Chile 
Partially 
randomiz
ed 
controlle
d trial 
30 days PP: 
N=103 EEl 
0.03 mg and 
LNG 0.15 mg; 
N=188 
received 
injectable 
placebo at 30 
days and non-
hormonal 
contraceptive 
at 90 days PP; 
N=118 used 
non-hormonal 
IUD 
N=330 
healthy, 
exclusively 
breastfeedin
g women. 
From 4 to 10 months, COC 
group had significantly 
lower exclusive 
breastfeeding rates than 
both control groups.  For 
most months, COC group 
had lower average infant 
weight than controls. 
Participants 
chose their 
treatment/c
ontrol 
status.  The 
COC group 
had higher 
parity than 
the 
controls. 
Croxatto 
HB, Diaz S, 
Peralta O, 
Juez G, 
Herreros C, 
Casado 
ME, et al.  
Fertility 
regulation 
in nursing 
women: IV. 
Long-term 
influence of 
a low-dose 
combined 
oral 
contracepti
ve initiated 
at day 30 
postpartum 
upon 
lactation 
and infant 
growth. 
Contracepti
on 1983 
Jan;27(1):1
3-25.  
Kaern 
1967 
Copenha
gen, 
Denmark RCT 
Trial window 
was 1 to 8 days 
PP: N=233 
received daily 
Norinyl-1 
N=451 
healthy 
postpartum 
women who 
planned to 
At discharge (day 8), 
11.2% of Treatment and 
3.2% of controls were 
giving supplemental 
feeding. 
Duration of 
follow-up 
was very 
short, 
randomizati
Kaern T. 
Effect of an 
oral 
contracepti
ve 
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tablet 
(norethisterone 
1 mg and 
mestranol 0.05 
mg); N=218 
received 
placebo 
breastfeed on and 
blinding 
process are 
unclear, 
statistical 
findings 
don't match 
their 
conclusions 
immediatel
y post 
partum on 
initiation of 
lactation. 
Br Med J 
1967 Sep 
9;3(5566):6
44-645.  
Miller 
and 
Hughes 
1970, 
USA RCT 
Intervention 
began at 2 
weeks 
postpartum 
N=24 received 
1mg 
norethindrone 
with 0.08 mg 
mestranol 
N=23 received 
placebo until 6 
weeks and then 
COCs N=48 no 
treatment 
N=100 
women who 
planned to 
breastfeed 
for at least 
3 months 
Breastfeeding continuation 
at 12 weeks: 21% of COC 
treatment group, 52% of 
placebo/COC group, 73% 
of controls. At weeks 4 
and 5, babies of nonusers 
had significantly higher 
weight gain. Week 5 COC 
users' babies needed more 
supplemental calories. 
Study failed 
to specify 
randomizati
on methods, 
statistical 
tests, and 
values of 
results 
Miller GH, 
Hughes LR. 
Lactation 
and genital 
involution 
effects of a 
new low-
dose oral 
contracepti
ve on 
breast-
feeding 
mothers and 
their 
infants. 
Obstet 
Gynecol 
1970 
Jan;35(1):4
4-50.  
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WHO 
Hungary 
and 
Thailand RCT 
Treatment 
began at 6 
weeks PP 
N=86 COC (30 
µg ethinyl 
estradiol and 
150 µg 
levonorgestrel) 
N=85 POP (75 
µg norgestrel) 
N=59 DMPA 
N=111 Non-
hormonal 
(barriers, 
sterilization, 
IUDs) 
N=341 
healthy 
women 
aged 20-35 
who wanted 
oral 
contracepti
ves. Had to 
have 2-5 
previous 
births and 
prior 
successful 
breastfeedin
g 
experience 
of at least 3 
months 
No differences found in 
breastfeeding continuation 
rates, mean infant weight, 
length, or rate of growth, 
or infant illness were 
found between COC and 
control groups, except 
female infants at one site 
were smaller in controls 
than COC group. Milk 
from COC group was 
lower in calories, and had 
different mineral content, 
and milk volume was 
lower than controls. 
No 
adjustment 
for 
confounder
s. Loss to 
follow-up 
was high in 
some 
groups. 
Supplement
ation not 
addressed.  
Method 
switching 
not 
addressed. 
WHO. 
Effects of 
hormonal 
contracepti
ves on 
breast milk 
compositio
n and infant 
growth. 
World 
Health 
Organizatio
n (WHO) 
Task Force 
on Oral 
Contracepti
ves. Stud 
Fam Plann 
1988 Nov-
Dec;19(6 Pt 
1):361-369.  
Guiloff 
et al 
1974, 
Chile 
randomiz
ed 
clinical 
trial/ 
case-only 
design 
with 
historical 
controls 
N=367 various 
regimens of 
COC; N=80 
DMPA; N=168 
POP; N=81 
IUD     (COC 
and IUD users 
began at 30 
days 
postpartum; 
DMPA users 
began at 1-2 
n=696 16-
40-year-old 
healthy, 
multiparous 
women 
Median duration of 
lactation (MDL) was 
shorter for COC users.  No 
significant difference in 
MDL for the group given 
an EE formulation (4.6 vs. 
5.3 for non-hormonal 
controls). Metrenol and 
quingestanol users had a 
significant (p<0.05) 
difference in MDL (2.5 vs. 
5.3) 
Control 
group was 
the previous 
births from 
the same 
women. No 
further 
accounting 
for 
confoundin
g. 
Guiloff E, 
Ibarra-Polo 
A, Zanartu 
J, Toscanini 
C, Mischler 
TW, 
Gomez-
Rogers C. 
Effect of 
contracepti
on on 
lactation. 
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days 
postpartum) 
Am J 
Obstet 
Gynecol 
1974 Jan 
1;118(1):42
-45.  
Gambrel
l 
1968-69     
US 
Military 
Hospital, 
Wiesbad
e, 
Germany 
Prospecti
ve 
Cohort 
Treatment 
started on PP 
day 5: N=363 
received COC 
of the type 
they had 
previously 
used or 
randomly 
selected from 9 
available 
options (83 
breastfeeding) 
N=245 
Controls (91 
breastfeeding) 
N=964 
immediatel
y 
postpartum 
women who 
wanted oral 
contracepti
on 
Among breastfeeding 
women, 54% of the COC 
group and 59% of the 
control group breastfed for 
6 or more weeks. The 
reason for breastfeeding 
cessation was due to 
decreased milk supply for 
25% of the COC group and 
13% of the controls  
No 
adjustment 
for 
confounder
s. variety of 
COCs 
grouped 
together in 
treatment 
group.  
Intervention 
was self-
selected. 
Time of 
breastfeedin
g initiation 
appears to 
vary. 
Gambrell 
RD,Jr. 
Immediate 
postpartum 
oral 
contracepti
on. Obstet 
Gynecol 
1970 
Jul;36(1):10
1-106.  
Nilsson 
et al 
1979 
Sweden 
Retrospe
ctive 
Cohort 
N=48 women 
who used 
COCs while 
breastfeeding 
N=48 Non-
hormonal users 
N=96 
women who 
asked for 
COCs at 2 
months 
postpartum 
and their 
matched 
Mean length of 
breastfeeding was shorter 
in the COC group than 
controls (3.7 vs. 4.6) , but 
no differences in number 
of serious illness or school 
performance were found 
were found up to age 8 
No 
adjustment 
for 
confounder
s. 
Retrospecti
ve design. 
Small 
Nilsson S, 
Mellbin T, 
Hofvander 
Y, Sundelin 
C, Valentin 
J, Nygren 
KG. Long-
term 
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controls numbers. follow-up 
of children 
breast-fed 
by mothers 
using oral 
contracepti
ves. 
Contracepti
on 1986 
Nov;34(5):
443-457.  
Peralta 
et al 
1983 
Chile 
Prospecti
ve cohort 
treatment 
began at 90 
days 
postpartum: 
N=59 EE 0.03 
mg and LNG 
0.15 mg; N=82 
received non-
hormonal 
method 
N=141 
healthy,  
exclusively 
breastfeedin
g women 
whose 
infants had 
normal 
weight gain 
at 3 months 
At 6 months, COC group 
had significantly lower 
exclusive breastfeeding 
rates than non-hormonal.  
At 4 months, COC group 
had lower infant weight 
gain than non-hormonal 
No 
adjustment 
for 
confounder
s, and COC 
group had 
higher 
parity than 
the 
controls. 
participants 
chose their 
treatment/c
ontrol status 
Peralta O, 
Diaz S, 
Juez G, 
Herreros C, 
Casado 
ME, 
Salvatierra 
AM, et al.  
Fertility 
regulation 
in nursing 
women: V. 
Long-term 
influence of 
a low-dose 
combined 
oral 
contracepti
ve initiated 
at day 90 
postpartum 
upon 
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lactation 
and infant 
growth. 
Contracepti
on 1983 
Jan;27(1):2
7-38.  
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Injectables: DMPA & NET-EN 
Study 
Year 
and 
Location 
Study 
Design Exposure Population Results 
Study 
problems Reference 
Guiloff et 
al 
1974 
Chile 
randomiz
ed 
clinical 
trial/ 
case-only 
design 
with 
historical 
controls 
Randomized 
to receive 
DMPA 
immediately 
PP (N=80) 
or at 1 
month PP 
(N=33) 
N=696 16 
to 40 year-
old 
multiparous 
women  
Median duration of 
breastfeeding for 
immediate postpartum use 
was 6.7 months vs. shot at 
1-month was 4.8 month 
breastfeeding duration; 
women who received a 
shot at 1 month breastfed 
longer than the control, 
group (9.3 vs. 5.3 months) 
Control group 
was the 
previous 
births from 
the same 
women. No 
further 
accounting for 
confounding. 
Guiloff E, 
Ibarra-Polo 
A, Zanartu 
J, 
Toscanini 
C, 
Mischler 
TW, 
Gomez-
Rogers C. 
Effect of 
contracepti
on on 
lactation. 
Am J 
Obstet 
Gynecol 
1974 Jan 
1;118(1):4
2-45.  
Hannon 
et al 
1997 
Baltimor
e, MD 
prospecti
ve cohort 
study 
At time of 
hospital 
discharge: 
N=45 
DMPA(150 
mg); N=52 
N=95, 
intended to 
breastfeed 
and were 
breastfeedin
g at hospital 
No significant difference 
between early postpartum 
use of 
medroxyprogesterone and 
use of non-hormonal 
methods but trend towards 
Statistically 
significant 
differences in 
age and 
marital status 
between the 
Hannon 
PR, 
Duggan 
AK, 
Serwint 
JR, 
A
PPE
N
D
IX
 4: PR
O
G
E
ST
IN
-O
N
L
Y
 C
O
N
T
R
A
C
E
PT
IO
N
 (PO
C
S) 
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non-
hormonal 
discharge longer breastfeeding 
duration in treatment group 
(10.14 weeks for DMPA 
vs. 6.57 weeks for non-
hormonal, P=.19) 
exposure 
groups were 
not addressed 
in the 
analysis, not 
controlling for 
these possible 
confounders at 
all. 
Vogelhut 
JW, Witter 
F, 
DeAngelis 
C. The 
influence 
of 
medroxypr
ogesterone 
on the 
duration of 
breast-
feeding in 
mothers in 
an urban 
community
. Arch 
Pediatr 
Adolesc 
Med 1997 
May;151(5
):490-496.  
Halderm
an and 
Nelson 
2002 Los 
Angeles, 
CA 
Prospecti
ve cohort 
women self-
selected to 
receive 
DMPA 
before 
discharge 
(N=102), 
receive a 
prescription 
for POPs or 
LNG 
N=319 
women of 
all ages, 
parity, and 
prior 
breastfeedin
g 
experience 
Women using hormonal 
contraception were 
significantly more likely to 
have ceased breastfeeding 
at 4 weeks (83.1% for non-
hormonal, 76.7% for 
POCs, p=0.022), but no 
difference was found at 2 
and 6 weeks.  
No adjustment 
for 
confounding. 
Groups were 
significantly 
different in 
their prior 
breastfeeding 
experience, 
mother's age, 
and mode of 
Halderman 
LD, 
Nelson 
AL. 
Impact of 
early 
postpartum 
administrat
ion of 
progestin-
only 
	  	  
271 
implant 
(N=77) or 
use condoms 
or 
abstinence 
(N=138) 
delivery. hormonal 
contracepti
ves 
compared 
with non-
hormonal 
contracepti
ves on 
short-term 
breast-
feeding 
patterns. 
Am J 
Obstet 
Gynecol 
2002 
Jun;186(6)
:1250-6; 
discussion 
1256-8.  
Lawrie et 
al 
(1998) 
South 
Africa RCT 
48 hours PP: 
N=85 
received 
NET-EN; 
N=84 
received 
placebo 
N=166 
breastfeedin
g women, 
over 19 
years old 
Breastfeeding continuation 
rates were 68% for NET-
EN group and 74% for 
placebo, but not 
statistically significant at 6 
or 12 weeks postpartum. 
No differences in infant 
weight  
Small sample 
size might 
have been 
underpowered 
to see effect. 
Lawrie 
TA, 
Hofmeyr 
GJ, De 
Jager M, 
Berk M, 
Paiker J, 
Viljoen E. 
A double 
blind 
randomize
d placebo-
controlled 
	  	  
272 
trial of 
postnatal 
norethister
one 
enanthate: 
the effect 
on 
postnatal 
depression 
and serum 
hormones. 
Br J Obstet 
Gynaecol 
1998 
Oct;105(10
):1082-
1090.  
Brito et al 
(2009) 
Brazil  RCT 
N= received 
ETG implant 
24-48 hours 
PP N= 
received 150 
mg DMPA, 
6 weeks PP 
N=40 
women 
with 
chronic 
disease, 
BMI<30, 
aged 18-35 
years, no 
history of 
thromboem
bolism 
At 12 weeks PP, no 
difference between implant 
and DMPA groups in 
exclusive breastfeeding 
rates (17/20 ETG, 15/20 
DMPA), no differences in 
infant weight observed. 
Comparison 
of one 
treatment to 
another 
treatment, 
combines time 
and treatment 
such that the 
two effects 
cannot be 
differentiated.  
Does not 
inform about 
either 
treatment 
relative to 
Brito MB, 
Ferriani 
RA, 
Quintana 
SM, Yazlle 
ME, Silva 
de Sa MF, 
Vieira CS. 
Safety of 
the 
etonogestr
el-
releasing 
implant 
during the 
immediate 
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biological 
norm.  
Follow-up 
only to 12 
weeks.   
postpartum 
period: a 
pilot study. 
Contracept
ion 2009 
Dec;80(6):
519-526.  
Karim et 
al.  
1969 
Egypt 
Prospecti
ve 
Cohort 
7 days PP: 
N=80 
DMPA; 
N=68 Net-
EN (200 mg 
every 84 
days); N=51 
DMPA (150 
mg every 3 
months); 
N=100 Non-
hormonal.  
42 days PP: 
N=57 NET-
EN; N=55 
DMPA. 
N=331 
women 
with normal 
delivery 
No difference in milk 
chemistry, volume, or 
infant growth was 
observed.  Women 
reported similar or longer 
duration breastfeeding 
compared to previous 
nursing experiences. 
Duration of 
breastfeeding 
was anecdotal.  
Karim M, 
Ammar R, 
el-
Mahgoub 
S, el-
Ganzoury 
B, Fikri F, 
Abdou I. 
Injected 
progestoge
n and 
lactation. 
Br Med J 
1971 Jan 
23;1(5742)
:200-203.  
Jimenez 
et al.  
(1984) 
Chile 
Retrospe
ctive 
Cohort 
2 months 
PP: N=128 
DMPA (150 
mg/3 
months); 
N=142 non-
hormonal 
N=270 
women 
who 
breastfed 
DMPA mothers reported 
longer breastfeeding 
duration, 21 months vs. 13 
for controls. No difference 
in child development 
measures or health 
measures.  No difference in 
child weight after 
adjustment for 
confounders.  
Retrospective 
design could 
lead to recall 
bias for 
breastfeeding 
outcomes. 
Exposure not 
randomized. 
Jimenez J, 
Ochoa M, 
Soler MP, 
Portales P. 
Long-term 
follow-up 
of children 
breast-fed 
by mothers 
receiving 
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depot-
medroxypr
ogesterone 
acetate. 
Contracept
ion 1984 
Dec;30(6):
523-533.  
Melis et 
al.  
(1981) 
Italy 
Observat
ional 
Cohort 
N=5 NET-
EN to 
puerperal 
women on 
2-5 day PP; 
N=20 NET-
EN to non-
puerperal 
women on 
5th day of 
menses 
N=25 
women 
No effect on breastfeeding 
reported. 
small sample 
size, no 
control for 
breastfeeding 
outcomes 
Melis GB, 
Strigini F, 
Fruzzetti 
F, Paoletti 
AM, 
Rainer E, 
Dusterberg 
B, et al.  
Norethister
one 
enanthate 
as an 
injectable 
contracepti
ve in 
puerperal 
and non-
puerperal 
women. 
Contracept
ion 1981 
Jan;23(1):7
7-88.  
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Shaaban 
et al.  
(1991) 
Egypt Cohort 
5-7 weeks 
PP: N=120 
LNG 
implant 
(Norplant); 
N=120 
NET-EN 
injectable; 
N=120 IUD 
inserted in 
2nd month 
PP; N=103 
PVR; N=83 
Copper IUD. 
Phase I: 
N=360 
healthy 
women. 
Phase II: 
N=186 
women 
Phase I: No difference in 
supplementation timing.  
IUD users ceased 
breastfeeding earlier than 
NET-EN users. No 
difference in infant 
outcomes.  Phase II: No 
difference in 
supplementation or infant 
growth between Vaginal 
ring and IUD users. 
Poor reporting 
of baseline 
characteristics
, follow-up, 
and methods. 
Shaaban 
MM. 
Contracept
ion with 
progestoge
ns and 
progestero
ne during 
lactation. J 
Steroid 
Biochem 
Mol Biol 
1991;40(4-
6):705-
710.  
Zacharias 
et al.  
(1986) 
Chile 
Prospecti
ve 
Cohort 
2 to 4 
months PP: 
N=143 
LAM; 
N=109 IUD; 
N=228 
DMPA; 
N=185 POP 
(Clogestone 
Acetate .6 
mg/day) 
N=665 term 
women 
who were 
willing to 
breastfeed 
Median breastfeeding 
duration was 17 months for 
LAM and 19 months for 
IUD, DMPA, and POP 
combined.  DMPA had the 
highest percentage of 
mothers nursing past 20 
months. 
Subjects self-
selected 
treatment and 
no adjustment 
for 
confounders. 
Zacharias 
S, Aguilera 
E, Assenzo 
JR, 
Zanartu J. 
Effects of 
hormonal 
and 
nonhormo
nal 
contracepti
ves on 
lactation 
and 
incidence 
of 
pregnancy. 
Contracept
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ion 1986 
Mar;33(3):
203-213.  
WHO 
(1994) 
Egypt, 
Iran, 
Thailand, 
Kenya, 
Chile, 
Hungary Cohort 
6-8 weeks 
PP: N=475 
POP (LNG 
or 
lynestrenol); 
N=541 
DMPA; N-
121 NET-
EN; N=453 
LNG 
implant 
(Norplant); 
N=876 non-
hormonal  
N=2466 
married 
women 
with term 
deliveries. 
No difference in frequency 
and duration of 
breastfeeding between 
contraceptive types at the 
same site, but differences 
seen between locations.  
Infant growth and 
development outcomes 
were inconsistent between 
sites. 
Breastfeeding 
outcomes 
varied greatly 
between sites. 
Progestoge
n-only 
contracepti
ves during 
lactation: I. 
Infant 
growth. 
World 
Health 
Organizati
on Task 
force for 
Epidemiol
ogical 
Research 
on 
Reproducti
ve Health; 
Special 
Programm
e of 
Research, 
Developm
ent and 
Research 
Training in 
Human 
Reproducti
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on. 
Contracept
ion 1994 
Jul;50(1):3
5-53.                                                                  
Progestoge
n-only 
contracepti
ves during 
lactation: 
II. Infant 
developme
nt. World 
Health 
Organizati
on, Task 
Force for 
Epidemiol
ogical 
Research 
on 
Reproducti
ve Health; 
Special 
Programm
e of 
Research, 
Developm
ent, and 
Research 
Training in 
Human 
Reproducti
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on. 
Contracept
ion 1994 
Jul;50(1):5
5-68.  
WHO 
Hungary 
and 
Thailand RCT 
6 weeks PP: 
N=86 COC 
(30 µg EE 
and 150 µg 
LNG N=85 
POP (75 µg 
norgestrel) 
N=59 
DMPA 
N=111 Non-
hormonal 
(barriers, 
sterilization, 
IUDs) 
N=341 
healthy 
women 
aged 20-35 
who wanted 
oral 
contracepti
ves. Had to 
have 2-5 
previous 
births and 
prior 
successful 
breastfeedin
g 
experience 
of at least 3 
months 
No differences found in 
breastfeeding continuation 
rates, mean infant weight, 
length, or rate of growth, 
or infant illness were found 
between COC and control 
groups, except female 
infants at one site were 
smaller in controls than 
COC group. Milk from 
COC group was lower in 
calories, and had different 
mineral content; milk 
volume was lower than 
controls. 
No adjustment 
for 
confounders. 
Loss to 
follow-up was 
high in some 
groups. 
Supplementati
on not 
addressed.  
Method 
switching not 
addressed. 
WHO. 
Effects of 
hormonal 
contracepti
ves on 
breast milk 
compositio
n and 
infant 
growth. 
World 
Health 
Organizati
on (WHO) 
Task Force 
on Oral 
Contracept
ives. Stud 
Fam Plann 
1988 Nov-
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Dec;19(6 
Pt 1):361-
369.  
WHO 
Hungary 
and 
Thailand 
Prospecti
ve 
Cohort/ 
RCT 
6 weeks PP: 
N=86 COC 
(30 µg EE 
and 150 µg 
LNG N=85 
POP (75 µg 
norgestrel) 
N=59 
DMPA 
N=111 Non-
hormonal 
(barriers, 
sterilization, 
IUDs) 
N=341 
healthy 
women 
aged 20-35 
who wanted 
oral 
contracepti
ves. Had to 
have 2-5 
previous 
births and 
prior 
successful 
breastfeedin
g 
experience 
of at least 3 
months 
No differences in 
breastfeeding continuation.  
Milk volume decreased 
over time for all groups, 
but COC to a greater 
extent.  
No adjustment 
for 
confounders. 
Method 
switching not 
addressed. 
Tankeyoon 
M, 
Dusitsin N, 
Chalapati 
S, 
Koetsawan
g S, 
Saibiang S, 
Sas M, et 
al.  Effects 
of 
hormonal 
contracepti
ves on 
milk 
volume 
and infant 
growth. 
WHO 
Special 
Programm
e of 
Research, 
Developm
ent and 
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Research 
Training in 
Human 
Reproducti
on Task 
force on 
oral 
contracepti
ves. 
Contracept
ion 1984 
Dec;30(6):
505-522.  
Baheiraei 
et al.  
(2001) 
Iran 
Prospecti
ve cohort 
6 weeks PP: 
N=51 
Progesterone
-only 
methods 
(DMPA or 
POP); N=89 
Non-
hormonal 
N=140 
healthy, 
term 
women 
No differences between 
groups in infant weight of 
length. 
Progesterone-
only methods 
were grouped 
together.  
Baheiraei 
A, 
Ardsetani 
N, 
Ghazizade
h S. 
Effects of 
progestoge
n-only 
contracepti
ves on 
breast-
feeding 
and infant 
growth. Int 
J Gynaecol 
Obstet 
2001 
Aug;74(2):
203-205.  
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Implants       
Study 
Year and 
Location 
Study 
Design 
Exposur
e Population Results Study problems Reference 
Brito et al 
(2009) 
Brazil RCT 
N= 
received 
ETG 
implant 
24-48 
hours PP 
N= 
received 
150 mg 
DMPA, 
6 weeks 
PP 
N=40 women 
with chronic 
disease, 
BMI<30, aged 
18-35 years, 
no history of 
thromboembol
ism 
At 12 weeks 
PP, no 
difference 
between 
implant and 
DMPA groups 
in exclusive 
breastfeeding 
rates (17/20 
ETG, 15/20 
DMPA), no 
differences in 
infant weight 
observed. 
Comparison of 
one treatment to 
another treatment, 
combines time 
and treatment 
such that the two 
effects cannot be 
differentiated.  
Does not inform 
about either 
treatment relative 
to biological 
norm.  Follow-up 
only to 12 weeks.  
Brito MB, 
Ferriani RA, 
Quintana SM, 
Yazlle ME, 
Silva de Sa 
MF, Vieira 
CS. Safety of 
the 
etonogestrel-
releasing 
implant during 
the immediate 
postpartum 
period: a pilot 
study. 
Contraception 
2009 
Dec;80(6):519
-526.  
Abdulla et 
al 
(1985) 
Egypt Cohort 
30 and 
39 days 
PP: 
N=LNG 
implant 
(Norplan
t); N=10 
non-
hormona
N=10 
breastfeeding 
women, with 
singleton, term 
birth 
No difference 
in immune 
factors seen at 
5 months PP 
Poor reporting of 
measures. 
Breastfeeding 
rates not reported. 
Abdulla KA, 
Élan SI, Salem 
HS, Shaaban 
MM. Effect of 
early 
postpartum use 
of the 
contraceptive 
implants, 
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l or no 
methods 
NORPLANT, 
on the serum 
levels of 
immunoglobul
ins of the 
mothers and 
their breastfed 
infants. 
Contraception 
1985 
Sep;32(3):261-
266.  
Abdel-
Aleem et al 
1992-94 
Egypt Cohort 
2 
months 
PP: 
N=120 
nomeges
trol 
subderm
al 
implant 
(Uniplan
t); 
N=120 
Copper 
IUD 
N=247 
exclusively 
breastfeeding 
mothers who 
asked for 
contraception 
No significant 
differences in 
episodes of 
breastfeeding, 
time of 
weaning, rates 
of exclusive 
and partial 
breastfeeding, 
infant weight , 
and infant 
growth 
between the 
two groups 
No adjustment for 
confounding and 
groups differed at 
baseline due to 
self-selection of 
treatment.   
Abdel-Aleem 
H, Abol-
Oyoun el-S M, 
Shaaban MM, 
el-Saeed M, 
Shoukry M, 
Makhlouf A, 
et al.  The use 
of nomegestrol 
acetate 
subdermal 
contraceptive 
implant, 
Uniplant, 
during 
lactation. 
Contraception 
1996 
Nov;54(5):281
-286.  
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Croxatoo et 
al.  
(1982) 
Chile Cohort 
30 days 
PP: 
N=84 
Progeste
rone 
pellets 
(100mg)
; N=130 
injectabl
e 
placebo; 
N=125 
Copper 
IUD 
N=439 
exclusively 
breastfeeding 
women, age 
18-35 
Duration of 
breastfeeding 
and child 
growth were 
the same in 
implant and 
control groups. 
At 6 months, 
the percentage 
of women 
fully 
breastfeeding 
was 51.2% for 
implant and 
58.3% for 
IUD, and at 12 
months 10.7% 
and 17.6% 
respectively 
(p<0.05).  
Not Randomized.  
High loss to 
follow-up and 
discontinuation. 
Croxatto HB, 
Diaz S, Peralta 
O, Juez G, 
Casado ME, 
Salvatierra 
AM, et al.  
Fertility 
regulation in 
nursing 
women. II. 
Comparative 
performance 
of 
progesterone 
implants 
versus placebo 
and copper T. 
Am J Obstet 
Gynecol 1982 
Sep 
15;144(2):201-
208.  
Diaz et al.  
(1984) 
Chile Cohort 
30 days 
PP: 
N=84 
Progeste
rone 
pellets 
(100mg)
; N=130 
injectabl
e 
placebo; 
N=439 healthy 
women, age 
18-35, vaginal 
term delivery, 
willing to 
breastfeed as 
long as 
possible 
No difference 
in continuation 
of 
breastfeeding 
or infant 
growth 
between 
groups 
No adjustment for 
confounding. 
High loss to 
follow-up and 
discontinuation. 
Diaz S, Peralta 
O, Juez G, 
Herreros C, 
Casado ME, 
Salvatierra 
AM, et al.  
Fertility 
regulation in 
nursing 
women. VI. 
Contraceptive 
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N=125 
Copper 
IUD. 60 
days PP: 
N=193 
Progeste
rone 
pellets 
(100mg)
; N=121 
Copper 
IUD.  
effectiveness 
of a subdermal 
progesterone 
implant. 
Contraception 
1984 
Oct;30(4):311-
325.  
Diaz et al.  
(1985) 
Chile Cohort 
55 days 
PP: 
N=100 
LNG 
implant 
(Norplan
t); 
N=100 
Copper 
IUD 
N=200 
exclusively 
breastfeeding 
women with 
adequate 
infant weight 
gain 
No significant 
difference 
between 
groups in 
percentage of 
women fully 
nursing, except 
for at 12 
months when 
lower 
percentage of 
Norplant 
group was still 
fully nursing. 
No significant 
difference in 
infant weight 
gain except in 
the 4th month 
when female 
infants of 
No adjustment for 
confounding.  
Diaz S, 
Herreros C, 
Juez G, 
Casado ME, 
Salvatierra 
AM, Miranda 
P, et al.  
Fertility 
regulation in 
nursing 
women: VII. 
Influence of 
NORPLANT 
levonorgestrel 
implants upon 
lactation and 
infant growth. 
Contraception 
1985 
Jul;32(1):53-
74.  
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mothers with 
the implant 
had lower 
weight gain 
than the IUD 
group   
Diaz et al.  
(1997) 
Chile 
Cohort with 
historical 
controls 
57 days 
PP: 
N=187 
Progeste
rone 
Vaginal 
Ring; 
N=117 
POP 
(lystreno
l); 
N=120 
LNG 
implant 
(Norplan
t); 
N=122 
Copper 
IUD; 
N=236 
LAM 
N= healthy, 
cohabitating, 
18-38 year-
olds, with 
normal 
delivery  and 
intending the 
breastfeed as 
long as 
possible 
No difference 
between 
groups in 
mean duration 
of 
breastfeeding 
or time of 
weaning Historical control 
Diaz S, 
Zepeda A, 
Maturana X, 
Reyes MV, 
Miranda P, 
Casado ME, et 
al.  Fertility 
regulation in 
nursing 
women. IX. 
Contraceptive 
performance, 
duration of 
lactation, 
infant growth, 
and bleeding 
patterns during 
use of 
progesterone 
vaginal rings, 
progestin-only 
pills, Norplant 
implants, and 
Copper T 380-
A intrauterine 
devices. 
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Contraception 
1997 
Oct;56(4):223-
232.  
Massai et 
al.  
(2001) 
Chile 
Prospective 
Cohort 
8 weeks 
PP: 
N=100 
NES; 
N=100 
Copper 
IUD 
N=200 
cohabitating 
women, aged 
18-38, who 
had   term 
deliveries 
No difference 
in episodes or 
duration of 
breastfeeding.  
No difference 
in infant 
growth 
High 
discontinuation 
rate (17% for 
NES, 2% for IUD) 
Massai MR, 
Diaz S, 
Quinteros E, 
Reyes MV, 
Herreros C, 
Zepeda A, et 
al.  
Contraceptive 
efficacy and 
clinical 
performance 
of Nestorone 
implants in 
postpartum 
women. 
Contraception 
2001 
Dec;64(6):369
-376.  
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Taneepanic
hskul et al 
(2006) 
Thailand 
Prospective 
cohort 
28-56 
days PP: 
N=42 
etonoges
trel 
implant 
(Implano
n); N=38 
copper 
IUD 
N=80 healthy, 
fully 
breastfeeding 
women with 
healthy, 
singleton 
births 
Mean duration 
of 
breastfeeding 
421 days for 
Implanon and 
423 for IUD 
users. No 
differences in 
child growth 
or 
development 
were observed. 
No information on 
contraceptive 
switching or 
discontinuation or 
response rate for 
study participation 
Taneepanichsk
ul S, 
Reinprayoon 
D, 
Thaithumyano
n P, 
Praisuwanna 
P, 
Tosukhowong 
P, Dieben T. 
Effects of the 
etonogestrel-
releasing 
implant 
Implanon and 
a 
nonmedicated 
intrauterine 
device on the 
growth of 
breast-fed 
infants. 
Contraception 
2006 
Apr;73(4):368-
371. 
Reinprayoo
n et al 
(2000) 
Thailand 
Prospective 
cohort 
28-56 
days PP: 
N=42 
etonoges
trel 
implant 
(Implano
N=80 healthy, 
fully 
breastfeeding 
women with 
healthy, 
singleton 
births 
No differences 
in milk 
composition or 
volume 
between 
groups. No 
difference in 
No information on 
contraceptive 
switching or 
discontinuation or 
response rate for 
study participation 
 Reinprayoon 
D, 
Taneepanichsk
ul S, 
Bunyavejchevi
n S, 
Thaithumyano
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n); N=38 
copper 
IUD 
timing or 
quantity of 
supplementatio
n.  No 
significant 
difference in 
infant growth 
or weight gain. 
n P, 
Punnahitanand
a S, 
Tosukhowong 
P, et al.  
Effects of the 
etonogestrel-
releasing 
contraceptive 
implant 
(Implanon on 
parameters of 
breastfeeding 
compared to 
those of an 
intrauterine 
device. 
Contraception 
2000 
Nov;62(5):239
-246. 
Schiappaca
sse et al 
(2002) 
Chile 
Prospective 
Cohort 
55-60 
days PP: 
N=220 
LNG 
implant 
(Norplan
t); 
N=222 
Copper 
IUD 
N=442 
cohabitating 
women, ages 
18-35, after 
term delivery 
Infants of 
Norplant users 
had higher 
rates of 
respiratory 
infections, skin 
conditions, and 
eye infections 
than the IUD 
group. No 
differences in 
breastfeeding 
High loss to 
follow-up (14% 
implant, 21% 
IUD). Health 
outcomes could be 
attributable to 
urban pollution at 
study site.  
Schiappacasse 
V, Diaz S, 
Zepeda A, 
Alvarado R, 
Herreros C. 
Health and 
growth of 
infants 
breastfed by 
Norplant 
contraceptive 
implants users: 
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patterns or 
infant growth 
between 
groups. 
a six-year 
follow-up 
study. 
Contraception 
2002 
Jul;66(1):57-
65.  
Seth et al 
(1977) 
India Cohort 
Norethin
drone 
acetate 
implant 
(40 mg): 
N=23 
insertion 
at 6 days 
PP; 
N=12  
insertion 
at 6 
weeks 
PP; 
N=15 
condoms
/gel. 
N=50 healthy, 
20 to 40 year 
old, 
breastfeeding 
women 
56.4% of 
implant group 
were 
supplementing 
at 3 months 
compared to 
40% of 
controls 
(p<0.05) 
Short-term 
reduction in 
milk volume 
observed 2 
weeks after 
insertion for 
early insertion 
group, as well 
as, a reduction 
in 
phosphorous 
content from 2 
to 4 months. 
No difference 
in infant 
weights 
between 
Small study size. 
Follow-up and 
baseline 
characteristics not 
reported. 
Seth U, 
Yadava HS, 
Agarwal N, 
Laumas KR, 
Hingorani V. 
Effect of a 
subdermal 
silastic implant 
containing 
norethindrone 
acetate on 
human 
lactation. 
Contraception 
1977 
Oct;16(4):383-
398.  
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groups. 
Shaaban et 
al.  
(1985) 
Egypt Cohort 
30-42 
days PP: 
N=50 
LNG 
implant 
(Norplan
t); 
N=Copp
er IUD; 
N=50 
non-
hormona
l 
N=150 
breastfeeding 
women 
No difference 
in duration of 
breastfeeding 
or rates of 
supplementatio
n. Infant 
weight and 
height was less 
in the Norplant 
group at 3 
months, but no 
significant 
difference at 6 
months. 
Differences 
between groups at 
baseline and no 
adjustment for 
confounders 
Shaaban MM, 
Salem HT, 
Abdullah KA. 
Influence of 
levonorgestrel 
contraceptive 
implants, 
NORPLANT, 
initiated early 
postpartum 
upon lactation 
and infant 
growth. 
Contraception 
1985 
Dec;32(6):623
-635.  
Shaaban et 
al.  
(1991) 
Egypt Cohort 
5-7 
weeks 
PP: 
N=120 
LNG 
implant 
(Norplan
t); 
N=120 
NET-EN 
Phase I: 
N=360 healthy 
women. Phase 
II: N=186 
women 
Phase I: No 
difference in 
supplementatio
n timing.  IUD 
users ceased 
breastfeeding 
earlier than 
NET-EN 
users. No 
difference in 
Poor reporting of 
baseline 
characteristics, 
follow-up, and 
methods. 
Shaaban MM. 
Contraception 
with 
progestogens 
and 
progesterone 
during 
lactation. J 
Steroid 
Biochem Mol 
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injectabl
e; 
N=120 
IUD 
inserted 
in 2nd 
month 
PP; 
N=103 
PVR; 
N=83 
Copper 
IUD. 
infant 
outcomes.  
Phase II: No 
difference in 
supplementatio
n or infant 
growth 
between 
Vaginal ring 
and IUD users. 
Biol 
1991;40(4-
6):705-710.  
Shikary et 
al 
(1986) 
India Cohort 
4-15 
weeks 
PP: N=9 
POP 
(LNG 30 
µg/day); 
N=10 
LNG 
implant 
(Norplan
t); N=10 
no 
method 
N=29 term 
women age 
20-35 with 
male infants  
No significant 
difference 
between 
groups in 
hormone 
levels present 
in urine from 
male infants 
Short follow-up. 
Small study size. 
Shikary ZK, 
Betrabet SS, 
Toddywala 
WS, Patel DM, 
Datey S, 
Saxena BN. 
Pharmacodyna
mic effects of 
levonorgestrel 
(LNG) 
administered 
either orally or 
supermall to 
early 
postpartum 
lactating 
mothers on the 
urinary levels 
of follicle 
stimulating 
	  	  
292 
hormone 
(FSH), 
luteinizing 
hormone (LH) 
and 
testosterone 
(T) in their 
breast-fed 
male infants. 
Contraception 
1986 
Oct;34(4):403-
412.  
WHO 
(1994) 
Egypt, 
Iran, 
Thailand, 
Kenya, 
Chile, 
Hungary Cohort 
6-8 
weeks 
PP: 
N=475 
POP 
(LNG or 
lynestren
ol); 
N=541 
DMPA; 
N-121 
NET-
EN; 
N=453 
LNG 
implant 
(Norplan
t); 
N=876 
non-
N=2466 
married 
women with 
term 
deliveries. 
No difference 
in frequency 
and duration of 
breastfeeding 
between 
contraceptive 
types at the 
same site, but 
differences 
seen between 
locations.  
Infant growth 
and 
development 
outcomes were 
inconsistent 
between sites. 
Breastfeeding 
outcomes varied 
greatly between 
sites. 
Progestogen-
only 
contraceptives 
during 
lactation: I. 
Infant growth. 
World Health 
Organization 
Task force for 
Epidemiologic
al Research on 
Reproductive 
Health; 
Special 
Programme of 
Research, 
Development 
and Research 
Training in 
Human 
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hormona
l  
Reproduction. 
Contraception 
1994 
Jul;50(1):35-
53.                                                                  
Progestogen-
only 
contraceptives 
during 
lactation: II. 
Infant 
development. 
World Health 
Organization, 
Task Force for 
Epidemiologic
al Research on 
Reproductive 
Health; 
Special 
Programme of 
Research, 
Development, 
and Research 
Training in 
Human 
Reproduction. 
Contraception 
1994 
Jul;50(1):55-
68.  
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Affandi et 
al.  
(1986) 
India 
Prospective 
cohort 
4 -6 
weeks 
PP: 
N=60 
LNG 
implant 
(Norplan
t); N=60 
Copper 
IUD 
N=120 term 
women 
planning to 
breastfeed at 
least 6 months 
who had a 
healthy 
delivery.  Ages 
18-40 years. 
Infants in the 
Norplant 
group gained 
significantly 
more than IUD 
group.  
Differences 
between groups at 
baseline. No 
adjustment for 
confounders.  
Affandi B, 
Karmadibrata 
S, Prihartono 
J, Lubis OF, 
Samil RS. 
Effect of 
Norplant on 
mothers and 
infants in the 
postpartum 
period. Adv 
Contracept 
1986 
Dec;2(4):371-
380.  
Gurtcheff 
et al 
(2011) 
Utah 
Randomize
d controlled 
trial 
Etonoge
strel 
implant 
(Implano
n): N=35 
insertion 
at 1-3 
PP; 
N=34 
insertion 
at 4-8 
weeks 
PP 
N= healthy, 
term women 
who wanted 
Implanon 
implant 
Lactogenesis 
II was not 
statistically 
different 
between the 
early and late 
insertion 
groups, 64.3 
vs. 65.2 hours 
PP.  The 
groups were 
similar in their 
rate of 
lactation 
failure, 3% for 
early vs. 0% 
for standard 
timing of 
Good 
randomization and 
design. 
Gurtcheff SE, 
Turok DK, 
Stoddard G, 
Murphy PA, 
Gibson M, 
Jones KP. 
Lactogenesis 
after early 
postpartum use 
of the 
contraceptive 
implant: a 
randomized 
controlled 
trial. Obstet 
Gynecol 2011 
May;117(5):11
14-1121.  
	  	  
295 
 
 
insertion. 
Supplementati
on timing was 
also similar 
between 
groups.   
Coutinho et 
al 
(1999) 
Brazil 
Prospective 
cohort 
6 weeks 
PP: 
N=66 
elcometr
ine 
implant; 
N=69 
Copper 
IUD 
N=135 
healthy, term 
women, ages 
18-35, 
planning to 
breastfeed for 
at least 6 
months. 
Breastfeeding 
continuation 
rates were 
higher for 
implant than 
IUD group at 3 
(95% vs. 84%) 
and 6 months 
(765 vs. 57%) 
(p<0.05), but 
no differences 
at 9 and 12 
months. No 
differences in 
infant growth 
and 
development 
between 
groups.  
No adjustment for 
confounding.  
Coutinho EM, 
Athayde C, 
Dantas C, 
Hirsch C, 
Barbosa I. Use 
of a single 
implant of 
elcometrine 
(ST-1435), a 
nonorally 
active 
progestin, as a 
long acting 
contraceptive 
for postpartum 
nursing 
women. 
Contraception 
1999 
Feb;59(2):115-
122.  
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Progesterone-only Pill (POP)     
Study 
Year and 
Location 
Study 
Design Exposure Population Results Study problems Reference 
Guiloff et al 
1974 
Chile 
randomiz
ed 
clinical 
trial/ 
case-only 
design 
with 
historical 
controls 
At 30 days PP, 
randomized to 
receive: N=54 
250 mg CMA; 
N=300 µg 
quingestanol 
acetate; N=81 
IUD 
N=696 16 
to40 year-
old, 
multiparou
s women 
Median duration 
of breastfeeding 
for CMA use was 
7.5 months vs. 4.2 
months for 
quingestanol 
acetate, 5.3 
months for 
historical control, 
and 7.7 months 
for Copper IUD. 
Control group was 
the previous births 
from the same 
women. No 
further accounting 
for confounding. 
Guiloff E, 
Ibarra-Polo 
A, Zanartu 
J, 
Toscanini 
C, Mischler 
TW, 
Gomez-
Rogers C. 
Effect of 
contracepti
on on 
lactation. 
Am J 
Obstet 
Gynecol 
1974 Jan 
1;118(1):42
-45.  
Halderman 
and Nelson 
2002 Los 
Angeles, 
CA 
Prospecti
ve cohort 
women self-
selected to 
receive DMPA 
before leaving 
the hospital 
(N=102), 
receive a 
prescription 
for POPs or 
LNG implant 
N=319 
women of 
all ages, 
parity, and 
prior 
breastfeedi
ng 
experience 
Women using 
hormonal 
contraception 
were significantly 
less likely to 
continue 
breastfeeding at 4 
weeks (83.1% for 
non-hormonal, 
76.7% for POCs, 
No adjustment for 
confounding. 
Groups were 
significantly 
different in their 
prior 
breastfeeding 
experience, 
mother's age, and 
mode of delivery. 
Halderman 
LD, Nelson 
AL. Impact 
of early 
postpartum 
administrat
ion of 
progestin-
only 
hormonal 
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(N=77) or use 
condoms or 
abstinence 
(N=138) 
p=.022), but no 
difference was 
found at 2 and 6 
weeks.  
contracepti
ves 
compared 
with 
nonhormon
al 
contracepti
ves on 
short-term 
breast-
feeding 
patterns. 
Am J 
Obstet 
Gynecol 
2002 
Jun;186(6):
1250-6; 
discussion 
1256-8.  
Giner et al 
(1976) 
Mexico RCT 
Initiated within 
14 hours of 
delivery N=12 
received 350 
µg NET; N=8 
received 
placebo 
20 healthy 
women, 
aged 18-36 
No significant 
differences in 
initiation of 
breastfeeding, 
milk volume, or 
infant growth 
between treatment 
and placebo 
groups. 
small sample size, 
methods not 
clearly described 
Giner 
Velazquez 
J, Cortes 
Gallegos 
V, Sotelo 
Lopez A, 
Bondani G. 
Effect of 
daily oral 
administrat
ion of 
0.350 mg 
of 
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norethindro
ne on 
lactation 
and on the 
compositio
n of milk. 
Ginecol 
Obstet Mex 
1976 
Jul;40(237)
:31-39. 
Kamal et al.  
(1970) 
Egypt 
Clinical 
trial 
2 days PP: 
N=10 POP 
(lynestrenol 
500 µg); N=10 
COC (100 µg 
mestranol and 
1 mg 
lynestrenol); 
N=10 EE (100 
µg); N=10 
placebo  
N=40 
women, 
age 20-37 
In 14 day follow-
up, POP group 
initiated lactation 
earlier than 
placebo (3 vs. 5 
days), had higher 
milk volume, and 
infant weight gain 
Short follow-up. 
Not randomized. 
Small study size. 
Kamal I, 
Hefnawi 
OF, 
Ghoneim 
M, 
Abdallah 
M, Abdel 
Razek S. 
Clinical, 
biochemica
l, and 
experiment
al studies 
on 
lactation. 
V. Clinical 
effects of 
steroids on 
the 
initiation of 
lactation. 
Am J 
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Obstet 
Gynecol 
1970 Oct 
15;108(4):6
55-658.  
Bjarnadotti
r et al 
(2001) 
Iceland Cohort 
28-56 days PP: 
N=42 
desogestrel (75 
µg/day); N=41 
Copper IUD 
N=83 
multiparou
s 
breastfeedi
ng women, 
age 18-40. 
Term 
delivery 
and prior 
breastfeedi
ng 
experience. 
By the 7th cycle 
of follow-up, 78% 
of POP and 59% 
of IUD users were 
still breastfeeding. 
No differences in  
composition of 
milk and child 
growth and 
development over 
2.5 year follow-up 
Initiation of 
treatment varied 
over a long period 
of time.  
Bjarnadotti
r RI, 
Gottfredsd
ottir H, 
Sigurdardot
tir K, 
Geirsson 
RT, Dieben 
TO. 
Comparativ
e study of 
the effects 
of a 
progestoge
n-only pill 
containing 
desogestrel 
and an 
intrauterine 
contracepti
ve device 
in lactating 
women. 
BJOG 
2001 
Nov;108(1
1):1174-
1180.  
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Diaz et al.  
(1997) 
Chile 
Cohort 
with 
historical 
controls 
57 days PP: 
N=187 
Progesterone 
Vaginal Ring; 
N=117 POP 
(lystrenol); 
N=120 LNG 
implant 
(Norplant); 
N=122 Copper 
IUD; N=236 
LAM 
N= 
healthy, 
cohabitatin
g, 18-38 
year-olds, 
with 
normal 
delivery  
and 
intending 
the 
breastfeed 
as long as 
possible 
No difference 
between groups in 
mean duration of 
breastfeeding or 
time of weaning Historical control 
Diaz S, 
Zepeda A, 
Maturana 
X, Reyes 
MV, 
Miranda P, 
Casado 
ME, et al.  
Fertility 
regulation 
in nursing 
women. 
IX. 
Contracepti
ve 
performanc
e, duration 
of 
lactation, 
infant 
growth, 
and 
bleeding 
patterns 
during use 
of 
progesteron
e vaginal 
rings, 
progestin-
only pills, 
Norplant 
implants, 
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and Copper 
T 380-A 
intrauterine 
devices. 
Contracepti
on 1997 
Oct;56(4):2
23-232.  
McCann et 
al.  
(1989) 
Argentin
a 
non-
randomiz
ed 
clinical 
trial 
1 week PP: 
N=250 POP 
(LNG 30 
µg/day); 
N=non-
hormonal 
methods 
N=500 
healthy, 
multiparou
s women, 
ages 30-35, 
with prior 
breastfeedi
ng 
experience 
Infant weight gain 
was similar 
between treatment 
and control. POP 
users began 
supplementation 
significantly later 
than controls (5.4 
months vs. 4.6) 
and also ceased 
breastfeeding 
later. 
High loss to 
follow-up (55% at  
months) 
McCann 
MF, 
Moggia 
AV, 
Higgins JE, 
Potts M, 
Becker C. 
The effects 
of a 
progestin-
only oral 
contracepti
ve 
(levonorges
trel 0.03 
mg) on 
breast-
feeding. 
Contracepti
on 1989 
Dec;40(6):
635-648.  
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McEwan et 
al -1977 
Clinical 
trial 
N=22 200 µg 
twice daily; 
N=115 350 
mcg of a novel 
chlormadione 
derivative 
N=137 
women 
including 
43 who 
were 
breastfeedi
ng 
None of the 
breastfeeding 
women reported 
an effect on 
lactation 
Lactation was not 
a primary 
outcome, and was 
only reported 
anecdotally 
McEwan 
JA, Joyce 
DN, Tothill 
AU, 
Hawkins 
DF. Early 
experience 
in 
contracepti
on with a 
new 
progestoge
n. 
Contracepti
on 1977 
Oct;16(4):3
39-350.  
Zanartu et 
al.  
(1976) 
Chile 
non-
randomiz
ed 
clinical 
trial 
Weeks 3 to 10 
PP: N=100 
Chlormadinon
e diacetate (0.6 
mg/day); 
N=173 Copper 
IUD. 
N=273 
healthy 
women, 
ages 19-42 
At 3 months, 
duration of 
breastfeeding was 
98% for POP and 
76% for IUD. At 
6 months it was 
80% and 56%, 
respectively.  At 
12 months it was 
42% and 0%, 
respectively.   
Subjects were 
grouped by 
breastfeeding 
motivation, 
making 
interpretation of 
the results 
difficult. 
Zanartu J, 
Aguilera E, 
Munoz-
Pinto G. 
Maintenanc
e of 
lactation by 
means of 
continuous 
low-dose 
progestoge
n given 
postpartum 
as a 
contracepti
ve. 
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Contracepti
on 1976 
Mar;13(3):
313-318.  
Shikary et 
al 
(1986) 
India Cohort 
4-15 weeks 
PP: N=9 POP 
(LNG 30 
µg/day); N=10 
LNG implant 
(Norplant); 
N=10 no 
method 
N=29 term 
women age 
20-35 with 
male 
infants  
No significant 
difference 
between groups in 
hormone levels 
present in urine 
from male infants 
Short follow-up. 
Small study size. 
Shikary 
ZK, 
Betrabet 
SS, 
Toddywala 
WS, Patel 
DM, Datey 
S, Saxena 
BN. 
Pharmacod
ynamic 
effects of 
levonorgest
rel (LNG) 
administere
d either 
orally or 
subdermall
y to early 
postpartum 
lactating 
mothers on 
the urinary 
levels of 
follicle 
stimulating 
hormone 
(FSH), 
luteinizing 
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hormone 
(LH) and 
testosteron
e (T) in 
their 
breast-fed 
male 
infants. 
Contracepti
on 1986 
Oct;34(4):4
03-412.  
West 
(1983) 
Scotland Cohort 
N=114 
norethisterone 
(.35 mg/day); 
N=89 
unknown or no 
use. 
N=203 
women,  
fully 
breastfeedi
ng at 
discharge 
(84 
breastfeedi
ng) 
Most common 
reason for 
discontinuation of 
method was 
cessation of 
breastfeeding. No 
significant 
differences in 
breastfeeding 
rates at 3 and 6 
months PP. 
self-selection for 
contraceptive use 
 West CP. 
The 
acceptabilit
y of a 
progestage
n-only 
contracepti
ve during 
breast-
feeding. 
Contracepti
on 1983 
Jun;27(6):5
63-569.  
Zacharias 
et al.  
(1986) 
Chile 
Prospecti
ve 
Cohort 
2 to 4 months 
PP: N=143 
LAM; N=109 
IUD; N=228 
DMPA; 
N=185 POP 
(Clogestone 
N=665 
term 
women 
who were 
willing to 
breastfeed 
Median 
breastfeeding 
duration was 17 
months for LAM 
and 19 months for 
IUD, DMPA, and 
POP combined.  
Subjects self-
selected treatment 
and no adjustment 
for confounders. 
Zacharias 
S, Aguilera 
E, Assenzo 
JR, Zanartu 
J. Effects 
of 
hormonal 
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Acetate .6 
mg/day) 
DMPA had the 
highest percentage 
of mothers 
nursing past 20 
months. 
and 
nonhormon
al 
contracepti
ves on 
lactation 
and 
incidence 
of 
pregnancy. 
Contracepti
on 1986 
Mar;33(3):
203-213.  
WHO 
(1994) 
Egypt, 
Iran, 
Thailand, 
Kenya, 
Chile, 
Hungary Cohort 
6-8 weeks PP: 
N=475 POP 
(LNG or 
lynestrenol); 
N=541 
DMPA; N-121 
NET-EN; 
N=453 LNG 
implant 
(Norplant); 
N=876 non-
hormonal  
N=2466 
married 
women 
with term 
deliveries. 
No difference in 
frequency and 
duration of 
breastfeeding 
between 
contraceptive 
types at the same 
site, but 
differences seen 
between locations.  
Infant growth and 
development 
outcomes were 
inconsistent 
between sites. 
Breastfeeding 
outcomes varied 
greatly between 
sites. 
Progestoge
n-only 
contracepti
ves during 
lactation: I. 
Infant 
growth. 
World 
Health 
Organizatio
n Task 
force for 
Epidemiolo
gical 
Research 
on 
Reproducti
ve Health; 
Special 
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Programme 
of 
Research, 
Developme
nt and 
Research 
Training in 
Human 
Reproducti
on. 
Contracepti
on 1994 
Jul;50(1):3
5-53.                                                                  
Progestoge
n-only 
contracepti
ves during 
lactation: 
II. Infant 
developme
nt. World 
Health 
Organizatio
n, Task 
Force for 
Epidemiolo
gical 
Research 
on 
Reproducti
ve Health; 
Special 
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Programme 
of 
Research, 
Developme
nt, and 
Research 
Training in 
Human 
Reproducti
on. 
Contracepti
on 1994 
Jul;50(1):5
5-68.  
WHO 
Hungary 
and 
Thailand RCT 
Treatment 
began at 6 
weeks PP 
N=86 COC 
(30 µg ethinyl 
estradiol and 
150 µg 
levonorgestrel) 
N=85 POP (75 
µg norgestrel) 
N=59 DMPA 
N=111 Non-
hormonal 
(barriers, 
sterilization, 
IUDs) 
N=341 
healthy 
women 
aged 20-35 
who 
wanted oral 
contracepti
ves. Had to 
have 2-5 
previous 
births and 
prior 
successful 
breastfeedi
ng 
experience 
of at least 3 
months 
No differences 
found in 
breastfeeding 
continuation rates, 
mean infant 
weight, length, or 
rate of growth, or 
infant illness were 
found between 
COC and control 
groups, except 
female infants at 
one site were 
smaller in controls 
than COC group. 
Milk from COC 
group was lower 
in calories, and 
had different 
No adjustment for 
confounders. Loss 
to follow-up was 
high in some 
groups. 
Supplementation 
not addressed.  
Method switching 
not addressed. 
WHO. 
Effects of 
hormonal 
contracepti
ves on 
breast milk 
compositio
n and 
infant 
growth. 
World 
Health 
Organizatio
n (WHO) 
Task Force 
on Oral 
Contracepti
ves. Stud 
Fam Plann 
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mineral content, 
an milk volume 
was lower than 
controls. 
1988 Nov-
Dec;19(6 
Pt 1):361-
369.  
WHO 
Hungary 
and 
Thailand 
Prospecti
ve 
Cohort/ 
RCT 
6 weeks PP: 
N=86 COC 
(30 µg EE and 
150 µg LNG 
N=85 POP (75 
µg norgestrel) 
N=59 DMPA 
N=111 Non-
hormonal 
(barriers, 
sterilization, 
IUDs) 
N=341 
healthy 
women 
aged 20-35 
who 
wanted oral 
contracepti
ves. Had to 
have 2-5 
previous 
births and 
prior 
successful 
breastfeedi
ng 
experience 
of at least 3 
months 
No differences in 
breastfeeding 
continuation.  
Milk volume 
decreased over 
time for all 
groups, but COC 
to a greater extent.  
No adjustment for 
confounders. 
Method switching 
not addressed. 
Tankeyoon 
M, Dusitsin 
N, 
Chalapati 
S, 
Koetsawan
g S, 
Saibiang S, 
Sas M, et 
al.  Effects 
of 
hormonal 
contracepti
ves on milk 
volume and 
infant 
growth. 
WHO 
Special 
Programme 
of 
Research, 
Developme
nt and 
Research 
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Training in 
Human 
Reproducti
on Task 
force on 
oral 
contracepti
ves. 
Contracepti
on 1984 
Dec;30(6):
505-522.  
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Vaginal Ring      
Study 
Year and 
Location 
Study 
Design Exposure Population Results 
Study 
problems Reference 
Diaz et al.  
(1997) 
Chile 
Cohort 
with 
historical 
controls 
57 days PP: 
N=187 
Progesterone 
Vaginal Ring; 
N=117 POP 
(lystrenol); 
N=120 LNG 
implant 
(Norplant); 
N=122 
Copper IUD; 
N=236 LAM 
N= healthy, 
cohabitating, 
18-38 year-
olds, with 
normal 
delivery  and 
intending the 
breastfeed as 
long as 
possible 
No difference 
between groups in 
mean duration of 
breastfeeding or 
time of weaning 
Historical 
control 
Diaz S, Zepeda 
A, Maturana X, 
Reyes MV, 
Miranda P, 
Casado ME, et 
al.  Fertility 
regulation in 
nursing 
women. IX. 
Contraceptive 
performance, 
duration of 
lactation, infant 
growth, and 
bleeding 
patterns during 
use of 
progesterone 
vaginal rings, 
progestin-only 
pills, Norplant 
implants, and 
Copper T 380-
A intrauterine 
devices. 
Contraception 
1997 
Oct;56(4):223-
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232.  
Massai et 
al.  
(1999) 
Chile Cohort 
5-9 weeks PP: 
N=285 PVR; 
N=262 
Copper IUD. 
N=547 
cohabitating, 
breastfeeding 
women aged 
18-38, after 
term delivery 
Similar 
breastfeeding 
duration, 257 for 
ring and 240 for 
IUD.  Similar 
infant weight 
gain.  
Large variation 
in time of 
initiation of 
use. Possible 
repeat 
reporting. 
Massai R, 
Miranda P, 
Valdes P, 
Lavin P, 
Zepeda A, 
Casado ME, et 
al.  
Preregistration 
study on the 
safety and 
contraceptive 
efficacy of a 
progesterone-
releasing 
vaginal ring in 
Chilean nursing 
women. 
Contraception 
1999 
Jul;60(1):9-14.  
Massai et 
al 
(2005) 
Chile Cohort 
54-64 days 
PP: N=192 
PVR replaced 
after 4 
months; 
N=220 
cohabitating, 
breastfeeding 
women aged 
18-38, after 
Mean duration of 
breastfeeding was 
287 days for the 
4-month group 
and 257 days for 
comparison 
was made 
between 
different types 
of treatment, 
Massai R, 
Quinteros E, 
Reyes MV, 
Caviedes R, 
Zepeda A, 
	  	  
312 
N=280 PVR 
replaced after 
for 3 months 
term delivery the 3-month 
group. Infant 
weight gain was 
similar between 
groups and in 
comparison to 
untreated women.  
not to a no-
treatment 
control 
Montero JC, et 
al.  Extended 
use of a 
progesterone-
releasing 
vaginal ring in 
nursing 
women: a 
phase II 
clinical trial. 
Contraception 
2005 
Nov;72(5):352-
357.  
Shaaban 
et al.  
(1991) 
Egypt Cohort 
5-7 weeks PP: 
N=120 LNG 
implant 
(Norplant); 
N=120 NET-
EN 
injectable; 
N=120 IUD 
inserted in 
2nd month 
PP; N=103 
PVR; N=83 
Copper IUD. 
Phase I: 
N=360 
healthy 
women. 
Phase II: 
N=186 
women 
Phase I: No 
difference in 
supplementation 
timing.  IUD users 
ceased 
breastfeeding 
earlier than NET-
EN users. No 
difference in 
infant outcomes.  
Phase II: No 
difference in 
supplementation 
or infant growth 
between Vaginal 
ring and IUD 
users. 
Poor reporting 
of baseline 
characteristics, 
follow-up, and 
methods. 
Shaaban MM. 
Contraception 
with 
progestogens 
and 
progesterone 
during 
lactation. J 
Steroid 
Biochem Mol 
Biol 
1991;40(4-
6):705-710.  
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Sivin et al 
(1997) 
Egypt, 
Singapore, 
USA, 
Chile, Sri 
Lanka Cohort 
29-63 days 
PP: N=802 
PVR; N=734 
Copper IUD 
N=1536 
healthy, term 
women age 
18-35.  
IUD users had 
higher 
breastfeeding 
continuation rates 
at 6 months and 1 
year 
Wide variation 
in initiation 
date. Centers 
were different 
at baseline.  
Sivin I, Diaz S, 
Croxatto HB, 
Miranda P, 
Shaaban M, 
Sayed EH, et 
al.  
Contraceptives 
for lactating 
women: a 
comparative 
trial of a 
progesterone-
releasing 
vaginal ring 
and the copper 
T 380A IUD. 
Contraception 
1997 
Apr;55(4):225-
232.  
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Levonorgestrel-releasing IUD (Mirena)   
Study 
Year 
and 
Location 
Study 
Design Exposure 
Populatio
n Results Study problems Reference 
Shaamash 
et al 
2001-
2003 
Assiut, 
Egypt 
Randomi
zed 
controlle
d trial 
N=163 
received 
Mirena 
(LNG-20 
µg IUS) 
N=157 
received 
Copper 
IUD 
(CuT380A 
IUD) 
women in 
their 2nd 
month 
postpartum
, 
exclusively 
breastfeedi
ng and 
planned to 
nurse for at 
least a 
year, 
healthy 
term 
infants 
Claimed no 
significant 
differences between 
Mirena and Copper 
IUD users on 
breastfeeding 
episodes, 
breastfeeding, full 
breastfeeding, partial 
breastfeeding, or 
weaning.  
This population has a 
breastfeeding 
continuation rate at 
1-year of 60-80% 
and is therefore not 
comparable to a US 
population. Across 
all categories, the 
Mirena group had 
lower breastfeeding 
rates than the Copper 
IUD, and more 
episodes of 
breastfeeding at 9 
and 12 months. 
Shaamash 
AH, Sayed 
GH, 
Hussien 
MM, 
Shaaban 
MM. A 
comparativ
e study of 
the 
levonorges
trel-
releasing 
intrauterin
e system 
Mirena 
versus the 
Copper 
T380A 
intrauterin
e device 
during 
lactation: 
breast-
feeding 
performan
ce, infant 
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growth and 
infant 
developme
nt. 
Contracept
ion 2005 
Nov;72(5):
346-351.  
Chen et al.  
2007-08 
Pittsburg
h, PA 
Prospecti
ve, 
randomiz
ed trial 
N= 50 
postplacent
al insertion 
of Mirena     
N=46 
insertion of 
Mirena at 
6-8 weeks 
postpartum 
pregnant 
women 
over 18 
years old 
who were 
interested 
in using 
Mirena 
after birth 
Median 
breastfeeding 
duration was shorter 
for postplacental 
than for delayed 
insertion group (5 vs. 
8.5 weeks). At six 
months, the delayed 
insertion group had a 
statistically 
significant (p=.02) 
difference in their 
continuation rate 
(11/46 vs. 3/50). 
Study groups were 
similar in their social 
and demographic 
factors.  Study may 
have been 
underpowered to see 
differences at earlier 
time-points. 
Comparison group 
allows for evaluation 
of timing of 
insertion, but not the 
effect of hormonal 
IUD use compared to 
no hormonal 
exposure.    
Chen BA, 
Reeves 
MF, 
Creinin 
MD, 
Schwarz 
EB. 
Postplacen
tal or 
delayed 
levonorges
trel 
intrauterin
e device 
insertion 
and breast-
feeding 
duration. 
Contracept
ion 2011 
Nov;84(5):
499-504.  
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Heikkilä 
and 
Luukainen 
1981 
Helsinki, 
Finland 
Prospecti
ve cohort 
N=37 
Nova-T 
copper 
IUD; N=29 
LNG-
releasing 
IUD 10 µg 
/day; N=34 
LNG-
releasing 
IUD 30 µg 
/day 
N=110 
Breastfeedi
ng, 
Amenorrhe
ic women 
at about 6 
weeks 
postpartum 
(range 32-
56 days)  
At 75 days post-
insertion,56% of the 
LNG-30 µg /day 
group continued to 
breastfeed compared 
with 79% for the 
Copper IUD group 
(<.05). These 
differences went 
away at later time 
points.  Initiation of 
supplementary 
feeding occurred  at 
3.9 months on 
average in the 
Copper IUD group, 
and 3.4 months in 
the LNG-30 µg /day 
group.    
Study participants 
self-selected the 
method used. 
Hormone exposure is 
different from that 
available in the US. 
Social context is 
different culturally 
and generationally. 
Methods not clearly  
described. 
Heikkila 
M, 
Luukkaine
n T. 
Duration 
of breast-
feeding 
and 
developme
nt of 
children 
after 
insertion of 
a 
levonorges
trel-
releasing 
intrauterin
e 
contracepti
ve device. 
Contracept
ion 1982 
Mar;25(3):
279-292.  
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Breastfeeding 
Combined 
oral 
contracep
tives   
(<35 µg 
ethinyl 
estradiol) 
Combine
d 
contrace
ptive 
patch 
Combine
d 
contracep
tive 
vaginal 
ring 
Combined 
injectable 
contracepti
ves# 
Progester
one-only 
pills 
Depot 
medroxyproge
sterone acetate 
(DMPA) / 
norethisterone 
enantate 
(NET-EN) 
Levonorges
trel and 
etonogestre
l implants 
<21 days 4 (4) 4 (4) 4 (4) 
Not 
Available 
(4) 2 (3) 2 (3) 2 (3) 
21 to <30 days        
w/o other risk 
factors for VTE 3 (4) 3 (4) 3 (4) 
Not 
Available 
(4) 2 (3) 2 (3) 2 (3) 
with other risk 
factors for VTE 3* (4) 3* (4) 3* (4) 
Not 
Available 
(4) 2 (3) 2 (3) 2 (3) 
30 to 42 days        
w/o other risk 
factors for VTE 2 (4) 2 (4) 2 (4) 
Not 
Available 
(4) 1 (3) 1 (3) 1 (3) 
with other risk 
factors for VTE 3* (4) 1 (4) 1 (4) 
Not 
Available 
(4) 1 (3) 1 (3) 1 (3) 
>=6 weeks to <6 
months postpartum 
(primarily breastfeeding 2 (3) 2 (3) 2 (3) 
Not 
Available 
(3) 1 (1) 1 (1) 1 (1) 
>=6 months 
postpartum 2 (2) 2 (2) 2 (2) 
Not 
Available 
(2) 1 (1) 1 (1) 1 (1) 
postpartum (in non-
breastfeeding women)        
A
PPE
N
D
IX
 5: SU
M
M
A
R
Y
 O
F C
D
C
 A
N
D
 W
H
O
 M
E
D
IC
A
L
 
E
L
IG
IB
IL
IT
Y
 C
R
IT
E
R
IA
 FO
R
 C
O
N
T
R
A
C
E
PT
IV
E
 U
SE 
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<21 days     1 (1) 1 (1) 1 (1) 
w/o other risk 
factors for VTE 4 (3) 4 (3) 4 (3)     
with other risk 
factors for VTE 4 (3/4) 4 (3/4) 4 (3/4) 
Not 
available 
(3/4)    
21-42 days     1 1 1 
w/o other risk 
factors for VTE  2 (2) 2 (2) 2 (2) 
Not 
available (2)    
with other risk 
factors for VTE  3* (2/3) 3* (2/3) 3* (2/3) 
Not 
available 
(2/3)    
>42 days 1 1 1 1 1 1 1 
  
# 1) Cyclofem = medroxyprogesterone acetate 25 mg plus estradiol cypionate 5 mg  2) Mesigyna = norethisterone enantate 50 
mg plus estradiol valerate 5 mg 
*"For women with other risk factors ofr VTE, these risk factors might increase the classification to "4" 
VTE=venous thromboembolism 
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Postpartum 
(breastfeeding and non-
breastfeeding women 
including cesarean 
section) 
Copper
-IUD 
Levonorgest
rel-releasing 
IUD (20 
µg/day)      
US = <10 minutes after 
placenta WHO = <48 
hours including 
insertion  immediately 
after delivery of the 
placenta        
breastfeeding 1 (1) 2(3)      
non-breastfeeding 1 (1) 1 (1)      
10 minutes (or 48 
hours) to 4 weeks 2 (3) 2 (3)      
> 4 weeks 1 (1) 1 (1)      
puerperal sepsis 4 (4) 4 (4)      
        
 
Summary from: 
Jacobson JC, Aikins Murphy P. United States medical eligibility criteria for contraceptive use 2010: a review of changes. J 
Midwifery Womens Health 2011 Nov-Dec;56(6):598-607.  
Centers for Disease Control and Prevention (CDC). U S. Medical Eligibility Criteria for Contraceptive Use, 2010. MMWR 
Recomm Rep 2010 Jun 18;59(RR-4):1-86.  
World Health Organization. Medical eligibility criteria for contraceptive use. 2009.  
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APPENDIX 6: FOREST PLOTS AND AIC AND BIC STATISTICS FOR THE 
MODEL WITH AND WITHOUT THE VARIABLE FOR INCOME 
 
Sample drawn from a survey evaluating the Period of Purple Crying Intervention 
Program, 2010-11. 
 
 
Progestin-only Methods vs. No Method 
 
    
Criterion                    Model1Stats     Model2Stats    LRChiSq    DF     pValue 
Log Likelihood                 -493.2568       -499.9317    13.3498     5    0.020312 
Full Log Likelihood            -493.2568       -499.9317    13.3498     5    0.020312 
AIC (smaller is better)        1058.5137       1061.8635      .         .     . 
AICC (smaller is better)       1060.2606       1063.1602      .         .     . 
BIC (smaller is better)        1251.2477       1227.8289      .         .     . 
 
 
Progestin-only Methods vs. Non-hormonal Methods 
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Criterion                    Model1Stats     Model2Stats    LRChiSq    DF     pValue 
Log Likelihood                 -558.6153       -562.7562    8.28164     5    0.14138 
Full Log Likelihood            -558.6153       -562.7562    8.28164     5    0.14138 
AIC (smaller is better)        1189.2307       1187.5123     .          .     . 
AICC (smaller is better)       1190.7732       1188.6578     .          .     . 
BIC (smaller is better)        1386.3429       1357.2478     .          .     . 
 
 
 
Combined Estrogen/Progestin Methods vs. No Method 
 
 
 
Criterion                    Model1Stats     Model2Stats    LRChiSq    DF     pValue 
Log Likelihood                 -325.0716       -328.6066    7.07001     5    0.21549 
Full Log Likelihood            -325.0716       -328.6066    7.07001     5    0.21549 
AIC (smaller is better)         722.1432        719.2132     .          .     . 
AICC (smaller is better)        724.6541        721.0744     .          .     . 
BIC (smaller is better)         902.1881        874.2519     .          .     . 
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Combined Estrogen/Progestin Methods vs. Non-hormonal Methods 
 
 
Criterion                    Model1Stats     Model2Stats    LRChiSq    DF     pValue 
Log Likelihood                 -365.1640       -366.0708    1.81363     5    0.87428 
Full Log Likelihood            -365.1640       -366.0708    1.81363     5    0.87428 
AIC (smaller is better)         802.3280        794.1416     .          .     . 
AICC (smaller is better)        804.4372        795.7063     .          .     . 
BIC (smaller is better)         988.4523        954.4153     .          .     . 
 
Combined Estrogen/Progestin Methods vs. Progestin-only Methods 
 
 
Criterion                    Model1Stats     Model2Stats    LRChiSq    DF     pValue 
Log Likelihood                 -395.6693       -397.8071    4.27551     5    0.51047 
Full Log Likelihood            -395.6693       -397.8071    4.27551     5    0.51047 
AIC (smaller is better)         863.3387        857.6142     .          .     . 
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AICC (smaller is better)        865.3769        859.1264     .          .     . 
BIC (smaller is better)        1050.6613       1018.9197     .          .     . 
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APPENDIX 7: FOREST PLOTS AND AIC AND BIC STATISTICS FOR THE 
MODEL WITH AND WITHOUT THE VARIABLE FOR REGION   
 
Sample drawn from a survey evaluating the Period of Purple Crying Intervention 
Program, 2010-11. 
 
Progestin-only Methods vs. No Method 
 
 
Criterion                    Model1Stats     Model2Stats    LRChiSq    DF     pValue 
Log Likelihood                 -553.0112       -554.7398    3.45726     2    0.17753 
Full Log Likelihood            -553.0112       -554.7398    3.45726     2    0.17753 
AIC (smaller is better)        1168.0224       1167.4797     .          .     . 
AICC (smaller is better)       1169.1881       1168.4984     .          .     . 
BIC (smaller is better)        1337.2262       1325.8339     .          .     . 
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Progestin-only Methods vs. Non-hormonal Methods 
 
 
Criterion                    Model1Stats     Model2Stats    LRChiSq    DF     pValue 
Log Likelihood                 -625.3078       -628.3413    6.06689     2    0.048149 
Full Log Likelihood            -625.3078       -628.3413    6.06689     2    0.048149 
AIC (smaller is better)        1312.6157       1314.6826     .          .     . 
AICC (smaller is better)       1313.6522       1315.5879     .          .     . 
BIC (smaller is better)        1485.3951       1476.4042     .          .     . 
 
Combined Estrogen/Progestin Methods vs. No Method 
 
 
Criterion                    Model1Stats     Model2Stats    LRChiSq    DF     pValue 
Log Likelihood                 -356.1844       -357.8901    3.41147     2    0.18164 
Full Log Likelihood            -356.1844       -357.8901    3.41147     2    0.18164 
AIC (smaller is better)         774.3688        773.7803     .          .     . 
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AICC (smaller is better)        776.0821        775.2751     .          .     . 
BIC (smaller is better)         931.9018        921.2472     .          .     . 
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Combined Estrogen/Progestin Methods vs. Non-hormonal Methods 
 
 
Criterion                    Model1Stats     Model2Stats    LRChiSq    DF     pValue 
Log Likelihood                 -396.5502       -400.4088    7.71725     2    0.021097 
Full Log Likelihood            -396.5502       -400.4088    7.71725     2    0.021097 
AIC (smaller is better)         855.1003        858.8176     .          .     . 
AICC (smaller is better)        856.5485        860.0803     .          .     . 
BIC (smaller is better)        1017.7156       1011.0654     .          .     . 
 
Combined Estrogen/Progestin Methods vs. Progestin-only Methods 
 
 
Criterion                    Model1Stats     Model2Stats    LRChiSq    DF     pValue 
Log Likelihood                 -436.3239       -440.0432    7.43860     2    0.024251 
Full Log Likelihood            -436.3239       -440.0432    7.43860     2    0.024251 
AIC (smaller is better)         934.6478        938.0864     .          .     . 
AICC (smaller is better)        936.0142        939.2765     .          .     . 
BIC (smaller is better)        1099.0252       1092.0147     .          .     . 
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APPENDIX 8: FOREST PLOTS AND AIC AND BIC STATISTICS FOR THE 
MODEL WITH MATERNAL AGE CODED AS CONTINUOUS OR BINNED 
 
Sample drawn from a survey evaluating the Period of Purple Crying Intervention 
Program, 2010-11. 
 
Progestin-only Methods vs. No Method 
 
Criterion               Model1Stats     Model2Stats 
AIC (smaller is better)        1017.8598       1017.1184 
AICC (smaller is better)       1018.9698       1017.9364 
BIC (smaller is better)        1166.4802       1144.5073 
 
 
Progestin-only Methods vs. Non-hormonal Methods 
 
Criterion               Model1Stats     Model2Stats 
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AIC (smaller is better)        1112.4625       1103.8397 
AICC (smaller is better)       1113.4731       1104.5846 
BIC (smaller is better)        1263.6628       1233.4399 
Combined Estrogen/Progestin Methods vs. No Method 
 
 
Criterion               Model1Stats     Model2Stats 
 
AIC (smaller is better)         647.1861        637.7368 
AICC (smaller is better)        648.8551        638.9650 
BIC (smaller is better)         784.6592        755.5709 
 
 
Combined Estrogen/Progestin Methods vs. Non-hormonal Methods 
 
  
Criterion             Model1Stats     Model2Stats 
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AIC (smaller is better)         683.1848        671.6221 
AICC (smaller is better)        684.6387        672.6926 
BIC (smaller is better)         824.4178        792.6789 
 
 
 
 
Combined Estrogen/Progestin Methods vs. Progestin-only Methods 
 
 
Criterion               Model1Stats     Model2Stats 
 
AIC (smaller is better)         755.5663        749.0037 
AICC (smaller is better)        756.9508        750.0232 
BIC (smaller is better)         898.1351        871.2055 
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APPENDIX 9: COMPARISON OF CODING FOR HOSPITAL PRACTICES 
INDIVIDUALLY OR AS AN INDEX VARIABLE USING AIC AND BIC   
 
Sample drawn from a survey evaluating the Period of Purple Crying Intervention 
Program, 2010-11. 
 
 
Progesterone-Only Methods vs. No Method 
 
Criterion               Model1Stats     Model2Stats 
 
AIC (smaller is better)        1017.1184       1010.4220 
AICC (smaller is better)       1017.9364       1010.9930 
BIC (smaller is better)        1144.5073       1116.5794 
 
 
Progesterone-Only Methods vs. Non-Hormonal Methods 
 
Criterion               Model1Stats     Model2Stats 
 
AIC (smaller is better)        1103.8397       1099.5674 
AICC (smaller is better)       1104.5846       1100.0876 
BIC (smaller is better)        1233.4399       1207.5676 
 
 
Combined Estrogen/Progesterone Methods vs. No Method 
 
Criterion               Model1Stats     Model2Stats 
 
AIC (smaller is better)         637.7368        634.8197 
AICC (smaller is better)        638.9650        635.6760 
BIC (smaller is better)         755.5709        733.0148 
 
 
Combined Estrogen/Progesterone Methods vs. Non-Hormonal Methods 
 
Criterion               Model1Stats     Model2Stats 
 
AIC (smaller is better)         671.6221        672.6603 
AICC (smaller is better)        672.6926        673.4070 
BIC (smaller is better)         792.6789        773.5410 
 
 
 
Combined Estrogen/Progesterone Methods vs. Progesterone-Only Methods 
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Criterion               Model1Stats     Model2Stats 
 
AIC (smaller is better)         749.0037        745.9313 
AICC (smaller is better)        750.0232        746.6425 
BIC (smaller is better)         871.2055        847.7661 
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APPENDIX 10: COMPARISON OF CODING FOR TIMING OF 
BREASTFEEDING INITIATION IN FIVE OR THREE CATEGORIES USING 
AIC AND BIC   
 
Sample drawn from a survey evaluating the Period of Purple Crying Intervention 
Program, 2010-11. 
 
Progesterone-Only Methods vs. No Method 
 
Criterion                 Model1Stats     Model2Stats 
 
AIC (smaller is better)        1010.4220       1007.1690 
AICC (smaller is better)       1010.9930       1007.6334 
BIC (smaller is better)        1116.5794       1102.7107 
 
Progesterone-Only Methods vs. Non-Hormonal Methods 
 
Criterion                 Model1Stats     Model2Stats 
 
AIC (smaller is better)        1099.5674       1098.2950 
AICC (smaller is better)       1100.0876       1098.7180 
BIC (smaller is better)        1207.5676       1195.4952 
 
Combined Estrogen/Progesterone Methods vs. No Method 
 
Criterion                 Model1Stats     Model2Stats 
 
AIC (smaller is better)         634.8197        631.3394 
AICC (smaller is better)        635.6760        632.0352 
BIC (smaller is better)         733.0148        719.7149 
 
Combined Estrogen/Progesterone Methods vs. Non-Hormonal Methods 
 
Criterion                 Model1Stats     Model2Stats 
 
AIC (smaller is better)         672.6603        675.5626 
AICC (smaller is better)        673.4070        676.1695 
BIC (smaller is better)         773.5410        766.3552 
 
Combined Estrogen/Progesterone Methods vs. Progesterone-Only Methods 
 
Criterion                 Model1Stats     Model2Stats 
 
AIC (smaller is better)         745.9313        743.4900 
AICC (smaller is better)        746.6425        744.0682 
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BIC (smaller is better)         847.7661        835.1414 
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APPENDIX 11: CRUDE AND ADJUSTED SURVIVAL CURVES FOR 
PROGESTIN-ONLY METHODS COMPARED TO NON-HORMONAL OR NO 
METHOD OF CONTRACEPTION  
 
From a survey evaluating the Period of Purple Crying intervention program, 2010-11, and 
limited to women who initiated breastfeeding. Adjusted curves are adjusted for maternal 
age, race/ethnicity, maternal education, pregnancy wantedness, parity, baby’s gender, 
NICU stay, intention to breastfeed, timing of initiation, receipt of a formula sample bag, 
and hospital practices through propensity score weights.  
 
 
Crude 
 
 
 
 
 
 
 
 
 
Adjusted 
 
 
 
 
 
 
Crude     
 
 
 
 
 
 
 
 
 
Adjusted 
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APPENDIX 12: CRUDE AND ADJUSTED SURVIVAL CURVES FOR 
COMBINED ESTROGEN/PROGESTIN METHODS COMPARED TO 
PROGESTIN-ONLY METHODS, NON-HORMONAL OR NO METHOD OF 
CONTRACEPTION  
 
From a survey evaluating the Period of Purple Crying intervention program, 2010-11, and 
limited to women who initiated breastfeeding. Adjusted curves are adjusted for maternal 
age, race/ethnicity, maternal education, pregnancy wantedness, parity, baby’s gender, 
NICU stay, intention to breastfeed, timing of initiation, receipt of a formula sample bag, 
and hospital practices through propensity score weights.  
 
Crude     
 
 
 
 
 
 
 
 
 
 
 
Adjusted 
 
 
 
 
 
 
 
 
 
 
 
Crude     
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 Adjusted 
 
 
 
 
 
 
 
 
 
 
 
Crude 
 
 
 
 
 
 
 
 
 
 
 
Adjusted
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APPENDIX 13: SURVEY QUESTIONNAIRE  
 
A_INTRO First, I need to gather some background information. 
 
A01. What is your child’s name? 
INTERVEWER NOTE:  THE FOCUS OF THE SURVEY SHOULD BE A CHILD 
YOUNGER THAN 9 MONTHS OLD, BORN IN NORTH CAROLINA, AND 
CURRENTLY LIVING IN THE HOUSEHOLD.   IF THERE IS MORE THAN ONE 
CHILD THAT MEETS THIS CRITERIA, THE FOCUS SHOULD BE THE 
YOUNGEST. 
OPEN TEXT [50 CHARACTERS / REFUSED] 
 
A02. I’m required to ask, is [BABY NAME] a boy or a girl? 
INTERVIEWER:  NO NEED TO ASK IF YOU ARE ALREADY CERTAIN OF THE 
ANSWER 
1. BOY 
2. GIRL 
8. REFUSED 
 
A03. How many months old is this child?  
INTERVIEWER NOTE:  FOR PARTIAL MONTHS (E.G. 6 WEEKS, 2 ½ MONTHS), 
ASK THE R TO ROUND TO WHICHEVER IS THE CLOSER MONTH (E.G.  1 
MONTH, 3 MONTHS); “Would you say s/he is closer to # month(s) or closer to # 
months?” 
INTERVIEWER NOTE: IT IS OKAY IF THE R REPORTS THAT THE YOUNGEST 
CHILD MEETING THE ABOVE CRITERIA IS OLDER THAN 9 MONTHS, 
CONFIRM CRITERIA, BUT CONTINUE THE SURVEY REGARDLESS OF AGE. 
_____NUMBER OF MONTHS [RANGE 0 TO 99 / REFUSED]  
 
A_INTRO2 We would like to ask you some questions about infant crying and 
educational materials you may have received around the time of pregnancy, delivery, and 
in the first months of your baby’s life. 
 
A10.  In this first section, I am going to read some statements about young babies to 
you, please tell me if you agree or disagree with them. 
Do you agree or disagree with this statement: “Sometimes healthy babies may cry for 5 
or more hours per day”? 
1. AGREE (GOTO A11) 
2. DISAGREE (GOTO A12) 
8. REFUSED (GOTO A20) 
9. DON’T KNOW (GOTO A20) 
 
A11. Would you say that you agree very much or a little? 
1. AGREE VERY MUCH (GOTO A20) 
2. AGREE A LITTLE (GOTO A20) 
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8. REFUSED (GOTO A20) 
9. DON’T KNOW (GOTO A20) 
 
A12. Would you say that you disagree very much or a little? 
1. DISAGREE VERY MUCH (GOTO A20) 
2. DISAGREE A LITTLE (GOTO A20) 
8. REFUSED (GOTO A20) 
9. DON’T KNOW (GOTO A20) 
 
A20. Do you agree or disagree with this statement:  “Babies cry the most between 2 and 3 
months of age”? 
1. AGREE (GOTO A21) 
2. DISAGREE (GOTO A22) 
8. REFUSED (GOTO A30) 
9. DON’T KNOW (GOTO A30) 
 
A21. Would you say that you agree very much or a little? 
1. AGREE VERY MUCH (GOTO A30) 
2. AGREE A LITTLE (GOTO A30) 
8. REFUSED (GOTO A30) 
9. DON’T KNOW (GOTO A30) 
 
A22. Would you say that you disagree very much or a little? 
1. DISAGREE VERY MUCH (GOTO A30) 
2. DISAGREE A LITTLE (GOTO A30) 
8. REFUSED (GOTO A30) 
9. DON’T KNOW (GOTO A30) 
 
A30.  (Do you agree or disagree with the following statement)  How about:  “A good 
parent should always be able to sooth his or her crying baby”? 
1. AGREE (GOTO A31) 
2. DISAGREE (GOTO A32) 
8. REFUSED (GOTO A40) 
9. DON’T KNOW (GOTO A40) 
 
A31. Would you say that you agree very much or a little? 
1. AGREE VERY MUCH (GOTO A40) 
2. AGREE A LITTLE (GOTO A40) 
8. REFUSED (GOTO A40) 
9. DON’T KNOW (GOTO A40) 
 
A32. Would you say that you disagree very much or a little? 
1. DISAGREE VERY MUCH (GOTO A40) 
2. DISAGREE A LITTLE (GOTO A40) 
8. REFUSED (GOTO A40) 
9. DON’T KNOW (GOTO A40) 
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A40.  How about: “Shaking a baby is one way to help a baby stop crying”? 
IF NEEDED:  “By shaking we mean grabbing the baby and moving it back and forth 
strong enough that it could hurt the baby.” 
1. AGREE (GOTO A41) 
2. DISAGREE (GOTO A42) 
8. REFUSED (GOTO A50) 
9. DON’T KNOW (GOTO A50) 
 
A41. Would you say that you agree very much or a little? 
1. AGREE VERY MUCH (GOTO A50) 
2. AGREE A LITTLE (GOTO A50) 
8. REFUSED (GOTO A50) 
9. DON’T KNOW (GOTO A50) 
 
A42. Would you say that you disagree very much or a little? 
1. DISAGREE VERY MUCH (GOTO A50) 
2. DISAGREE A LITTLE (GOTO A50) 
8. REFUSED (GOTO A50) 
9. DON’T KNOW (GOTO A50) 
 
A50.  Have you ever heard of a specific program or campaign called “The Period of 
Purple Crying”? 
0. NO (GOTO B_INTRO) 
1. YES (GOTO A51) 
8. REFUSED (GOTO B_INTRO) 
9. DON’T KNOW (GOTO B_INTRO) 
 
A51. How did you hear about it? (CHECK ALL THAT APPLY) 
INTERVIEWER:  PROBE WITH “Anywhere else?” AS NEEDED 
1. AT THE HOSPITAL (GOTO B_INTRO) 
2. AT A COMMUNITY HEALTH CENTER OR HEALTH DEPARTMENT 
(GOTO B_INTRO) 
3. FROM NURSE VISITING IN MY HOME (GOTO B_INTRO) 
4. FROM THE MEDIA (GOTO B_INTRO) 
5. FROM A DOCTOR’S OFFICE (GOTO B_INTRO) 
6. FROM A FRIEND OR RELATIVE (GOTO B_INTRO) 
7. OTHER (GOTO A52) 
8. REFUSED (GOTO B_INTRO) 
9. DON’T KNOW (GOTO B_INTRO) 
 
A52. SPECIFY OTHER SOURCE 
OPEN TEXT [250 CHARACTERS]  
 
B_INTRO The Period of Purple Crying program is designed to help parents and 
people who care for infants understand the characteristics of normal infant crying, crying 
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which may be associated with shaken baby syndrome.  For these next questions, try to 
think back to the days after [BABY NAME]’s birth. 
 
B10.  Did you learn about The Period of Purple Crying in the hospital or birth center? 
INTERVIEWER NOTE:  THIS IS INTENTIONALLY REDUNDANT.  ASK EVEN IF 
A51 INDICATES HOSPITAL. 
0. NO 
1. YES 
8. REFUSED 
9. DON’T KNOW 
 
B20.  While in the hospital, did a nurse or healthcare provider talk to you about any of the 
following . . . (CHECK ALL THAT APPLY) 
1. that crying is normal?    
2. that shaking a baby is dangerous? 
3. that normal crying peaks at 2-3 months? 
4. about making sure to watch the DVD about normal infant crying at home? 
5. about making sure to read the booklet about normal infant crying at home? 
6. about sharing the information about crying and the dangers of shaking with others 
who will take care of your baby? 
7. NONE OF THE ABOVE 
8. REFUSED 
9. DON’T KNOW 
 
B30. Did you watch a video about normal infant crying while in the hospital or birth 
center after your baby was born? 
0. NO (GOTO B60) 
1. YES (GOTO B40) 
8. REFUSED (GOTO B60) 
9. DON’T KNOW (GOTO B60) 
 
B40. Did any family members or friends watch the video with you in the hospital? 
0. NO (GOTO B60) 
1. YES (GOTO B50) 
8. REFUSED (GOTO B60) 
9. DON’T KNOW (GOTO B60) 
 
B50. Who watched the video with you in the hospital? (CHECK ALL THAT APPLY) 
INTERVIEWER NOTE:  IF R ANSWERS ‘BOYFRIEND’, ENTER ‘BOYFRIEND’.  IF 
R VOLUNTEERS THAT THE BOYFRIEND IS THE FATHER, ENTER ‘FATHER’. 
INTERVIEWER:  PROBE WITH “Anyone else?” AS NEEDED 
1. [BABY NAME]’S FATHER (GOTO B60) 
2. [BABY NAME]’S SISTER/BROTHER (GOTO B60) 
3. [BABY NAME]’S STEPMOTHER (GOTO B60) 
4. [BABY NAME]’S STEPFATHER (GOTO B60) 
5. [BABY NAME]’S GRANDPARENT (GOTO B60) 
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6. [BABY NAME]’S AUNT/UNCLE (GOTO B60) 
7. [BABY NAME] COUSIN (GOTO B60) 
8. FRIEND (GOTO B60) 
9.  ANOTHER FAMILY MEMBER (GOTO B60) 
10. BOYFRIEND/GIRLFRIEND (GOTO B60) 
11. [BABY NAME]’S BABYSITTER (GOTO B60) 
12. OTHER (GOTO B51) 
88. REFUSED (GOTO B60) 
99. DON’T KNOW (GOTO B60) 
 
B51. SPECIFY OTHER 
OPEN TEXT [100 CHARACTERS] 
 
B60.  Did you get your own copy of a video and booklet about normal infant crying 
before leaving the hospital? 
0.  NO (GOTO B65) 
1. YES (GOTO B65) 
8.  REFUSED (GOTO B65) 
9. DON’T KNOW (GOTO B65) 
 
B65.  Do you have any way to watch DVDs at home? 
0.  NO (IF B60=YES, GOTO B70; ELSE GOTO C10) 
1. YES (IF B60=YES, GOTO B70; ELSE GOTO C10) 
8.  REFUSED (IF B60=YES, GOTO B70; ELSE GOTO C10) 
9. DON’T KNOW (IF B60=YES, GOTO B70; ELSE GOTO C10) 
 
B70. Did you watch the video after leaving the hospital or birth center? 
0. NO 
1. YES 
8. REFUSED 
9. DON’T KNOW 
 
B80. Did you look at the booklet after leaving the hospital or birth center? 
IN NOTE:  ENTER ‘NO’ IF R SAYS THEY RECEIVED THE VIDEO ONLY 
0. NO 
1. YES 
8. REFUSED 
9. DON’T KNOW 
 
B90. Did you show the video to anyone after leaving the hospital? 
0. NO (GOTO B110) 
1. YES (GOTO B100) 
8. REFUSED (GOTO B110) 
9. DON’T KNOW (GOTO B110) 
 
B100.  Who did you show the video to? (CHECK ALL THAT APPLY) 
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INTERVIEWER NOTE:  IF R ANSWERS ‘BOYFRIEND’, ENTER ‘BOYFRIEND’.  IF 
R VOLUNTEERS THAT THE BOYFRIEND IS THE FATHER, ENTER ‘FATHER’. 
INTERVIEWER:   PROBE WITH “Anyone else?” AS NEEDED 
1. [BABY NAME]’S FATHER (GOTO B110) 
2. [BABY NAME]’S SISTER/BROTHER (GOTO B110) 
3. [BABY NAME]’S STEPMOTHER (GOTO B110) 
4. [BABY NAME]’S STEPFATHER (GOTO B110) 
5. [BABY NAME]’S GRANDPARENT (GOTO B110) 
6. [BABY NAME]’S AUNT/UNCLE (GOTO B110) 
7. [BABY NAME] COUSIN (GOTO B110) 
8. FRIEND (GOTO B110) 
9.  ANOTHER FAMILY MEMBER (GOTO B110) 
10. BOYFRIEND/GIRLFRIEND (GOTO B110) 
11. [BABY NAME]’S BABYSITTER (GOTO B110) 
12. OTHER (GOTO B101) 
88. REFUSED (GOTO B110) 
99. DON’T KNOW (GOTO B110) 
 
B101. SPECIFY OTHER 
OPEN TEXT [50 CHARACTERS] 
 
B110. Did you show the booklet to anyone after leaving the hospital? 
IN NOTE:  ENTER ‘NO’ IF R SAYS THEY RECEIVED THE VIDEO ONLY 
0. NO (GOTO C10) 
1. YES (GOTO B120) 
8. REFUSED (GOTO C10) 
9. DON’T KNOW (GOTO C10) 
 
B120.  Who did you show the booklet to? (CHECK ALL THAT APPLY) 
INTERVIEWER NOTE:  IF R ANSWERS ‘BOYFRIEND’, ENTER ‘BOYFRIEND’.  IF 
R VOLUNTEERS THAT THE BOYFRIEND IS THE FATHER, ENTER ‘FATHER’. 
INTERVIEWER:   PROBE WITH “Anyone else?” AS NEEDED 
1. [BABY NAME]’S FATHER (GOTO C10) 
2. [BABY NAME]’S SISTER/BROTHER (GOTO C10) 
3. [BABY NAME]’S STEPMOTHER (GOTO C10) 
4. [BABY NAME]’S STEP FATHER (GOTO C10) 
5. [BABY NAME]’S GRANDPARENT (GOTO C10) 
6. [BABY NAME]’S AUNT/UNCLE (GOTO C10) 
7. [BABY NAME]’S COUSIN (GOTO C10) 
8. FRIEND (GOTO C10) 
9.  ANOTHER FAMILY MEMBER (GOTO C10) 
10. BOYFRIEND/GIRLFRIEND (GOTO C10) 
11. [BABY NAME]’S BABYSITTER (GOTO C10) 
12. OTHER (GOTO B121) 
88. REFUSED (GOTO C10) 
99. DON’T KNOW (GOTO C10) 
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B121. SPECIFY OTHER 
OPEN TEXT [50 CHARACTERS] 
 
C10.  During any visit to [BABY NAME]’s doctor’s office or clinic, did anyone in the 
office speak with you about the characteristics of normal infant crying? 
0. NO 
1. YES 
8. REFUSED 
9. DON’T KNOW 
 
C20. Did you receive written information about normal infant crying at your baby’s 
doctor’s office or clinic? 
0. NO (GOTO C30) 
1. YES (GOTO C21) 
8. REFUSED (GOTO C30) 
9. DON’T KNOW (GOTO C30) 
 
C21. What did you do with that information? Did you . . . (CHECK ALL THAT APPLY) 
1. Read it? 
2. Share it with anyone? 
3. Save it? 
4. NONE OF THE ABOVE 
8. REFUSED 
9. DON’T KNOW 
 
C30. Did you see a poster about normal infant crying at [BABY NAME]’s doctor’s office 
or clinic? 
0. NO 
1. YES 
8. REFUSED 
9. DON’T KNOW 
 
C40. In the past 12 months, have you seen any information about normal infant crying in 
. . .  (CHECK ALL THAT APPLY) 
1. a newspaper story? 
2. a newspaper advertisement? 
3. a poster? 
4. a billboard? 
5. on the radio? 
6. on television? 
7. on the internet? 
8. NONE OF THE ABOVE 
88. REFUSED 
99. DON’T KNOW 
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C50.  Have you seen or received information about normal infant crying anywhere else? 
0. NO (GOTO D_INTRO) 
1. YES (GOTO C51) 
8. REFUSED (GOTO D_INTRO OR E_INTRO) 
9. DON’T KNOW (GOTO D_INTRO OR E_INTRO) 
 
C51. Where else have you seen or received this information? (CHECK ALL THAT 
APPLY) 
1. DURING PRENATAL CARE (GOTO D_INTRO OR E_INTRO) 
2. DURING BIRTH EDUCATION (GOTO D_INTRO OR E_INTRO) 
3. FROM A PROFESSIONAL HOME VISITOR LIKE A NURSE OR SOCIAL 
WORKER (GOTO D_INTRO OR E_INTRO) 
4. IN THE EMERGENCY DEPARTMENT (GOTO D_INTRO OR E_INTRO) 
5. AT WIC OR WOMEN, INFANT, AND CHILDREN’S NUTRITION 
PROGRAM (GOTO D_INTRO OR E_INTRO) 
6. AT SOCIAL SERVICES (GOTO D_INTRO OR E_INTRO) 
7. AT DAY CARE (GOTO D_INTRO OR E_INTRO) 
8. FROM FRIENDS OR FAMILY MEMBERS (GOTO D_INTRO OR E_INTRO) 
9. OTHER (GOTO C52) 
88. REFUSED (GOTO D_INTRO OR E_INTRO) 
99. DON’T KNOW (GOTO D_INTRO OR E_INTRO) 
 
C52.  SPECIFY OTHER 
OPEN TEXT [100 CHARACTERS] 
 
IF ANY OF THE FOLLOWING QUESTIONS WERE ANSWERED 1: A50, B10, B30, 
B70, B80, C10, C20, C30 OR B20 RESPONSES 1-6, C40 RESPONSES 1-7, OR C51 
RESPONSES 1-9, ASK THE FOLLOWING QUESTIONS; ELSE, GOTO E_INTRO  
 
D_INTRO Thinking about what you have learned about the characteristics of normal 
infant crying, please tell me if you agree or disagree with the following series of 
statements:  
 
D10. “Learning about normal infant crying helped me to feel less frustrated when my 
baby was crying.” (Do you agree or disagree with this statement?) 
1. AGREE (GOTO D11) 
2. DISAGREE (GOTO D12) 
8. REFUSED (GOTO D20) 
9. DON’T KNOW (GOTO D20) 
 
D11. Would you say that you agree very much or a little? 
1. AGREE VERY MUCH (GOTO D20) 
2. AGREE A LITTLE (GOTO D20) 
8. REFUSED (GOTO D20) 
9. DON’T KNOW (GOTO D20) 
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D12. Would you say that you disagree very much or a little? 
1. DISAGREE VERY MUCH (GOTO D20) 
2. DISAGREE A LITTLE (GOTO D20) 
8. REFUSED (GOTO D20) 
9. DON’T KNOW (GOTO D20) 
 
D20. “Learning about normal infant crying helped me to understand that my otherwise 
healthy baby’s crying can be very normal even if it goes on for hours.” (Do you agree or 
disagree with this statement?) 
1. AGREE (GOTO D21) 
2. DISAGREE (GOTO D22) 
8. REFUSED (GOTO D30) 
9. DON’T KNOW (GOTO D30) 
 
D21. Would you say that you agree very much or a little? 
1. AGREE VERY MUCH (GOTO D30) 
2. AGREE A LITTLE (GOTO D30) 
8. REFUSED (GOTO D30) 
9. DON’T KNOW (GOTO D30) 
 
D22. Would you say that you disagree very much or a little? 
1. DISAGREE VERY MUCH (GOTO D30) 
2. DISAGREE A LITTLE (GOTO D30) 
8. REFUSED (GOTO D30) 
9. DON’T KNOW (GOTO D30) 
 
D30. “Learning about normal infant crying made me less stressed when my baby was 
crying.”  (Do you agree or disagree with this statement?) 
1. AGREE (GOTO D31) 
2. DISAGREE (GOTO D32) 
8. REFUSED (GOTO D40) 
9. DON’T KNOW (GOTO D40) 
 
D31. Would you say that you agree very much or a little? 
1. AGREE VERY MUCH (GOTO D40) 
2. AGREE A LITTLE (GOTO D40) 
8. REFUSED (GOTO D40) 
9. DON’T KNOW (GOTO D40) 
 
D32. Would you say that you disagree very much or a little? 
1. DISAGREE VERY MUCH (GOTO D40) 
2. DISAGREE A LITTLE (GOTO D40) 
8. REFUSED (GOTO D40) 
9. DON’T KNOW (GOTO D40) 
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D40. “The information about the characteristics of normal infant crying was new to me 
when my baby was born.” (Do you agree or disagree with this statement?) 
1. AGREE (GOTO D41) 
2. DISAGREE (GOTO D42) 
8. REFUSED (GOTO D70) 
9. DON’T KNOW (GOTO D70) 
 
D41. Would you say that you agree very much or a little? 
1. AGREE VERY MUCH (GOTO D70) 
2. AGREE A LITTLE (GOTO D70) 
8. REFUSED (GOTO D70) 
9. DON’T KNOW (GOTO D70) 
 
D42. Would you say that you disagree very much or a little? 
1. DISAGREE VERY MUCH (GOTO D70) 
2. DISAGREE A LITTLE (GOTO D70) 
8. REFUSED (GOTO D70) 
9. DON’T KNOW (GOTO D70) 
 
D70. “Learning about normal infant crying made me more likely to leave my infant alone 
in a safe place when I was frustrated with the crying.” (Do you agree or disagree with this 
statement?) 
1. AGREE (GOTO D71) 
2. DISAGREE (GOTO D72) 
8. REFUSED (GOTO D50 OR E_INTRO) 
9. DON’T KNOW (GOTO D50 OR E_INTRO) 
 
D71. Would you say that you agree very much or a little? 
1. AGREE VERY MUCH (GOTO D50 OR E_INTRO) 
2. AGREE A LITTLE (GOTO D50 OR E_INTRO) 
8. REFUSED (GOTO D50 OR E_INTRO) 
9. DON’T KNOW (GOTO D50 OR E_INTRO) 
 
D72. Would you say that you disagree very much or a little? 
1. DISAGREE VERY MUCH (GOTO D50 OR E_INTRO) 
2. DISAGREE A LITTLE (GOTO D50 OR E_INTRO) 
8. REFUSED (GOTO D50 OR E_INTRO) 
9. DON’T KNOW (GOTO D50 OR E_INTRO) 
 
ASK D50 AND D60 ONLY IF B20 OPTIONS 4 AND/OR 5 ARE CHECKED OR 
B30=1 OR B60=1; ELSE, GOTO E_INTRO  
 
D50. “It is important for me to be able to use my own copy of the DVD and booklet at 
home.”    (Do you agree or disagree with this statement?) 
1. AGREE (GOTO D51) 
2. DISAGREE (GOTO D52) 
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8. REFUSED (GOTO D60) 
9. DON’T KNOW (GOTO D60) 
 
D51. Would you say that you agree very much or a little? 
1. AGREE VERY MUCH (GOTO D60) 
2. AGREE A LITTLE (GOTO D60) 
8. REFUSED (GOTO D60) 
9. DON’T KNOW (GOTO D60) 
 
D52. Would you say that you disagree very much or a little? 
1. DISAGREE VERY MUCH (GOTO D60) 
2. DISAGREE A LITTLE (GOTO D60) 
8. REFUSED (GOTO D60) 
9. DON’T KNOW (GOTO D60) 
 
D60.   “It is important for me to have my own copy of the DVD and booklet at home to 
share with my baby’s other caregivers.”  (Do you agree or disagree with this statement?) 
1. AGREE (GOTO D61) 
2. DISAGREE (GOTO D62) 
8. REFUSED (GOTO E_INTRO) 
9. DON’T KNOW (GOTO E_INTRO) 
 
D61. Would you say that you agree very much or a little? 
1. AGREE VERY MUCH (GOTO E_INTRO) 
2. AGREE A LITTLE (GOTO E_INTRO) 
8. REFUSED (GOTO E_INTRO) 
9. DON’T KNOW (GOTO E_INTRO) 
 
D62. Would you say that you disagree very much or a little? 
1. DISAGREE VERY MUCH (GOTO E_INTRO) 
2. DISAGREE A LITTLE (GOTO E_INTRO) 
8. REFUSED (GOTO E_INTRO) 
9. DON’T KNOW (GOTO E_INTRO) 
 
E_INTRO  I am now going to ask you a few questions about understanding and 
feeding your infant, and about birth control.   
 
E10.  How do you know when [BABY NAME] is too stimulated or overwhelmed?  Does 
[he/she/he or she] . . . (CHOOSE ALL THAT APPLY) 
1. turn [his/her/his or her] head away? (GOTO E20) 
2. cry? (GOTO E20) 
3. become red or flushed? (GOTO E20) 
4. go to sleep? (GOTO E20) 
5. or something else? (GOTO E11) 
8 REFUSED (GOTO E20) 
9 DON’T KNOW (GOTO E20) 
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E11.  SPECIFY OTHER  
OPEN TEXT [150 CHARACTERS] 
 
E20.  Before [BABY NAME] was born, did you intend to breastfeed? 
0. NO (GOTO E22) 
1. YES (GOTO E21) 
8. REFUSED (GOTO E22) 
9. DON’T KNOW (GOTO E22) 
 
E21.  How long did you intend to breastfeed [BABY NAME]?  
ENTER NUMBER OF WEEKS (IF ANSWER GIVEN IN MONTHS, MULTIPLY BY 
4) 
ENTER 0 FOR LESS THAN ONE WEEK 
_____WEEKS [RANGE 0 TO 300 / REFUSED / DON’T KNOW]  
 
E22.  Did you ever breast feed [BABY NAME]? 
0. NO (GOTO E30) 
1. YES (GOTO E23) 
8. REFUSED (GOTO E30) 
9. DON’T KNOW (GOTO E30) 
 
E23. When [BABY NAME] was born, how many hours was it until the first 
breastfeeding?  
1. <1 HOUR  
2.  1-2 HOURS  
3. >2-6 HOURS  
4. >6-24 HOURS  
5. >24 HOURS 
8. REFUSED 
9. DON’T KNOW 
 
E24.  Are you still breastfeeding [BABY NAME]? 
0. NO (GOTO E25) 
1. YES (GOTO E26) 
8. REFUSED (GOTO E25) 
9. DON’T KNOW (GOTO E25) 
 
E25. How long did you breastfeed [BABY NAME]? 
ENTER NUMBER OF WEEKS 
_____WEEKS [RANGE 0 TO 396 / REFUSED / DON’T KNOW] (GOTO E30)  
{HARD CHECK IF > A03 x 4} 
 
E26.  Is [BABY NAME] being fed other foods, formula or liquids other than breast milk 
more than once or twice a week? 
0. NO (GOTO E30) 
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1. YES (GOTO E27) 
8. REFUSED (GOTO E30) 
9. DON’T KNOW (GOTO E30) 
 
E27. At what age was [BABY NAME] first fed other foods, formula or liquids other than 
breast milk more than once or twice a week?  
ENTER AGE IN WEEKS 
______WEEKS OF AGE WHEN OTHER FOODS ADDED WITH SOME 
REGULARITY [RANGE 0 TO 396 / REFUSED / DON’T KNOW]  
{HARD CHECK IF > A03 x 4} 
 
E30.  When [BABY NAME] was born . . . (CHECK ALL THAT APPLY) 
IF NEEDED FOR OPTION 2-4: “All new mothers are supposed to be visited and 
supported by lactation consultants regardless of whether or not they intend to breastfeed, 
so we’re asking everyone these questions.” 
1. was [he/she/he or she] placed immediately on your skin? 
2. did a lactation consultant or breastfeeding specialist visit you and help you breast 
feed? 
3. did a lactation consultant or breastfeeding specialist observe you feeding [BABY 
NAME]?  
4. did you feel supported by all hospital staff in your decision regarding 
breastfeeding? 
5. was [BABY NAME] with you at least 22 hours of each 24 hour day? 
6. did you receive a bag with formula samples when you left the hospital? 
7. NONE OF THE ABOVE 
8. REFUSED 
9. DON’T KNOW 
 
E40.  Before leaving the hospital, did someone teach you how to care for [BABY 
NAME]’s umbilical cord? 
0. NO  
1. YES 
8. REFUSED 
9. DON’T KNOW 
 
E50.  Before leaving the hospital, did someone talk to you about safe infant sleep? 
'SAFE INFANT SLEEP' = 'on back, no comforters, pillows, or stuffed animals' 
0. NO  
1. YES 
8. REFUSED 
9. DON’T KNOW 
 
E60.  Did [BABY NAME] spend any time in the neonatal intensive care unit or “NICU” 
before being discharged from the hospital? 
INTERVIEWER NOTE:  NICU IS PRONOUNCE “NICK-YOU” 
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IF R IS UNSURE WHAT THE NICU IS, ASK: “Did [BABY NAME] ever have to leave 
the maternity ward to be taken someplace for sick or fragile babies?” 
0. NO  
1. YES 
8. REFUSED 
9. DON’T KNOW 
 
E70.  Would you say your pregnancy with [BABY NAME] . . .  
1. was wanted and occurred at about the time you planned,  
2. was wanted, but not at this time,  
3. was wanted, because all pregnancies are wanted, or  
4. was not wanted?  
8. REFUSED 
9. DON’T KNOW 
 
E80. Which of the following birth control method or methods have you used since 
[BABY NAME] was born? (CHOOSE ALL THAT APPLY) 
INTERVIEWER NOTE: IF R SAYS "YES" TO #1, YOU DO NOT NEED TO READ 
REMAINING OPTIONS, OTHERWISE READ ALL 
IF R IS UNSURE OF IUD TYPE, CHOOSE ‘OTHER’ AND WRITE ‘UNKNOWN 
IUD’ 
1. No form of birth control (GOTO E90)  
2. Contraceptive shot, also called Depo-Provera (GOTO E90) 
3. Combined pill, also known as the regular pill (GOTO E90)  
4. Mini-pill, also known as the progesterone-only pill (GOTO E90) 
5. IUD with hormones or Mirena, also known as the 5-year IUD (PRONOUNCED 
MER-AYNA)(GOTO E90) 
6. IUD with Copper, also known as the 10-year IUD (GOTO E90) 
7. Condoms (GOTO E90) 
8. OTHER (SPECIFY) (GOTO E81) 
88. REFUSED (GOTO E90) 
99. DON’T KNOW (GOTO E90) 
 
E81. SPECIFY OTHER 
OPEN TEXT [100 CHARACTERS] 
 
E90. Do you have any biological children older than [BABY NAME]? 
INTERVIEWER:  WE ARE NOT INTERESTED IN FOCUS CHILD’S TWIN. 
0. NO (GOTO F_INTRO) 
1. YES (GOTO E91) 
8. REFUSED (GOTO F_INTRO) 
9. DON’T KNOW (GOTO F_INTRO) 
 
E91. How old, in months or years and months is the next oldest biological child? 
ENTER YEARS 
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INTERVIEWER:  WE ARE NOT INTERESTED IN FOCUS CHILD’S TWIN.  IF R ‘S 
ANSWER INDICATES A TWIN/MULTIPLE, GO BACK AND RE-ASK/ENTER E90 
______YEARS [RANGE 0 TO 25 / REFUSED / DON’T KNOW] 
 
E92. HOW OLD, IN MONTHS OR YEARS AND MONTHS IS THE NEXT OLDEST 
BIOLOGICAL CHILD?  
ENTER MONTHS 
______MONTHS [RANGE 0 TO 11 / REFUSED / DON’T KNOW] 
 
F_INTRO We’re almost done.  I just have a few final questions that will help us 
understand what the results mean for our state. 
 
F01.   How old are you? 
______YEARS [RANGE 12 TO 65 / REFUSED] 
 
F10. Is your total family household income, before taxes, under or over $40,000? 
1. UNDER $40,000 (GOTO F15) 
2. OVER $40,000 (GOTO F20) 
3. EXACTLY $40,000 (GOTO F40) 
8. REFUSED (GOTO F40) 
9. DON’T KNOW (GOTO F40) 
 
F15. Is your total annual family income under $20,000? 
0. NO (GOTO F40) 
1. YES (GOTO F40) 
8. REFUSED (GOTO F40) 
9. DON’T KNOW (GOTO F40) 
 
F20. Is your total annual family income over $60,000? 
0. NO (GOTO F40) 
1. YES (GOTO F25) 
8. REFUSED (GOTO F40) 
9. DON’T KNOW (GOTO F40) 
 
F25. Is your total annual family income over $80,000? 
0. NO (GOTO F40) 
1. YES (GOTO F30) 
8. REFUSED (GOTO F40) 
9. DON’T KNOW (GOTO F40) 
 
F30. Is your total annual family income over $100,000? 
0. NO 
1. YES 
8. REFUSED 
9. DON’T KNOW 
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F40. Are you Hispanic or Latino? 
0. NO 
1. YES 
8. REFUSED 
9. DON’T KNOW 
 
F50. Which one or more of the following would you say is your race? 
1. White (GOTO F60) 
2. Black or African American (GOTO F60) 
3. Asian (GOTO F60) 
4. Native Hawaiian or Pacific Islander (GOTO F60) 
5. American Indian or Alaska Native (GOTO F60) 
6. OTHER (SPECIFY) (GOTO F51) 
8. REFUSED (GOTO F52) 
9. DON’T KNOW (GOTO F52) 
 
F51.  SPECIFY OTHER RACE 
OPEN TEXT [50 CHARACTERS] 
 
IF MORE THAN ONE (1-5) OPTION OR ‘OTHER’, ‘REFUSED’, OR ‘DON’T 
KNOW’ CHOSEN IN F50, ASK: 
F52. Would you consider yourself white or non-white? 
1. WHITE 
2. NON-WHITE 
 
F60. What is the highest level of school you’ve completed so far?   
INTERVIEWER: ONLY RECORD COMPLETED DEGREES 
1. BELOW HIGH SCHOOL 
2. HIGH SCHOOL GRADUATE OR GED 
3. COLLEGE DEGREE (ASSOCIATES OR BACHELORS) 
4. GRADUATE DEGREE 
8. REFUSED 
9. DON’T KNOW 
 
F70.  What county was [BABY NAME] born in? 
DROP-DOWN MENU OF 100 NC COUNTIES 
REFUSED 
DON’T KNOW 
 
F80. What hospital or birth center was [BABY NAME] born in? 
DROP-DOWN MENU OF 133 NC HOSPITALS AND BIRTH CENTERS 
REFUSED 
DON’T KNOW 
 
F81.    SPECIFY OTHER HOSPITAL 
OPEN TEXT [50 CHARACTERS] 
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F90. Does your household have more than one phone number? 
0. NO (GOTO END_SUR) 
1. YES (GOTO F91) 
8. REFUSED (GOTO END_SUR) 
9. DON’T KNOW (GOTO END_SUR) 
 
F91. What are these numbers used for? (CHECK ALL THAT APPLY) 
1. CELL PHONE (GOTO END_SUR) 
2. DEDICATED FAX LINE (GOTO END_SUR) 
3. DEDICATED COMPUTER LINE (GOTO END_SUR) 
4. DEDICATED BUSINESS LINE (GOTO END_SUR) 
5. ADDITIONAL HOUSEHOLD NUMBER(S) (GOTO F92) 
8. REFUSED (GOTO END_SUR) 
9. DON’T KNOW (GOTO END_SUR) 
 
F92. You said your household has phone numbers that are not for cell phones or 
computer, fax, or business lines.  How many of these additional numbers do you have? 
______HOUSEHOLD NUMBERS [RANGE 1 TO 7 / REFUSED / DON’T KNOW] 
(IF 1-7, GOTO F92_CHK; IF REFUSED/DON’T KNOW, GOTO END_SUR) 
 
F92_CHK So, you have [F92 + 1] phone lines reaching your household, including 
this one, that are not for cell phones or computer, fax, or business lines? 
 
END_SUR That’s the end of our survey.  Thank you so much for taking the time to 
answer our questions.  Good bye. 
 
 
 
 
	  355 	  
REFERENCES 
 
(1) The optimal duration of exclusive breastfeeding. J Adv Nurs 2001 Aug;35(3):313-
315. 
 
(2) Gartner LM, Morton J, Lawrence RA, Naylor AJ, O'Hare D, Schanler RJ, et al. 
Breastfeeding and the use of human milk. Pediatrics 2005 Feb;115(2):496-506. 
 
(3) Ip S, Chung M, Raman G, Chew P, Magula N, DeVine D, et al. Breastfeeding and 
maternal and infant health outcomes in developed countries. Evid Rep Technol Assess 
(Full Rep) 2007 Apr;(153)(153):1-186. 
 
(4) Department of Health and Human Services. Healthy People 2010. 2000;DHHS # 01-
50213. 
 
(5) CDC. Breastfeeding Report Card - United States 2012. 
 
(6) Department of Health and Human Services. Healthy People 2020. Friday, October 05, 
2012; Available at: http://healthypeople.gov/2020/default.aspx. Accessed 10/10, 2012. 
 
(7) Blaymore Bier JA, Oliver T, Ferguson A, Vohr BR. Human milk reduces outpatient 
upper respiratory symptoms in premature infants during their first year of life. J Perinatol 
2002 Jul-Aug;22(5):354-359. 
 
(8) Dewey KG, Heinig MJ, Nommsen-Rivers LA. Differences in morbidity between 
breast-fed and formula-fed infants. J Pediatr 1995 May;126(5 Pt 1):696-702. 
 
(9) Duncan B, Ey J, Holberg CJ, Wright AL, Martinez FD, Taussig LM. Exclusive 
breast-feeding for at least 4 months protects against otitis media. Pediatrics 1993 
May;91(5):867-872. 
 
(10) Heinig MJ. Host defense benefits of breastfeeding for the infant. Effect of 
breastfeeding duration and exclusivity. Pediatr Clin North Am 2001 Feb;48(1):105-23, 
ix. 
 
(11) Istre GR, Conner JS, Broome CV, Hightower A, Hopkins RS. Risk factors for 
primary invasive Haemophilus influenzae disease: increased risk from day care 
attendance and school-aged household members. J Pediatr 1985 Feb;106(2):190-195. 
 
(12) Lucas A, Cole TJ. Breast milk and neonatal necrotising enterocolitis. Lancet 1990 
Dec 22-29;336(8730):1519-1523. 
 
(13) Marild S, Hansson S, Jodal U, Oden A, Svedberg K. Protective effect of 
breastfeeding against urinary tract infection. Acta Paediatr 2004 Feb;93(2):164-168. 
 
	  356 	  
(14) Bener A, Denic S, Galadari S. Longer breast-feeding and protection against 
childhood leukaemia and lymphomas. Eur J Cancer 2001 Jan;37(2):234-238. 
 
(15) Davis MK. Review of the evidence for an association between infant feeding and 
childhood cancer. Int J Cancer Suppl 1998;11:29-33. 
 
(16) Horne RS, Parslow PM, Ferens D, Watts AM, Adamson TM. Comparison of evoked 
arousability in breast and formula fed infants. Arch Dis Child 2004 Jan;89(1):22-25. 
 
(17) Kostraba JN, Cruickshanks KJ, Lawler-Heavner J, Jobim LF, Rewers MJ, Gay EC, 
et al. Early exposure to cow's milk and solid foods in infancy, genetic predisposition, and 
risk of IDDM. Diabetes 1993 Feb;42(2):288-295. 
 
(18) McVea KL, Turner PD, Peppler DK. The role of breastfeeding in sudden infant 
death syndrome. J Hum Lact 2000 Feb;16(1):13-20. 
 
(19) Pettitt DJ, Forman MR, Hanson RL, Knowler WC, Bennett PH. Breastfeeding and 
incidence of non-insulin-dependent diabetes mellitus in Pima Indians. Lancet 1997 Jul 
19;350(9072):166-168. 
 
(20) Scragg LK, Mitchell EA, Tonkin SL, Hassall IB. Evaluation of the cot death 
prevention programme in South Auckland. N Z Med J 1993 Jan 27;106(948):8-10. 
 
(21) Gdalevich M, Mimouni D, Mimouni M. Breast-feeding and the risk of bronchial 
asthma in childhood: a systematic review with meta-analysis of prospective studies. J 
Pediatr 2001 Aug;139(2):261-266. 
 
(22) Oddy WH, Peat JK, de Klerk NH. Maternal asthma, infant feeding, and the risk of 
asthma in childhood. J Allergy Clin Immunol 2002 Jul;110(1):65-67. 
 
(23) Armstrong J, Reilly JJ, Child Health Information Team. Breastfeeding and lowering 
the risk of childhood obesity. Lancet 2002 Jun 8;359(9322):2003-2004. 
 
(24) Arenz S, Ruckerl R, Koletzko B, von Kries R. Breast-feeding and childhood obesity-
-a systematic review. Int J Obes Relat Metab Disord 2004 Oct;28(10):1247-1256. 
 
(25) Jacobson SW, Chiodo LM, Jacobson JL. Breastfeeding effects on intelligence 
quotient in 4- and 11-year-old children. Pediatrics 1999 May;103(5):e71. 
 
(26) Mortensen EL, Michaelsen KF, Sanders SA, Reinisch JM. The association between 
duration of breastfeeding and adult intelligence. JAMA 2002 May 8;287(18):2365-2371. 
 
(27) Horwood LJ, Fergusson DM. Breastfeeding and later cognitive and academic 
outcomes. Pediatrics 1998 Jan;101(1):E9. 
 
	  357 	  
(28) Labbok MH. Effects of breastfeeding on the mother. Pediatr Clin North Am 2001 
Feb;48(1):143-158. 
 
(29) Cumming RG, Klineberg RJ. Breastfeeding and other reproductive factors and the 
risk of hip fractures in elderly women. Int J Epidemiol 1993 Aug;22(4):684-691. 
 
(30) Enger SM, Ross RK, Paganini-Hill A, Bernstein L. Breastfeeding experience and 
breast cancer risk among postmenopausal women. Cancer Epidemiol Biomarkers Prev 
1998 May;7(5):365-369. 
 
(31) Lopez JM, Gonzalez G, Reyes V, Campino C, Diaz S. Bone turnover and density in 
healthy women during breastfeeding and after weaning. Osteoporos Int 1996;6(2):153-
159. 
 
(32) Newcomb PA, Storer BE, Longnecker MP, Mittendorf R, Greenberg ER, Clapp RW, 
et al. Lactation and a reduced risk of premenopausal breast cancer. N Engl J Med 1994 
Jan 13;330(2):81-87. 
 
(33) Rosenblatt KA, Thomas DB. Lactation and the risk of epithelial ovarian cancer. The 
WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Int J Epidemiol 1993 
Apr;22(2):192-197. 
 
(34) Ball TM, Wright AL. Health care costs of formula-feeding in the first year of life. 
Pediatrics 1999 Apr;103(4 Pt 2):870-876. 
 
(35) Bartick M, Reinhold A. The burden of suboptimal breastfeeding in the United 
States: a pediatric cost analysis. Pediatrics 2010 May;125(5):e1048-56. 
 
(36) Gillespie D, Maguire ES, Neuse M, Sinding SW, Speidel JJ. International family-
planning budgets in the "new US" era. Lancet 2009 May 2;373(9674):1505-1507. 
 
(37) Speidel JJ, Sinding S, Gillespie D, Maguire E, Neuse M. Making the Case for US 
International family planning assistance. Available at: 
http://www.jhsph.edu/research/centers-and-institutes/bill-and-melinda-gates-institute-for-
population-and-reproductive-health/policy_practice/publications/index.html. Accessed 
10/10, 2012. 
 
(38) CDC. From the Centers for Disease Control and Prevention. Achievements in public 
health, 1900-1999: family planning. JAMA 2000 Jan 19;283(3):326-7, 331. 
 
(39) Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United 
States, 1994 and 2001. Perspect Sex Reprod Health 2006 Jun;38(2):90-96. 
 
(40) Mosher WD, Jones J. Use of contraception in the United States: 1982-2008. Vital 
Health Stat 23 2010 Aug;(29)(29):1-44. 
 
	  358 	  
(41) Trussell J, Henry N, Hassan F, Prezioso A, Law A, Filonenko A. Burden of 
unintended pregnancy in the United States: potential savings with increased use of long-
acting reversible contraception. Contraception 2012 Sep 6. 
 
(42) Truitt ST, Fraser AB, Grimes DA, Gallo MF, Schulz KF. Combined hormonal 
versus nonhormonal versus progestin-only contraception in lactation. Cochrane Database 
Syst Rev 2003;(2)(2):CD003988. 
 
(43) Conde-Agudelo A, Belizan JM. Maternal morbidity and mortality associated with 
interpregnancy interval: cross sectional study. BMJ 2000 Nov 18;321(7271):1255-1259. 
 
(44) Shipp TD, Zelop CM, Repke JT, Cohen A, Lieberman E. Interdelivery interval and 
risk of symptomatic uterine rupture. Obstet Gynecol 2001 Feb;97(2):175-177. 
 
(45) Hight-Laukaran V, Labbok MH, Peterson AE, Fletcher V, von Hertzen H, Van Look 
PF. Multicenter study of the Lactational Amenorrhea Method (LAM): II. Acceptability, 
utility, and policy implications. Contraception 1997 Jun;55(6):337-346. 
 
(46) Labbok MH, Hight-Laukaran V, Peterson AE, Fletcher V, von Hertzen H, Van Look 
PF. Multicenter study of the Lactational Amenorrhea Method (LAM): I. Efficacy, 
duration, and implications for clinical application. Contraception 1997 Jun;55(6):327-
336. 
 
(47) Kennedy KI, Visness CM. Contraceptive efficacy of lactational amenorrhoea. 
Lancet 1992 Jan 25;339(8787):227-230. 
 
(48) Hale TW, Hartmann P editors. Textbook of Human Lactation. First ed. Amarillo, 
Texas: Hale Publishing; 2007. 
 
(49) Riordan J, Wambach K. Breastfeeding and Human Lactation. Fourth ed. Sudbury, 
MA: Jones and Bartlett Publishers, LLC; 2010. 
 
(50) Lawrence RA, Lawrence RM. Breastfeeding: A Guide for the Medical Professional. 
Sixth ed. Philadelphia, PA: Elsevier Mosby; 2005. 
 
(51) Czank C, Henderson J, Kent J, Lai C, Hartmann P. Hormonal Control of the 
Lactation Cycle. In: Hale T, Hartmann P, editors. Textbook of Human Lactation. First 
ed.: Hale Publishing, L.P.; 2007. p. 89. 
 
 
(52) Cregan MD, Hartmann PE. Computerized breast measurement from conception to 
weaning: clinical implications. J Hum Lact 1999 Jun;15(2):89-96. 
 
(53) Cox DB, Kent JC, Casey TM, Owens RA, Hartmann PE. Breast growth and the 
urinary excretion of lactose during human pregnancy and early lactation: endocrine 
relationships. Exp Physiol 1999 Mar;84(2):421-434. 
	  359 	  
 
(54) Tyson JE, Hwang P, Guyda H, Friesen HG. Studies of prolactin secretion in human 
pregnancy. Am J Obstet Gynecol 1972 May 1;113(1):14-20. 
 
(55) Hartmann PE, Trevethan P, Shelton JN. Progesterone and oestrogen and the 
initiation of lactation in ewes. J Endocrinol 1973 Nov;59(2):249-259. 
 
(56) Kuhn NJ. Progesterone withdrawal as the lactogenic trigger in the rat. J Endocr 1969 
Sep;44:39-54. 
 
(57) Turkington RW, Hill RL. Lactose synthetase: progesterone inhibition of the 
induction of alpha-lactalbumin. Science 1969 Mar 28;163(3874):1458-1460. 
 
(58) Neifert MR, McDonough SL, Neville MC. Failure of lactogenesis associated with 
placental retention. Am J Obstet Gynecol 1981 Jun 15;140(4):477-478. 
 
(59) Nguyen DA, Parlow AF, Neville MC. Hormonal regulation of tight junction closure 
in the mouse mammary epithelium during the transition from pregnancy to lactation. J 
Endocrinol 2001 Aug;170(2):347-356. 
 
(60) Neville MC, Allen JC, Archer PC, Casey CE, Seacat J, Keller RP, et al. Studies in 
human lactation: milk volume and nutrient composition during weaning and lactogenesis. 
Am J Clin Nutr 1991 Jul;54(1):81-92. 
 
(61) Saint L, Smith M, Hartmann PE. The yield and nutrient content of colostrum and 
milk of women from giving birth to 1 month post-partum. Br J Nutr 1984 Jul;52(1):87-
95. 
 
(62) Madden JD, Boyar RM, MacDonald PC, Porter JC. Analysis of secretory patterns of 
prolactin and gonadotropins during twenty-four hours in a lactating woman before and 
after resumption of menses. Am J Obstet Gynecol 1978 Oct 15;132(4):436-441. 
 
(63) Kenyon CAP. Hormone Levels During Pregnancy. Available at: 
http://www.flyfishingdevon.co.uk/salmon/year2/psy221maternal_behaviour/maternal_be
haviour.htm. Accessed 10/10, 2012. 
 
(64) Neville MC, Morton J. Physiology and endocrine changes underlying human 
lactogenesis II. J Nutr 2001 Nov;131(11):3005S-8S. 
 
(65) Kulski JK, Hartmann PE. Changes in human milk composition during the initiation 
of lactation. Aust J Exp Biol Med Sci 1981 Feb;59(1):101-114. 
 
(66) Neville MC, McFadden TB, Forsyth I. Hormonal regulation of mammary 
differentiation and milk secretion. J Mammary Gland Biol Neoplasia 2002 Jan;7(1):49-
66. 
 
	  360 	  
(67) Chao S. The effect of lactation on ovulation and fertility. Clin Perinatol 1987 
Mar;14(1):39-50. 
 
(68) Noel GL, Suh HK, Frantz AG. Prolactin release during nursing and breast 
stimulation in postpartum and nonpostpartum subjects. J Clin Endocrinol Metab 1974 
Mar;38(3):413-423. 
 
(69) Neville MC. Anatomy and physiology of lactation. Pediatr Clin North Am 2001 
Feb;48(1):13-34. 
 
(70) Battin DA, Marrs RP, Fleiss PM, Mishell DR,Jr. Effect of suckling on serum 
prolactin, luteinizing hormone, follicle-stimulating hormone, and estradiol during 
prolonged lactation. Obstet Gynecol 1985 Jun;65(6):785-788. 
 
(71) Cox DB, Owens RA, Hartmann PE. Blood and milk prolactin and the rate of milk 
synthesis in women. Exp Physiol 1996 Nov;81(6):1007-1020. 
 
(72) Tay CC, Glasier AF, McNeilly AS. Twenty-four hour patterns of prolactin secretion 
during lactation and the relationship to suckling and the resumption of fertility in breast-
feeding women. Hum Reprod 1996 May;11(5):950-955. 
 
(73) Groer MW. Differences between exclusive breastfeeders, formula-feeders, and 
controls: a study of stress, mood, and endocrine variables. Biol Res Nurs 2005 
Oct;7(2):106-117. 
 
(74) Baron JA, Bulbrook RD, Wang DY, Kwa HG. Cigarette smoking and prolactin in 
women. Br Med J (Clin Res Ed) 1986 Aug 23;293(6545):482-483. 
 
(75) Stallings JF, Worthman CM, Panter-Brick C, Coates RJ. Prolactin response to 
suckling and maintenance of postpartum amenorrhea among intensively breastfeeding 
Nepali women. Endocr Res 1996 Feb;22(1):1-28. 
 
(76) Ostrom KM. A review of the hormone prolactin during lactation. Prog Food Nutr Sci 
1990;14(1):1-43. 
 
(77) Zuppa AA, Tornesello A, Papacci P, Tortorolo G, Segni G, Lafuenti G, et al. 
Relationship between maternal parity, basal prolactin levels and neonatal breast milk 
intake. Biol Neonate 1988;53(3):144-147. 
 
(78) Hill PD, Chatterton RT,Jr, Aldag JC. Serum prolactin in breastfeeding: state of the 
science. Biol Res Nurs 1999 Jul;1(1):65-75. 
 
(79) Ueda T, Yokoyama Y, Irahara M, Aono T. Influence of psychological stress on 
suckling-induced pulsatile oxytocin release. Obstet Gynecol 1994 Aug;84(2):259-262. 
 
	  361 	  
(80) Djiane J, Durand P. Prolactin-progesterone antagonism in self regulation of prolactin 
receptors in the mammary gland. Nature 1977 Apr 14;266(5603):641-643. 
 
(81) Tucker HA. Hormones, mammary growth, and lactation: a 41-year perspective. J 
Dairy Sci 2000 Apr;83(4):874-884. 
 
(82) Nguyen DA, Neville MC. Tight junction regulation in the mammary gland. J 
Mammary Gland Biol Neoplasia 1998 Jul;3(3):233-246. 
 
(83) Berg MN, Dharmarajan AM, Waddell BJ. Glucocorticoids and progesterone prevent 
apoptosis in the lactating rat mammary gland. Endocrinology 2002 Jan;143(1):222-227. 
 
(84) Feng Z, Marti A, Jehn B, Altermatt HJ, Chicaiza G, Jaggi R. Glucocorticoid and 
progesterone inhibit involution and programmed cell death in the mouse mammary gland. 
J Cell Biol 1995 Nov;131(4):1095-1103. 
 
(85) Rosen JM, Wyszomierski SL, Hadsell D. Regulation of milk protein gene 
expression. Annu Rev Nutr 1999;19:407-436. 
 
(86) Stocklin E, Wissler M, Gouilleux F, Groner B. Functional interactions between Stat5 
and the glucocorticoid receptor. Nature 1996 Oct 24;383(6602):726-728. 
 
(87) Stoecklin E, Wissler M, Moriggl R, Groner B. Specific DNA binding of Stat5, but 
not of glucocorticoid receptor, is required for their functional cooperation in the 
regulation of gene transcription. Mol Cell Biol 1997 Nov;17(11):6708-6716. 
 
(88) Collier RJ, Tucker HA. Regulation of cortisol uptake in mammary tissue of cows. J 
Dairy Sci 1978 Dec;61(12):1709-1714. 
 
(89) Maki M, Hirose M, Chiba H. Occurrence of common binding sites for progestin and 
glucocorticoid in the lactating mammary gland of the rat. J Biochem 1980 
Dec;88(6):1845-1854. 
 
(90) Mesiano S. Roles of estrogen and progesterone in human parturition. Front Horm 
Res 2001;27:86-104. 
 
(91) Booker DE, Pahl IR, Forbes DA. Control of postpartum breast engorgement with 
oral contraceptives. II. Am J Obstet Gynecol 1970 Sep 15;108(2):240-242. 
 
(92) Gambrell RD,Jr. Immediate postpartum oral contraception. Obstet Gynecol 1970 
Jul;36(1):101-106. 
 
(93) Tankeyoon M, Dusitsin N, Chalapati S, Koetsawang S, Saibiang S, Sas M, et al. 
Effects of hormonal contraceptives on milk volume and infant growth. WHO Special 
Programme of Research, Development and Research Training in Human Reproduction 
Task force on oral contraceptives. Contraception 1984 Dec;30(6):505-522. 
	  362 	  
 
(94) Treffers PE. Breastfeeding and contraception. Ned Tijdschr Geneeskd 1999 Sep 
18;143(38):1900-1904. 
 
(95) Booker DE, Pahl IR. Control of postpartum breast engorgement with oral 
contraceptives. Am J Obstet Gynecol 1967 Aug 15;98(8):1099-1101. 
 
(96) Raymond V, Beaulieu M, Labrie F, Boissier J. Potent antidopaminergic activity of 
estradiol at the pituitary level on prolactin release. Science 1978 Jun 9;200(4346):1173-
1175. 
 
(97) Ek CJ, Dziegielewska KM, Habgood MD, Saunders NR. Barriers in the developing 
brain and Neurotoxicology. Neurotoxicology 2012 Jun;33(3):586-604. 
 
(98) World Health Organization. Medical eligibility criteria for contraceptive use. 2009. 
 
(99) Centers for Disease Control and Prevention (CDC). U S. Medical Eligibility Criteria 
for Contraceptive Use, 2010. MMWR Recomm Rep 2010 Jun 18;59(RR-4):1-86. 
 
(100) Curtis KM, Jamieson DJ, Peterson HB, Marchbanks PA. Adaptation of the World 
Health Organization's medical eligibility criteria for contraceptive use for use in the 
United States. Contraception 2010 Jul;82(1):3-9. 
 
(101) Jacobson JC, Aikins Murphy P. United States medical eligibility criteria for 
contraceptive use 2010: a review of changes. J Midwifery Womens Health 2011 Nov-
Dec;56(6):598-607. 
 
(102) Division of Reproductive Health, National Center for Chronic Disease Prevention 
and Health Promotion. U.s. Selected practice recommendations for contraceptive use, 
2013: adapted from the world health organization selected practice recommendations for 
contraceptive use, 2nd edition. MMWR Recomm Rep 2013 Jun 21;62(RR-05):1-60. 
 
(103) Lawrence RA. Challenges to successful breastfeeding. Breastfeed Med 2012 
Feb;7(1):1-2. 
 
(104) Kapp N, Curtis KM. Combined oral contraceptive use among breastfeeding 
women: a systematic review. Contraception 2010 Jul;82(1):10-16. 
 
(105) Kapp N, Curtis K, Nanda K. Progestogen-only contraceptive use among 
breastfeeding women: a systematic review. Contraception 2010 Jul;82(1):17-37. 
 
(106) Nath A, Sitruk-Ware R. Progesterone vaginal ring for contraceptive use during 
lactation. Contraception 2010 Nov;82(5):428-434. 
 
(107) Brownell EA, Fernandez ID, Howard CR, Fisher SG, Ternullo SR, Buckley RJ, et 
al. A systematic review of early postpartum medroxyprogesterone receipt and early 
	  363 	  
breastfeeding cessation: evaluating the methodological rigor of the evidence. Breastfeed 
Med 2012 Feb;7(1):10-18. 
 
(108) Erwin PC. To use or not use combined hormonal oral contraceptives during 
lactation. Fam Plann Perspect 1994 Jan-Feb;26(1):26-30, 33. 
 
(109) Croxatto HB, Diaz S, Peralta O, Juez G, Herreros C, Casado ME, et al. Fertility 
regulation in nursing women: IV. Long-term influence of a low-dose combined oral 
contraceptive initiated at day 30 postpartum upon lactation and infant growth. 
Contraception 1983 Jan;27(1):13-25. 
 
(110) Diaz S, Peralta O, Juez G, Herreros C, Casado ME, Salvatierra AM, et al. Fertility 
regulation in nursing women: III. Short-term influence of a low-dose combined oral 
contraceptive upon lactation and infant growth. Contraception 1983 Jan;27(1):1-11. 
 
(111) WHO. Effects of hormonal contraceptives on breast milk composition and infant 
growth. World Health Organization (WHO) Task Force on Oral Contraceptives. Stud 
Fam Plann 1988 Nov-Dec;19(6 Pt 1):361-369. 
 
(112) Nilsson S, Mellbin T, Hofvander Y, Sundelin C, Valentin J, Nygren KG. Long-
term follow-up of children breast-fed by mothers using oral contraceptives. 
Contraception 1986 Nov;34(5):443-457. 
 
(113) Peralta O, Diaz S, Juez G, Herreros C, Casado ME, Salvatierra AM, et al. Fertility 
regulation in nursing women: V. Long-term influence of a low-dose combined oral 
contraceptive initiated at day 90 postpartum upon lactation and infant growth. 
Contraception 1983 Jan;27(1):27-38. 
 
(114) Diaz S, Zepeda A, Maturana X, Reyes MV, Miranda P, Casado ME, et al. Fertility 
regulation in nursing women. IX. Contraceptive performance, duration of lactation, infant 
growth, and bleeding patterns during use of progesterone vaginal rings, progestin-only 
pills, Norplant implants, and Copper T 380-A intrauterine devices. Contraception 1997 
Oct;56(4):223-232. 
 
(115) Massai R, Miranda P, Valdes P, Lavin P, Zepeda A, Casado ME, et al. 
Preregistration study on the safety and contraceptive efficacy of a progesterone-releasing 
vaginal ring in Chilean nursing women. Contraception 1999 Jul;60(1):9-14. 
 
(116) Massai R, Quinteros E, Reyes MV, Caviedes R, Zepeda A, Montero JC, et al. 
Extended use of a progesterone-releasing vaginal ring in nursing women: a phase II 
clinical trial. Contraception 2005 Nov;72(5):352-357. 
 
(117) Shaaban MM. Contraception with progestogens and progesterone during lactation. 
J Steroid Biochem Mol Biol 1991;40(4-6):705-710. 
 
	  364 	  
(118) Sivin I, Diaz S, Croxatto HB, Miranda P, Shaaban M, Sayed EH, et al. 
Contraceptives for lactating women: a comparative trial of a progesterone-releasing 
vaginal ring and the copper T 380A IUD. Contraception 1997 Apr;55(4):225-232. 
 
(119) WHO. Combined hormonal contraceptive use during the postpartum period. 2010. 
 
(120) Shaamash AH, Sayed GH, Hussien MM, Shaaban MM. A comparative study of the 
levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A 
intrauterine device during lactation: breast-feeding performance, infant growth and infant 
development. Contraception 2005 Nov;72(5):346-351. 
 
(121) Khella AK, Fahim HI, Issa AH, Sokal DC, Gadalla MA. Lactational amenorrhea as 
a method of family planning in Egypt. Contraception 2004 Apr;69(4):317-322. 
 
(122) Heikkila M, Luukkainen T. Duration of breast-feeding and development of children 
after insertion of a levonorgestrel-releasing intrauterine contraceptive device. 
Contraception 1982 Mar;25(3):279-292. 
 
(123) Seth U, Yadava HS, Agarwal N, Laumas KR, Hingorani V. Effect of a subdermal 
silastic implant containing norethindrone acetate on human lactation. Contraception 1977 
Oct;16(4):383-398. 
 
(124) Brito MB, Ferriani RA, Quintana SM, Yazlle ME, Silva de Sa MF, Vieira CS. 
Safety of the etonogestrel-releasing implant during the immediate postpartum period: a 
pilot study. Contraception 2009 Dec;80(6):519-526. 
 
(125) Gurtcheff SE, Turok DK, Stoddard G, Murphy PA, Gibson M, Jones KP. 
Lactogenesis after early postpartum use of the contraceptive implant: a randomized 
controlled trial. Obstet Gynecol 2011 May;117(5):1114-1121. 
 
(126) Abdulla KA, Elwan SI, Salem HS, Shaaban MM. Effect of early postpartum use of 
the contraceptive implants, NORPLANT, on the serum levels of immunoglobulins of the 
mothers and their breastfed infants. Contraception 1985 Sep;32(3):261-266. 
 
(127) Abdel-Aleem H, Abol-Oyoun el-S M, Shaaban MM, el-Saeed M, Shoukry M, 
Makhlouf A, et al. The use of nomegestrol acetate subdermal contraceptive implant, 
uniplant, during lactation. Contraception 1996 Nov;54(5):281-286. 
 
(128) Croxatto HB, Diaz S, Peralta O, Juez G, Casado ME, Salvatierra AM, et al. 
Fertility regulation in nursing women. II. Comparative performance of progesterone 
implants versus placebo and copper T. Am J Obstet Gynecol 1982 Sep 15;144(2):201-
208. 
 
(129) Diaz S, Peralta O, Juez G, Herreros C, Casado ME, Salvatierra AM, et al. Fertility 
regulation in nursing women. VI. Contraceptive effectiveness of a subdermal 
progesterone implant. Contraception 1984 Oct;30(4):311-325. 
	  365 	  
 
(130) Diaz S, Herreros C, Juez G, Casado ME, Salvatierra AM, Miranda P, et al. Fertility 
regulation in nursing women: VII. Influence of NORPLANT levonorgestrel implants 
upon lactation and infant growth. Contraception 1985 Jul;32(1):53-74. 
 
(131) Massai MR, Diaz S, Quinteros E, Reyes MV, Herreros C, Zepeda A, et al. 
Contraceptive efficacy and clinical performance of Nestorone implants in postpartum 
women. Contraception 2001 Dec;64(6):369-376. 
 
(132) Taneepanichskul S, Reinprayoon D, Thaithumyanon P, Praisuwanna P, 
Tosukhowong P, Dieben T. Effects of the etonogestrel-releasing implant Implanon and a 
nonmedicated intrauterine device on the growth of breast-fed infants. Contraception 2006 
Apr;73(4):368-371. 
 
(133) Reinprayoon D, Taneepanichskul S, Bunyavejchevin S, Thaithumyanon P, 
Punnahitananda S, Tosukhowong P, et al. Effects of the etonogestrel-releasing 
contraceptive implant (Implanon on parameters of breastfeeding compared to those of an 
intrauterine device. Contraception 2000 Nov;62(5):239-246. 
 
(134) Schiappacasse V, Diaz S, Zepeda A, Alvarado R, Herreros C. Health and growth of 
infants breastfed by Norplant contraceptive implants users: a six-year follow-up study. 
Contraception 2002 Jul;66(1):57-65. 
 
(135) Shaaban MM, Salem HT, Abdullah KA. Influence of levonorgestrel contraceptive 
implants, NORPLANT, initiated early postpartum upon lactation and infant growth. 
Contraception 1985 Dec;32(6):623-635. 
 
(136) Shikary ZK, Betrabet SS, Toddywala WS, Patel DM, Datey S, Saxena BN. 
Pharmacodynamic effects of levonorgestrel (LNG) administered either orally or 
subdermally to early postpartum lactating mothers on the urinary levels of follicle 
stimulating hormone (FSH), luteinizing hormone (LH) and testosterone (T) in their 
breast-fed male infants. Contraception 1986 Oct;34(4):403-412. 
 
(137) WHO. Progestogen-only contraceptives during lactation: II. Infant development. 
World Health Organization, Task Force for Epidemiological Research on Reproductive 
Health; Special Programme of Research, Development, and Research Training in Human 
Reproduction. Contraception 1994 Jul;50(1):55-68. 
 
(138) WHO. Progestogen-only contraceptives during lactation: I. Infant growth. World 
Health Organization Task force for Epidemiological Research on Reproductive Health; 
Special Programme of Research, Development and Research Training in Human 
Reproduction. Contraception 1994 Jul;50(1):35-53. 
 
(139) Affandi B, Karmadibrata S, Prihartono J, Lubis F, Samil RS. Effect of Norplant on 
mothers and infants in the postpartum period. Adv Contracept 1986 Dec;2(4):371-380. 
 
	  366 	  
(140) Coutinho EM, Athayde C, Dantas C, Hirsch C, Barbosa I. Use of a single implant 
of elcometrine (ST-1435), a nonorally active progestin, as a long acting contraceptive for 
postpartum nursing women. Contraception 1999 Feb;59(2):115-122. 
 
(141) Hannon PR, Duggan AK, Serwint JR, Vogelhut JW, Witter F, DeAngelis C. The 
influence of medroxyprogesterone on the duration of breast-feeding in mothers in an 
urban community. Arch Pediatr Adolesc Med 1997 May;151(5):490-496. 
 
(142) Halderman LD, Nelson AL. Impact of early postpartum administration of 
progestin-only hormonal contraceptives compared with nonhormonal contraceptives on 
short-term breast-feeding patterns. Am J Obstet Gynecol 2002 Jun;186(6):1250-6; 
discussion 1256-8. 
 
(143) Lawrie TA, Hofmeyr GJ, De Jager M, Berk M, Paiker J, Viljoen E. A double-blind 
randomised placebo controlled trial of postnatal norethisterone enanthate: the effect on 
postnatal depression and serum hormones. Br J Obstet Gynaecol 1998 Oct;105(10):1082-
1090. 
 
(144) Guiloff E, Ibarra-Polo A, Zanartu J, Toscanini C, Mischler TW, Gomez-Rogers C. 
Effect of contraception on lactation. Am J Obstet Gynecol 1974 Jan 1;118(1):42-45. 
 
(145) Karim M, Ammar R, el-Mahgoub S, el-Ganzoury B, Fikri F, Abdou I. Injected 
progestogen and lactation. Br Med J 1971 Jan 23;1(5742):200-203. 
 
(146) Jimenez J, Ochoa M, Soler MP, Portales P. Long-term follow-up of children breast-
fed by mothers receiving depot-medroxyprogesterone acetate. Contraception 1984 
Dec;30(6):523-533. 
 
(147) Zacharias S, Aguilera E, Assenzo JR, Zanartu J. Effects of hormonal and 
nonhormonal contraceptives on lactation and incidence of pregnancy. Contraception 1986 
Mar;33(3):203-213. 
 
(148) Baheiraei A, Ardsetani N, Ghazizadeh S. Effects of progestogen-only 
contraceptives on breast-feeding and infant growth. Int J Gynaecol Obstet 2001 
Aug;74(2):203-205. 
 
(149) McEwan JA, Joyce DN, Tothill AU, Hawkins DF. Early experience in 
contraception with a new progestogen. Contraception 1977 Oct;16(4):339-350. 
 
(150) Zanartu J, Aguilera E, Munoz-Pinto G. Maintenance of lactation by means of 
continuous low-dose progestogen given post-partum as a contraceptive. Contraception 
1976 Mar;13(3):313-318. 
 
(151) Kamal I, Hefnawi F, Ghoneim M, Abdallah M, Abdel Razek S. Clinical, 
biochemical, and experimental studies on lactation. V. Clinical effects of steroids on the 
initiation of lactation. Am J Obstet Gynecol 1970 Oct 15;108(4):655-658. 
	  367 	  
 
(152) McCann MF, Moggia AV, Higgins JE, Potts M, Becker C. The effects of a 
progestin-only oral contraceptive (levonorgestrel 0.03 mg) on breast-feeding. 
Contraception 1989 Dec;40(6):635-648. 
 
(153) Giner Velazquez J, Cortes Gallegos V, Sotelo Lopez A, Bondani G. Effect of daily 
oral administration of 0.350 mg of norethindrone on lactation and on the composition of 
milk. Ginecol Obstet Mex 1976 Jul;40(237):31-39. 
 
(154) West CP. The acceptability of a progestagen-only contraceptive during breast-
feeding. Contraception 1983 Jun;27(6):563-569. 
 
(155) Bjarnadottir RI, Gottfredsdottir H, Sigurdardottir K, Geirsson RT, Dieben TO. 
Comparative study of the effects of a progestogen-only pill containing desogestrel and an 
intrauterine contraceptive device in lactating women. BJOG 2001 Nov;108(11):1174-
1180. 
 
(156) Pippins JR, Brawarsky P, Jackson RA, Fuentes-Afflick E, Haas JS. Association of 
breastfeeding with maternal depressive symptoms. J Womens Health (Larchmt) 2006 Jul-
Aug;15(6):754-762. 
 
(157) McDonald SD, Pullenayegum E, Chapman B, Vera C, Giglia L, Fusch C, et al. 
Prevalence and predictors of exclusive breastfeeding at hospital discharge. Obstet 
Gynecol 2012 Jun;119(6):1171-1179. 
 
(158) Geraghty S, Davidson B, Tabangin M, Morrow A. Predictors of breastmilk 
expression by 1 month postpartum and influence on breastmilk feeding duration. 
Breastfeed Med 2012 Apr;7(2):112-117. 
 
(159) Bogen DL, Hanusa BH, Moses-Kolko E, Wisner KL. Are maternal depression or 
symptom severity associated with breastfeeding intention or outcomes? J Clin Psychiatry 
2010 Aug;71(8):1069-1078. 
 
(160) Singh GK, Kogan MD, Dee DL. Nativity/immigrant status, race/ethnicity, and 
socioeconomic determinants of breastfeeding initiation and duration in the United States, 
2003. Pediatrics 2007 Feb;119 Suppl 1:S38-46. 
 
(161) Flower KB, Willoughby M, Cadigan RJ, Perrin EM, Randolph G, Family Life 
Project Investigative Team. Understanding breastfeeding initiation and continuation in 
rural communities: a combined qualitative/quantitative approach. Matern Child Health J 
2008 May;12(3):402-414. 
 
(162) Kehler HL, Chaput KH, Tough SC. Risk factors for cessation of breastfeeding prior 
to six months postpartum among a community sample of women in Calgary, Alberta. 
Can J Public Health 2009 2009;100(5):376-380. 
 
	  368 	  
(163) Taveras EM, Capra AM, Braveman PA, Jensvold NG, Escobar GJ, Lieu TA. 
Clinician support and psychosocial risk factors associated with breastfeeding 
discontinuation. Pediatrics 2003 Jul;112(1 Pt 1):108-115. 
 
(164) Belanoff CM, McManus BM, Carle AC, McCormick MC, Subramanian SV. 
Racial/ethnic variation in breastfeeding across the US: a multilevel analysis from the 
National Survey of Children's Health, 2007. Matern Child Health J 2012 Apr;16 Suppl 
1:S14-26. 
 
(165) Liu J, Smith MG, Dobre MA, Ferguson JE. Maternal obesity and breast-feeding 
practices among white and black women. Obesity (Silver Spring) 2010 Jan;18(1):175-
182. 
 
(166) Gill SL. Breastfeeding by Hispanic women. Journal of obstetric, gynecologic, and 
neonatal nursing : JOGNN / NAACOG JID - 8503123 0707. 
 
(167) Soni S, Gupta A, Jacobs AJ. Exclusive breastfeeding rates in a multiethnic 
population at a community hospital. J Reprod Med 2011 May-Jun;56(5-6):195-198. 
 
(168) Centers for Disease Control and Prevention. Breastfeeding among U.S. children 
born 2000–2009, 
 CDC National Immunization Survey. August 1, 2012; Available at: 
http://www.cdc.gov/breastfeeding/data/NIS_data/2007/map_1.htm. Accessed 06/10, 
2013. 
 
(169) Chapman DJ, Perez-Escamilla R. Maternal perception of the onset of lactation is a 
valid, public health indicator of lactogenesis stage II. J Nutr 2000 Dec;130(12):2972-
2980. 
 
(170) Kitsantas P, Gaffney KF, Kornides ML. Prepregnancy body mass index, 
socioeconomic status, race/ethnicity and breastfeeding practices. J Perinat Med 2011 Nov 
2;40(1):77-83. 
 
(171) Hilson JA, Rasmussen KM, Kjolhede CL. High prepregnant body mass index is 
associated with poor lactation outcomes among white, rural women independent of 
psychosocial and demographic correlates. J Hum Lact 2004 Feb;20(1):18-29. 
 
(172) Li R, Ogden C, Ballew C, Gillespie C, Grummer-Strawn L. Prevalence of exclusive 
breastfeeding among US infants: the Third National Health and Nutrition Examination 
Survey (Phase II, 1991-1994). Am J Public Health 2002 Jul;92(7):1107-1110. 
 
(173) Li R, Jewell S, Grummer-Strawn L. Maternal obesity and breast-feeding practices. 
Am J Clin Nutr 2003 Apr;77(4):931-936. 
 
	  369 	  
(174) Kugyelka JG, Rasmussen KM, Frongillo EA. Maternal obesity is negatively 
associated with breastfeeding success among Hispanic but not Black women. J Nutr 2004 
Jul;134(7):1746-1753. 
 
(175) Hilson JA, Rasmussen KM, Kjolhede CL. Excessive weight gain during pregnancy 
is associated with earlier termination of breast-feeding among White women. J Nutr 2006 
Jan;136(1):140-146. 
 
(176) Entwistle F, Kendall S, Mead M. Breastfeeding support - the importance of self-
efficacy for low-income women. Matern Child Nutr 2010 Jul 1;6(3):228-242. 
 
(177) Dunn S, Davies B, McCleary L, Edwards N, Gaboury I. The relationship between 
vulnerability factors and breastfeeding outcome. J Obstet Gynecol Neonatal Nurs 2006 
Jan-Feb;35(1):87-97. 
 
(178) Wolfberg AJ, Michels KB, Shields W, O'Campo P, Bronner Y, Bienstock J. Dads 
as breastfeeding advocates: results from a randomized controlled trial of an educational 
intervention. Am J Obstet Gynecol 2004 Sep;191(3):708-712. 
 
(179) Shapiro-Mendoza C, Selwyn BJ, Smith DP, Sanderson M. Parental pregnancy 
intention and early childhood stunting: findings from Bolivia. Int J Epidemiol 2005 
Apr;34(2):387-396. 
 
(180) Marston C, Cleland J. Do unintended pregnancies carried to term lead to adverse 
outcomes for mother and child? An assessment in five developing countries. Popul Stud 
(Camb) 2003;57(1):77-93. 
 
(181) David HP. Born unwanted: mental health costs and consequences. Am J 
Orthopsychiatry 2011 Apr;81(2):184-192. 
 
(182) Taylor JS, Cabral HJ. Are women with an unintended pregnancy less likely to 
breastfeed? J Fam Pract 2002 May;51(5):431-436. 
 
(183) Chapman DJ, Morel K, Bermudez-Millan A, Young S, Damio G, Perez-Escamilla 
R. Breastfeeding education and support trial for overweight and obese women: a 
randomized trial. Pediatrics 2013 Jan;131(1):e162-70. 
 
(184) Bunik M, Shobe P, O'Connor ME, Beaty B, Langendoerfer S, Crane L, et al. Are 2 
weeks of daily breastfeeding support insufficient to overcome the influences of formula? 
Acad Pediatr 2010 Jan-Feb;10(1):21-28. 
 
(185) Kramer MS, Barr RG, Dagenais S, Yang H, Jones P, Ciofani L, et al. Pacifier use, 
early weaning, and cry/fuss behavior: a randomized controlled trial. JAMA 2001 Jul 
18;286(3):322-326. 
 
	  370 	  
(186) Chapman DJ, Damio G, Young S, Perez-Escamilla R. Effectiveness of 
breastfeeding peer counseling in a low-income, predominantly Latina population: a 
randomized controlled trial. Arch Pediatr Adolesc Med 2004 Sep;158(9):897-902. 
 
(187) Petrova A, Ayers C, Stechna S, Gerling JA, Mehta R. Effectiveness of exclusive 
breastfeeding promotion in low-income mothers: a randomized controlled study. 
Breastfeed Med 2009 Jun;4(2):63-69. 
 
(188) Wambach KA, Aaronson L, Breedlove G, Domian EW, Rojjanasrirat W, Yeh HW. 
A randomized controlled trial of breastfeeding support and education for adolescent 
mothers. West J Nurs Res 2011 Jun;33(4):486-505. 
 
(189) Pugh LC, Milligan RA, Frick KD, Spatz D, Bronner Y. Breastfeeding duration, 
costs, and benefits of a support program for low-income breastfeeding women. Birth 
2002 Jun;29(2):95-100. 
 
(190) Anderson AK, Damio G, Young S, Chapman DJ, Perez-Escamilla R. A 
randomized trial assessing the efficacy of peer counseling on exclusive breastfeeding in a 
predominantly Latina low-income community. Arch Pediatr Adolesc Med 2005 
Sep;159(9):836-841. 
 
(191) Bonuck KA, Trombley M, Freeman K, McKee D. Randomized, controlled trial of a 
prenatal and postnatal lactation consultant intervention on duration and intensity of 
breastfeeding up to 12 months. Pediatrics 2005 Dec;116(6):1413-1426. 
 
 
(192) Bonuck KA, Freeman K, Trombley M. Randomized controlled trial of a prenatal 
and postnatal lactation consultant intervention on infant health care use. Arch Pediatr 
Adolesc Med 2006 Sep;160(9):953-960. 
 
(193) Chaudron LH, Klein MH, Remington P, Palta M, Allen C, Essex MJ. Predictors, 
prodromes and incidence of postpartum depression. J Psychosom Obstet Gynaecol 2001 
Jun;22(2):103-112. 
 
(194) Groer MW, Morgan K. Immune, health and endocrine characteristics of depressed 
postpartum mothers. Psychoneuroendocrinology 2007 Feb;32(2):133-139. 
 
(195) McLearn KT, Minkovitz CS, Strobino DM, Marks E, Hou W. Maternal depressive 
symptoms at 2 to 4 months post partum and early parenting practices. Arch Pediatr 
Adolesc Med 2006 Mar;160(3):279-284. 
 
(196) Ramsay M, Gisel EG, McCusker J, Bellavance F, Platt R. Infant sucking ability, 
non-organic failure to thrive, maternal characteristics, and feeding practices: a 
prospective cohort study. Dev Med Child Neurol 2002 Jun;44(6):405-414. 
 
	  371 	  
(197) Dennis CL, McQueen K. Does maternal postpartum depressive symptomatology 
influence infant feeding outcomes? Acta Paediatr 2007 Apr;96(4):590-594. 
 
(198) Protecting, promoting and supporting breastfeeding: the special role of maternity 
services. A joint WHO/UNICEF statement. International journal of gynaecology and 
obstetrics: the official organ of the International Federation of Gynaecology and 
Obstetrics JID - 0210174 0713. 
 
(199) Kramer MS, Chalmers B, Hodnett ED, Sevkovskaya Z, Dzikovich I, Shapiro S, et 
al. Promotion of Breastfeeding Intervention Trial (PROBIT): a randomized trial in the 
Republic of Belarus. JAMA 2001 Jan 24-31;285(4):413-420. 
 
(200) Declercq E, Labbok MH, Sakala C, O'Hara M. Hospital practices and women's 
likelihood of fulfilling their intention to exclusively breastfeed. Am J Public Health 2009 
May;99(5):929-935. 
 
(201) DiGirolamo AM, Grummer-Strawn LM, Fein SB. Effect of maternity-care 
practices on breastfeeding. Pediatrics 2008 Oct;122 Suppl 2:S43-9. 
 
(202) Nickel NC, Labbok MH, Hudgens MG, Daniels JL. The extent that noncompliance 
with the ten steps to successful breastfeeding influences breastfeeding duration. J Hum 
Lact 2013 Feb;29(1):59-70. 
 
(203) Colaizy TT, Saftlas AF, Morriss FH,Jr. Maternal intention to breast-feed and 
breast-feeding outcomes in term and preterm infants: Pregnancy Risk Assessment 
Monitoring System (PRAMS), 2000-2003. Public Health Nutr 2012 Apr;15(4):702-710. 
 
(204) Taylor JS, Geller L, Risica PM, Kirtania U, Cabral HJ. Birth order and 
breastfeeding initiation: results of a national survey. Breastfeed Med 2008 Mar;3(1):20-
27. 
 
(205) Glanz K, Rimer BK, Lewis FM. Health Behavior and Health Education. Theory, 
Research and Practice. San Fransisco: Wiley & Sons; 2002. 
 
(206) Allison P. Survival Analysis Using SAS: A Practical Guide. Cary, NC: SAS 
Institute INc.; 1995. 
 
(207) Cole SR, Hernan MA. Adjusted survival curves with inverse probability weights. 
Comput Methods Programs Biomed 2004 Jul;75(1):45-49. 
 
(208) Robins JM, Hernan MA, Brumback B. Marginal structural models and causal 
inference in epidemiology. Epidemiology 2000 Sep;11(5):550-560. 
 
(209) Rosenbaum P.R. RDB. The central role of the propensity score in observational 
studies for causal effects. Biometrika 1983;70:41–55. 
 
	  372 	  
(210) North Carolina Breastfeeding Coalition. Ban the Bags. Available at: 
http://www.ncbfc.org/index.php?option=com_content&view=category&id=40&Itemid=8
3. Accessed June 24, 2013. 
 
(211) Osterman MJ, Martin JA, Mathews TJ, Hamilton BE. Expanded data from the new 
birth certificate, 2008. Natl Vital Stat Rep 2011 Jul 27;59(7):1-28. 
 
(212) Ford K, Labbok M. Who is breast-feeding? Implications of associated social and 
biomedical variables for research on the consequences of method of infant feeding. Am J 
Clin Nutr 1990 Sep;52(3):451-456. 
 
(213) Saadeh R, Akre J. Ten steps to successful breastfeeding: a summary of the rationale 
and scientific evidence. Birth 1996 Sep;23(3):154-160. 
 
(214) United Nations Population Division. Report of the International Conference on 
Population and Development. Available at: 
http://www.un.org/popin/icpd/conference/offeng/poa.html. Accessed June 27, 2013. 
 
(215) Office of the Surgeon General (US), Centers for Disease Control and Prevention 
(US), Office on Women's Health (US). 2011. 
 
(216) Labbok M, Taylor E, Parry K. Achieving Exclusive Breastfeeding in the US. 
Amarillo, Texas: Hale Press; 2013. 
 
(217) Spiegelman D, Hertzmark E. Easy SAS Calculations for Risk or Prevalence Ratios 
and Differences. Am J Epidemiol 2005 1 August;162(3):199-200. 
 
(218) Cole SR, Hernan MA. Constructing inverse probability weights for marginal 
structural models. Am J Epidemiol 2008 Sep 15;168(6):656-664. 
 
(219) Lee BK, Lessler J, Stuart EA. Weight trimming and propensity score weighting. 
PLoS One 2011 Mar 31;6(3):e18174. 
 
